VAERS Reports pfizer /EN6207

VAERS 2714050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 71,0
Geschlecht: M
Eingang: 15.11.2023
Impfdatum: 06.04.2021
Beginn: 03.02.2022
Tage bis Beginn: 303,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Adenocarcinoma of colon Atrial fibrillation COVID-19 COVID-19 pneumonia Death Dependence on respirator Endotracheal intubation Haematuria Haemodynamic instability Haemorrhage Hypoxia Lung infiltration Metastases to liver Metastases to spine Pneumonia Pneumothorax Radiation pneumonitis Sepsis

Symptomtext

Patient was admitted to hospital and was diagnosed with adenocarcinoma of colon with mets to liver and C spine. He required C5-T1 anterior fusion, C6, C7 corpectomy on 12/1 and he was sent to rehab. Re admitted 12/23-1/23 for radiation pneumonitis or pneumonia with COVID-19. He was discharged to rehab and re admitted to another hospital 2/3-2/7 for hematuria. He was discharged and re admitted 2/10 with worsening hypoxemia and bilateral infiltrates. He declined and was intubated 2/11. His course was complicated by ventilator dependency, sepsis, atrial fibrillation with RVR, COVID-19 pneumonia, right pneumothorax and ongoing blood loss requiring multiple transfusions. Patient underwent tracheostomy placement on 2/16. Palliative care met with family multiple times. Family understood mortality and poor prognosis, and decided to make patient DNR, but refused to withdraw care. They did not wish to escalate care. Patient became hemodynamically unstable on 3/3 and expired at 0116 hours.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2689707

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 83,0
Geschlecht: M
Eingang: 03.10.2023
Impfdatum: 17.03.2021
Beginn: 15.02.2022
Tage bis Beginn: 335,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy COVID-19 pneumonia Chest X-ray abnormal Dyspnoea

Symptomtext

Presented with SOB; CXR with Covid PNA; admitted for Covid-19 pneumonia and acute hypoxemic respiratory failure. He was treated with dexamethasone, oxygen support, and supportive care (Vit C, Vit D3, Lovenox, Zinc). He improved clinically with treatment and was discharged home on day 5 in stable condition without oxygen supplement.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2686435

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 74,0
Geschlecht: F
Eingang: 26.09.2023
Impfdatum: 17.03.2021
Beginn: 26.02.2022
Tage bis Beginn: 346,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Angiogram pulmonary abnormal Catheterisation cardiac abnormal Chest X-ray abnormal Chest discomfort Coronary angioplasty Coronary artery occlusion Cough Death Dyspnoea Hypotension Intestinal ischaemia Intracardiac thrombus Lung opacity Pericarditis Pleural effusion Revascularisation procedure Septic shock

Symptomtext

presented shortness of breath, chest discomfort, vomiting and cough.CTA of chest on admission was negative for PE but suggestive for pericarditis. Troponin was markedly elevated. She underwent left heart catheterization on 02/27/2022 that demonstrates 100% stenosis thrombotic occlusion, successful revascularization with balloon angioplasty and thrombectomy aspiration. Chest X ray on 02/27/2022 suggestive of large left sided pleural effusion with reticulonodular interstitial opacities. Patient general condition seemed to improve. However she worsened after that. She developed abdominal distension. Seen by General surgery. She seems to have chronic superior mesenteric artery occlusion. It was worsened by recent hypotension leading to mesenteric ischemia and septic shock. She was felt not to be a surgical candidate. Family wanted her to be DNR. She expired that night. Meds Tx: Vit C, maxipime, Vit b12, steroids, zinc;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2686427

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 88,0
Geschlecht: F
Eingang: 26.09.2023
Impfdatum: 16.03.2021
Beginn: 02.02.2022
Tage bis Beginn: 323,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray normal Death Dyspnoea Fibrin D dimer General physical health deterioration Mental status changes SARS-CoV-2 test positive Serum ferritin normal

Symptomtext

Presented with SOB, AMS; + covid; dx covid PNA; CXR: clear on admission; Labs: D-dimer 0.92; CRP: 8.34; Ferritin 148; pt was started on IV Decadron,2/3 pt with increasing oxygen needs: Oxygen and nebs. Pulmonary and ID consults were obtained. Pt was started on Remdesvir which was completed. Also received 1 dose Actemra; and started on IV Meropenem. Tx with Vit D3, Vit C, lovenox, zinc. With the above - pt did not improve and her Oxygen requirements increased and she required maximum Oxygen via Airvo . Pt did not improve and was not doing well. Palliative care eval was obtained and after discussion with pt's daughter - they did not want to continue aggressive treatment. Pt was started on comfort measures. Pt expired the same day 2/19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2684621

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 69,0
Geschlecht: F
Eingang: 21.09.2023
Impfdatum: 22.03.2023
Beginn: 16.08.2023
Tage bis Beginn: 147,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Cardiac failure chronic Cardiac telemetry abnormal Chest X-ray normal Extrasystoles Headache Hypoxia Laboratory test Left ventricular failure Procalcitonin Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient is a 71 y.o. female with past medical history of essential hypertension, OSA on CPAP and oxygen at bedtime, hypertension, chronic diastolic heart failure, and morbid obesity who presented to an outside hospital on 8/16/2023 with fevers and generalized weakness, was found to have hypoxia and COVID-19, and she was transferred to Hospital for further care. Assessment and Plan Acute hypoxic respiratory failure COVID-19 - Presented with: generalized weakness and headache - Symptom onset: 8/14/23 - Positive COVID-19: 8/16/23 at Med ED - Vaccination status: Received first to Pfizer shots but no boosters due to reaction to initial vaccination. - CXR on admission showed CXR on admission showed normal - Oxygen status: Room air during the day as of 8/19/2023 - Decadron: Yes. Expected end date 8/26/23 - Remdesivir: Yes. Expected end date 8/20/2023??stopped due to resolution of hypoxia - DVT prophylaxis:Lovenox - Serial COVID labs ordered: Yes - Case Management/Social Services consulted: Yes -Procalcitonin only 0.07 on 8/18/2023, hence low likelihood for bacterial infection. -Continue albuterol and Tessalon perles as needed for cough/congestion -As of 8/19/2023 weaned to room air during the daytime and back to baseline. -Discharged on 8/20/2023. Chronic heart failure with preserved ejection fraction -Mentioned in her history from OSU however per cardiology note from July 2022 there is "no evidence of heart failure/HFpEF". -Home medications include Coreg 3 mg twice daily, lisinopril 10 mg daily, and Lasix 40 mg daily. -Last echocardiogram 1/23/2023 demonstrated ejection fraction of 60% -Stable and home medications continued as before. Bigeminy/trigeminy -Intermittent on telemetry and she had this previously at OSU on 3/31/2023 per review of their rhythm strips. -Chronic and no further evaluation warranted as she was asymptomatic and this is not a new finding. Type 2 diabetes mellitus without complications -Patient is not on any medications for diabetes (Patient was on metformin in the past). -A1c was 5.9 in November 2022. -Continue ongoing outpatient monitoring as before. Essential hypertension -Home medications include Coreg 25 mg twice daily, hydralazine 25 mg 3 times daily, lisinopril 10 mg daily. -Stable and home medications continued as before. Major depression in remission -Patient continue with home Wellbutrin 450 mg daily OSA -Secondary to morbid obesity -She wears CPAP with 3.5 L of oxygen at bedtime at baseline. -Stable and no acute issues. History of chronic pain syndrome Peripheral neuropathy OA -Continue with gabapentin 600 mg TID Morbid obesity -History of gastric stapling in 1980 that was later reversed in 1981. -BMI 54.21 -Advised lifestyle changes -Patient has been getting Wegovy injections every week

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2674907

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 90,0
Geschlecht: M
Eingang: 22.08.2023
Impfdatum: 06.04.2021
Beginn: 29.01.2022
Tage bis Beginn: 298,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anticoagulant therapy Atrial fibrillation Bradycardia COVID-19 pneumonia Fall Hypoxia Lethargy SARS-CoV-2 test positive

Symptomtext

ground level fall, hypoxia, O2 at 10L oxymask ; + covid PN; acute resp failure; AFIB on eliquis; Zinc, Vit C. Pt experiencing some bradycardia. Made DNR on 2/2. O2 increased to 15 L NRB on 2/3. remdisiver held. Decadron. more lethargic, placed on comfort care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: AFIB, CHF
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2663871

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 83,0
Geschlecht: M
Eingang: 01.08.2023
Impfdatum: 19.03.2021
Beginn: 17.01.2022
Tage bis Beginn: 304,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia

Symptomtext

Admitted for acute hypoxic respiratory failure /Pneumonia due to COVID-19. Received all treatments including tocilizumab, Remdesivir, high-dose steroids. Did not improve despite efforts. Pt dc'd to hospice.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2653105

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 85,0
Geschlecht: M
Eingang: 06.07.2023
Impfdatum: 17.03.2021
Beginn: 08.01.2022
Tage bis Beginn: 297,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cough Death Dyspnoea Mechanical ventilation Oxygen saturation decreased Renal failure

Symptomtext

Presented to the ER with a chief complaint of progressively worsening shortness of breath that acutely worsened 4 days prior to admission as well a cough; pt required ventilator; poor diagnosis d/t worsening FiO2 and development of renal failure resulted in family electing for comfort measures and pt expired 1/19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2640547

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 73,0
Geschlecht: F
Eingang: 04.06.2023
Impfdatum: 28.09.2022
Beginn: 02.06.2023
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient expired 6/2/2023.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: Unknown
Vorgeschichte: HTN, DMII, tobacco use disorder, CAD, chronic systolic heart failure, COPD, metastatic lung cancer
Andere Medikamente: Unknown
Allergien: Azithromycin
Vorherige Impfungen: -

VAERS 2603964

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 27.03.2023
Impfdatum: 19.03.2021
Beginn: 08.02.2023
Tage bis Beginn: 691,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure Ammonia normal Anaemia of chronic disease Anticoagulant therapy Anxiety Aspiration pleural cavity Atelectasis Atrial fibrillation Blood creatinine increased Blood culture negative Blood folate normal Blood thyroid stimulating hormone normal Brain natriuretic peptide normal COVID-19 Cardiac failure Cardiac failure congestive Chest X-ray abnormal

Symptomtext

Patient is a 70 y.o. female patient with history of CAD, HFpEF, CKD, COPD, dementia, GERD, HTN, OSA, seizure and obesity who presented with dyspnea, found to have pleural effusions and COVID+ Goals of care Given rapid decompensation, multiple co-morbidities and changes in mental status, family elected for comfort care and compassionate extubation Pt. Passed away 2/24 @ 1519 Acute on Chronic Hypoxemic Respiratory Failure Bilateral pleural Effusions Multifactorial, including volume overload, COVID, anxiety, COPD Requiring 4L NC on admission Baseline O2 requirement: 2L CT w/large bilateral pleural effusions w/compressive atelectasis VIR consulted for thoracentesis - removed 1L 2/13, transudate Was on IV diuresis (held for AKI) CXR 2/19: Multifocal airspace opacities improved on right and stable on left Decompensated 2/20 requiring intubation Compassionate extubation 2/24 Leukocytosis WBC 9k (2/12) > 22k (9/23) No clear source was identified and had no change in steroids for COVID CXR with decreased pleural effusion and mild right basilar consolidation CXR 2/19 as above MRSA probe positive On Vanco/cefepime (2/19) Now WBC increased from 22k (2/22) > 45K (2/23) BCX (2/23) NGTD at the time of discharge, Sputum Cx pending ID followed Possible Cholecystitis Given rising WBC count, ordered CT C/A/P CT C/A/P with cholelithiasis with gallbladder hydrops concerning for possible acute Coley US abdomen with sludge in gallbladder with mild distention HIDA scan negative for acute cholecystitis Antibiotics changed from cefepime to Zosyn Surgery followed and does not think cholecystitis COVID-19 Symptom onset unclear in setting of CHF exacerbation Test positive 2/10 Mild GGO present on CT chest, may be largely pulm edema Given dexamethasone course and remdesivir 2/10 stopped remdesivir after 2/11 due to decreased CrCl Out of isolation 2/20 Acute on Chronic HFpEF Presented with volume overload and b/l pleural effusions Looks like diuretic not included on her discharge med list 2/6, cardiology had recommended torsemide 20mg BID and renal had recommended no diuretic until outpatient follow up Per CHF RN note, no issue with intended compliance but multiple barriers including no insurance, no transportation BNP 11k, baseline ~11-12k ECHO 8/2022: EF 67%, grade 2 diastolic dysfxn Given IV Lasix in ED, held briefly for rising Cr as above Strict in/outs, daily weights Net IO Since Admission: -10,326.87 mL [03/02/23 1532] AKI on CKD Stage IIIa Suspect pre-renal 2/2 diuresis vs secondary to CRS Recent admission w/AKI, Cr peak 2.07 Creatinine around 1.4 on admission, up to 2.0 with diuresis; hold lasix for now, resume diuretic when able Home ARB previously stopped Strict in/outs, monitor UOP Generalized Anxiety Disorder Symptomatic, uncontrolled Largely driving respiratory distress on admission As needed Atarax ordered BH consult: continue buspirone, mirtazapine, and duloxetine at home dosing Acute Metabolic Encephalopathy Multifactorial, including hypoxia, hypercarbia, polypharmacy, infection Fluctuating status since admission, presents as delirium No focal neuro deficits on exam UDS, UA, TSH, Ammonia, B12/Folate unrevealing Limit sedating medications as able Delirium precautions Was resolved prior to intubation Concern for not following commands while sedated CT Head STAT 2/22 w/o acute process. LTM EEG 2/23 with severe encephalopathy, generalized and L hemispheric sharp activity suggesting increased risk for seizure but no active seizure noted Neuro followed and ordered MRI brain and family refused as planned for compassionate extubation COPD, w/o acute exacerbation No wheeze, presentation primarily due to CHF + COVID Resume home controller therapy Aggressive pulmonary hygiene PRN Nebs T2DM, insulin dependent A1c 7.3 but anemic Home Lantus 25U at bedtime Titrating Lantus up to 30u BID Anemia of Chronic Disease Stable, w/o active bleeding Hgb 8-9, baseline 8-9 Iron studies 1/31 AoCD pattern Monitor, transfuse <7 Persistent atrial fibrillation Chronic, borderline tachycardic Continue home diltiazem Added metoprolol 25mg BID, rates trended down to <60 on this, stopped 2/14 Eliquis held for procedure, resumed thereafter OSA/OHS Chronic, controlled CPAP when weaned off of vent Sacral Decubitus Ulcer, POA Secondary to immobility Wound care consulted

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2603352

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 86,0
Geschlecht: F
Eingang: 24.03.2023
Impfdatum: 06.10.2021
Beginn: 22.11.2022
Tage bis Beginn: 412,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 32,0
Labordaten: Positive COVID test on 10/23/2022.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2601682

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 58,0
Geschlecht: M
Eingang: 22.03.2023
Impfdatum: 27.03.2021
Beginn: 05.04.2021
Tage bis Beginn: 9,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebrovascular accident Computerised tomogram Magnetic resonance imaging

Symptomtext

I had a stroke

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: MRI Cat scans
Aktuelle Erkrankungen: None
Vorgeschichte: Back pain
Andere Medikamente: Proscar 5mg
Allergien: None
Vorherige Impfungen: -

VAERS 2590275

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 88,0
Geschlecht: F
Eingang: 02.03.2023
Impfdatum: 11.04.2022
Beginn: 03.12.2022
Tage bis Beginn: 236,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia COVID-19 COVID-19 pneumonia Confusional state Cough Death Dysphagia Encephalopathy Pneumonia aspiration Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED by EMS on 12/3/22 for generalized weakness, persistent cough, and confusion. En route to the ED, patient's oxygen sats was 88% so was placed on oxygen. She tested positive for COVID by PCR in the ED, and was admitted on 12/3/22 for hypoxic respiratory failure due to COVID-19 pneumonia, dysphagia and possible aspiration pneumonia, among other problems. She initially required O2 and was on decadron, however was able to be weaned off oxygen. Her COVID pneumonia resolved during her admission. Patient has received the COVID primary vaccine series and two boosters. Of note, during admission patient continued to have persistent encephalopathy, dysphagia, and suspected LLL aspiration pneumonia. Ultimately she was transitioned to comfort focused care on 12/27, and expired in the hospital on 12/30/22. Cause of death documented in the chart is respiratory failure secondary to aspiration pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2579737

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 65,0
Geschlecht: F
Eingang: 10.02.2023
Impfdatum: 26.01.2022
Beginn: 03.11.2022
Tage bis Beginn: 281,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had a breakthrough infection and expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: Positive COVID test on 9/27/22 and 10/14/22.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2578828

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 63,0
Geschlecht: M
Eingang: 09.02.2023
Impfdatum: 19.10.2021
Beginn: 21.04.2022
Tage bis Beginn: 184,0
Dosis: 3
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 pneumonia Chest X-ray abnormal Hypoxia Lung opacity Pneumonia aspiration Sepsis

Symptomtext

4/21/2022-Transfer from SNF. Hypoxia since 8am. Placed on 6L NRB o2 sat 89%. T: 101, P-105 and RR-26. CXR-perihilar intersitial and patchy alveolar opacities. Admit sepsis with acute hypoxic respiratory failure Covid pneumonia. Start Decadron, remedesivir, Unasyn and Vanco. 4/23/2022-D/C vanco continue unasyn as pt improved more likely aspiration pneumonia. Afebrile. VSS. Now on 2l via NC 96% 02. 4/25/2022-Sepsis resolved. VSS. 4/27/2022- VSS, improved. D/C to SNF.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CVA, HTN and hyperlipidemia
Andere Medikamente: -
Allergien: None
Vorherige Impfungen: -

VAERS 1179718

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: -
Geschlecht: U
Eingang: 01.02.2023
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Chest X-ray Chest pain Computerised tomogram Electrocardiogram Pulmonary embolism Thrombosis Ultrasound scan

Symptomtext

pulmonary embolisms; blood clots; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP), Program ID. The reporter is the patient. A patient (no qualifiers provided) received BNT162b2 (BNT162B2 NOS), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PULMONARY EMBOLISM (medically significant), outcome "unknown", described as "pulmonary embolisms"; THROMBOSIS (medically significant), outcome "unknown", described as "blood clots". Clinical course: Patient reported that your covid vaccine almost killed myself, my son and my daughter. All 3 of us developed blood clots (pulmonary embolisms) in the same time frame after getting the vaccine. We have all suffered life changing effects and have ongoing medical issues. And no we're not old and fat and out of shape. In fact, if it hadn't been for being somewhat in shape none of us would have lived through it. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2567747

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 82,0
Geschlecht: M
Eingang: 25.01.2023
Impfdatum: 01.04.2022
Beginn: 15.11.2022
Tage bis Beginn: 228,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chills Cough Dyspnoea Hyperhidrosis Oxygen saturation increased Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient brought to the ED by EMS on 11/15 with cough, weakness, fever, chills, and sweats that started 6 days prior. Patient also reported he noticed his shortness of breath was getting worse. He tested positive for COVID-19 by PCR in the ED. Ultimately patient admitted on 11/15 with acute hypoxic respiratory failure likely due to COVID-19 pneumonia. Oxygen saturations were in high 80s and patient was placed on 1-2L oxygen nasal cannula. He was able to eventually be weaned off oxygen. Patient discharged 11/18/22. He has received the primary COVID vaccine series and two boosters.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2539033

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 81,0
Geschlecht: M
Eingang: 21.12.2022
Impfdatum: 12.03.2021
Beginn: 26.09.2022
Tage bis Beginn: 563,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute myocardial infarction Anticoagulant therapy COVID-19 Chest X-ray abnormal Electrocardiogram T wave abnormal Fall Haemoglobin decreased Hypoxia International normalised ratio increased Lung disorder Lymphocyte count decreased Pain in extremity Pyrexia SARS-CoV-2 test positive Tachycardia Tachypnoea Troponin X-ray of pelvis and hip normal

Symptomtext

This is a 83y.o. male with PMH of CAD s/p CABG (1982, redo in 1992), CHF, ICM s/p ICD, T2DM, HLD, hypothyroidism, BPH who presented as a transfer from emergency room for management of NSTEMI and COVID-19 infection. He also has BLE pain after a fall three days prior. Pelvis XR was unremarkable. He tested positive for COVID-19. Workup revealed NSTEMI with troponin of 2.20. Of note, EKG revealed nonspecific t wave abnormalities however no evidence of St elevations or reciprocals. He received heparin bolus and started on heparin gtt. He was found to be hypoxic on room air which improved to 95% on 2L O2 NC. Patient was transferred to hospital for further management. In the ED, patient noted to be tachycardic in 120s, febrile (Tmax 100.5F), tachypneic, hypoxic in 80s. SpO2 currently maintained on 6L O2 NC. CXR shows mild coarsening of pulmonary interstitium - acute vs chronic. Labs significant for hgb 10.9, lymphocytes 0.8, INR 1.3. troponin 2.20 -- > 4.19. COVID-19 PCR detected. Patient was started on drcadron and remdesevir for 5 days. Patient was weaned off oxygen and passed home oxygen eval. Cleared by endocrine and pulmonary and discharged in a stable condition. Patient lives wife who can assist at home. Resume home Dm regimen per endo and follow up as outpatient. rx sent to pharmacy. Discussed with nursing staff.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 5,0
Labordaten: 9/26 SARS-CoV-2 (COVID-19) by Nucleic Acid Amplification, POC
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2507234

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 84,0
Geschlecht: F
Eingang: 21.12.2022
Impfdatum: 24.02.2021
Beginn: 29.09.2022
Tage bis Beginn: 582,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Blood gases abnormal COVID-19 Chronic obstructive pulmonary disease Condition aggravated Hypercapnia Hypoxia Intensive care Lung consolidation Respiratory distress SARS-CoV-2 test positive Pleural effusion Respiratory failure

Symptomtext

85y.o. female presenting with acute on chronic hypoxic respiratory failure. She has history of COPD on home oxygen as well as nocturnal BiPAP. Upon presentation, ABG showed significant CO2 retention. She was begun on broad-spectrum antibiotics. She did require temporary transfer to MICU due to worsening hypoxia. Fortunately, patient did improve and did not require intubation. Further work-up included CTA PE protocol which did not show PE but did show partially loculated effusions as well as near complete consolidation of left lower lobe. Patient was seen by infectious disease as well as pulmonology. Eventually, her oxygenation improved back towards her previous baseline. She completed her courses of antibiotics inpatient. She was also treated with steroid burst due to COPD. She was mobilized with PT/OT and was determined appropriate for home with home care. Following this, she was stable for discharge and was discharged home to complete 1 additional day of her steroid burst. She will follow-up with primary care as well as pulmonology outpatient.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 9/29 SARS-CoV-2 -COVID-19 by NAA, Micro -- detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2528534

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

kritisch

Staat: -
Alter: 31,0
Geschlecht: F
Eingang: 11.12.2022
Impfdatum: 20.12.2021
Beginn: 05.12.2022
Tage bis Beginn: 350,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebral haemorrhage Coma Intraventricular haemorrhage Respiratory failure Subarachnoid haemorrhage

Symptomtext

Patient in coma, respiratory failure 2/2 intracerebral hemorrhage, intraventricular hemorrhage, and subarachnoid hemorrhage.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2526329

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 85,0
Geschlecht: F
Eingang: 08.12.2022
Impfdatum: 13.03.2021
Beginn: 01.02.2022
Tage bis Beginn: 325,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anxiety Condition aggravated Death Dizziness Pulmonary embolism

Symptomtext

dizziness, increased anxiety pulmonary embolism DEATH

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Clinic-Feb 2022 through June 2022
Aktuelle Erkrankungen: -
Vorgeschichte: remission Lymphoma Chronic Anxiety GI irritable bowl syndrome Hospitalized on Feb 2022 with blood clots in bilateral legs and pulmonary embolism, direct cause of MRNA injections x 3. Heart failure, blood clots Tried to convince patient not to take the shot, but she would not listen. Too many side effects known early 2021.
Andere Medikamente: Anti Diareal OTC OTC Tums OTC Nexium 1st Pfizer shot 3/13/21 Lot # EN6207, exp. 7/31/21 2nd Pfizer shot on 4/3/2021 - at 9:45 am #320308D, Lot # ER8733, exp. 7/31/2021 Pfizer Booster shot on 10/28/21-#320308D, no expiration date documented
Allergien: -
Vorherige Impfungen: -

VAERS 2024544

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NC
Alter: 82,0
Geschlecht: M
Eingang: 11.11.2022
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arterial tortuosity syndrome Arthralgia Arthropod bite Atrial fibrillation Blood pressure measurement Blood pressure systolic Blood test C-reactive protein Cardiac disorder Cardiomyopathy Carotid arteriosclerosis Cellulitis Cerebrovascular accident Chest X-ray Chest pain COVID-19 Drug ineffective SARS-CoV-2 test

Symptomtext

A-fib 6 times; tachycardia; heart problems; orthostatic hypotension in his right leg and was not pumping blood back to his heart/diagnosed with clots and orthostatic hypotension on his right leg (24 inch circumference); blood clot/diagnosed with clots/clots; legs; right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/right leg swollen to 24 inch in circumference; right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/leg had ruptured on 3 sides, blood and tissue fluid; right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/leg had ruptured on 3 sides, blood and tissue fluid; clots in his lungs; cardiomyopathy; can hardly move; dizzy all the time; can no longer drive/can't drive his car; RLE cellulitis; vertigo; shoulder and leg pain; shoulder and leg pain; skin eruptions; have not died but fear it will be shortly; chronic fatigue; difficulty standing; carotid duplex bilateral: minimal plaque; CT head w/o chest: chronic small renal ischemic disease; can barely walk/could not walk/difficulty with walking/cannot walk upstairs; blood pressure went to 300/297 and thought he was having a stroke or heart attack/elevated blood pressure reading; blood pressure went to 300/297 and thought he was having a stroke or heart attack; blood pressure went to 300/297 and thought he was having a stroke or heart attack; CXR: tortuosity of descending aorta; chest pains; vaccine has not been properly tested, believed they have been injected with poison; insect bite; pain all over/severe body pain; leg had ruptured on 3 sides, blood and tissue fluid/legs ruptured and bled along with clear tissue fluid; lesions; swollen legs that were red from haemoglobin; quality of life has been destroyed; This is a spontaneous report received from contactable reporter (consumer or other non HCP and Physician) from product quality group and medical information team. The reporter is the patient. An 82-year-old male patient received BNT162b2 (BNT162B2), on 31Mar2021 at 13:00 as dose 2, single (batch/lot number: ER8734) at the age of 82 years intramuscular, in right deltoid for covid-19 immunization. The patient's relevant medical history included: "hyperlipidemia", start date: 2007 (ongoing); "prediabetes", start date: 2014 (ongoing); "obesity" (unspecified if ongoing); "non smoker" (unspecified if ongoing); "polymyalgia rheumatica", start date: 2018 (ongoing), notes: based on symptoms elevated CRP and ESR; rheumatologist in 2021 was not sure about the diagnosis; rheumatologist in 2021 is not sure about the diagnosis; "hypertension", start date: 2007 (ongoing); "thrombocytopenia", start date: 2013 (ongoing). The patient's family history included: "diabetes" (unspecified if ongoing); "heart failure" (unspecified if ongoing); "heart disease" (unspecified if ongoing). Concomitant medications included: TRAMADOL; PREDNISONE oral taken for polymyalgia rheumatica, start date: 2018 (ongoing); 60 ml amour thyroid, date started in 2000 and still taking. Vaccination history included: BNT162b2 (dose 1, batch/lot number EN6207), administration date: 10Mar2021, when the patient was 82-year-old, for COVID-19 Immunization, reaction(s): "skin lesion", "redness", "skin eruption", "leg pain", "shoulder pain", "general body pain", "difficulty in standing", "chronic fatigue", "driving ability disturbed", "vertigo", "impaired quality of life", "difficulty in walking", "dizzy", "cardiomyopathy". The following information was reported: POOR QUALITY PRODUCT ADMINISTERED (non-serious) with onset 31Mar2021, outcome "unknown", described as "vaccine has not been properly tested, believed they have been injected with poison"; ATRIAL FIBRILLATION (hospitalization) with onset 2021, 5 months after the suspect product(s) administration, outcome "not recovered", described as "A-fib 6 times"; THROMBOSIS (hospitalization) with onset 2021, outcome "unknown", described as "blood clot/diagnosed with clots/clots; legs"; CARDIAC DISORDER (hospitalization) with onset 2021, 5 months after the suspect product(s) administration, outcome "unknown", described as "heart problems"; ARTHROPOD BITE (non-serious) with onset 2021, outcome "unknown", described as "insect bite"; WOUND SECRETION (non-serious) with onset 2021, outcome "unknown", described as "leg had ruptured on 3 sides, blood and tissue fluid/legs ruptured and bled along with clear tissue fluid"; SKIN LESION (non-serious) with onset 2021, outcome "not recovered", described as "lesions"; ORTHOSTATIC HYPOTENSION (hospitalization) with onset 2021, outcome "unknown", described as "orthostatic hypotension in his right leg and was not pumping blood back to his heart/diagnosed with clots and orthostatic hypotension on his right leg (24 inch circumference)"; PAIN (non-serious) with onset 2021, outcome "recovered" (2021), described as "pain all over/severe body pain"; IMPAIRED QUALITY OF LIFE (non-serious) with onset 2021, outcome "unknown", described as "quality of life has been destroyed"; MUSCLE RUPTURE (hospitalization), HAEMORRHAGE (hospitalization) all with onset 2021, outcome "not recovered" and all described as "right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/leg had ruptured on 3 sides, blood and tissue fluid"; PERIPHERAL SWELLING (hospitalization) with onset 2021, outcome "not recovered", described as "right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/right leg swollen to 24 inch in circumference"; ERYTHEMA (non-serious) with onset 2021, outcome "not recovered", described as "swollen legs that were red from haemoglobin"; TACHYCARDIA (hospitalization) with onset 2021, 5 months after the suspect product(s) administration, outcome "not recovered"; CHEST PAIN (medically significant) with onset Sep2021, outcome "not recovered", described as "chest pains"; ARTERIAL TORTUOSITY SYNDROME (non-serious) with onset 26Sep2021, outcome "unknown", described as "CXR: tortuosity of descending aorta"; CEREBROVASCULAR ACCIDENT (medically significant), MYOCARDIAL INFARCTION (medically significant) all with onset 26Sep2021, outcome "recovering" and all described as "blood pressure went to 300/297 and thought he was having a stroke or heart attack"; HYPERTENSION (medically significant) with onset 26Sep2021, outcome "recovering", described as "blood pressure went to 300/297 and thought he was having a stroke or heart attack/elevated blood pressure reading"; GAIT DISTURBANCE (non-serious) with onset 26Sep2021, outcome "unknown", described as "can barely walk/could not walk/difficulty with walking/cannot walk upstairs"; RENAL ISCHAEMIA (medically significant) with onset 29Sep2021, outcome "unknown", described as "CT head w/o chest: chronic small renal ischemic disease"; CAROTID ARTERIOSCLEROSIS (medically significant) with onset 19Jan2022, outcome "unknown", described as "carotid duplex bilateral: minimal plaque"; CELLULITIS (medically significant), outcome "unknown", described as "RLE cellulitis"; PULMONARY THROMBOSIS (medically significant), outcome "unknown", described as "clots in his lungs"; CARDIOMYOPATHY (medically significant), outcome "unknown"; MOBILITY DECREASED (non-serious), outcome "unknown", described as "can hardly move"; DIZZINESS (non-serious), outcome "not recovered", described as "dizzy all the time"; IMPAIRED DRIVING ABILITY (non-serious), outcome "unknown", described as "can no longer drive/can't drive his car "; VERTIGO (non-serious), outcome "unknown"; FEAR OF DEATH (non-serious), outcome "unknown", described as "have not died but fear it will be shortly"; ARTHRALGIA (non-serious), PAIN IN EXTREMITY (non-serious), outcome "unknown" and all described as "shoulder and leg pain"; RASH (non-serious), outcome "unknown", described as "skin eruptions"; FATIGUE (non-serious), outcome "not recovered", described as "chronic fatigue"; DYSSTASIA (non-serious), outcome "unknown", described as "difficulty standing". The patient was hospitalized for orthostatic hypotension, thrombosis, peripheral swelling, muscle rupture, haemorrhage (hospitalization duration: 3 days). The events "chest pains" and "cardiomyopathy" required physician office visit. The events "heart problems", "clots in his lungs", "carotid duplex bilateral: minimal plaque", "can barely walk/could not walk/difficulty with walking/cannot walk upstairs", "pain all over/severe body pain", "have not died but fear it will be shortly", "insect bite", "leg had ruptured on 3 sides, blood and tissue fluid/legs ruptured and bled along with clear tissue fluid" and "cxr: tortuosity of descending aorta" required emergency room visit. The events "blood pressure went to 300/297 and thought he was having a stroke or heart attack/elevated blood pressure reading", "blood pressure went to 300/297 and thought he was having a stroke or heart attack", "orthostatic hypotension in his right leg and was not pumping blood back to his heart/diagnosed with clots and orthostatic hypotension on his right leg (24 inch circumference)", "blood clot/diagnosed with clots/clots; legs", "right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/right leg swollen to 24 inch in circumference", "right leg, the calf muscle swelled to 24 inches wide, it ruptured, and was bleeding from three sides of his leg/leg had ruptured on 3 sides, blood and tissue fluid", "a-fib 6 times" and "tachycardia" required physician office visit and emergency room visit. The patient underwent the following laboratory tests and procedures: blood pressure: (unspecified date) 150/85; (26Sep2021) 300/297, notes: elevated; systolic BP: (2021) 210; (2021) 170, notes: conc down from 210; blood work: (unspecified date) unknown results, notes: multiple blood work; CXR: (26Sep2021) no acute disease, notes: tortuosity of descending aorta; CRP: (2018) elevated; EKG/ECG: (unspecified date) unknown results, notes: multiple; (unspecified date) heart was perfect; CMP/CBC: (unspecified date) unknown results, notes: baseline; (29Sep2021) CMP WNL, CBC uncharged from baseline; (29Jul2022) unknown results; ESR: (2018) elevated; brain scan/CT head w/o chest: (unspecified date) healthy brain; (29Sep2021) no acute intracranial process, notes: chronic small renal ischemic disease; (29Jul2022) no acute intracranial process, notes: chronic small renal ischemic disease; HS troponin: (29Sep2021) negative, notes: CMP WNL; (29Jul2022) negative; arterial duplex BLE: (19Jan2022) no (illegible) significant disease; doppler on his leg/carotid duplex bilateral (unspecified date) did not have a blood clot; (19Jan2022) minimal plaque, notes: no significant disease or stenosis; sonogram: (unspecified date) left leg was normal, right leg still swollen; ultrasounds on legs and carotids (unspecified date) see if he has blockages and he did not; body X-rays: (unspecified date) no inflammation on his body, notes: entire body; (unspecified date) unknown results, notes: several body X-rays. Therapeutic measures were taken as a result of hypertension, cerebrovascular accident, myocardial infarction, orthostatic hypotension, thrombosis, peripheral swelling, atrial fibrillation, tachycardia, cellulitis, cardiac disorder, arthralgia, pain in extremity. Therapeutic measures were not taken as a result of muscle rupture, haemorrhage, dizziness, fatigue. Clinical course: Since they have gotten the vaccine they have been progressively getting worse. The patient has been active all of his life and since the vaccine he can hardly move. The patient started having his blood pressure went to 300/297 and thought he was having a stroke or heart attack. He went to the emergency room, Sep2021, improved at this time, took 12.5 mg hydrochlorothiazide treat blood pressure now and to keep it down and stated it keeps him running. His blood pressure now, it runs around 150/85. The patient was so dizzy all the time and can no longer drive, can barely walk. His right leg, the calf muscle swelled to 24 (also reported as 23) inches wide, it ruptured, and was bleeding from three sides of his leg. The doctors told him that he had orthostatic hypotension in his right leg and was not pumping blood back to his heart, now it was 19.5 inches. The patient informed that they would not admit him to the hospital for this, did nothing to treat this, they first thought he had a blood clot, they did a doppler on his leg and fortunately he did not have a blood clot. Since then, he has had ultrasounds on legs and carotids to see if he has blockages and he did not. Since he has had vaccines, he has had A-fib 6 times. The patient was not being treated for it because he will convert on his own within an hour. The patient was randomly experiencing tachycardia since he got the vaccine. The patient did all the testing, a brain scan and found a healthy brain, blood tests on top of blood tests, completely x ray'd his entire body, has found no inflammation in his body. Some doctors that were telling him all of his events were vaccine related, his DNA was being changed. The patient thinks maybe he has the bad batch in his body. The patient quality of life has been destroyed. On 11Mar2022, the patient informed that he has been in the hospital 3 times. He has been diagnosed with clots and orthostatic hypotension on his right leg (24 inch circumference). He has had blood pressure of 300/297. The patient feels dizzy all the time, can't drive his car and can barely walk. In the past 3 weeks, he experienced tachycardia and chest pains. They believed vaccine has not been properly tested, believed they have been injected with poison and that the mRNA contained in the vaccine attaches to their DNA. The patient blamed the vaccine for all these health problems. The patient informed that he has not received the booster. He was fearful of the COVID-19 vaccine and the vaccine has not been properly tested. The patient experienced tachycardia started 3 weeks ago and chest pain almost daily. He assumed the chest pain was from the Afib and tachycardia. The patient informed that he has been to his primary care doctor, rheumatologist, ER physician, cardiology, and ENT. They said he had vertigo but he didn't have vertigo. The reporter informed that the chest pain started in Sep (2021) and was ongoing, the same every day. The patient has been to a cardiologist and had an EKG. The cardiologist said his heart was perfect. There were doctors out here that know that this was not right. This product was not properly tested before it was given to the general population. On 04Apr2022, the patient informed that BP 300/297 (also reported as 197) was on 26Sep2021; admission to hospital due to the event was no (no rooms), treatment was yes and still experiencing. The patient experienced chronic fatigue from Oct to Mar; admission to hospital due to the event was no, treatment received was no and still experiencing. The patient experienced difficulty standing. The patient was delayed into the adverse reaction with Pfizer vaccine and was astonished that the proper testing and conditions of manufacturing were not done in aseptic conditions. The patient informed that they went to urgent care on 15Oct2021. They were sent to ER. The patient had pain all over plus a right leg swollen to 24 inch in circumference. The leg had ruptured on 3 sides, blood and tissue fluid. The patient had no rooms. The patient as of yet we have not died but fear it will be shortly. The patient had sonar sonograms looking for leg clots. The left leg was normal, right leg still swollen. The patient was taking off 2.5 mg prednisone for 57 days. On 58th day could not walk. The patient experienced severe body pain for 72 hours sitting in a chair. This vaccine has destroyed their lives. The patient experienced swollen leg right on 15Oct2021 12:00 noon. The event patient required a visit to emergency room and physician office for events both right leg and blood clots. The patient was hospitalized for 3 days. On 29Apr2022, the physician informed that the patient provided information regarding the reported adverse events with the use of the product. The physician did not consider the Pfizer product had a causal effect to the adverse event. The vaccination facility type was at hospital and the vaccine was not administered at military facility. The physician saw the patient in the office for a positive HTN follow-up on 15Jun2021 and at that time, the physician did not repeat anything new/out of the ordinary. The patient using HCTZ PRN (when necessary) and self-adjusting prednisone up to 10 mg daily based on (illegible). On 26Sep2021, the patient precured to ED with elevated blood pressure reading with increased leg swelling. The patients systolic BP conc down to 170 from 210 as its own in the ED and patient was instructed to follow-up with PCP rheumatologist. The patient weaved down off prednisone PCP rheumatology. In Nov2021, with treated for RLE cellulitis with doxycycline, Oct2021 in ED s/p insect bite. On 15Dec2021 physician visit, patient was on HCTZ still daily but back on prednisone per dermatology due to reoccurrence of shoulder and leg pain. On 23Mar2022 visit, was when the patient requested much difficulty with walking and (illegible) since Sep2021 to vaccine series. On 24May2022, the physician informed that event onset date was on 26Sep2021. The patient was not hospitalized. The patient had 2 ED visits, 26Sep2021 and 15Oct2021. On 12Oct2022, the patient informed that he has heart problems and skin eruptions since they have taken the vaccine. The patient informed that he has no report reference number with him and has a large folder upstairs with the Pfizer information but he cannot walk upstairs to get it. The patient informed that his wife and himself were spending 600 dollars a month on heart medicine. The patient informed that in his research the past year, he will call it a vaccine, but it was a drug that was not tested properly and not even manufactured under aseptic conditions. The patient informed that they screwed up and got the 2nd vaccine. It was reported the vaccine product had a bad batch of vaccine and he did not know if he and his wife got that bad batch or not, but it caused major problems of blood clots and he has clots in his lungs and legs. The patient informed that he took the Pfizer vaccine and it caused him to have cardiomyopathy, after he met with the cardiologist, they were going to put him in the hospital and give them Tikosyn and Pfizer made the vaccine, and may make Tikosyn too and not one of those products worked. On 25Oct2022, the patient informed that he had both legs swollen in excess of 25" in circumference. His legs ruptured and bled along with clear tissue fluid. The patient still has lesions and swollen legs that were red from haemoglobin. The patient was very dizzy all the time with difficulty walking and no longer able to drive. The patient informed that he has Afib and tachycardia. He was taking very expensive anti-clotting meds, Xarelto. The patient informed he was due compensation for life-altering poison injected into them. On 02Nov2022, the patient got 2 shots of the Pfizer so-called COVID vaccine, five months later he developed heart problems, Afib and tachycardia. In and out of ER's and hospitals 3 times for him. The patient cannot convert blood clots lungs-legs. The patient informed that the cardiologist suggested 3 day stay for us at hospital to stabilize with "Tikosyn" and then daily regimens on a monthly basis. The patient informed that they read the side effects and opted to take anti-clotting med. On 04Mar2022 product quality group investigational results for compound BNT 162 COVID-19 Vaccine Suspension for Intramuscular 2ML Multiple Dose Vial X 1, Lot-# (CR): ER8734; The conclusion of previously completed investigation: The complaint for lack of effect of the PFIZER BIONTECH COVID-19 Vaccine Injectable lot ER8734 was investigated. The investigation included reviewing manufacturing and packaging batch records, deviation investigations, analytical release test results, and an analysis of complaint history for the reported lot. The final scope was determined to be the reported finished goods lot ER8734, fill lot EP8686, and the formulated drug product lot EP8573. A complaint sample was not returned. No related quality issues were identified during the investigation. There is no impact on product quality. No root cause or CAPA were identified as the complaint was not confirmed. All release testing performed prior to the release of the reported batch was within specifications.; Sender's Comments: Linked Report(s) : US-PFIZER INC-202200354728 same patient/vaccine, different dose/events;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:150/85; Test Date: 20210926; Test Name: blood pressure; Result Unstructured Data: Test Result:300/297; Comments: elevated; Test Date: 2021; Test Name: systolic BP; Result Unstructured Data: Test Result:210; Test Date: 2021; Test Name: systolic BP; Result Unstructured Data: Test Result:170; Comments: conc down from 210; Test Name: blood work; Result Unstructured Data: Test Result:unknown results; Comments: multiple blood work; Test Date: 20210926; Test Name: CXR; Result Unstructured Data: Test Result:no acute disease; Comments: tortuosity of descending aorta; Test Date: 2018; Test Name: CRP; Result Unstructured Data: Test Result:elevated; Test Name: EKG/ECG; Result Unstructured Data: Test Result:unknown results; Comments: multiple; Test Name: EKG/ECG; Result Unstructured Data: Test Result:heart was perfect; Test Name: CMP/CBC; Result Unstructured Data: Test Result:unknown results; Comments: baseline; Test Date: 20210929; Test Name: CMP/CBC; Result Unstructured Data: Test Result:CMP WNL, CBC uncharged from baseline; Test Date: 20220729; Test Name: CMP/CBC; Result Unstructured Data: Test Result:unknown results; Test Date: 2018; Test Name: ESR; Result Unstructured Data: Test Result:elevated; Test Name: brain scan/CT head w/o chest; Result Unstructured Data: Test Result:healthy brain; Test Date: 20210929; Test Name: brain scan/CT head w/o chest; Result Unstructured Data: Test Result:no acute intracranial process; Comments: chronic small renal ischemic disease; Test Date: 20220729; Test Name: brain scan/CT head w/o chest; Result Unstructured Data: Test Result:no acute intracranial process; Comments: chronic small renal ischemic disease; Test Date: 20210929; Test Name: HS troponin; Test Result: Negative ; Comments: CMP WNL; Test Date: 20220729; Test Name: HS troponin; Test Result: Negative ; Test Date: 20220119; Test Name: arterial duplex BLE; Result Unstructured Data: Test Result:no (illegible) significant disease; Test Name: doppler on his leg/carotid duplex bilateral; Result Unstructured Data: Test Result:did not have a blood clot; Test Date: 20220119; Test Name: doppler on his leg/carotid duplex bilateral; Result Unstructured Data: Test Result:minimal plaque; Comments: no significant disease or stenosis; Test Name: sonogram; Result Unstructured Data: Test Result:left leg was normal, right leg still swollen; Test Name: ultrasounds on legs and carotids; Result Unstructured Data: Test Result:see if he has blockages and he did not; Test Name: body X-rays; Result Unstructured Data: Test Result:no inflammation on his body; Comments: entire body; Test Name: body X-rays; Result Unstructured Data: Test Result:unknown results; Comments: several body X-rays
Aktuelle Erkrankungen: Hyperlipidemia; Hypertension; Polymyalgia rheumatica (based on symptoms elevated CRP and ESR; rheumatologist in 2021 was not sure about the diagnosis); Prediabetes; Thrombocytopenia
Vorgeschichte: Medical History/Concurrent Conditions: Diabetes; Heart disorder; Heart failure; Non-smoker; Obesity
Andere Medikamente: TRAMADOL; PREDNISONE
Allergien: -
Vorherige Impfungen: -

VAERS 2504614

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 49,0
Geschlecht: M
Eingang: 10.11.2022
Impfdatum: 07.04.2021
Beginn: 16.10.2022
Tage bis Beginn: 557,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Ammonia increased Atrial fibrillation COVID-19 Central venous catheterisation Contusion Death Depressed level of consciousness Endotracheal intubation Hepatic cirrhosis Hepatic encephalopathy Jaundice Mental status changes Metabolic encephalopathy Rib fracture SARS-CoV-2 test positive Septic shock

Symptomtext

TESTED + FOR COVID 9-24-22 AT HOSPITAL. ADMITTED 9-24-22 WITH ALTERED MENTAL STATUS, HAD JAUNDICE , BRUISING. DX INCLUDE HEPATITIC ENCEPHALOPATHY, CIRRHOSIS, mrsa BACTEREMIA, ACUTE RESP FAILURE WITH HYPOXIA, SEPTIC SHOCK , ACUTE KIDNEY INJURY, FRACTURES OF RIBS, ACUTE METABOLIC ENCEPHALOPATHY, ACUTE COVID, THROMBOCYTOPENIA, AFIB WITH rvr, TREATED WITH VANCO, ZOSYN AND LATER ZOSYN STOPPED AND GIVEN DAPTOMYCIN. , IV FLUIDS, IV REMDESIVIR WAS ATTEMPTED TBUT HE DEVELOPED AFIB RVR. GIVEN LOPRESSOR. HIGH AMMONIA LEVELS. GIVEN FLAGYL, XIFAXAN LACTULOSE , pICC LINE. INTUBATED DUE TO OBTUNDED MENTAL STATUS. DECEASED 10-16-22 AS INPATIENT. i DONT HAVE THOSE RECORDS.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CARDIAC DISEASE, HEP -C, HTN, ANXIETY , DEPRESSION. H/O HEART ATTACK, GERD,
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2484345

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: FL
Alter: 59,0
Geschlecht: M
Eingang: 20.10.2022
Impfdatum: 18.03.2021
Beginn: 18.09.2022
Tage bis Beginn: 549,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blindness unilateral Carotid artery aneurysm Cerebrovascular accident Computerised tomogram Fatigue Intracranial aneurysm Joint swelling Laboratory test Magnetic resonance imaging Scan with contrast X-ray

Symptomtext

chronic fatigue, swollen joints shortly after 2nd dose. Then Sept 18, 2022 lost vision in left eye went to ER was admitted due to a stroke. Further testing showed a previous stroke along with a Brain and Carotid Artery Aneurysm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: Labs, CT Scans, MRI w/contrast Sept 19-20, 2022 and several xrays
Aktuelle Erkrankungen: None
Vorgeschichte: removal of squamous cell skin cancers
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2456152

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 78,0
Geschlecht: F
Eingang: 23.09.2022
Impfdatum: 30.03.2021
Beginn: 21.08.2022
Tage bis Beginn: 509,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arteriosclerosis COVID-19 COVID-19 pneumonia Death SARS-CoV-2 test positive

Symptomtext

patient tested + for covid on 7/25/22 and deceased on 8/21/2022. Patient died at Hospice in County. Had COVID 19 PNEUMONIA __ ARTERIOSCLEROTIC CARDIOVASCULAR DISEASE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2454683

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 22.09.2022
Impfdatum: 18.03.2021
Beginn: 28.01.2022
Tage bis Beginn: 316,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Breakthrough case admission after 2 vaccines; patient expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2306705

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 68,0
Geschlecht: F
Eingang: 22.09.2022
Impfdatum: 25.03.2021
Beginn: 11.01.2022
Tage bis Beginn: 292,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient received two vaccines; was admitted to facility and expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2298549

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

kritisch

Staat: MI
Alter: 89,0
Geschlecht: M
Eingang: 22.09.2022
Impfdatum: 18.03.2021
Beginn: 30.11.2021
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient admitted having received 2 vaccines; patient expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: COVID +
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2453590

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 64,0
Geschlecht: M
Eingang: 21.09.2022
Impfdatum: 14.04.2021
Beginn: 15.09.2022
Tage bis Beginn: 519,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Acute myocardial infarction Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac arrest Cardio-respiratory arrest Death Dyspnoea Endotracheal intubation General physical health deterioration Haemofiltration Hepatic failure Inappropriate schedule of product administration Intensive care Lactic acidosis Neurological symptom Renal failure

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization/Death. Rec'd Pfizer-BioNTech on 3/17/21 and 4/14/21. Presented to ED w/worsening SOB and vomiting. Dx'd w/covid 2 weeks prior. Admitted to ICU for acute hypoxemic resp failure requiring intubation, COVID PNA, AKI, and severe septic shock. Had an NSTEMI; evaluated and tx'd by cardiology. Condition deteriorated w/worsening lactic acidosis, renal failure requiring CRRT, liver failure, and signs of worsening neurologic function. Per surgery not stable for acute abdomen exploration. Code blue called for asystole, no ROSC. Exp'd on 9/15/22. Pt tx'd with cefepime, metronidazol, bactrim, azithromycin, decadron, and ceftriaxone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 6,0
Labordaten: Covid + 9/09/22 - This sample was analyzed using the Roche LIAT SARS assay platform using PCR or equivalent Nucleic Acid Amplification (NAA) technology.
Aktuelle Erkrankungen: -
Vorgeschichte: DM2, HTN, polycystic kidney disease s/p renal transplant 2011, OSA, hypothyroidism, chronic combined systolic and diastolic heart failure, COPD, and CAD s/p CABG x3 and PCI
Andere Medikamente: albuterol, allopurinol, aspirin, bumetanide, clonidine, doxazosin, famotidine, hydrocortisone, HC/pramoxine, insulin glargine, insulin lispro, insulin regular, isosorbide mononitrate, levothyroxine, metoprolol, mycophenolate mofetil, potass
Allergien: Shrimp
Vorherige Impfungen: -

VAERS 2446201

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 91,0
Geschlecht: F
Eingang: 15.09.2022
Impfdatum: 02.12.2021
Beginn: 09.09.2022
Tage bis Beginn: 281,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cough Fatigue Hypoxia Pneumonia Pneumonia bacterial Pyrexia SARS-CoV-2 test positive Sepsis

Symptomtext

Patient brought into the ED on 9/9 by EMS for weakness and fatigue. A week prior to this, she began to have a cough and tested positive for COVID on 9/8. When EMS arrived to the scene, the patient was hypoxic in the 70's and febrile, so was placed on oxygen. She was admitted 9/9-9/11. Discharge diagnoses include severe COVID-19, COVID pneumonia, bilateral lung bacterial pneumonia with sepsis, and acute hypoxemic respiratory failure. During admission, patient was able to be weaned off supplemental oxygen. Patient has received COVID vaccine and one booster. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2444889

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

kritisch

Staat: MI
Alter: 64,0
Geschlecht: M
Eingang: 14.09.2022
Impfdatum: 31.03.2021
Beginn: 13.09.2022
Tage bis Beginn: 531,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Acute respiratory failure Anion gap Anticoagulant therapy Asthenia Blood creatine phosphokinase increased Blood creatinine increased Blood culture Blood lactic acid Blood test COVID-19 Chemotherapy Chest X-ray Computerised tomogram head abnormal Cough Dehydration Dyspnoea Electrocardiogram

Symptomtext

Patient is a 66-year-old male With history of colon cancer with metastasis to the liver and recent COVID diagnosis on August 31 presenting to the emergency department via EMS from home for increased shortness of breath and generalized weakness. Patient was seen at facility on Sunday for cough with his COVID, he was given azithromycin to go home with. Family states ever since then he has been declining at home. He has been very weak and unable to get out of bed much. He is normally alert and oriented x4 and active, however today family had a hard time even getting him off the couch and noticed he seemed to be breathing fast so they called 911. Per EMS, patient was 90% on room air at his home, and he was tachypneic. They gave a DuoNeb breathing treatment in route along with Solu-Medrol 125 mg IV. Patient states he feels very fatigued and generally weak, he denies any chest pain, abdominal pain, nausea, vomiting or diarrhea. His last chemotherapy dose was 2 weeks ago, he is scheduled to have another 1 tomorrow, however this will be canceled. Associated Symptoms: cough, fatigue, shortness of breath, weakness

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 2,0
Labordaten: o ED Clinical Course Patient seen upon arrival to emergency room. Vitals are reviewed and noted for tachycardia with a heart rate of 130, patient is also tachypneic, he is 92% on room air upon arrival. EMS is already established an IV and gave Solu-Medrol 125 mg IV along with a DuoNeb breathing treatment. Patient will receive an additional DuoNeb breathing treatment, blood work performed including blood cultures and lactate, EKG and bedside chest x-ray. Due to his increased work of breathing and tachypnea, he is placed on BiPAP upon his arrival. A CTA chest is also ordered to rule out PE. Given his colon cancer and metastasis to the liver, a CT head is also added. I did discuss with wife at bedside, they only believe it has been to the liver at this time. 1605 patient seems to have worsening respiratory distress even while on the BiPAP. He continues to be tachypneic and tachycardic. Ativan 0.5 mg IV is given. Patient is closely monitored. Discussed with patient and wife at bedside the neck step would be intubation, and they are agreeable to this. 1626 patient's wife, was contacted on the phone as she had to step out to go pick up a prescription. I did discuss with her that patient continues to decline, his heart rate and respiratory rate are too fast and the BiPAP is no longer sufficient. At this time I do recommend patient be placed on a ventilator for respiratory support, and she is agreeable to this. Patient has been informed of this as well and does agree. 1635 patient was intubated with a 7.5 ET tube. A post procedure x-ray is ordered. I reviewed this at bedside, ET tube is in correct placement. 1700 patient's labs are reviewed creatinine is 2.2 which when compared to labs performed 2 days ago it was 0.9. Patient's anion gap is 21. CK is 1200. Troponin is 0.27. We will hold off on heparin until we are able to obtain a CT head. Patient's lactate is 9.6. This is likely due to his hypoxia and dehydration. I do not have a source of infection at this time. He is COVID-positive. Due to his elevated creatinine, CTA will not be able to be performed. We will continue with a CT head, and as long as that is negative, heparin drip will be ordered. A fentanyl drip has been ordered in addition to the propofol drip to help with sedation. 1749 patient taken to CT. He did require multiple medications for adequate sedation including ketamine 50 mcg IV prior to obtaining CT. 1814 CT head results appreciated, there is areas of hypoattenuation in the bilateral areas of the basal ganglia, this is likely due to old lacunar infarcts. There is no acute hemorrhage or mass-effect. Heparin will be ordered along with an aspirin suppository. 1830 patient now has a fever, his temperature is now 102.3. He will be given a rectal Tylenol suppository 650 mg. Ice packs will also be applied to patient's axilla. Patient's wife has been updated at bedside, we did review all lab results and treatments. I d/w Dr., he states as long as patient second troponin is not very much elevated compared to the first, we will be able to manage this patient here. He does agree with the fluid bolus. 1900 patient continues to be difficult to sedate on the vent. He is currently on a fentanyl drip, the propofol has been discontinued due to hypotension. His blood pressure is currently 119/100. He will be given Versed 5 mg IV, and a Precedex drip is ordered. Patient's repeat troponin is 1.09, this is likely due to patient's initial hypoxia and strain on the heart. This will be continued to be trended. He is currently on heparin. Diagnosis Acute hypoxic respiratory failure, suspect PE NSTEMI
Aktuelle Erkrankungen: unknown
Vorgeschichte: heart failure. colon cancer, immunosuppressed
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 2433614

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 08.09.2022
Impfdatum: 12.03.2021
Beginn: 22.08.2022
Tage bis Beginn: 528,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Catheterisation cardiac abnormal Confusional state Hypoxia Lethargy Respiratory failure SARS-CoV-2 test positive Syncope Pulmonary embolism Thrombectomy

Symptomtext

62y.o. male who recently traveled and was diagnosed with COvid about 1 week ago, treated with zithromax/ amoxicillin then atovaquone and proguanil presents with acut syncope. EMS found him quite hypoxic put on NRB and brought to ER where massive PE found. He was taken urgently to cath lab for thrombectomy- 5-6 thrombectomies were performed in both left and right sides. After, Right heart pressures were much improved. Oxygen has been weaned to room air. Evaluation on Day of Discharge: Feeling great, denies any dyspnea chest pain or bleeding, no overnight events. No lower extremity edema, lungs clear to auscultation, patient is eager to go home as soon as possible. is very lethargic and confused. Attempts to follow directions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 5,0
Labordaten: 8/23/22 SARS-COV-2 (COVID-19) by NAA, Micro -- detected
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2427902

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 90,0
Geschlecht: F
Eingang: 02.09.2022
Impfdatum: 15.04.2022
Beginn: 21.07.2022
Tage bis Beginn: 97,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure acute Chronic obstructive pulmonary disease Condition aggravated Dyspnoea Left ventricular failure Positive airway pressure therapy Respiratory failure SARS-CoV-2 test positive

Symptomtext

Patient has a history of COPD. She was seen in the ED on 7/21 with difficulty breathing and shortness of breath. Patient normally wears 7L O2 at home. She was placed on BiPAP in the ED, and had a COVID-19 PCR swab that was positive. She ultimately was admitted to the hospital from 7/21-7/23 and was diagnosed with acute on chronic hypoxic respiratory failure due to COVID-19 pneumonia, suspected acute on chronic diastolic heart failure, and COPD exacerbation. Patient is fully vaccinated and has received two boosters. This meets criteria for vaccine breakthrough case review.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Patient with history of congestive heart failure, COPD, diabetes.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2425109

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MD
Alter: 72,0
Geschlecht: F
Eingang: 31.08.2022
Impfdatum: 19.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Resident expired.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2440433

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 76,0
Geschlecht: M
Eingang: 27.08.2022
Impfdatum: 25.02.2021
Beginn: 27.04.2022
Tage bis Beginn: 426,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute coronary syndrome Acute kidney injury Acute myocardial infarction COVID-19 Chest pain Death Dyspnoea Electrolyte substitution therapy Endotracheal intubation Haemofiltration Myocarditis Pericarditis Respiratory failure SARS-CoV-2 test positive Troponin increased

Symptomtext

Narrative: Patient received two doses of Pfizer COVID 19 Vaccine and one dose Moderna COVID 19 vaccine on 26 March 2022. The patient tested positive for COVID 19 on 27 April 2022. The patient presented to the ED on 27 April 2022 with chest pain and shortness of breath for one month. The patient was admitted to the hospital with elevated troponins (NSTEMI), acute kidney injury, pericarditis, and myocarditis. The patient was treated with steroids, antibiotics, and electrolyte replacement. The patient was intubated on 28 April 2022 due to respiratory failure and acute coronary syndrome. The patient started CRRT (dialysis) on 2 May 2022. The patent died on 12 May 2022. Reported per EUA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2417313

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 71,0
Geschlecht: M
Eingang: 22.08.2022
Impfdatum: 01.04.2021
Beginn: 05.11.2021
Tage bis Beginn: 218,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Back pain COVID-19 Chest X-ray abnormal Death Dyspnoea Electrocardiogram abnormal Endotracheal intubation Fall Intensive care Intentional medical device removal by patient Mental status changes Pneumonia Positive airway pressure therapy Resuscitation SARS-CoV-2 test positive Shock Sinus tachycardia

Symptomtext

Patient brought to Regional Medical Center on 11/05/2021 for c/o falls, generalized weakness, and back pain. In the ED the patient had increased work of breathing. The patient was placed on BiPAP. CXR showed left lower lobe that was consistent with PNA. His Covid-19 test was positive. EKG revealed sinus tachycardia with nonspecific changes. The patient was given Decadron. The patient was given vancomycin and cefepime. Patient was admitted to the ICU and required intubation. Patient self-extubated on 11/7, required CPR 2-3 min and re-intubated. Patient again self extubated but was able to be maintained on BiPap and went to 2LNC. Patient improved with course of dexamethasone and baricitinib. He developed worsening mental status and on 11/25 required reintubation. Patient also developed shock again requiring vasopressor support. Palliative care was consulted and the patient was transitioned to comfort measures. The patient expired on 11/30/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 23,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2395133

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 77,0
Geschlecht: F
Eingang: 29.07.2022
Impfdatum: 30.03.2021
Beginn: 17.01.2022
Tage bis Beginn: 293,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Angiogram pulmonary normal Anticoagulant therapy COVID-19 COVID-19 pneumonia Chest X-ray Death Dyspnoea Electrocardiogram Fibrin D dimer increased Cardiac failure congestive Chest X-ray abnormal Dyspnoea exertional General physical health deterioration Intensive care Laboratory test Positive airway pressure therapy Respiratory failure

Symptomtext

Patient admitted to Hospital 1/17/2022 with shortness of breath. Patient was positive for COVID-19 infection. She rapidly worsened during stay and developed acute on chronic hypoxic respiratory failure. She initially required transition on 1/ 19/2022 and then was transferred to the ICU on 1/21/2022. She was transitioned to BiPAP. She was evaluated by pulmonology and infectious disease. Patient had an elevated D-dimer and CTA of the chest was performed without evidence of pulmonary embolism. D-dimer was trending upward to greater than 20. She was treated with therapeutic Lovenox dosing was initiated. She was initially started on dexamethasone and transition to high-dose methyl prednisone 60 mg every 6 hours. She was also started on remdesivir and vitamin C/E by infectious disease. Patient was vaccinated with Pfizer vaccine x2 in March 2021. She was transitioned to DNR/DNI and then eventually comfort measures; her family was in agreement. Comfort measures were provided. Patient died on 1/23/2022 of acute on chronic respiratory failure and covid pneumonia at 15:47 with her family present.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: Labs EKG Chest xray Chest CT with PE
Aktuelle Erkrankungen: unknown
Vorgeschichte: IPF (Idiopathic pulmonary fibrosis), neuromuscular disorder, hypertension, diabetes, CKD, PVD, MR (mitral regurgitation, RBBB (Rt bundle branch block) and TR (Tricuspid regurgitation)
Andere Medikamente: unknown
Allergien: ? Amoxicillin ? Codeine ? Hydrochlorothiazide ? Morphine
Vorherige Impfungen: -

VAERS 2393336

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 75,0
Geschlecht: F
Eingang: 27.07.2022
Impfdatum: 18.03.2021
Beginn: 01.01.2022
Tage bis Beginn: 289,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Cough Death Endotracheal intubation General physical health deterioration Mechanical ventilation Respiratory disorder SARS-CoV-2 test positive Streptococcal bacteraemia

Symptomtext

PFIZER COVID VACCINE # 3 GIVEN 10/22/21, LOT #FE3590; pt states she had a positive home COVID test on 1/6/22; has had a cough and generalized weakness; 1/11/22 pt to ED with worsening sx; O2 saturation in 80s%; given dexamethasone, Vitamin C; pneumonia due to COVID; AHRF; pt's respiratory condition worsened requiring intubation; developed streptococcus bactremia; given IV ABX; on maximum ventilator support; pt's condition continued to worsened; transitioned to comfort care; pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 27,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN,HLD, renal transplant
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2393190

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 27.07.2022
Impfdatum: 25.03.2021
Beginn: 08.02.2022
Tage bis Beginn: 320,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Bacteraemia Blood creatine phosphokinase increased Blood creatinine abnormal Blood culture positive Blood sodium decreased Blood urea abnormal C-reactive protein increased COVID-19 Cardiac arrest Clostridium test negative Death Dehydration Diarrhoea Echocardiogram abnormal Ejection fraction normal Electrolyte imbalance Endotracheal intubation

Symptomtext

History of present illness: Patient was admitted after she fell, she was found on the floor by her family, she was on the floor for over 12 hr, she denied hitting her head, she denied any syncopal episodes, she was tachycardic with heart rate as high as 177, Cardiology was consulted, labs were suggestive of acute kidney injury and Nephrology was consulted, INR was elevated and sodium level was low. Hospital Course: Patient was seen by Nephrology for acute kidney injury, advised fluid resuscitation since this was felt to be secondary to dehydration, she was given IV fluids, however, BUN and creatinine failed to improve, CPK was markedly elevated on admission and was slowly trending down, she was seen by Cardiology and advised intravenous diltiazem in addition to Toprol-XL, echocardiogram was done and showed ejection fraction 60%, moderately dilated left atrium, it was felt that DC cardioversion may be considered once she was more stable. Test for corona virus disease 19 came back positive, patient reported that she had received 2 doses of vaccine for corona virus disease 19, she denied shortness of breath, she was treated with vitamin-C, zinc, vitamin-D. She was noted to have diarrhea, stool negative for C diff, positive for leukocytes, stool was also positive for occult blood, seen by Gastroenterology, advised to transfuse as needed and colonoscopy as well as possible EGD as outpatient. There was concern regarding diverticulitis on imaging, she was treated with ceftriaxone and metronidazole. Gram-positive bacteremia was noted, 1/2 blood cultures, initially given vancomycin, subsequently vancomycin stopped since microbiology showed coagulase negative staph and patient was already having renal problems. She was nauseous in the evening on February 11th, electrolyte abnormalities were being corrected, she had emesis and subsequently developed respiratory failure, she went into asystole and was not breathing, CPR was initiated and carried on for approximately 20 min, she was pulseless for about 20 min, she was intubated and moved to the intensive care unit in the evening on February 11th with a consult to Critical Care. After discussion with multiple family members by Critical Care, decision was made to focus care on comfort only, ventilator placed on standby, patient was noted without vital signs early morning on February 12

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 4,0
Labordaten: On 2/08/22: CRP non cardiac 14.9 WBC: 22.4 Positive COVID19 test on 02/08/2022
Aktuelle Erkrankungen: -
Vorgeschichte: 12/15/16 Carotid stenosis, right Date Unknown Angina pectoris Date Unknown Arrhythmia Date Unknown Chronic kidney disease Date Unknown COPD (chronic obstructive pulmonary disease) Date Unknown Depression with anxiety Date Unknown GERD (gastroesophageal reflux disease) Date Unknown HTN (hypertension) Date Unknown Hyperlipidemia Date Unknown Hypothyroid Date Unknown Pneumonia, unspecified organism Date Unknown PVD (peripheral vascular disease)
Andere Medikamente: amLODIPine (NORVASC) 10 MG tablet aspirin (HALFPRIN) 81 MG tablet bumetanide (BUMEX) 1 MG tablet DULoxetine (CYMBALTA) 60 MG DR capsule isosorbide mononitrate (IMDUR) 30 MG SR tablets levothyroxine (SYNTHROID) 75 MCG tablet lisinopril
Allergien: Lipitor
Vorherige Impfungen: -

VAERS 2367593

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 74,0
Geschlecht: M
Eingang: 13.07.2022
Impfdatum: 25.03.2021
Beginn: 12.08.2021
Tage bis Beginn: 140,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 pneumonia Computerised tomogram head normal Death Encephalopathy Respiratory failure

Symptomtext

Patient was being treated at local Medical Center for Covid-19 PNA with hypoxic respiratory failure but showed no improvement despite all interventions. Patient was on max Airvo 100% flow rate of 60L, patient was also encephalopathic, head CT was negative for any acute process. Patient transferred to hospice care service and was placed on comfort care. Patient expired on 08/17/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2344873

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 76,0
Geschlecht: F
Eingang: 30.06.2022
Impfdatum: 19.03.2021
Beginn: 16.12.2021
Tage bis Beginn: 272,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood glucose increased COVID-19 Chest X-ray abnormal Death Hypotension Malaise Oedema SARS-CoV-2 test positive Unresponsive to stimuli

Symptomtext

Patient resident of nursing home. Patient had tested positive for Covid-19 on 12/16/2021. On 01/05/2022 patient reported to nurse she was not feeling well. Patients blood pressure was low, and blood glucose high. No SOB noted on exam. Edema noted on CXR. Midodrine 5mg x 1 given. Patient was then found unresponsive and expired at 1102.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2338922

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IA
Alter: 69,0
Geschlecht: M
Eingang: 28.06.2022
Impfdatum: 27.03.2021
Beginn: 10.01.2022
Tage bis Beginn: 289,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acquired diaphragmatic eventration Acute respiratory failure Asthenia Atrial fibrillation Blood creatinine increased Blood test abnormal Blood urea increased COVID-19 Cardioversion Chest X-ray abnormal Cough Death Diarrhoea Dyspnoea Endotracheal intubation Hyponatraemia Hypotension Hypoxia

Symptomtext

Pfizer Dose 1 3/6/21 (EN6199) Pfizer Dose 2 3/27/21 (EN6207) COVID Positive 1/10/22 1/14/22: A 70-year-old male with a past medical history of type 2 DM, hypertension, hyperlipidemia and gout brought to ED by ambulance for worsening shortness of breath and hypoxia. Patient states that he has been feeling sick for 1 week, with generalized weakness, cough, SOB and body aches. Patient states he got tested for COVID 19 about 4 days ago, and was reported positive. Patient was seen by family physician, was asked to monitor pulse ox. Patient states his pulse ox has been mostly in 70s, but he did not come to the emergency room. He received monoclonal antibody infusion yesterday. Patient says he is vaccinated against COVID-19 x2 doses, but no booster. His friend who lives with him also has mild symptoms. Denies nausea or vomiting, but had some loose stools. Per EMS his oxygen saturation was 74% on room air. In the ED, he was afebrile, blood pressure stable, pulse ox 92% on 15 L oxygen by mask. Blood work shows leukocytosis with neutrophilia and lymphopenia. Mild hyponatremia and elevated BUN and creatinine noted. Chest x-ray showed extensive bilateral infiltrates, with left hemidiaphragm elevation with mass effect. Patient was given IV dexamethasone 6 mg in the ED. 1/30/22: 70 year old male with hypertension presented for dyspnea and hospitalized for acute hypoxic respiratory failure secondary to COVID 19. Patient's oxygen requirement progressively increased and ended up getting intubated and requiring progressively increasing support on the ventilator. Patient received Actemra, Remdesivir, Dexamethasone and later Solu-Medrol. Patient was treated for superimposed bacterial pneumonia with course of antibiotics including ceftazidime and vancomycin. Patient developed afib w RVR which was appropriately treated medically and converted after synchronized cardioversion for hypotension. Patient's oxygen requirement worsened requiring maximal oxygenation support on the ventilator and developed septic shock with multiorgan failure which was refractory to vasopressors. Gaols of care was discussed with the family by the critical care attending and they decided on DNR/DNI and patient died on 1/30/2022 at 1836. Cause of death COVID 19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM II HTN HLD gout
Andere Medikamente: allopurinol 300 mg PO QD aspirin 81 mg PO QD atorvastatin 40 mg PO QD cyclosproine eye drops 1 drop Q12h diltiazem XR 240 mg PO QD fluticasone 2 sprays QD glipizide 5 mg PO AC hydrochlorothiazide 25 mg PO QD losartan 100 mg PO QD metformin
Allergien: NKA
Vorherige Impfungen: -

VAERS 2323058

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 75,0
Geschlecht: M
Eingang: 17.06.2022
Impfdatum: 19.03.2021
Beginn: 06.06.2022
Tage bis Beginn: 444,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Atrial fibrillation COVID-19 Condition aggravated Death Echocardiogram Heart sounds abnormal Laboratory test abnormal Mechanical ventilation Oxygen saturation abnormal Pleural effusion Positive airway pressure therapy Pulse absent Renal failure Renal impairment Respiratory distress Respiratory failure SARS-CoV-2 test positive Tachypnoea

Symptomtext

Pt to ED 6/6 by EMS for respiratory distress, arrived to ED on bipap. COVID+ 6/6, maintained on vancomycin and zosyn. 6/8 pt in respiratory failure due to COVID-19 and large pleural effusion, paroxysmal atrial fibrillation, pt is on vent. 6/9 pt remains on the vent; no respiratory difficulties noted. 6/11 pt remains on the vent; no respiratory difficulties noted, labs show worsening renal function. 6/12 pt remains sedated & on vent, tachypneic, Prop & fent gtts infusing per order. Pt with decreased urine output, worsening kidney function, and worsening oxygenation. 6/13 pt unresponsive, kidney started to deteriorate. 6/14 no pulse on doppler, no heart sounds noted, no response to stimuli. Pt deceased 6/14.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: see above
Aktuelle Erkrankungen: None
Vorgeschichte: Acute respiratory failure with hypoxia, Acute respiratory failure with hypoxia Atelectasis of left lung Pneumonia due to COVID-19 virus Sepsis Acute renal failure with tubular necrosis
Andere Medikamente: None
Allergien: Iodinated Diagnostics Agents
Vorherige Impfungen: -

VAERS 2322134

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 62,0
Geschlecht: F
Eingang: 16.06.2022
Impfdatum: 22.03.2021
Beginn: 11.06.2022
Tage bis Beginn: 446,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Anticoagulant therapy Blood gases Chronic obstructive pulmonary disease Condition aggravated Death Gastrointestinal tube insertion Haemoptysis Mechanical ventilation Mental status changes Pneumonia klebsiella Pneumonia pseudomonal Pulmonary oedema Pyrexia Red blood cell transfusion Sepsis Supraventricular tachycardia Urinary tract infection

Symptomtext

Hospital Course: 4/9 off vent 4/11 RRT for AMS, back on vent (was not hypercapnic on ABG done before being put back on vent), sepsis, ID consult 4/14 AECOPD/pulm edema, steroids and lasux started, FEES: pureed diet/thin liquids 4/17 ceftriaxone completed 4/20 LUE WBAT per ortho 4/21 TF changed to nocturnal 4/25 minced/moist diet with thin liquids 5/6 prednisone taper completed 5/8 AKI, IVF started 5/13 junctional tachycardia, sepsis, Klebsiella pneumonia and UTI 5/15 1 PRBC 5/17 1 PRBC 5/19 recurrent fever 5/24 Pseudomonas pneumonia 5/31 Merrem completed 6/6 hemoptysis, subQ heparin stopped 6/7 1 PRBC 6/11 pt expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: obesity, BMI 34, dementia (mild), COPD, HTN, hyperlipidemia, HIV, GERD, chronic pain, L elbow fx/ORIF 3/2022, lumbar surgery, bilateral hip surgery, L shoulder surgery.
Andere Medikamente: Unknown-Pt not hospitalized at time of vaccination
Allergien: Cefepime, Demerol, Haldol, PCN's
Vorherige Impfungen: -

VAERS 2320359

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 18.03.2021
Beginn: 01.01.2022
Tage bis Beginn: 289,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Cardiac arrest Death Dyspnoea Gastrointestinal tube insertion Intentional medical device removal by patient Mental status changes Pulse absent SARS-CoV-2 test positive

Symptomtext

1/3/22 pt in Medical Center for AMS; tested positive for COVID; hx of falls at home; NRB in hospital; dobhoff tube placed, but pt ripped it out; family decided on comfort feeding with comfort measures and hospice; 1/11/22 admitted to Hospice with dx COVID PNA; on O2 6 L via NC for SOB; pt found by nurse without a pulse or heart beat; expired in Hospice

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DEMENTIA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2320343

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 15.06.2022
Impfdatum: 19.03.2021
Beginn: 01.12.2021
Tage bis Beginn: 257,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Atrial fibrillation COVID-19 Cardiac arrest Cardiomegaly Death Failure to thrive Hypophagia Malaise Pleural effusion SARS-CoV-2 test positive Troponin increased Ventricular fibrillation

Symptomtext

12/28/21 pt to ED with generalized malaise and poor po intake; FTT x 3-4 months; found to be positive for COVID; no respiratory sx; elevated tropins; NSTEMI; no intervention recommended; pt does not want a feeding tube; supplemental shakes; pt had an episode of A Fib; 2 L O2 via NC; small pleural effusion and enlarged heart; pt went into V Fib arrest and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: FTT x 3-4 months
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2316724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 57,0
Geschlecht: M
Eingang: 12.06.2022
Impfdatum: 09.12.2021
Beginn: 03.06.2022
Tage bis Beginn: 176,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Brain herniation Brain oedema Cerebellar haemorrhage Cerebral haemorrhage Cerebral mass effect Computerised tomogram abnormal Computerised tomogram head abnormal Craniotomy Depressed level of consciousness Endotracheal intubation Fall Headache Hydrocephalus Medical device site haemorrhage Platelet transfusion Transfusion Ventricular assist device insertion

Symptomtext

Patient presented to Facility with sudden onset headache and falls. CT head large right cerebellar intraparenchymal hemorrhage with surrounding edema resulting in mass effect as well as 4mm right to leftward midline shift. Platelets, Vitamin K and Plasma given. Patient quickly had decreased level of consciousness. Stat Head CT showed increased ICH, increased mass effect with new hemorrhage in R cerebellum, upward transtentorial herniation and obstructive hydrocephalus. Patient intubated and taken to emergent OR for suboccipital craniotomy and External Ventricular Device placement. Post-op assessment was poor. Stat CT showed hemorrhage on EVD track. On 6/8 patient had MRI that showed upward transtentorial and downward foramen magnum herniation. Goals of Care meeting was held on 6/9. Patient will be terminally extubated 6/13/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: 9,0
Labordaten: See above.
Aktuelle Erkrankungen: alcohol abuse
Vorgeschichte: alcohol abuse, ADHD
Andere Medikamente: -
Allergien: peanuts
Vorherige Impfungen: -

VAERS 2308543

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 84,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 15.03.2021
Beginn: 24.05.2022
Tage bis Beginn: 435,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Alanine aminotransferase increased Angiogram pulmonary abnormal Aspartate aminotransferase increased Atelectasis Blood creatinine normal COVID-19 Cardiomegaly Chest pain Echocardiogram Inappropriate schedule of product administration Legionella test Lung consolidation Lung opacity Lymphadenopathy mediastinal Pleural effusion Pleuritic pain Pneumonia

Symptomtext

The patient is a 85 y.o. female with pmhx relevant for paroxysmal atrial flutter fibrillation on Eliquis, obstructive sleep apnea adherent with home CPAP, carotid stenosis, hypertension, hyperlipidemia, endometrial cancer, GERD admitted for sepsis and acute respiratory failure with hypoxia. She was found to be COVID+ and treated with steroids and remdesivir. Imaging suspicious for RML pneumonia and completed five day course of antibiotics for CAP. Did well and improved to room air prior to discharge. SLP did evaluate due to concerns for dysphagia and has recommended outpatient VFSS. She did have mild transaminase elevation on admission and statin was held. Other chronic conditions were stable. Crestor temporarily held with AST of 69 and ALT of 77. New to this MD today 5/29/2022 She is awake and alert, pleasant . Denies SOB, admits to very mild just bothersome pleuritic pain R ant axillary line. O2 sat at rest and on ambulation are normal. Lowest on ambulation was 92. BP of 149/96 at rest was without her usual cozaar, her creatinine is normal and cozaar resumed with this BP on discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: Procedure Component Value Ref Range Date/Time CV Echo Limited with Contrast Collected: 05/25/22 1056 Order Status: Completed Updated: 05/25/22 1332 Narrative: Hospital LIMITED ECHOCARDIOGRAPHY REPORT Name: Patient Study Date: 05/25/2022 MRN: Patient Location: DOB: Patient Class: Inpatient Gender: Female Ordering Physician: Age: 85 yrs Referring Physician: Height: 172 cm Performed By: RDCS, RVT Weight: 76 kg Resting HR: 80 BSA: 1.9 m2 Resting BP: 128/62 mmHg Reason For Study: Chest pain, nonspecific, ., Abnormal troponin History/Symptoms: Hypertension, Carotid artery disease, Hyperlipidemia, Obstructive sleep apnea, Atrial fibrillation Electronically signed by: MD on 05/25/2022 01:32 PM Interpretation Summary The technical quality of the exam was limited due to suboptimal acoustic windows. Left ventricular systolic function is normal. No obvious regional wall motion abnormalities with definity contrast. The right ventricular systolic function is normal. No obvious pericardial effusion on suboptimal images. Today's study was compared to one performed on 4/28/22. The LVEF was 65% on the prior report. STUDY PERFORMED/QUALITY: AORTIC VALVE: A two-dimensional transthoracic The aortic valve is not well echocardiogram with color flow and visualized. spectral flow Doppler was performed in limited views only. The technical MITRAL VALVE: quality of the exam was limited due to The mitral valve is not well suboptimal acoustic windows. Due to visualized. There is no mitral limited acoustic windows, Definity was regurgitation noted. administered. Location: Portable. LEFT VENTRICLE: TRICUSPID VALVE: The left ventricle is not well The tricuspid valve is not well visualized. Left ventricular systolic visualized. There was insufficient function is normal. No obvious tricuspid regurgitation envelope regional wall motion abnormalities detected to calculate right with definity contrast. ventricular systolic pressure. PULMONIC VALVE: RIGHT VENTRICLE: The pulmonic valve is not well The right ventricle is not well visualized. visualized. The right ventricular systolic function is normal. PERICARDIUM/PLEURAL: No obvious pericardial effusion on suboptimal images. INFERIOR VENA CAVA: The inferior vena cava was not visualized during the exam. Reference Table: Normal Mild ModerateSevere Men LVEF > 52% 41-51% 30-40% <30% Women LVEF > 54% 41-53% 30-40% <30% Men LVIDd 4.2-5.8 5.9-6.3 6.4-6.8 >6.8 Women LVIDd 3.8-5.2 5.3-5.6 5.7-6.1 >6.1 LA Volume (ml/m^2) < 34 35-41 42-48 >48 LVEDVI (mL/m2) Male 34-74 75-89 89-100 >100 LVEDVI (mL/m2) Female 29-61 62-70 70-80 >80 ____________________________________________________________________________ Electronically signed by: MD on 05/25/2022 01:32 PM All sources of data reside in the Cardiology PACS USV Venous Lower Extremity Duplex Bilateral Collected: 05/25/22 0312 Order Status: Completed Updated: 05/25/22 0318 Narrative: EXAMINATION: Complete Right and Left Lower Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 5/25/2022 2:27 AM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left lower extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: Bilateral Leg Pain Swelling COMPARISON: None ____________________ Right Lower Extremity Findings: Right Common Femoral Vein: No DVT. Right Femoral Vein: No DVT. Right Popliteal Vein: No DVT. Right Posterior Tibial Veins: No DVT. Right Peroneal Veins: No DVT. Right Gastrocnemius Veins: Not Included. Right proximal Greater Saphenous Vein: No thrombus. Left Lower Extremity Findings: Left Common Femoral Vein: No DVT. Left Femoral Vein: No DVT. Left Popliteal Vein: No DVT. Left Posterior Tibial Veins: No DVT. Left Peroneal Veins: No DVT. Left Gastrocnemius Veins: Not Included. Left proximal Greater Saphenous Vein: No thrombus. Duplex Doppler: Reflected cardiac pulsations are present in the common femoral vein waveform. This finding may be seen with right heart failure or tricuspid insufficiency. Additional Findings: None. _____________________ Impression: There is no deep venous thrombosis in the visualized deep veins of the right or left lower extremity. Reflected cardiac pulsations are present in the common femoral vein waveforms. This finding may be seen with right heart failure or tricuspid insufficiency. Electronically signed by: MD on 5/25/2022 3:14 AM. CT ANGIO THORAX WITH IV CONTRAST Collected: 05/25/22 0112 Order Status: Completed Updated: 05/25/22 0123 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 5/25/2022 12:25 AM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, high prob. COMPARISON: None ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: A few mildly enlarged mediastinal lymph nodes. Multiple thyroid nodules measure up to 2.1 cm. Cardiovascular: Four-chamber cardiac enlargement. There is no pericardial effusion. The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: No pulmonary embolism is present. Lungs & Airways: There is smooth interlobular septal thickening throughout both lungs. There is focal consolidation within the right middle lobe medially. Partial atelectasis of the right lower lobe due to the pleural effusion. Pleural Space: Small right pleural effusion. Upper Abdomen: Included portions of the upper abdomen are unremarkable. Chest Wall & Musculoskeletal: No significant abnormality. ___________________ Impression: 1. Pulmonary interstitial edema with a small right pleural effusion. 2. Focal consolidation in the right middle lobe likely pneumonia though follow-up chest CT is recommended in 2-3 months to ensure resolution and exclude a neoplastic process. 3. No evidence for pulmonary embolus. 4. Mild mediastinal adenopathy, nonspecific. 5. Thyroid nodules measure up to 2.1 cm, which could be further assessed with nonemergent thyroid ultrasound. Electronically signed by: MD on 5/25/2022 1:22 AM. DR CHEST SINGLE VIEW Resulted: 05/24/22 1933 Order Status: Completed Updated: 05/24/22 1935 Narrative: EXAMINATION: Single View Chest EXAM DATE: 5/24/2022 7:15 PM TECHNIQUE: Single view chest INDICATION: Right lower chest pain. COVID+ COMPARISON: April 28, 2021 ENCOUNTER: Initial _________________________ FINDINGS: Cardiac size is enlarged. Interstitium of the lungs has increased in density with abnormal parenchymal opacification at the lung bases left greater than right. _________________________ Impression: Chronic cardiac enlargement with diffuse prominence of the interstitium of the lungs probable pulmonary infiltrates at the lung bases with at least a left pleural effusion. Findings are quite possible to represent interstitial pneumonitis. Procedure Component Value Ref Range Date/Time Legionella Antigen, Urine (Normal) Collected: 05/25/22 1311 Order Status: Completed Specimen: Urine, clean catch Updated: 05/25/22 1551 Legionella Ag Urine Negative Negative Streptococcus Pneumoniae Antigen, Urine (Normal) Collected: 05/25/22 1311 Order Status: Completed Specimen: Urine, Voided Updated: 05/25/22 1550 STREPTOCOCCUS PNEUMONIAE ANTIGEN Negative Negative, Invalid COVID-19 PCR (Abnormal) Collected: 05/24/22 1931 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 05/24/22 2049 COVID-19 PCR Detected Abnormal Not Detected Comment: COVID-19 (SARS-CoV-2) RT-PCR test is positive. Clinical correlation with patient history and other diagnostic information is necessary to determine infection status. This test has received Emergency Use Authorization (EUA), but performance has not been evaluated for asymptomatic patients. Testing was performed using a nucleic acid amplification method. The specimen source may have been changed from the original order per patient situation or symptoms. Covid 19 Result Comment See Comment Comment: COVID-19 results reported as "detected" means COVID-19 positive. Positive patients should self-isolate for at least 5 days after symptom onset and until you have been fever free for 24 hours without the use of fever-reducing medications and until symptoms are improving. A mask should be worn for days 6-10 when in public. - Stay home except to get medical care and wear a facemask if you must leave - Separate yourself from other people in your home, known as home isolation - Cover your coughs and sneezes - Wash your hands often - Avoid sharing household items - Clean high-touch surfaces everyday - If you have a medical emergency and need to call emergency number, notify dispatch personnel that you may have COVID-19 and put on a facemask before emergency medical services arrive.
Aktuelle Erkrankungen: Cellulitis Left lower extremity- 02/21/2021
Vorgeschichte: Respiratory Obstructive sleep apnea on CPAP Pneumonia due to COVID-19 virus Circulatory Paroxysmal atrial fibrillation/flutter Essential hypertension Asymptomatic bilateral carotid artery stenosis Genitourinary Endometrial cancer (HCC) Endocrine/Metabolic Hypercholesteremia Other History of endometrial cancer
Andere Medikamente: acetaminophen (TYLENOL) 650 MG extended release tablet apixaban (ELIQUIS) 5 MG TABS benzonatate (TESSALON) 100 MG capsule carboxymethylcellulose (REFRESH PLUS) 0.5 % SOLN CARTIA XT 120 MG 24 hr capsule dexamethasone (DECADRON) 6 MG tablet E
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 2308418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 69,0
Geschlecht: F
Eingang: 03.06.2022
Impfdatum: 18.03.2021
Beginn: 27.10.2021
Tage bis Beginn: 223,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 pneumonia Dyspnoea Hypoxia Malaise

Symptomtext

Presented to ED w/COVID symptoms x 1 wk; SOB & hypoxic on arrival; admitted for COVID-19 PNA and acute on chronic resp failure w/hypoxia;10/27 - tx w/ steroids, zin, pulmicort & bronchodilator nebs;10/28 - added zinc; 10/29 - added remdesivir; pt was O2 dependent on 2L/NC prior to arrival and was weaned down to 2L at discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2296470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 26.05.2022
Impfdatum: 16.03.2021
Beginn: 16.09.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: IM / OT

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory distress syndrome COVID-19 COVID-19 pneumonia Death Disseminated intravascular coagulation Endotracheal intubation Influenza B virus test positive Mental status changes Multiple organ dysfunction syndrome Nausea SARS-CoV-2 test negative SARS-CoV-2 test positive Upper gastrointestinal haemorrhage Vomiting

Symptomtext

presented with AMS, n/v, Upper GI bleed?; Initial Covid test negative but + Influenza B; + covid 9/21; tx with : 9/17 rocephin, 9/22 steroids, 9/23 actemra; Pt had GI bleed throughout visit; Initially no O2 needed; 9/23 resp decline and dx with covid PNA; began Covid tx; 9/24 intubated 0200.010201.010202.010203.010204.010205.010206.010207.010208.01Patient developed multiorgan failure, along with ARDS/DIC. Family decided withdrawal of care. And she is pronounced dead at 1803.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2287307

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 71,0
Geschlecht: F
Eingang: 20.05.2022
Impfdatum: 19.03.2021
Beginn: 20.12.2021
Tage bis Beginn: 276,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute kidney injury Acute respiratory failure Anaemia Antiplatelet therapy Biopsy Bladder catheterisation COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest discomfort Chest pain Colonoscopy normal Computerised tomogram head normal Culture negative Dyspnoea Exposure to SARS-CoV-2 Faeces discoloured Haemoglobin decreased

Symptomtext

COVID Vaccine Breakthrough Case Pfizer Dose 1 2/26/21 (EN6198) Pfizer Dose 2 3/19/21 (EN6207) COVID Positive 12/22/21 12/22/21: Patient is a 71-year-old female who originally presented to the emergency room with some chest pain symptoms and went on to develop some shortness of breath and dyspnea. Along with this the patient had noted several days of her stools being dark black in color with no bright red blood per rectum. No fever, chills or night sweats are noted with no abdominal pain complaints. Patient denies any recent changes to her medical regimen and denies any recent travel. Patient does have recent exposure to COVID-19 yesterday with a family member that has tested positive. At the time the patient was seen at the bedside she is currently denying any chest pain symptoms but does endorse some ongoing shortness of breath and dyspnea. Patient had denied any hematuria, hemoptysis or hematemesis. Patient's medical history, current medications, imaging studies, vital signs, laboratory data and emergency room records were personally reviewed. Case was also discussed directly with the emergency room provider. Repeat chest x-ray was also discussed reviewed which showed significant worsening versus the initial chest x-ray and may have been related to fluid overload given the patient's history of severe heart failure with her last ejection fraction being 35-40%. 12/31/21: Patient is a 71-year-old female with past medical history of CAD, type 2 diabetes, hypertension, history of PE, hyperlipidemia, hypothyroidism, dextrocardia situs inversus, Chronic HFrEF presented to the ED on 12/22/21 with shortness of breath, chest pressure and complained of dark stools. Patient admitted for acute hypoxic respiratory distress secondary to COVID-19 pneumonia, acute metabolic encephalopathy, new AKI, concern for upper GI bleed and and NSTEMI. - CT head negative. Encephalopathy resolved. - There was a concern for NSTEMI, Cardiology was consulted and the thought was patient is elevated troponin was secondary to acute anemia. Recommendations for patient to follow up with Cardiology as outpatient. - Patient presented with a hemoglobin 6.6 and receive 2 units RBC. Hemoglobin has remained stable. Patient had EGD and colonoscopy without acute finding. Patient will need to follow up with GI for biopsy results. Given patient's extensive cardiac history Will continue aspirin and Plavix, the risk extensively reviewed. - Patient also tested positive for COVID-19. The patient did require supplemental oxygen however shows wean to room air. Cultures negative. Patient did not receive remdesivir due to renal function. Patient completed antibiotics. Patient will be discharged on Decadron. - Patient also noted to have acute kidney injury. Nephrology was consulted. Nephrotoxic medications was discontinued. Renal function did improve. Foley has been removed patient has been able to void. Patient will follow-up with PCP or Nephrology as needed. Precautions return to the ED extensively reviewed with patient and family at the bedside, they have verbalized understanding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: CAD CHF uterine cancer DM HTN PE HLD hypothyroidism mild anemia obesity situs inversus with dextrocardia smoker systolic heart failure
Vorgeschichte: CAD CHF uterine cancer DM HTN PE HLD hypothyroidism mild anemia obesity situs inversus with dextrocardia smoker systolic heart failure
Andere Medikamente: amiodarone 400 mg PO BID aspirin 81 mg PO QD baclofen 10 mg PO TID clopidogrel 75 mg PO QD vitamin B12 1000 mcg PO QD ferrous sulfate 325 mg PO BID glipizide 10 mg PO BID insulin isophane 35 units SQ TID insulin regular 18-20 units SQ HS me
Allergien: codeine - vomiting, delusions, hives fentanyl - unknown ibuprofen - hives, hallucinations, vomiting
Vorherige Impfungen: -

VAERS 2254601

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 74,0
Geschlecht: M
Eingang: 27.04.2022
Impfdatum: 20.03.2021
Beginn: 01.11.2021
Tage bis Beginn: 226,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Condition aggravated Confusional state Death Disease progression Fall General physical health deterioration Hypophagia Magnetic resonance imaging abnormal Mental status changes Metastatic neoplasm SARS-CoV-2 test positive Unresponsive to stimuli Urinary tract infection

Symptomtext

pt had a hospital stay (name of facility not in med records) from 11/12 - 11/24/21 for generalized weakness and acute mental status changes; found to be positive for COVID on 11/18/21; MRI consistent of cystic progression, metastatic disease; treated with corticosteroids and ABX for UTI; dc'd to skilled nursing facility for rehab; poor oral intake; pt has fallen since been in rehab; increase in confusion; overall decline; pt was found unresponsive and passed away in the center

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: metastatic melanoma with brain and pancreatic mets, colon CA (with partial colectomy), prostate CA, seizure disorder, CKD iii, PVD, RA, GERD, DM
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2249517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 68,0
Geschlecht: M
Eingang: 23.04.2022
Impfdatum: 22.10.2021
Beginn: 11.01.2022
Tage bis Beginn: 81,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

Patient had breakthrough infection and passed away,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 test on 1/11/2022.
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Seizures COPD Sleep Apnea CAD HTN Dysrhythmia Pacemaker DM type 2 hyperlipidemia anxiety depression panic
Andere Medikamente: Atorvastatin Carvedilol Montelukast Nitroglycerin Sacubitril Finasteride Tamsulosin Fluticasone propionate Oxycodone Aspirin Insulin glargine Omeprazole Pramipexole Kombiglyze Insulin aspart Isosorbide mononitrate albuterol sulfate biotin d
Allergien: ACE inhibitors furosemide hydrocodone hydroxyzine latex tizanidine tape
Vorherige Impfungen: -

VAERS 2246009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 82,0
Geschlecht: M
Eingang: 21.04.2022
Impfdatum: 27.03.2021
Beginn: 03.09.2021
Tage bis Beginn: 160,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 Chronic kidney disease Confusional state Death Dehydration Fall General physical health deterioration Hypoglycaemia Hypoxia Intensive care Limb injury Positive airway pressure therapy SARS-CoV-2 test positive Tachycardia

Symptomtext

pt to hosp after a fall at home; hit shoulder; found to be positive for COVID, hypoglycemic, dehydrated, acute on chronic kidney disease; ICU; AHRF; O2 supplementation, dexamethasone, ABX; increased confusion and tachycardic; more hypoxic; increased need for O2, placed on BiPAP; DNR/DNI; pt's condition worsened and he was placed on comfort measures only; pt passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: cardiac stent, HTN, melanoma, left eye CA, depression
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2241185

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IA
Alter: 65,0
Geschlecht: M
Eingang: 19.04.2022
Impfdatum: 31.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 204,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acidosis Acute kidney injury Anion gap Asymptomatic COVID-19 Atrial fibrillation Blood alkaline phosphatase increased Blood bicarbonate decreased Blood creatinine increased Blood gases Blood glucose increased Blood ketone body absent Blood lactic acid Blood magnesium increased Blood osmolarity increased Blood pH decreased Blood sodium increased Body temperature decreased Carbon dioxide decreased

Symptomtext

COVID Vaccine Breakthrough Case Pfizer Dose 1 3/8/21 (EN6199) Pfizer Dose 2 3/31/12 (EN6207) COVID Negative 10/25/21 COVID Positive 11/5/21 10/25/21: Patient is a 66-year-old male the past medical history of type 2 diabetes, COPD, CAD with stents, hypertension, and seizure disorder who presented to the ER via EMS due to unresponsiveness. Patient lives at home with roommates, per EMS report he has been intermittently unresponsive the past 4 days and lying on the floor. He has been smoking less than usual. Further history is limited due to patient's current condition, he is not currently responding to questioning. His sister was contacted. Reports patient's roommate called her today stating patient has been on the ground and unresponsive for possibly 4 days. It is the patient's sister who called for an ambulance. She states seizures have been well controlled. As far she knows he has been compliant with his diabetic medications. Substance use: unclear, does smoke cigarettes Family history: Diabetes in both parents. In the ED, patient was minimally responsive with GCS 9-10. He was hypothermic with a temperature of 95.6?. He was also noted to be tachycardic with heart rate in the 110s, blood pressure initially 79/60, he was placed on 2 L of oxygen. Lab work significant for sodium 146, CO2 12, anion gap 40, glucose 1238, creatinine 4.38, serum osm 396, alk-phos 169, magnesium 4.7, lactic acid 5.0, lipase 426. WBC 24, hemoglobin 17.2. ABG pH 7.1, pCO2 46, PO2 92, bicarb 14. Troponin was negative, acetone negative. Chest x-ray showed no acute process, head CT showed changes representing chronic microvascular ischemic changes, no acute changes. EKG showed AFib with RVR, rate 114. He received 1 L normal saline via EMS, 2.5 L LR in the ER. He was given Zosyn and started on an insulin drip. 11/17/21: Patient is a 66-year-old male the past medical history of type 2 diabetes, COPD, CAD with stents, hypertension, and seizure disorder who presented to the ER on 10/25 via EMS due to unresponsiveness. It is believed that patient may have been unresponsive for as long as 4 days. In the ED, patient was minimally responsive with GCS 9-10. He was hypothermic with a temperature of 95.6?. He was also noted to be tachycardic with heart rate in the 110s, blood pressure initially 79/60, he was placed on 2 L of oxygen. Lab work significant for sodium 146, CO2 12, anion gap 40, glucose 1238, creatinine 4.38, serum osm 396, alk-phos 169, magnesium 4.7, lactic acid 5.0, lipase 426. WBC 24, hemoglobin 17.2. ABG pH 7.1, pCO2 46, PO2 92, bicarb 14. Troponin was negative, acetone negative. Chest x-ray showed no acute process, head CT showed changes representing chronic microvascular ischemic changes, no acute changes. EKG showed AFib with RVR, rate 114. He received 1 L normal saline via EMS, 2.5 L LR in the ER. He was given Zosyn and started on an insulin drip. On 10/26, the day following admission a code blue was called on the patient. CPR and chest compressions were started, he received 2 amps of bicarb for acidosis as well as 1 round of epi, ROSC was achieved. Patient was subsequently intubated. Patient was extubated on 11/2 and moved to the floor on 11/3. During the time that he was intubated nephrology and pulmonology were consulted and manged his AKI and vent settings. While on the floor patient worked with PT/OT and was undergoing swallow evaluations while looking for placement. Patient was placed on a dysphagia diet. On 11/5 patient tested positive for COVID19 after his sister who had visited him tested positive. Patient was thus unable to transfer until he was out of the quarantine window. Patient remained asymptomatic during this time. He was then able to be transferred.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: 24,0
Labordaten: -
Aktuelle Erkrankungen: aortic stenosis arthritis COPD CVD generalized convulsive epilepsy heart murmur HLD HTN insomnia occipital neuralgia of left side peripheral neuropathy CAD s/p stent h/o tension headache DM type 2 tobacco use
Vorgeschichte: aortic stenosis arthritis COPD CVD generalized convulsive epilepsy heart murmur HLD HTN insomnia occipital neuralgia of left side peripheral neuropathy CAD s/p stent h/o tension headache DM type 2 tobacco use
Andere Medikamente: aspirin 81 mg PO QD atorvastatin 80 mg PO QD dulaglutide 0.75 mg SQ Qweek duloxetine DR 30 mg PO QD lisinopril 40 mg PO QD metoprolol tartrate 50 mg PO BID
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2223241

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 71,0
Geschlecht: F
Eingang: 08.04.2022
Impfdatum: 17.03.2021
Beginn: 01.12.2021
Tage bis Beginn: 259,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Respiratory failure SARS-CoV-2 test positive

Symptomtext

very little information sent in medical records; pt in respiratory failure; admitted to hospital; COVID pneumonia; positive COVID test on 12/20/21; pt transitioned to hospice( in hospital) and passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: BREAST CA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2217925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 79,0
Geschlecht: F
Eingang: 06.04.2022
Impfdatum: 17.03.2021
Beginn: 08.09.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: SYR / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death

Symptomtext

Information unavailable. Patient died at home. Covid 19 listed as a cause of death on death certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2216698

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: GA
Alter: 54,0
Geschlecht: M
Eingang: 05.04.2022
Impfdatum: 14.04.2021
Beginn: 05.06.2021
Tage bis Beginn: 52,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Anticoagulant therapy Blood test Chest X-ray Computerised tomogram Deep vein thrombosis Pulmonary embolism Scan Ultrasound Doppler

Symptomtext

Pulmonary embolism DVT in right leg Treatment: 8 days in hospital, after hospital Eliquis, 5 mg twice per day from June 2021 - January 2022. Scans of legs and lungs every three months, visits with pulmonologist, consultation with vascular surgeon, and currently undergoing examinations with hematologist. At present, no underlying blood condition observed that could have caused clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 8,0
Labordaten: Admitted to hospital on Saturday June 19, 2021. Between 6/19/21 and 6/26/21 when I was discharged I underwent numerous blood tests, CT scans, ultrasounds, and x-rays. Since being discharged, approximately every three months I have had ultrasounds on my leg, numerous blood tests in an attempt to determine the cause of my clots, and several x-rays of my lungs.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2206456

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 75,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 23.02.2021
Beginn: 29.03.2022
Tage bis Beginn: 399,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 Dyspnoea SARS-CoV-2 test positive Upper respiratory tract infection

Symptomtext

Pt has a history of CAD, status post CABG, history of lung cancer status post lobectomy, diabetes, and obesity. She has had 8 days of increased work of breathing at which time she states she caught a URI. She is COVID positive and admitted with acute hypoxic respiratory failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2206412

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 30.03.2022
Impfdatum: 25.03.2021
Beginn: 16.01.2022
Tage bis Beginn: 297,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary normal Atelectasis Azotaemia Blood bicarbonate abnormal Blood gases abnormal Blood sodium increased COVID-19 Chest X-ray abnormal Diarrhoea Enteral nutrition Fall Fibrin D dimer increased Gastrointestinal tube insertion General physical health deterioration Hypercapnia Hyperkalaemia Hypernatraemia

Symptomtext

Patient is a 74-year-old female with history of hypertension, CAD, HFpEF, COPD on 5 L home oxygen, diabetes who presented to the ER after a fall at home. Patient reported to have profuse foul-smelling diarrhea previous to this. In the ER patient was desatting requiring 6 L nasal cannula which worsened to requiring high-flow nasal cannula. CXR showed mild patchy atelectasis superimposed upon chronic pulmonary fibrosis. Patient found to be COVID-19 positive and was admitted for acute hypoxic respiratory failure requiring BiPAP. Pulm and ID on consult. Pt having worsening azotemia with hypernatremia and hyperkalemia and poor oral intake, Nephrology consulted. Continues to be hypernatremic on freewater and D5W. Code status changed to DNAR after speaking to daughter. patient requiring high-flow nasal cannula with taking breaks on BiPAP. Patient's hypoxia advanced and requiring nearly persistent BiPAP. Pulmonology and Infectious Disease were consulted. Patient's Decadron was increased to 6 mg b.i.d. And Baricitinib was initiated by Infectious Disease. Patient was already on Remdesivir. Patient had some CO2 retention on ABG, after 48 hr patient's bicarb continue to worsen so ABG is being repeated. Patient has poor oral intake and sodium increased to 156 placed on D5W with good effect. Nasogastric tube was placed and patient was started on tube feeds. Patient on persistent BiPAP with oxygen requirements improving. Patient still having trouble transitioning to high-flow nasal cannula. On January 24th patient did vomit with BiPAP it was removed very quickly patient is alert. Patient was initiated on cefepime and Flagyl as prophylaxis for aspiration pneumonia. NG tube was placed to suction, D-dimer returned greater than 15,000. CT angio of the chest negative for PE. Patient started to improve but improvement was only for about 2 hr on high-flow than patient was back on BiPAP. The following day family elected for hospice care. Patient's NG tube was transitioned back to tube feeds but then discontinued in anticipation of discharge home on hospice. Patient will be discharged on BiPAP and BiPAP were removed in the home. Patient is being discharged home on January 28, 2022 in grave condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: Positive COVID 19 test on 01/16/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Date Unknown CAD (coronary artery disease) Date Unknown CHF (congestive heart failure) Date Unknown COPD (chronic obstructive pulmonary disease) Date Unknown Diabetes Date Unknown HTN (hypertension) Date Unknown MI (myocardial infarction) Current Every Day Smoker, 2 ppd, 60 pack-years
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet aspirin (HALFPRIN) 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet atropine (ATROPISOL) 1 % ophthalmic solution calcitRIOL (ROCALTROL) 0.25 MCG capsule clopidogrel (PLAVIX) 75 MG tablet fluticasone-sa
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2202128

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MT
Alter: 65,0
Geschlecht: M
Eingang: 28.03.2022
Impfdatum: 12.03.2021
Beginn: 23.01.2022
Tage bis Beginn: 317,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Cardiac failure Death Endotracheal intubation Mechanical ventilation Melaena Respiratory failure SARS-CoV-2 RNA SARS-CoV-2 test positive

Symptomtext

Case was vaccinated x2 but not boosted for Covid as of March 2021. He was hospitalized for and died of Covid in February 2022. Hospitalized at: Hospital. Case was admitted to hospital overtly for melena, but was found to have Covid pneumonia and acute respiratory failure due to said pneumonia. He was intubated for respiratory failure, but due to complexity of medical issues, and poor response to ventilation, was transitioned to comfort care, and died 2/2/22 of respiratory and heart failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 10,0
Labordaten: Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe Ordered Test Codes: (LN LOINC)/ Status: Final Accession Number: Specimen Source: SOFT TISSUE SAMPLE Specimen Site: ENTIRE NASOPHARYNX Specimen Collection Date/Time: 2022-01-23 12:15:00.0 * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe Coded Result: DETECTED Numeric Result: Units: Text Result: Reference Range From: Not Detected Reference Range To: Performing Facility Details: Date/Time: 2022-01-23 13:22:22.0 Performing Facility: HOSPITAL Facility ID: Interpretation: Very abnormal Result Method: LAB DEVICE: SYSTEM Status: Final Test Code: (LN LOINC)/ Result Code: (SCT/
Aktuelle Erkrankungen: Asthma ? Bipolar 1 disorder ? Chronic low back pain ? Depression ? Gout ? Heart disease PAD ? Hypertension ? PTSD (post-traumatic stress disorder)
Vorgeschichte: Asthma ? Bipolar 1 disorder ? Chronic low back pain ? Depression ? Gout ? Heart disease PAD ? Hypertension ? PTSD (post-traumatic stress disorder)
Andere Medikamente: amlodipine (NORVASC) 10 MG tablet Take 10 mg by mouth Daily. aspirin 81 MG tablet Take 81 mg by mouth Daily. beclomethasone (QVAR) 80 mcg/puff inhaler Inhale 2 puffs into the lungs 2 times daily. buPROPion (WELLBUTRIN SR) 150 mg 12 hr table
Allergien: Lipitor, Statins, Zestril, Zocor
Vorherige Impfungen: -

VAERS 2192400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 22.03.2022
Impfdatum: 19.03.2021
Beginn: 13.12.2021
Tage bis Beginn: 269,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Dyspnoea Endotracheal intubation General physical health deterioration Hypotension Mechanical ventilation Pneumothorax Sputum culture positive Staphylococcus test positive

Symptomtext

12/18/21 pt presents to ED with increasing SOB; had a hospital admission from 12/13/21 - 12/15/21 due to COVID; was dc'd to home; worsening SOB in ED; O2 supplementation; given Remdesivir, dexamethasone; pt stable; developed a pneumothorax; DNR; pt's condition worsened; poor prognosis; initially refused intubation then changed her mind; pt intubated on mechanical ventilation; worsening respiratory status and hypotension; sputum positive for MRSA; pt deteriorated and passed away in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 20,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DMT2, MS
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2192119

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 89,0
Geschlecht: F
Eingang: 22.03.2022
Impfdatum: 18.03.2021
Beginn: 19.12.2021
Tage bis Beginn: 276,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient tested positive for Covid-19 on 12/18/21 and died on 1/17/22

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Covid-19 Antigen test 12/19/21; Covid-19 RNA test collected on 12/17/21, positive result reported on 12/21/21
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiovascular Disease, Chronic Renal Disease, Cerebrovascular Disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2192111

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 68,0
Geschlecht: F
Eingang: 22.03.2022
Impfdatum: 17.03.2021
Beginn: 01.09.2021
Tage bis Beginn: 168,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury COVID-19 COVID-19 pneumonia Death Dyspnoea Dyspnoea exertional Endotracheal intubation Hypoxia Intensive care Orthopnoea Positive airway pressure therapy SARS-CoV-2 test positive Staphylococcal bacteraemia

Symptomtext

pt brought to hosp with increasing SOB, dyspnea on exertion, orthopnea, significant hypoxemia; placed on CPAP; positive for COVID; COVID pneumonia; acute renal failure; transferred to ICU; placed on bronchodilators, ABX, remdesivir, dexamethasone, baricitinib; poor prognosis; required intubation; complicated with MRSA bacteremia; status changed to DNR and eventually comfort care; pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 25,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM, Hypothyroidism, Hyperlipidemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2171067

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 10.03.2022
Impfdatum: 17.03.2021
Beginn: 27.12.2021
Tage bis Beginn: 285,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Cardio-respiratory arrest Confusional state Death Dyspnoea Hypotension Life support Respiratory failure Resuscitation SARS-CoV-2 test positive

Symptomtext

pt had positive COVID test on 12/27/21; took monoclonal antibodies; was hospitalized from 1/6 - 1/8/22 for HRF associated with COVID 19; dc'd to home; pt returns to ED with increase in SOB and O2 sats at home in the 70s% on 2L O2; admitted to hosp; treated with dexamethasone, ABX, heparin; acute on chronic HRF, pneumonia due to COVID, and bilateral PE; pt worsened, became hypotensive with increase in confusion; went into cardio-respiratory arrest; CPR per ACLS protocol with success; pt expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2165617

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 08.03.2022
Impfdatum: 19.03.2021
Beginn: 01.09.2021
Tage bis Beginn: 166,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 pneumonia Death Decreased appetite Diarrhoea Dyspnoea Pyrexia Vomiting

Symptomtext

pt died at home after being in the hospital from 9/27 - 10/8/21 with COVID pneumonia; pt took monoclonal antibodies but started having and increase in SOB; poor appetite, V/D, fevers; started on Decadron and Remdesivir; pt was dc'd to home hospice where he died the next day

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2165478

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 08.03.2022
Impfdatum: 13.03.2021
Beginn: 29.09.2021
Tage bis Beginn: 200,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anaemia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Dementia Dialysis Encephalopathy End stage renal disease Hypotension Lung infiltration Pneumonia Renal function test normal

Symptomtext

HPI: ESRD, DM 2, hypertension; presented to ER for hypotension ; hx of dementia; given IV fluids in ER and started on antibiotics for pneumonia and a few L O2 via nasal cannula; dx'd with covid approx 10 days prior; treated with merrem and transitioned back to room air; family discussed making pt DNR and hospice care; pt had stable anemia and renal function; CXR showed improved perihilar infiltrate and persistent LLL pneumonia; pt was on 3L O2 via nc; meds: aouxaban 2.5 mg 1/2 tab bid; atorvastatin 20mg qd; D50W inj 12.5 gm = 25 ml iv push, as indicated prn, desvenlafaxine 50mg = 1 qd; dexamethasone 6mg = 0.6ml iv qd; flonase 50 mcg 100mcg 2 sprays nasal daily; glucagon 1mg prn, humalog qid, renvela 800mg 3 tab tid, singulair 10mg 1 tab qpm, sodium 650 mg 2 tabs bid, tylenol 650 2 tab q4h prn, zithromax, zofran 4mg 2ml iv push q8h prn, zosyn assessment: acute encephalopathy, hypotension resolved, ESRD on dialysis, dementia, acute respiratory failure with hypoxia, pneumonia due to COVID, not a candidate for remdesivir due to renal function, given decadron

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2163510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 07.03.2022
Impfdatum: 14.10.2021
Beginn: 26.02.2022
Tage bis Beginn: 135,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Atelectasis Blood gases abnormal Blood glucose decreased Blood potassium increased Corynebacterium test positive Endotracheal intubation Fatigue Haemodialysis Haemoglobin increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Hypoglycaemia Hypophagia Intensive care

Symptomtext

Hospitalized 2.26.22 - PRESENT (currently in ICU); COVID-19 positive; Fully Vaccinated PLUS Booster Admitted 2.26.22 CHIEF COMPLAINT: Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) HPI: 61 y.o. vaccinated male, active smoker, ESRD (T/R/S) chronic hypoxic, hypercapnic (pCO2 60s) respiratory failure, pulmonary htn, chronic diastolic dysfunction, insulin dependent T2 diabetes presented hypoglycemic (50 to EMS) and altered after having low PO intake, fatigue and 8 days of missed dialysis after testing positive for COVID-19 a week ago. Initial POC K 8.5, treated, glucose responded to D10 but became obtunded and intubated in the ER with acute on chronic respiratory hypoxic, hypercapnic respiratory failure, acute on chronic diastolic dysfunction and ESRD. Found to have polycythemia, hgb 22, new since December 2021. Monoclonal gammopathy is on his problem list. ASSESSMENT / PLAN: 61 y.o. vaccinated male, active smoker, ESRD (T/R/S) chronic hypoxic, hypercapnic respiratory failure, pulmonary htn, chronic diastolic dysfunction, insulin dependent T2 diabetes presented hypoglycemic (50 to EMS) and altered after having low PO intake, fatigue and 8 days of missed dialysis after testing positive for COVID-19 a week ago. Initial POC K 8.5, treated, glucose responded to D10 but became obtunded and intubated in the ER with acute on chronic respiratory hypoxic, hypercapnic respiratory failure, acute on chronic diastolic dysfunction and ESRD. Found to have polycythemia, hgb 22, new since December 2021. Monoclonal gammopathy is on his problem list. Assessment and Plan COVID-19 Overview Vaccinated 3/11/21, 4/1/21, 10/14/21 Symptom onset ~ 2/19 Positive 2/26/22 Assessment & Plan Noncontrast chest CT to evaluate for COVID pneumonia Check DDimer If elevated, BUE/BLE dopplers If evidence of possible COVID pneumonia on CT, will start steroids Remdesivir contraindicated with his renal disease Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) Assessment & Plan Due to pulmonary edema on baseline diastolic dysfunction, WHO group 2 and 3 pulmonary hypertension, COPD Also diagnosed with COVID a week prior, positive on today's PCR and may be playing a role CXR 2/26 w/enlarged PAs, vascular congestion, unable to differentiate a pneumonia in the bilateral lower lobes 7.14/94/63 on bipap, became obtunded in ER and intubated Intubation date: 2/26/22 Progress Note from 3.7.22: ASSESSMENT / PLAN: * Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) Assessment & Plan Due to pulmonary edema on top of baseline chronic diastolic heart failure and WHO group 2 and 3 pulmonary hypertension, +/- component of COPD and/or component of pneumonia Pt also COVID positive, with symptoms x 1 week and positive PCR test 2/26 - however, not felt likely to be playing a role in current state of respiratory failure (discussed below) Intubated 2/26/22. Extubated 3/2/22. Now on BIPAP 20/8. Despite poor seal with BIPAP mask, blood gases do improve with BIPAP. Will check a blood gas after completion of HD today. If improved, will trial him off BIPAP and repeat a blood gas a few hours afterwards. He should sleep on BIPAP tonight. - continue BIPAP. - HD today for volume removal Pneumonia Assessment & Plan Treated for CAP. Sputum cultures positive for Corynebacterium striatum. Completed 7 day course of ceftriaxone and 10 days of vancomycin today COVID-19 Overview Vaccinated 3/11/21, 4/1/21, 10/14/21 Symptom onset ~2/16 Tested positive via home test 2/18 Seen in urgent care 2/23, discharged home as he was doing well Positive PCR test 2/26 Film array 2/28 negative, including negative COVID PCR Strep and legionella urine Ag's negative Assessment & Plan CT findings demonstrate bibasilar consolidations, LLL>medial RLL, more suggestive of bacterial pneumonia vs atelectasis than COVID-related infiltrates. No obvious GGO consistent with typical COVID pneumonitis. Clinically, he has improved fairly quickly with positive pressure mechanical ventilation, diuresis/hemodialysis, and empiric abx, suggesting that COVID is not likely responsible for his respiratory failure and perhaps an incidental finding. He was previously treated with solumedrol 125 mg x 1. Steroids not continued. Will continue holding further steroids for now, unless he manifests clinical worsening. Remdesivir contraindicated with his renal disease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: 2.23.22: Urgent Care visit - Medical Decision Making: Patient is a 61-year-old male with multiple chronic comorbidities, that presents to the urgent care due to a cough. Patient reports that he has had a cough for approximately 1 week. He states that he was at dialysis yesterday and they told him he needed to come to the urgent care or emergency department due to the cough. Reports that the cough has actually improved for the past few days. He denies fevers, body aches, chills or systemic signs of illness. Coincidentally the patient does report a positive COVID-19 test at home 5 days ago. He did not initially present with this information of front. It was noted during his COVID-19 screen when he 1st arrived to the urgent care. I did ask the patient about this and he reports that his dialysis provider and his primary care provider both note that he has COVID-19 and they still recommended that he come to the Urgent Care for assistance. Patient reports that he feels as if he does not really need to be here. He states that his cough is improving. The patient is alert and oriented. No acute distress noted. skin is pink warm and dry. Vital signs are stable. Patient is nontoxic appearing. Assessment is unremarkable. His lung sounds are clear throughout. He did not have a single episode of coughing during my assessment. Ambulatory pulse ox was completed and the patient did remained above 94 percent the entire time. He did not require supplemental oxygenation. I do not believe chest x-ray is necessary at this time due to his known COVID-19 status. Patient was educated on this. He did agree with this plan of care. He was discharged home with recommendations on how to care for himself at home. He was encouraged to follow up with primary care doctor next week for recheck. Results return to the urgent care doctor to the emergency department sooner were discussed. Patient verbalized understanding of discharge plan and all questions were answered.
Vorgeschichte: Acute on chronic diastolic heart failure (HCC) End-stage renal disease on hemodialysis (HCC) Type 2 diabetes mellitus (HCC) COPD (chronic obstructive pulmonary disease) (HCC) Acute on chronic respiratory failure with hypoxia and hypercapnia (HCC) Pulmonary HTN (HCC) Atrial Flutter Hypertensive heart disease, malignant, with congestive failure (HCC) 2013 Abdominal wall cellulitis Hyponatremia Moraxella catarrhalis pneumonia (HCC) Frostbite of finger of right hand Scrotal infection Closed right ankle fracture Hypoxia Cellulitis of scrotum Acute kidney failure (HCC) History of biliary T-tube placement Injury of kidney Monoclonal gammopathy Morbid obesity (HCC) Uremic encephalopathy Coronary artery disease involving native coronary artery of native heart without angina pectoris Personal history of tobacco use, presenting hazards to health
Andere Medikamente: albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet B-Complex-C-Biotin-Fe & FA (DIALYVITE 800/IRON) 29-0.8 MG TABS FLUoxetine (PROZAC) 20 MG capsule insulin glargine
Allergien: PenicillinsHives
Vorherige Impfungen: -

VAERS 2163498

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 57,0
Geschlecht: F
Eingang: 07.03.2022
Impfdatum: 13.10.2021
Beginn: 27.02.2022
Tage bis Beginn: 137,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Abdominal pain Acute respiratory failure Anticoagulant therapy Back pain Blood gases abnormal Computerised tomogram spine Culture negative Dehydration Depressed level of consciousness Electrocardiogram normal COVID-19 Cardiac telemetry Chest X-ray normal Computerised tomogram abdomen normal Computerised tomogram head normal Fall Feeling abnormal Fibrin D dimer normal

Symptomtext

Hospitalized (2.27.22 - 3.3.22); COVID-19 positive (2.27.22); Fully Vaccinated PLUS booster Discharge Provider: MD Primary Care Provider: MD Admission Date: 2/27/2022 Discharge Date: Mar 3, 2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Vasovagal syncope [R55] Somnolence [R40.0] Hypoxia, sleep related [G47.34] Acute respiratory failure with hypoxia and hypercapnia (HCC) [J96.01, J96.02] DC summary edit pending HOSPITAL COURSE: A 57 y.o. female with h/o COPD, T2DM, HTN, HLD, GERD/DUD, IBS, migraines, bipolar disorder and chronic pain with opioid dependence, presenting to the Butterworth ER on 2/27 following a syncopal episode. She was laying in bed today nursing chronic back pain, when she became nauseous and felt the need to vomit and have a BM. She then suffered a syncopal episode, whereafter she rapidly regained consciousness and immediately returned to baseline mentation. She did endorse some left-sided neck pain after her fall. Family noted to the ED provider that she has been feeling poorly in recent days and, as such, is not eating/drinking normally per her baseline. In the ER, she was afebrile, hypotensive, with normal HR, tachypnic and hypoxic to 85% on baseline RA. Initial labs were notable for AGMA, leukocytosis, hypoalbuminemia. Serial VBG showed mild respiratory acidosis with pCO2 in 50s. COVID screen was positive and she is vaccinated. EKG shows NSR. CTH and CTCS negative for acute processes. CXR was clear. She was treated with Zofran, Decadron and IV fluids, and admission to IM was requested for management of acute hypoxic and hypercapnic respiratory failure. BiPAP trial in setting of persistent lethargy and persistently elevated pCO2 with respiratory acidosis was started. CT of the abdomen and pelvis was performed which showed no obvious source of her leukocytosis and abdominal pain. She was transferred to Hospital to the hospitalist service. Hypotension, asx HTN by hx HOLD lisinopril 10 and prazosin 1 HS at DC given presenting and persistent hypotension with resumption only after verifying BPs high enough to support DASH diet at discharge Acute hypoxic and hypercapnic respiratory failure Attributed to polypharmacy w/ sedating meds including opioid, COVID infection, poor oral intake, and continued anti-HTNs COVID + COPD Hypoxic to 85% on baseline RA VBG w/ hypercapnia and mild respiratory acidosis CXR clear BiPAP trial in ER given persistent lethargy and hypercapnia w/ repeat VBG w/ improvement in both; was still very sleepy. Dexamethasone 6 d with plan to stop at DC given no support for this indication INH inhalers Sx mngt, supportive care, encourage IS use D-dimer not elevated Syncope w/ collapse Presumed vasovagal v orthostatic hypotension due to decreased oral intake, continued anti-HTN med use, illness w/ Covid infection Neck pain possible muscle strain from fall CT head and CT cervical spine with no acute processes Encephalopathy, acute toxic metabolic: Resolved Likely secondary to polypharmacy esp w/ opioid, hypercapnic respiratory failure, and infection Avoid sedating meds/doses Telemetry and continuous pulse ox AGMA: Resolved IVFs now off so verify taking oral to avoid return of si/sx that led to admission Bipolar disorder Chronic pain with opioid dependence Abdominal pain CT AP w/o clear source of pain; chronic opioid not likely helpful Tylenol w/ Suboxone in lieu of buprenorphine 8 PO q8 for past year when home Med effect noted despite pt more alert 3/2/22 - Monitor for S/Sx of opioid withdrawal, consider Addiction Med consult for re-dosing if needed. SIRS, no clear source for sepsis Likely reactive and due to acute viral illness Pyuria w/ mod leuks and few bacteria, no growth from ctx sent from ER. CXR and CT AP without e/o acute processes Hold on abx for now, but monitor for infectious si/sx DMII, A1c 6.8 Hold metformin No indication for insulin so canceled HLD Aspirin and statin continued GERD/PUD PPI continued VTE ppx: High risk so Lovenox SQ; note low wt so may need dose adjust over time Diet: Consistent carb Partial code, desires intubation and ventilation if needed but no CPR DC home 3/3/22 given consistently awake, alert and not intermittently somnolent w/ hypoxia or respiratory insufficiency to suggest hypercapnia The following was provided in writing at discharge: Opioid pain medicine, buprenorphine and other sedating medicine Do not take more than scribed given risk of death by doing so Work with your doctor on pain management strategies that do not involve opioid given this risk Taking opioid medications during time of illness (Covid infection), not consuming enough food/fluids (dehydrated), and continuing meds such as anti-hypertensives leading to low blood pressures can come together leading to decreased levels of consciousness and hospitalization. Work with your doctor on safe medicine use, especially when ill or not eating/drinking enough. Your dose of Lyrica was reduced while here, from 200 mg twice daily to 150 mg twice daily in the setting of excess sedation You did very well with this dose reduction. Consider lowering your dose so you take the lowest effective dose of medicines like these No adjustment to this medicine and its dose was made at discharge Hypotension HOLD lisinopril and prazosin These medicines lower blood pressure. Your pressures were too soft during your stay to support safe use at discharge Keep them near, however as you and your doctor may decide they need to be restarted in the future We recommend your blood pressures are at least 130/80

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Fibromyalgia;GERD (gastroesophageal reflux disease);COPD (chronic obstructive pulmonary disease) (HCC);Tremor, essential; Bipolar 1 disorder, mixed (HCC);Diabetes mellitus type 2 without retinopathy (HCC); Hyperopia, bilateral; Abnormal MRA, brain;S/P cervical spinal fusion;H/O: hysterectomy Tobacco use; Dysphagia;Basilar artery aneurysm (HCC);Fibromuscular; Dysplasia (HCC);Cervical radiculopathy.
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler;Amitriptyline (ELAVIL);Aspirin;Atorvastatin (LIPITOR); Budesonide/formoterol (SYMBICORT); ACT inhaler;Buprenorphine HCl Duloxetine (CYMBALTA); Ergocalcif
Allergien: Chocolate Rash; Codeine; Environmental; Sulfa Drugs-Hives; Tylenol With Codeine #3 [Acetaminophen-codeine]Hives.
Vorherige Impfungen: -

VAERS 2157752

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 04.03.2022
Impfdatum: 02.04.2021
Beginn: 21.02.2022
Tage bis Beginn: 325,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anaemia Asthenia COVID-19 Cerebrovascular accident Chemotherapy Computerised tomogram head normal Culture Dysarthria Fatigue Febrile neutropenia Haemoglobin decreased Laboratory test abnormal Malaise Mental status changes Neutropenia Neutrophil count decreased Packed red blood cell transfusion Pancytopenia

Symptomtext

Patient is fully vaccinated and boosted. COVID positive 2/21/2022 on admission to the hospital. 63y.o. male with history of diffuse large B cell lymphoma on active chemotherapy, CVA (12/2021), hypertension, hyperlipidemia, who presented as a stroke code with slurred speech. CT head stroke protocol was negative for acute hemorrhage, territorial infarct or mass effect. Labs revealed severe pancytopenia including WBC<0.1, severe neutropenia with ANC <0.1, thrombocytopenia with PLT 51, and acute on chronic anemia with Hgb 6.3. Cultures were drawn and broad spectrum antibiotics cefepime and vancomycin were initiated. One unit of pRBCs was ordered. Does not require oxygen for COVID. Positive for mental status changes, malaise/fatigue, speech change (slurred) and weakness. + fever 103.2; Neutropenic fever. Discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2157578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 80,0
Geschlecht: M
Eingang: 04.03.2022
Impfdatum: 09.03.2021
Beginn: 15.02.2022
Tage bis Beginn: 343,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute kidney injury Acute respiratory failure COVID-19 COVID-19 pneumonia Dyspnoea Fibrin D dimer increased SARS-CoV-2 test positive Troponin increased

Symptomtext

Patient is fully vaccinated and boosted. COVID positive 2/15/2022 on admission to the hospital. 81-year-old male who presented to the hospital shortness of breath and was found to be in acute hypoxic respiratory failure in the setting of covid 19 pneumonia. D dimer 1366, Tropinin 0.07 He was treated with supplemental oxygen, breathing treatments, and IV remdesivir For 5 days. Patient symptomatically and clinically improved throughout his stay. He also had AKI, which resolved with IV fluid hydration. Patient is medically stable for discharge home. Patient discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2149332

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 66,0
Geschlecht: M
Eingang: 28.02.2022
Impfdatum: 12.05.2021
Beginn: 16.02.2022
Tage bis Beginn: 280,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram cerebral normal Angiogram pulmonary abnormal Arteriogram carotid normal Atrial fibrillation Atrial flutter COVID-19 Cardiac failure Cardiac failure acute Cardiac failure congestive Cardiac monitoring Chest pain Chills Chronic obstructive pulmonary disease Complication of device insertion Computerised tomogram abdomen abnormal Computerised tomogram normal Condition aggravated

Symptomtext

Hospitalized; COVID-19 positive; Fully vaccinated (J&J x1 dose); started Pfizer series (only 1 dose prior to J&J); no booster Discharge Provider: MD Primary Care Provider at Discharge: DO Admission Date: 2/16/2022 Discharge Date: 2/23/2022 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute on chronic respiratory failure with hypercapnia (HCC) [J96.22] HOSPITAL COURSE: Patient is a 67 y.o. male with medical history of stroke without residual deficit suspected possible TIA, cardiomyopathy, heart failure with both systolic and diastolic component, chronic obstructive pulmonary disease, gout, morbid obesity, and is currently in AFib with RVR presents today with from home with bleeding in his left ear. He states he felt something wet in his ear and his home healthcare nurse sent him to the hospital. Ear was inspected and there was just a small excoriation. When probed deeper, patient stated that he has been progressively worse lung function and difficult time standing to even do self-care. While speaking to the emergency room physician, he lost peripheral view in the left side. Stated that this has happened to him the past and resolved. Consulted Neuro. Hospital group accepted patient for TIA workup and acute on chronic respiratory failure with hypercapnia in the setting of COVID-19 positive, acute on chronic heart failure, and a flutter with RVR. Reports that while in the ER, the patient lost left-sided peripheral visual field leaving him with an and NIHSS score of 1. Upon assessment, he had no deficit in vision. He stated this has happened to him multiple times in the past and quickly resolved. Working diagnosis, possible TIA in the setting of a history of a CVA without residual effects. MRI imaging unobtainable related to severe Orthopnea and body habitus. Carotid Dopplers were performed which did not reveal any significant stenosis. Follow-up CT scan was negative as was CTA head and neck. Neuro felt he may have had a TIA. Echocardiogram showed reduced ejection fraction. He was diuresed with intravenous Lasix and made steady improvement. Oxygen was able to be weaned down to 2 L which is his baseline. His renal function improved. Regarding his COVID he was treated with steroids; he was outside the window for treatment with remdesivir. It was felt his respiratory symptoms were more likely related to COPD and CHF exacerbations. It was felt that he needed aggressive diuresis. Lasix was increased and fluid restriction increase to augment diuresis. His edema steadily improved and his respiratory function also improved. Patient was discharged home on oral Lasix 40 mg 2 times a day increase from his home dose in stable condition after adequate diuresis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: Hospital admission 2.4.22 - 2.11.22: DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Empyema (HCC) [J86.9] Empyema of left pleural space (HCC) [J86.9] Respiratory acidosis [E87.2] HOSPITAL COURSE: Per H&P:"Patient is a 67 y.o. male who presents to hospital with left-sided chest pain and difficulty breathing. The patient is known to have history of nonischemic cardiomyopathy, chronic congestive heart failure with normal left ventricular ejection fraction, severe, hypertension, obstructive sleep apnea on CPAP, morbid obesity with body mass index 48, gout, chronic obstructive pulmonary disease, pneumonia a year ago and quit tobacco almost a year ago. In the last 3 days, the patient started to complain of progressive increase of difficulty breathing, more with ambulation, and associated with acute left-sided chest pain. The patient left-sided chest pain is severe at time, increases in intensity with deep breathing, and coughing. He denies fever but reported chills and diaphoresis. The patient oral intake has been declining in the last 2 days as well. He has productive cough with clear phlegm but sometime with a tinge of blood. At the emergency department, the patient was mildly hypoxic with oxygen saturation 89% on room air and initially needed 2 liters/minute oxygen supplement nasal cannula. His NT-proBNP was more elevated than baseline 2325, and late last year it was 1456. The CT scan of the abdomen pelvis with IV contrast showed left pleural effusion which was confirmed with the CT angiogram of the chest with contrast and raise the suspicion for left-sided empyema. The patient has no pulmonary emboli. To attempt to do thoracentesis and places chest tube in the emergency department were not successful. The patient is being admitted to the hospital for further evaluation treatment."" Patient was admitted for pleural effusion with suspicion for an empyema. Multiple attempts at thoracentesis were unsuccessful. Patient was started on IV abx. After patient began to improve an amoxicillin challenge was done. Patient had no reactions to amoxicillin so it was decided to transition him to augment. ID was consulted and recommended medical management (no need for chest tube or IR guided thora) and to complete a 4 week course of antibiotics with Augmentin. I did delete penicillin allergy from allergy list this visit. Patient was mildly hypoxic on admission and remains mildly hypoxic at discharge. He is being set up with home o2. Unsure if hypoxia is strictly related to empyema and infection or if multifactorial in nature from COPD, heart failure, and OSA. Other issues managed while hospitalized: A. Fib with RVR prolonged patient's hospitalization. I did change his coreg to metoprolol succinate in attempts at better HR control. Patient had an echocardiogram done but due to habitus the EF was unable to be determined. Since I was unable to have an accurate determination of systolic dysfunction I opted to start patient on amiodarone to assist in HR control. Patient is being discharged on a loading dose of amio and a Zio patch. I recommend that patient be referred to cardiology for further treatment of atrial fibrillation and heart failure. He may be a candidate for further imagining in order to better assist in evaluating systolic/diastolic dysfunction. Hypercapnic respiratory failure/COPD/OSA- patient was found to be hypercapnic this hospitalization. I suspect this is related to OSA and obesity hypoventilation syndrome. We were able to arrange home bipap machine and encouraged patient to use machine with naps and at night. At this time he is tolerating mask.
Vorgeschichte: OSA on CPAP Pleural effusion, left with empyema Hypoxia Atrial flutter (HCC) Chronic diastolic heart failure (HCC) Tobacco use disorder Microscopic hematuria Nonischemic cardiomyopathy (HCC) Essential hypertension Hyperlipidemia, unspecified hyperlipidemia type History of CVA (cerebrovascular accident) without residual deficits Morbid obesity with BMI of 45.0-49.9, adult (HCC) Chronic obstructive pulmonary disease, unspecified COPD type (HCC) Chronic edema - bilateral lower extremity Stage 3 chronic kidney disease (HCC) Vitamin D deficiency Venous stasis dermatitis of both lower extremities Pre-diabetes Major depressive disorder with single episode, in partial remission (HCC) Empyema (HCC) Elevated troponin Acute on chronic respiratory failure with hypercapnia (HCC) Acute on chronic systolic heart failure (HCC)
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amiodarone (PACERONE) 200 MG tablet apixaban (ELIQUIS) 5 MG tablet atorvastatin (LIPITOR) 40 MG tablet fluticasone-umeclidin-vilant (TRELEGY ELLIPTA) 100-
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2148532

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 82,0
Geschlecht: F
Eingang: 28.02.2022
Impfdatum: 18.03.2021
Beginn: 14.02.2022
Tage bis Beginn: 333,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Death

Symptomtext

PT HAD VACCINES. EVENTUALLY DEVELOPED COVID, AND PASSED.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: UTI, HTN, LUNG CANCER, COPD, ANXIETY, PNEUMONIA SLEEP APNEA
Vorgeschichte: SEE ABOVE
Andere Medikamente: UNKNOWN
Allergien: UNKNOWN
Vorherige Impfungen: -

VAERS 2134418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 73,0
Geschlecht: M
Eingang: 23.02.2022
Impfdatum: 04.03.2021
Beginn: 11.02.2022
Tage bis Beginn: 344,0
Dosis: 3
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood creatinine increased Blood pH decreased Blood sodium decreased COVID-19 Death Extra dose administered General physical health deterioration Inappropriate schedule of product administration Malaise Metabolic acidosis Oxygen saturation decreased Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Tachypnoea

Symptomtext

Pfizer COVID Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccine on 1/15/21, 3/04/21, and 3/25/21. Covid + 1/18/22. Presented to ED 1/27 w/symptoms x9 days related to COVID-19 infection. In ED, vitals showed T 99.4F, BP 104/70 mmHg, satting 99% on RA. Metabolic acidosis (venous pH 7.29), elevated Cr of 1.96, Na 133. Morning of 01/31, acutely desatted to mid 80s and developed mild tachypnea, later fevered to 102.2F placed on CPAP. Continued to deteriorate, transitioned to DNAR. Tx'd with cefepine remdesivir, dexamethasone and vancomycin. Pt expired on 2/11/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: 1/18/22 -This sample was analyzed using the Hologic Panther System platform using PCR or equivalent Nucleic Acid Amplification(NAA)technology.
Aktuelle Erkrankungen: -
Vorgeschichte: ESRD s/p kidney transplant, HFrEF s/p orthotopic heart transplant HTN, HLD, Secondary hyperparathyroidism,, metabolic bone disease, OSA on CPAP, DM, neuropathy
Andere Medikamente: mycophenolate, pravastatin,tacrolimus, tylenol, aspirin, calcium carbonate, carvedilol, vitamin d3, empagliflozin, gabapentin, insulin glargine, insulin lispro, lactobacillus, omega3, omeprazole, patiromer, PEG 3350, prednisone, sodium bica
Allergien: amoxicillin, recephin, sulfasalazine, penicillins, sulfa, aldoseterone antagonists, beta blockers, entresto, tramadol, codeine, niaspan, terazosin
Vorherige Impfungen: -

VAERS 2123093

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 78,0
Geschlecht: F
Eingang: 18.02.2022
Impfdatum: 18.03.2021
Beginn: 06.12.2021
Tage bis Beginn: 263,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest tube insertion Death Haemorrhage Lung disorder Lung infiltration Pneumonia Pneumothorax Pneumothorax spontaneous SARS-CoV-2 test positive Sepsis Subcutaneous emphysema Unresponsive to stimuli

Symptomtext

Patient is 79-year-old female with complex medical history notably immunosuppressed secondary to myeloproliferative disease, CAD status with aortic valve (bioprosthetic). She was admitted with acute hypoxic respiratory failure meeting sepsis criteria in setting of Covid-19 pneumonia. She received aggressive treatment with Remdesivir, Empiric antibiotics, Baricitinib, Decadron and had multiple consults from specialists. Despite treatments, she developed bilateral spontaneous pneumothoraxes and required Emergent Right chest tube. Right lung subsequently with no air movement and one frank bleeding with concern for on pneumothorax. Repeat chest x-ray revealed stable bilateral infiltrates with increasing right pneumothorax use and continued left pneumothorax with subcutaneous emphysema the base of the Right neck. During this time, patient became unresponsive. After family discussion, patient was transitioned to comfort care. She died at 12/27/2021 1929 from Sepsis due to Covid-19 with Bilateral Pneumothorax, Pneumonia and Acute Hypoxic Respiratory Failure in setting of Immunocompromise due to Myeloproliferative Disease/Cancer.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 19,0
Labordaten: COVID-19 PCR Positive on 12-06-21 and 12-08-21.
Aktuelle Erkrankungen: Cancer
Vorgeschichte: (myeloproliferative neoplasm)
Andere Medikamente: allopurinol (ZYLOPRIM) 100 MG tablet, amLODIPine (NORVASC) 5 MG tablet, aspirin (HALFPRIN) 81 MG tablet, atorvastatin (LIPITOR) 10 MG tablet, Cholecalciferol (VITAMIN D3) 2000 UNIT CAPS, ferrous sulfate (FEOSOL, 65 FE,) 325 (65 FE) MG table
Allergien: Senna, Norco
Vorherige Impfungen: -

VAERS 2116864

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 83,0
Geschlecht: M
Eingang: 16.02.2022
Impfdatum: 26.03.2021
Beginn: 23.11.2021
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Chemotherapy Cough Death Diarrhoea Dyspnoea Lung neoplasm malignant Nausea Pyrexia Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/05/2021 and 03/26/2021. They tested positive for COVID-19 on 11/23/2021. A surviving family member reported this individual had a symptom onset of approx 11/24/2021. They were admitted to hospital on 11/23/2021 with cough, shortness of breath, fever, nausea, diarrhea, and respiratory failure. The decision was made to put the individual on palliative care, and transition to comfort care only. They remained hospitalized until their death on 12/02/2021. This individual had significant medical history of COPD, lung cancer, and a past pulmonary embolism. The individual's last infusion of Keytruda was approx 11/04/2021. The individual had made the decision to discontinue chemotherapy for the lung cancer on 11/23/2021, which is the same day they were admitted to hospital for shortness of breath.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: Positive COVID-19 test on 11/23/2021 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Adenocarcinoma (stage I); Osteoarthritis; COPD; past pulmonary embolism
Andere Medikamente: The individual had been receiving chemotherapy for lung cancer; their last infusion of Keytruda was approx 11/04/2021. The individual had made the decision to discontinue chemotherapy for the lung cancer on 11/23/2021, which is the same day
Allergien: -
Vorherige Impfungen: -

VAERS 2116374

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 16.02.2022
Impfdatum: 05.10.2021
Beginn: 07.02.2022
Tage bis Beginn: 125,0
Dosis: 3
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anticoagulant therapy Biopsy prostate COVID-19 Cardio-respiratory arrest Cardiogenic shock Cardioversion Death Echocardiogram Endotracheal intubation Haemoglobin decreased Hypotension Incision site haemorrhage Intensive care Rectal haemorrhage SARS-CoV-2 test positive Thrombectomy Thrombosis Ventricular tachycardia

Symptomtext

The patient is a 79 y male with H.o CAD s/p CABG and stents with last DES placed in Jan 2021, Essential HTN, dyslipidemia, Atrial fibrillation, H.o AV block s/p PPM, BPH with H.o recent transrectal prostate biopsy done on 2/1/22, admitted to the hospital for 0 days with the chief complaint of bleeding per rectum. During this admission, he also tested positive for COVID 19 infection on routine testing. He is asymptomatic and also had all 3 doses of COVID 19 vaccination. He is on contact and droplet isolation precautions He states that his rectal bleeding had started on the day of admission. He states that he started taking his Plavix from last Friday, Eliquis since Saturday. He underwent Biopsy on the Tuesday of that week. Denies abdominal pain. No prior history of GI bleed in the past. No lightheadedness. No shortness of breath. His hemoglobin at the time of admission was 12. Complained of bright red colored bleeding per rectum. Repeat Hg the following day of admission was 10. Cardiology - (Privacy) and Dr. (Privacy) - colorectal surgeon were consulted. Recommended to continue to hold off Plavix and Eliquis as long as deemed safe to be held per Cardiology. Aspirin to be continued per cardiology. Underwent rectal examination under anesthesia in OR on 2/9/22 - which showed bleeding from the biopsy site from the previous transrectal US biopsy site in the right posterior quadrant. Old rectal clots were evacuated. No complications at the time of post procedure. Later in the night he became hypotensive with BP in 70's/30's, unstable V.tach. Monomorphic ventricular tachycardia per code note. Code blue was called. Vtach with HR in 180's-190's. He was intubated to protect his airway. Received Magnesium, amiodarone during the ICU and was then transferred to ICU. Patient never lost a pulse during the code per code documentation. He was cardioverted at 200 joules, was started on dopamine drip and amiodarone drip initially. However, because of hypotension - amiodarone drip was stopped. He was transferred to SICU He was SICU he was placed on multiple pressors - Norepinephrine, dopamine, vasopressin, Neo synephrine and epinephrine. No active Upper or Lower GI bleed was suspected at that time and there was no drop in hemoglobin noted. Emergent bedside Echo was done by cardiology and it was negative for PE or right ventricular strain. Later family was approached to discuss goals of care including comfort measures to which eventually family agreed to with draw life support. He was extubated at 0219 on 2/10/22 and was pronounced dead at 0222. Cause of death: Cardiorespiratory arrest secondary to unstable/refractory V.tach Cardiogenic shock Unstable/refractory ventricular tachycardia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardio-respiratory arrest
Hospital-Tage: -
Labordaten: COVID 19 PCR: presumptive positive
Aktuelle Erkrankungen: -
Vorgeschichte: 05/22/2015 Third degree heart block (HCC) 2012 Pneumonia 05/18/11 Angina pectoris (HCC) 1/04/2021 Abnormal finding on cardiovascular stress test Date Unknown CAD (coronary artery disease) Date Unknown Chest pain Date Unknown Coronary atherosclerosis Date Unknown Gout Date Unknown Heart disease, unspecified Date Unknown Hyperlipidemia Date Unknown Hypertension 1987, 2004 MI (myocardial infarction) (HCC) Date Unknown S/P CABG (coronary artery bypass graft)
Andere Medikamente: allopurinol (ZYLOPRIM) 100 MG tablet apixaban (ELIQUIS) 5 MG TABS tablet atorvastatin (LIPITOR) 20 MG tablet carvedilol (COREG) 12.5 MG tablet clopidogrel (PLAVIX) 75 MG tablet famotidine (PEPCID) 20 MG tablet hydrochlorothiazide (HYD
Allergien: Colchicine, indigotindi sulfonate, Norvasc.
Vorherige Impfungen: -

VAERS 2110520

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 101,0
Geschlecht: M
Eingang: 14.02.2022
Impfdatum: 08.11.2021
Beginn: 10.01.2022
Tage bis Beginn: 63,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asymptomatic COVID-19 Death Exposure to SARS-CoV-2 SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/18/2021, 04/08/2021, and 11/08/2021. The individual reported no symptoms, but was tested after a known COVID-19 exposure. They tested positive for COVID-19 on 01/10/2022 via PCR test. They were admitted to hospital on 01/10/2022 and discharged 01/14/2022. However, they were admitted to a different hospital on 01/16/2022 and remained hospitalized until their death on 01/31/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 19,0
Labordaten: Positive COVID-19 PCR test on 01/10/2022 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Stage 3 Chronic Kidney Disease, Hyperglycemia, Atrial Fibrillation, Mild Coronary Artery Disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 53,0
Geschlecht: M
Eingang: 12.02.2022
Impfdatum: 24.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary abnormal Deep vein thrombosis Dyspnoea Pain in extremity Pulmonary embolism Asthenia Fatigue Feeling abnormal Myalgia Somnolence Ultrasound Doppler abnormal

Symptomtext

Very tired, most days; Muscle aches, really, really bad, especially bad in calves; he has very little energy sometimes, but right now he is feeling energetic, but he takes a lot of naps.; he has very little energy sometimes, but right now he is feeling energetic, but he takes a lot of naps.; it is kind of foggy; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 53 year-old male patient received bnt162b2 (BNT162B2), intramuscular, administered in deltoid right, administration date 24Mar2021 11:50 (Lot number: EL9264) at the age of 53 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Congestive Heart Failure" (ongoing), notes: guessing 6 years ago, he has a Pacemaker and a Defibrillator. He states the Defibrillator shocks his system back to life.; "Schizoaffective disorder" (ongoing), notes: combination of two disorders, Schizophrenia and Bipolar Disorder.; "major Depression", start date: 1986 (unspecified if ongoing), notes: he was diagnosed with major Depression in 1986, does not have depression or suicidal problems anymore. Family history included: "Diabetes" (unspecified if ongoing), notes: Caller mentions family history, there is a lot of Diabetes in his family; "mental illness" (ongoing), notes: Caller commented there is mental illness on both sides of his family. The patient took concomitant medications. Vaccination history included: Bnt162b2 (DOSE 1, deltoid, right muscle, dose unknown, Vaccine Lot Number: EL9264, time: 11:50), administration date: 25Feb2021, when the patient was 53 years old, for Covid-19 Immunization. The following information was reported: FATIGUE (non-serious), outcome "not recovered", described as "Very tired, most days"; MYALGIA (non-serious), outcome "not recovered", described as "Muscle aches, really, really bad, especially bad in calves"; ASTHENIA (non-serious), SOMNOLENCE (non-serious), outcome "not recovered" and all described as "he has very little energy sometimes, but right now he is feeling energetic, but he takes a lot of naps."; FEELING ABNORMAL (non-serious), outcome "not recovered", described as "it is kind of foggy". Additional information: The probably the same time when the muscle aches came, reclarified, as 14:00 in the afternoon. The patient stated that the same day as the tiredness that Saturday after the shot. Stated it was kind of foggy. He stated that even on the day of reporting was killing him. Outcome confirmed as persisting. He mentioned being foggy. Reclarified, that he was usually foggy, in thoughts, even before both vaccines, as he has some issues with memory. The patient stated that same as the second one, deltoid, right, in the muscle. He gives the lot as EL9264, then provided, letters and states maybe that was where the shot was administered. He also reported another number, Pfizer EN6207, and there was no dose that he can see. He was on 11 types of medications, between cardiac and psychiatric, but he does not think they are relevant. Vaccine was not administered at military facility. The patient did not visit to emergency room and physician office. No relevant tests. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Congestive heart failure (guessing 6 years ago, he has a Pacemaker and a Defibrillator.); Mental disorder (Caller commented there is mental illness on both sides of his family.); Schizoaffective disorder (combination of two disorders, Schizophrenia and Bipolar Disorder.)
Vorgeschichte: Medical History/Concurrent Conditions: Diabetes (Caller mentions family history, there is a lot of Diabetes in his family); Major depression (he was diagnosed with major Depression in 1986, does not have anymore.)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2101626

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 67,0
Geschlecht: M
Eingang: 10.02.2022
Impfdatum: 25.03.2021
Beginn: 30.01.2022
Tage bis Beginn: 311,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Cardiac arrest Death Haematochezia Hypotension Lactic acidosis Respiratory disorder SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 3/5/2021 and 3/25/2021. Presented from nursing home, admitted for acute hypoxemic respiratory failure due to COVID-19 PNA, lactic acidosis and NSTEMI. Received: oxygen supplementation, dexamethasone, antibiotics, and heparin. Patient had bloody bowel movements, hypotension, and respiratory status decline. Suffered cardiac arrest without ROSC. Expired on 2/4/2022 at 0458.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 6,0
Labordaten: 1/30/2022: COVID positive
Aktuelle Erkrankungen: -
Vorgeschichte: End stage renal disease on dialysis, coronary artery disease, chronic diastolic heart failure, hyperlipidemia, hypertension, depression, peripheral vascular disease, cirrhosis, diabetes, hyperparathyroidism , thrombocytopenia, Gastroesophageal reflux disease without esophagitis, monoclonal gammopathy of unknown significance, allergies, anemia, Pancreatic insufficiency, multiple DVTs, PUD (s/p partial gastrectomy)
Andere Medikamente: aranesp, nephro carb steady, hydroxyzine, lipitor, vitamin B complx-C-FA-zinc cit, ergocalciferol, lexapro, pepcid, flonase, norco, humalog, loperamide, nitrostat, creon, trazodone
Allergien: NSAIDS
Vorherige Impfungen: -

VAERS 2101624

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 73,0
Geschlecht: M
Eingang: 10.02.2022
Impfdatum: 19.03.2021
Beginn: 24.01.2022
Tage bis Beginn: 311,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute myocardial infarction Acute respiratory failure COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer-BioNTech Vaccines on 2/26/2021 and 3/19/2021. Patient's wife reported patient tested positive for COVID on 1/24/2022. Admitted for NSTEMI and acute hypoxic respiratory failure 2/2 COVID-19 infection. Patient received: vitamin C and zinc. Patient's respiratory status continued to decompensate and patient was transitioned to DNR/AND. Patient expired 2/3/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Lewy body dementia, coronary artery disease, sick sinus syndrome, hypertension, hyperlipidemia, diabetes, pacemaker
Andere Medikamente: Vitamin D3, ubiquinol, aricept, namenda, protonix, zinc
Allergien: Penicillins
Vorherige Impfungen: -

VAERS 2099742

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MO
Alter: 96,0
Geschlecht: F
Eingang: 09.02.2022
Impfdatum: 09.10.2021
Beginn: 01.02.2022
Tage bis Beginn: 115,0
Dosis: 1
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Bronchitis COVID-19 Chest scan Pulmonary embolism SARS-CoV-2 test positive

Symptomtext

SARS-COVID19PCR, NP (+) signs of COVID bronchitis bilateral pulmonary embolism dx'd during recent hospitalization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: SARS COVID PCR; hospital assessment incl chest scans
Aktuelle Erkrankungen: none known
Vorgeschichte: none other than chronic sinus infections
Andere Medikamente: none reported at time of vaccination, although reports chronic sinus infections
Allergien: none known
Vorherige Impfungen: -

VAERS 2093579

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 48,0
Geschlecht: M
Eingang: 07.02.2022
Impfdatum: 08.06.2021
Beginn: 12.01.2022
Tage bis Beginn: 218,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chills Chronic obstructive pulmonary disease Condition aggravated Cough Decreased appetite Dyspnoea Headache Lung infiltration Nasal congestion Oropharyngeal pain Pyrexia SARS-CoV-2 test positive

Symptomtext

01/16/22 Patient presents with shortness of breath. Patient stated over the past four days he has been having subjective fevers, chills, headaches, nasal congestion, sore throat, cough. Addition patient has generalized weakness with decreased appetite. On presentation patient was satting 80% on room air requiring 2 L by nasal cannula. Patient was diagnosed with acute hypoxic respiratory failure secondary to COVID-19 pneumonia causing COPD exacerbation. He was prescribed dexamethasone, and received IV Remdesvir. He was readmitted on 1/28/22 he received 2 L IV fluids IV Rocephin Zithromax 2 g calcium gluconate, Chest x-ray showed bilateral interstitial infiltrates likely residual from covid infection. Pt stayed an additional 10 days in the hospital upon his second admission.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: Positive PCR COVID 19 test 01/16/22
Aktuelle Erkrankungen: unknown
Vorgeschichte: 1. COPD. 2. Alcohol abuse with pending DTs 3. Primary hypertension 4. Tobacco use disorder
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2647101

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MD
Alter: 90,0
Geschlecht: F
Eingang: 04.02.2022
Impfdatum: 23.03.2021
Beginn: 08.04.2021
Tage bis Beginn: 16,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

NO NEGATIVE OUTCOME AFTER RESIDENT RECEIVED 2 DOSES OF COVID VACCINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: NONE
Aktuelle Erkrankungen: anemia, dysphagia, history of falls, age related osteoporosis
Vorgeschichte: protein calorie malnutrition,COPD,displacedIntertrochanteric fracture right femur, wedge compression fracture of t-7 wedge compression fracture of T-8 T-9 T-10 Patient died in house under hospice care
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: -

VAERS 2082976

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 91,0
Geschlecht: F
Eingang: 02.02.2022
Impfdatum: 08.04.2021
Beginn: 10.01.2022
Tage bis Beginn: 277,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Malaise Rib fracture SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/18/2021 and 04/08/2021. They became symptomatic for COVID-19 disease on 01/09/2022 and tested positive via PCR COVID-19 test on 01/10/2022. They were tested again upon hospital admission later on 01/10/2022 which was also positive via PCR. They were discharged from hospital on 01/14/2022 but then seen in Emergency Department on 01/20/2022 and were admitted to hospital again, they died later on the same day (on 01/22/2022). Rib fracture is listed on death certificate, as is COVID-19 pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: COVID-19 tests positive x2 despite being vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma, Hypertension, Possible COPD, Obstructive Sleep Apnea
Andere Medikamente: -
Allergien: Documented allergies to penicillin, codeine, erythromycin, morphine sulfate, sulfa drugs
Vorherige Impfungen: -

VAERS 2075565

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MO
Alter: 70,0
Geschlecht: F
Eingang: 31.01.2022
Impfdatum: 23.09.2021
Beginn: 07.10.2021
Tage bis Beginn: 14,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Aortic bypass Aortic occlusion COVID-19 COVID-19 pneumonia Chest X-ray abnormal Death Diplegia Haematochezia Intestinal ischaemia Peripheral ischaemia SARS-CoV-2 test positive Septic shock

Symptomtext

Tested positive for COVID-19 on 10/7/21 via PCR test. Admitted to Hospital on 10/24/21 because of sudden paralysis of lower extremities. Patient had evaluation including x-rays that showed evidence of acute aortic occlusion. With the acute occlusion, patient had a left axillary to femoral and let to right fem-fem bypass done on 10/24/21. Patient had been passing blood in her stool. Expired at Hospital on 10/25/21 with cause of death reported; Septic shock, Ischemic Bowel, Lower Limb Ischemia, COVID pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: RT-PCR positive for COVID-19 10/7/2021
Aktuelle Erkrankungen: Information not available
Vorgeschichte: Per hospital records: Longstanding vascular disease 100 pack-year smoker. Up to 5 packs of cigarettes a day for many years, history of previous vascular surgery. COVID test positive on 10/7/2021.
Andere Medikamente: Information not available
Allergien: None reported
Vorherige Impfungen: -

VAERS 2065457

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 26.01.2022
Impfdatum: 25.03.2021
Beginn: 03.01.2022
Tage bis Beginn: 284,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation COVID-19 Condition aggravated Culture urine positive Death Escherichia infection Malaise Pneumonia Pseudomonas infection SARS-CoV-2 test negative SARS-CoV-2 test positive

Symptomtext

Patient was an 82yr old female with PMH of Chronic UTI's (possibly related to a pessary), Aortic stenosis, Arthritis, OSA on CPAP, Depression, hypertension, Hypothyroidism and Shingles who initially presented to the hospital on 12/22 with frequency, generalized malaise and a urine culture positive for E Coli - she was also noted to be in Afib with RVR. She ws commenced on Ceftriaxone and on a Diltiazem infusion. While on admission pt. had a urine culture positive for Pseudomonas and was also diagnosed with pneumonia. At admission SARS-CoV-2 testing was negative, but became positive on 1/3/21 . She completed a course of Remdesivir and Linezolid and remained on Piperacillin-Tazobactam. Patient was deceased on 1/20/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: positive COVID-19 test on 1/3/22
Aktuelle Erkrankungen: -
Vorgeschichte: Cardiac and Vasculature Aortic stenosis Hypertension Atrial fibrillation with RVR (HCC) ENT Sinusitis, chronic Endocrine and Metabolic Obesity (BMI 30.0-34.9) Hypothyroidism Gastrointestinal and Abdominal Umbilical hernia with obstruction Partial small bowel obstruction (HCC) Small bowel obstruction (HCC) Nausea Genitourinary and Reproductive Hypokalemia Lower urinary tract infectious disease Urinary tract infection Complicated UTI (urinary tract infection) Infectious Diseases MRSA nasal colonization Mental Health Depression Musculoskeletal and Injuries Status post foot surgery Primary osteoarthritis of left knee Status post total right knee replacement Neuro Encephalopathy Skin OSA (obstructive sleep apnea)
Andere Medikamente: -
Allergien: Sulfa
Vorherige Impfungen: -

VAERS 2065343

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 76,0
Geschlecht: F
Eingang: 26.01.2022
Impfdatum: 09.04.2021
Beginn: 24.01.2022
Tage bis Beginn: 290,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Death related COVID 19 infection as a OSC

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSC: COVID-19; HTN; PVD; COPD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2062813

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 77,0
Geschlecht: M
Eingang: 25.01.2022
Impfdatum: 17.03.2021
Beginn: 19.01.2022
Tage bis Beginn: 308,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure COVID-19 Chest X-ray abnormal Chest tube insertion Inappropriate schedule of product administration Lung consolidation Malaise Malignant pleural effusion Pain Pleural effusion SARS-CoV-2 test positive

Symptomtext

Received Pfizer vaccine on 3/17/21, 04/15/21, and 9/11/21. Presented to ER on 1/19/22 and found to be COVID positive. Recently hospitalized for right-sided pleural effusion, which was a malignant effusion. He had PleurX catheter placed. He was picked up by EMS. Oxygenation was apparently in the 80s. He has not been feeling well. He has had body aches. He has been diagnosed with COVID-19 despite being vaccinated and receiving a booster. Chest x-ray shows bilateral small pleural effusions. Due to the acute hypoxic respiratory failure and inability of anyone to take care of him at home, patient will be admitted to the hospital at this time. No antibiotics during this admission. Discharged on 1/22/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: 1/19/22 COVID19: positive 1/19/22 chest xray: Worsened bibasilar consolidative change may represent worsening bibasilar atelectasis with superimposed pneumonia not excluded.
Aktuelle Erkrankungen: -
Vorgeschichte: He has a past medical history of Anesthesia, Arthritis, Bladder cancer (HCC), CAD (coronary artery disease), Carcinoma (HCC), History of kidney stones, History of tobacco abuse, Hypercholesterolemia, Hypertension, Macular degeneration, Myocardial infarct (HCC) (1994), Nausea and vomiting (12/30/2021), Osteoarthritis, and PONV (postoperative nausea and vomiting). He also has no past medical history of Anesthesia complication or Sleep apnea.
Andere Medikamente: Cholecalciferol (VITAMIN D) 5000 UNIT Capsule Sig: Take 1 Cap by mouth daily. Cranberry 450 MG Tablet Sig: Take 450 mg by mouth. HYDROcodone-acetaminophen (NORCO) 5-325 MG Tablet Sig: Take 1 Tablet by mouth every 6 hours as n
Allergien: flomax, tape, levofloxacin
Vorherige Impfungen: -

VAERS 2059305

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 74,0
Geschlecht: M
Eingang: 24.01.2022
Impfdatum: 30.03.2021
Beginn: 30.09.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Angiogram pulmonary abnormal Aspartate aminotransferase increased Blood culture negative COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Dyspnoea Dyspnoea exertional Fibrin D dimer normal Lung opacity Nasal congestion PO2 increased Pneumonia viral Pyrexia SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

COVID Vaccine Breakthrough Case Pfizer Dose 1 3/1/21 (lot not listed in online system) Pfizer Dose 2 3/30/21 (EN6207) COVID Positive 10/1/21 10/5/21: Patient is a 74-year-old male who tested positive for COVID-19 on 9/30/2021. He presented to the emergency department today with complaints of increasing shortness of breath, dyspnea on exertion, cough, and nasal congestion. He was noted to be 83% SpO2 on room air. He was placed on 3L of supplemental oxygen which has kept him greater than 90% SpO2. He was also noted to have a fever of 101.3? F. His labs were significant for AST 59, PO2 56, WBC 14.34, but were otherwise unremarkable. D-dimer was negative when corrected for age. He had a chest x-ray which suggested viral pneumonitis. He had a CTA chest which showed ground-glass infiltrates in both lungs consistent with viral pneumonitis, but no PE. On arrival to the floor, patient is requiring 3L of supplemental oxygen. He denies fever, chills, chest pain, palpitations, nausea, vomiting, diarrhea . Biggest complaint is cough with deep breathing and mild shortness of breath at rest. Says he is feeling much better now with the oxygen. 10/10/21: Patient is a 74-year-old male who was admitted on 10/5/2021 with acute hypoxic respiratory failure, secondary to bilateral COVID pneumonia. He also had elevated LFTs secondary to COVID and leukocytosis secondary to recent corticosteroid use. The patient was admitted to the medical floor. He was started on Remdesivir, Levaquin, and dexamethasone. He also reported a significant cough, so he was started on Robitussin AC which seemed to help. His blood cultures have had no growth to date. He was not able to provide a sputum sample. He completed his remdesivir course yesterday evening. He reports today that he is feeling much better. He is asking to go home. He denies chest pain or palpitations. Denies shortness of breath at rest, but does report some dyspnea on exertion. His oxygen need has significantly improved. He is currently on room air at rest, but requires 3L by nasal cannula with activity, per the home oxygen walk this morning. Patient is being discharged home with home nursing services for nursing and respiratory therapy due to his need for home oxygen. He is also being discharged with the at Home COVID care program. They will follow-up with him after discharge. He should continue dexamethasone 6 mg p.o. daily x5 days, Levaquin 750 mg p.o. daily x3 days, and Robitussin AC 10 mL p.o. t.i.d. a.c. p.r.n. cough. His self-quarantine is complete today. He should continue with home oxygen, on room air at rest, 3L by nasal cannula with activity. He should follow-up with his primary care provider in 1-2 weeks. I recommend a chest x-ray in 4-6 weeks to document clearance. The patient has been provided education for COVID pneumonia, home oxygen, Robitussin AC, dexamethasone, and levofloxacin. I have answered all of his questions and addressed all of his concerns. The patient is being discharged in improved and stable condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: see above
Aktuelle Erkrankungen: HTN BPH H/o prostate CA hypercholesterolemia
Vorgeschichte: HTN BPH H/o prostate CA hypercholesterolemia
Andere Medikamente: albuterol 1 puff Q6h PRN aspirin 81 mg PO QD benzonatate 200 mg PO TID HCTZ 12.5 mg PO QD losartan 50 mg PO QD multivitamin 1 tab PO QD simvastatin 20 mg PO QD
Allergien: NKDA
Vorherige Impfungen: -

VAERS 2050884

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 51,0
Geschlecht: M
Eingang: 20.01.2022
Impfdatum: 02.04.2021
Beginn: 17.08.2021
Tage bis Beginn: 137,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 COVID-19 pneumonia Death Dyspnoea General physical health deterioration Hypoxia Malaise Multimorbidity SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individiual was vaccinated with the Pfizer product on 03/12/2021 and 04/02/2021. They became symptomatic for COVID-19 disease on approx 08/13/2021 and presented to emergency department on 08/17/2021 for shortness of breath. They were found to be hypoxic and were admitted to hospital on 08/17/2021. The individual tested positive for COVID-19 via PCR test on 08/17/2021 and a second PCR test on 08/19/2021 was also positive. They were diagnosed with COVID-19 pneumonia. Their health deteriorated and they died on 08/21/2021. This individual had several complex, underlying medical conditions.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 4,0
Labordaten: COVID-19 tests x2 were positive despite being fully vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Morbid Obesity, Anemia, Acute renal failure imposed on stage 3 chronic kidney disease, Type II Diabetes, Obstructive Sleep Apnea, high anion gap acidosis, edema, hyperlipidemia, hypertension
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2043661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 69,0
Geschlecht: M
Eingang: 18.01.2022
Impfdatum: 04.10.2021
Beginn: 10.01.2022
Tage bis Beginn: 98,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 COVID-19 pneumonia Chest X-ray normal Chest discomfort Cough Dyspnoea exertional Electrocardiogram ST-T change Electrocardiogram abnormal Feeling abnormal Magnetic resonance imaging heart Myocardial injury Productive cough Prohormone brain natriuretic peptide increased SARS-CoV-2 test positive Supportive care

Symptomtext

Hospitalized 01/11/2022-still currently admitted; COVID-19 positive 01/10/2022; fully vaccinated plus booster 70-year-old man who was vaccinated induced that against COVID-19. He reports he has not been feeling himself for past 2 weeks. He reports that he has been having intermittent chest pressure, that comes and goes, it is not precipitated by activity. He reports that this has been ongoing for the past few weeks. He reports no chest pain currently. Patient also reports that he has been having some shortness of breath, cough that is nonproductive of sputum for approximately 2 weeks as well. ASSESSMENT / PLAN: Troponinemia 2/2 myocardial injury Recently elevated proBNP with DOE - Admit to GMF as inpatient, anticipate >2 midnight hospital stay. - Recently found to have elevated proBNP (11k), scheduled for outpatient TTE. - Trops 376 ? 345, EKG with non-specific ST-T wave changes. - CXR clear and maintaining appropriate SpO2 on baseline RA. - Cardiology contacted from ER ? no need for IV heparin, follow trops, will consult. - Obtain ECHO - Monitor volume status with daily weights and I/O?s. Monitor telemetry. COVID-19 infection - Symptom onset > 2 weeks. + PCR on 1/10. - Comfortable and saturating normally on baseline RA. - CXR clear without e/o opacities or infiltrates. - Not a candidate for remdesivir or dexamethasone. - Supportive care, encourage IS/pulm toilet. In regards to COVID-19, symptom onset does appear to be greater than 2 weeks. He is vaccinated and boosted. He is on room air. Chest x-ray without evidence of pneumonia. Agree he is not currently a candidate for remdesivir dexamethasone but would initiate dexamethasone if he were to develop hypoxemia. 01/14/2022 notes: Acute hypoxic respiratory failure; resolved COVID-19 pneumonia Continue Decadron 6 mg q.day Supplemental oxygen to maintain O2 sats greater than 90% Continue severe respiratory precautions 01/17/2022 notes: Acute hypoxic respiratory failure; resolved currently on room air COVID-19 pneumonia Continue Decadron 6 mg q.day Supplemental oxygen to maintain O2 sats greater than 90% Continue severe respiratory precautions Dispo: Transitioned to oral torsemide a nephrology; nephrology anticipating discharge from their perspective 1 2 days; cardiology recommending cardiac MRI tomorrow; still considering whether not to discharge patient on a Life Vest; likely patient will be hospitalized for at least 2-3 more days

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Syncope Syncope and collapse Type 2 diabetes mellitus without complication, without long-term current use of insulin Hypertension associated with diabetes Dyslipidemia associated with type 2 diabetes mellitus Shortness of breath Snoring Bilateral hearing loss, unspecified hearing loss type
Andere Medikamente: amLODIPine (NORVASC) 10 MG tablet aspirin 81 MG enteric coated tablet cholecalciferol (VITAMIN D3) 25 MCG (1000 UT) tablet cilostazol (PLETAL) 50 MG tablet citalopram (CELEXA) 40 MG tablet cyanocobalamin 1000 MCG tablet fenofibrate (TRIGLID
Allergien: NKA
Vorherige Impfungen: -

VAERS 2043650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 73,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 12.03.2021
Beginn: 11.08.2021
Tage bis Beginn: 152,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Malaise Pneumonia Renal failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of COVID-19 breakthrough disease after which a death occurred. The individual was vaccinated with the Pfizer product on 02/19/2021 and 03/12/2021. They became symptomatic for COVID-19 disease on 08/11/2021 and tested positive via both antigen and PCR on the same day. They were admitted to the hospital on 08/16/2021 and experienced complications of pneumonia and renal failure. They remained hospitalized until their death on 08/19/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive COVID-19 tests x2 despite being fully vaccinated: one PCR and one antigen test collected on the same .
Aktuelle Erkrankungen: -
Vorgeschichte: Type II Diabetes, Obesity
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2040680

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 59,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 23.08.2021
Beginn: 11.01.2022
Tage bis Beginn: 141,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Blood culture negative COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram abnormal Depression Diarrhoea Dyspnoea Electrocardiogram QT prolonged Gastrooesophageal reflux disease Hypokalaemia Hypoxia Lung opacity Papillary thyroid cancer Plasma cell myeloma Post procedural hypothyroidism Respiratory symptom SARS-CoV-2 test positive

Symptomtext

Hospitalized (1.10.22); COVID-19 positive (1.11.22); Fully vaccinated PLUS booster DATE OF ADMISSION: 01/10/2022 DATE OF DISCHARGE: 01/13/2022 DISCHARGE DIAGNOSES 1. COVID-19 pneumonia with acute hypoxemic respiratory failure. 2. Acute drop in hemoglobin, lab error. 3. Acute on chronic diarrhea. 4. Episode of ventricular tachycardia, prolonged QTc. 5. Hypokalemia. 6. Multiple myeloma. 7. Papillary carcinoma of the thyroid. 8. Postsurgical hypothyroidism. 9. Anxiety and depression. 10. Gastroesophageal reflux disease HOSPITAL COURSE The patient is a very pleasant 60-year-old female with past medical history as listed above including multiple myeloma and bone marrow transplant x2, who presented initially to Urgent Care secondary to worsening shortness of breath and cough. She initially developed upper respiratory symptoms, January 1st and with progression of symptoms, she proceeded to Urgent Care where her COVID test was positive. She was sent to a local Emergency Department for septic workup. She was hypoxic with ambulation down to 79% on room air in the ER. Chest x-ray showed bilateral pulmonary opacities consistent with COVID pneumonia. CT was negative for PE. Peripheral ground-glass opacities bilaterally were noted. She was placed on 2 L of oxygen. Blood cultures were obtained and were negative for bacteria. She was started on Decadron 6 mg and remdesivir. Infectious Disease was consulted for possible compassionate use of monoclonal antibodies, although she was outside her window. Infectious Disease discontinued broad-spectrum antibiotics as they felt there was no bacterial infection component. The patient had acute on chronic diarrhea. C diff was negative. Diarrhea was felt related to her COVID. This improved with Imodium and Lomotil. Overall, the patient did very well and was weaned off oxygen at room air. Pulmonary Rehab was consulted and recommended 2 L of oxygen with ambulation. Her oxygen level dropped to 87% with ambulation. We encouraged the patient to stay for at least 1 more dose of remdesivir. However, the patient was very eager to get home as she has 2 sons at home, 1 with COVID and she is a single mother. She discharged in stable condition on 01/13/2022. The patient is encouraged to call our office or proceed to the ED if her symptoms should worsen. She was sent home with a prescription for Decadron to complete a 10-day course. Please see report for full discharge instructions. Chemotherapy will be delayed at least 1 week and followup will be arranged in the Oncology office.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Non-toxic multinodular goiter Metastatic papillary thyroid carcinoma Postsurgical hypothyroidism Stem cells transplant status (HCC) Gastroesophageal reflux disease, esophagitis presence not specified Multiple myeloma in remission (HCC) Anxiety associated with depression Irritable bowel syndrome with both constipation and diarrhea Hypertriglyceridemia without hypercholesterolemia Colitis due to Clostridium difficile Abnormal liver function tests Hemorrhoid Papillary carcinoma of thyroid (HCC) Shoulder pain Subcutaneous cyst, right upper arm Intraductal papilloma of breast, left Routine general medical examination at a health care facility Vasculitis (HCC) History of multiple myeloma History of thyroid cancer Multiple myeloma in relapse (HCC) Multiple myeloma not having achieved remission (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet acyclovir (ZOVIRAX) 400 MG tablet ALPRAZolam (XANAX) 0.25 MG tablet benzonatate (TESSALON) 100 MG capsule citalopram (CELEXA) 40 MG tablet dexamethasone (DECADRON) 4 MG tablet dexamethasone (DECADRON) 6
Allergien: erythromycin
Vorherige Impfungen: -

VAERS 2039480

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 79,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 21.04.2021
Beginn: 28.12.2021
Tage bis Beginn: 251,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bacteraemia COVID-19 Cough Death Endotracheal intubation General physical health deterioration Intensive care Pneumonia Respiratory failure SARS-CoV-2 test positive Sepsis Septic shock Staphylococcal infection

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/24/2021 and 4/21/2021. Presented to ER 12/28 due to cough and hypoxic respiratory failure. Admitted to floor, started therapy for sepsis and pneumonia. Tested positive for COVID 12/29 started decadron and remdesivir, continued to decline, transferred to ICU 12/31. Intubated 1/1. Completed COVID therapy, but severe respiratory failure continued. She then developed septic shock with CONS bacteremia. Continued to decline, expired 01/09/22.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: Positive COVID-19 on 12/29/21 using the Cepheid GeneXpert platform using PCR or equivalent Nucleic Acid Amplification technology.
Aktuelle Erkrankungen: -
Vorgeschichte: Anemia, Anxiety, Asthma, Cellulitis of leg, Chronic DVT, Chronic diastolic heart failure, CKD stage 3, Chronic Pain, Primary biliary cirrhosis, congenital absence of right kidney, depression, dysrhythmia, gout, granuloma annulare, hyperlipidemia, hypertension, morbid obesity (BMI 40 or greater), Osteoarthritis, Peripheral neuropathy, Peripheral vascular disease, H/O Pulmonary embolism, Seasonal allergic rhinitis, Sleep apnea, H/O squamous cell carcinoma, ulcerative colitis, urinary incontinence, varicose veins, venous insufficiency.
Andere Medikamente: Acetaminophen PRN, Allopurinol 100 mg QD, Aspirin 81 mg QD, Colchicine 0.6 mg QD PRN Gout, Docusate PRN, Gabapentin 600 mg QHS, Loratidine 10 mg QD, Losartan 100 mg QD, Metoprolol 25 mg QD, Mupirocin Ointment TID PRN, Nystatin powder TID, P
Allergien: ACE Inhibitors, Codeine, Doxycycline
Vorherige Impfungen: -

VAERS 2039270

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 91,0
Geschlecht: F
Eingang: 17.01.2022
Impfdatum: 18.03.2021
Beginn: 02.01.2022
Tage bis Beginn: 290,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Autopsy Bladder catheterisation Blood creatinine increased Blood pressure increased Brain natriuretic peptide increased C-reactive protein COVID-19 Cardiac arrest Cardiac failure congestive Chest X-ray abnormal Chronic obstructive pulmonary disease Cough Death Dyspnoea Echocardiogram abnormal Ejection fraction decreased

Symptomtext

91 y.o. female who was admitted on 1/2/2022 to the outside local Medical Center due to cough and shortness of breath. She was found to have COVID positive. She was started on steroid and antibiotics for possible superimposed bacterial infection. Patient found to be hypoxic. Echocardiogram was done and found to have severely decreased ejection fraction with global hypokinesis. Cardiology was consulted and recommended diuretics. Prognosis was discussed with patient and family members, patient transitioned to comfort care. Palliative care team was able to assist the patient who was found to be a systolic at 14:75 with family at the bedside. Patient was pronounced dead at 14:65. Family and loved ones at the bedside. Autopsy offered. #Pneumonia pneumonia, Chest x-ray with bilateral infiltrates more pronounced on the left. Likely from Covid. Decadron 6 mg daily, Trend Covid labs including CRP and D-dimer, As needed supplemental oxygen, Avoid aggressive volume replacement, #Acute on Chronic respiratory failure, #Increased Dyspnea with orthopnea, #COPD- likely multifactorial. CHF exacerbation vs underlying PNA- BNP 2,914- ECHO done and showed severely decrease SEF with global hypokinesis- Cardiology consulted- she was given Lasix 20 mg IV TID- Foley cath. was placed to monitor I&O- she was started on ceftriaxone and Azithiram for possible CAP. #DM2: allergy to NovoLog and changed to Humulin- SSI- Likely needs scheduled insulin with steroids. #Hypertension- BP currently mildly up- Resume home meds. #AKI on CKD 3:- Creatinine slightly up from baseline-Likely secondary to prerenal AKI. #Chronic microcytic anemia- Likely related to known HO CLL- Hgb at baseline. #History of CLL- Gets monthly Fulvestrant- Follow with Oncology as OP. #Hypothyroidism- Resume home meds.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: 91 yo female with a prior history of chronic respiratory failure on 3L O2 at baseline, DMII, CAD, HTN, CKD III, CLL
Andere Medikamente: -
Allergien: Atenolol, Codeine, Fluticasone, Januvia [sitagliptin], Nitroglycerin, Novolog [insulin aspart], Oxycodone, Statins-HMG-COA reductase inhibitors, and Sulfa (sulfonamide antibiotics)
Vorherige Impfungen: -

VAERS 2028077

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 84,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 07.04.2021
Beginn: 02.01.2022
Tage bis Beginn: 270,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Agonal respiration COVID-19 Chest X-ray abnormal Death Dyspnoea Mechanical ventilation Pneumonia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/18/2021 and 4/7/2021. Patient admitted to hospital on 1/2/2022 with complaints of worsening dyspnea. Patient received dexamethasone, remdesivir, enoxaparin, and antibiotics. On 1/4/2021, patient was transferred to hospital. Patient developed agonal breathing and required mechanical ventilation and vasopressor support. Patient expired on 1/5/2022 at 1325.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: 1/2/2022: Chest x-ray revealed multifocal pneumonia; 1/2/2022: Covid positive
Aktuelle Erkrankungen: -
Vorgeschichte: Pulmonary fibrosis, dyslipidemia, gastroesophageal reflux disease, hypertension, hyperlipidemia, depression, allergies, coronary artery disease
Andere Medikamente: atovastatin 40 md daily, plavix 75 mg daily, lidex 0.05% oint, topically twice daily, atarax 10-20 mg every 8 hours as needed for anxiety, lisinopril 10 mg daily, loratadine 10 mg daily, mirtazapine 7.5 mg nightly, sertaline 25 mg daily, ta
Allergien: augmentin, codeine, morphine
Vorherige Impfungen: -

VAERS 2658696

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 91,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: -
Beginn: 03.01.2022
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acquired diaphragmatic eventration Acute respiratory failure Aortic dilatation Atrial fibrillation COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Hypoxia Intensive care Lung infiltration Pneumonia Pulmonary fibrosis SARS-CoV-2 test positive Superinfection Tachycardia

Symptomtext

ADMITTED: JAN 3,2022 DISCHARGED: JAN 8,2022 DISCHARGE DIAGNOSIS: Acute Hypoxic Respiratory Failure due to Covid Pneumonia 90 yo Male w/ significant vascular history {CABG 1990's, EVAR 2020, bilateral LE amputations}, HTN, HLD here w/ abdominal pain found to be positive for COVID19 {fully vaccinated, boosted}. He was initially stable on room air without conversational dyspnea and was admitted for closer monitoring given his age and solitary living situation. However, within few hours of being on the floor, he had rapid escalation in O2 requirement {up to 12L oxymizer} and new tachycardia to 120 w/ AF RVR. He was transferred to the ICU for further care. Pt was quickly weaned to 10L oxymizer. Pt initially in A-fib w/ RVR during hypoxic episode, though became rate-controlled without intervention in the ICU. Acute Hypoxic Respiratory Failure in setting of COVID10, w/ concern for superimposed Pneumonia. Patient received remdesivir and prednisone and enoxaparin as described. Discharged to home when stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Date Test Name Result 01/03/2022@16:30 COVID-19 PCR {FLUVID CEPH} DETECTED Exam Date/Time 01/03/2022 17:30 Procedure Name CHEST-1 VIEW {AP/PA} Impression 1. Diffuse interstitial and alveolar infiltrates involving the right lower lobe, along with the lateral portion of the right upper lobe. 2. Left basilar pleural proximal scarring, without pleural effusion. 3. Status post median sternotomy and CABG, without cardiomegaly. 4. Chronic obstructive pulmonary disease. Report Technique: A single frontal view of the chest was performed. Prior chest x-ray available for comparison dated 9/24/2020. Findings: The patient is status post median sternotomy and CABG. Cardiac silhouette is normal in size. Diffuse ectasia of the thoracic aortic arch. Lung fields demonstrate mild chronic elevation left hemidiaphragm. There are diffuse alveolar and interstitial infiltrates within the right upper and lower lobes. Linear pleural-parenchymal scarring involving the left lower lobe without pleural fluid. No pneumothorax. Visualized osseous structures are unremarkable. Primary Diagnostic Code: SIGNIFICANT ABNORMALITY, ATTN NEEDED Secondary Diagnostic Codes: NONE
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2025716

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 54,0
Geschlecht: M
Eingang: 11.01.2022
Impfdatum: 20.10.2021
Beginn: 06.12.2021
Tage bis Beginn: 47,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/03/2020, 03/24/2021, and 10/20/2021. It is not specifically known if this person experienced symptoms of COVID-19 disease, but they tested positive on 12/06/2021 and 12/08/2021. They were admitted to hospital on 12/12/2021 and remained hospitalized until their death on 12/19/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 7,0
Labordaten: Positive COVID019 tests x2 despite being fully vaccinated
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2021614

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 62,0
Geschlecht: F
Eingang: 10.01.2022
Impfdatum: 06.04.2021
Beginn: 10.12.2021
Tage bis Beginn: 248,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 Cerebrovascular accident Coronary artery disease Death Peripheral vascular disorder Pulmonary oedema Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which death occurred. The individual was vaccinated with the Pfizer product on 03/16/2021 and 04/06/2021. They became symptomatic on 12/07/2021 and tested positive on 12/10/2021. They were admitted to hospital on 12/09/2021 with a primary complaint of CVA evaluation. They were discharged on 12/11/2021 but then re-admitted on 12/15/2021. They remained hospitalized until their death on 12/20/2021. Death Certificate details are as follows: Part I Cause of Death A: Hypoxemic Respiratory Failure B: Pulmonary Edema C: COVID 19 Part II Other Significant Conditions: Severe Coronary Artery Disease, Severe Peripheral Vascular Disease

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 7,0
Labordaten: Positive COVID-19 test despite being fully vaccinated against COVID-19.
Aktuelle Erkrankungen: Admitted to hospital 12/09/2021-12/11/2021 for cerebrovascular accident
Vorgeschichte: COPD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2005697

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 61,0
Geschlecht: M
Eingang: 05.01.2022
Impfdatum: 05.04.2021
Beginn: 04.01.2022
Tage bis Beginn: 274,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood lactic acid C-reactive protein COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Dyspnoea Electrocardiogram ST segment abnormal Fibrin D dimer increased Procalcitonin Pulmonary congestion Pyrexia Respiratory failure SARS-CoV-2 test positive Septic shock Serum ferritin increased Sinus tachycardia Troponin I increased Vomiting

Symptomtext

Patient arrived to the ED on 1/4/2022 with fever (up to 103), vomiting and shortness of breath (for past couple of "days") Patient admitted for septic shock, covid19 pneumonia, respiratory failure requiring high levels of oxygen via high flow nasal cannula, started on Remdesivir and steroids. Cardiac consult obtained, noted the following: Elevated troponin I level Check serial troponins, cannot exclude myocarditis will get a limited bedside echocardiogram to look at LV and RV function.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: -
Labordaten: 01/04/2022 COVID19 Rapid positive The following tests were all obtained on 01/04/2022 : D DIMER 0.95 Troponin 1165 CRP 1.6 Lactic Acid 5.5 Ferritin 369 Procalcitonin 8.52 WBC 21.5 CXR: IMPRESSION: Cardiomegaly, pulmonary vascular congestion and increased pulmonary interstitial prominence. Findings could be selectively pulmonary edema. Interstitial infectious process cannot be excluded. EKG demonstrates sinus tachycardia with mild inferior ST changes
Aktuelle Erkrankungen: -
Vorgeschichte: 1 pack per day smoking history Diabetes mellitus Chronic Kidney Disease
Andere Medikamente: None
Allergien: NKA
Vorherige Impfungen: -

VAERS 2532978

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 74,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 26.03.2021
Beginn: 05.04.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Atrial flutter Cardiac failure Death Intensive care Life expectancy shortened Mitral valve stenosis

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. Patient was brought to the ED on 3/15/21 and transferred to another hospital MICU for decompensated heart failure and atrial flutter in the setting of severe mitral stenosis suffering with acute hypoxic respiratory failure. Attending predicted with patient's severe mitral stenosis he did not have but 1-2 months of life left. He was transitioned to palliative care and transferred to inpatient hospice on 3/23/21 where he passed away on 4/5/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2002153

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 72,0
Geschlecht: M
Eingang: 04.01.2022
Impfdatum: 21.04.2021
Beginn: 04.05.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Cardiogenic shock Death Malaise SARS-CoV-2 test positive Septic shock Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough disease after which death occurred. The individual was vaccinated with the Pfizer COVID-19 vaccine on 03/30/2021 and 04/21/2021. The individual became symptomatic for COVID-19 disease on 05/01/2021 and tested positive via PCR on 05/04/2021. The individual was admitted to the hospital on 05/04/2021, stabalized, and discharged 05/08/2021. The individual was then re-admitted on 05/12/2021. An additional PCR test was positive on 05/16/2021. The individual remained hospitalized until their death on 06/02/2021. Death Certificate details are as follows: Part I: Cause of Death: A. Acute Hypoxic Respiratory Failure B. Septic Shock C. Cardiogenic Shock D. COVID-10 Part II: Other Significant Conditions: None Listed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 25,0
Labordaten: Positive PCR tests for COVID-19 x2 despite being fully vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Rheumatoid arthritis; History of atrial fibrillation, hypertension, history of traumatic brain injury,
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1999651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 78,0
Geschlecht: M
Eingang: 03.01.2022
Impfdatum: 19.10.2021
Beginn: 01.01.2022
Tage bis Beginn: 74,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

fully vaccinated covid related death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Hx of CLL; DM; COPD; a-fib; CAD; HLD; HTN; obesity
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498920

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 81,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 18.03.2021
Beginn: 30.03.2021
Tage bis Beginn: 12,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiac failure congestive Cardiac output decreased Cardiogenic shock Catheterisation cardiac abnormal Computerised tomogram thorax abnormal Echocardiogram abnormal Left ventricular dysfunction Left ventricular failure Pulmonary embolism Pulmonary hypertension Right ventricular failure Systolic dysfunction Ventricular failure Ventricular hypokinesia

Symptomtext

Narrative: Patient developed symptoms within 3 days of 2nd COVID-19 vaccination that by day 10 resulted in hospitalization and diagnosis of unprovoked bilateral pulmonary emboli, with resultant recurrent hospitalizations over the next 2 months for progressive right and now left heart failure and worsening RV/LV systolic function.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: CT PE protocol 3/30/21 with multiple pulmonary emboli bilateral lungs in multiple lobes. Echo with RV hypokinesia with evidence of pressure overload on 3/31/21. Repeat echo 2 months later with biventricular heart failure and LV/RV systolic dysfunction all new. Cardiac cath 5/21/21 with nonobstructive coronaries but moderate pulmonary hypertension and very low cardiac output/index of 2.0/1.0 c/w cardiogenic shock followed by a transient
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2498853

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 02.01.2022
Impfdatum: 24.03.2021
Beginn: 13.05.2021
Tage bis Beginn: 50,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Craniectomy Death Deep vein thrombosis Headache Meningitis Pulmonary embolism Vision blurred

Symptomtext

Narrative: Patient was not previously COVID-19 positive and did not have any predisposing factors(PMH, allergies, etc.) for experiencing an adverse drug event. The ADR did not occur at the time of the administration of the vaccine nor was there an ADR that occurred between the observation period and the date of death. PMH significant for hx of subdural intracranial hematoma, cognitive disorder, functional gait abnormality, dysphagia with peg tube placement. Patient was taken to outside entity hospital on 4/30/21 with CC of blurriness and headache. Was admitted and diagnosed with meningitis. Craniectomy and washout performed 5/1. Also suffered from P/E and DVT. Patient deceased 5/13/2021. Lack of information regarding death and hospital records.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1992155

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 72,0
Geschlecht: F
Eingang: 30.12.2021
Impfdatum: 23.03.2021
Beginn: 14.09.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary normal Anticoagulant therapy COVID-19 COVID-19 pneumonia Chest X-ray abnormal Endotracheal intubation Lung opacity SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: patient hospitalized with COVID-19 pneumonia leading to acute hypoxemic respiratory failure requiring intubation. Received steroids, remdesivir, anticoagulation, and oxygen. Recovered and discharged to inpatient physical rehabilitation unit then to home medically stable on oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: SARS-CoV-2: positive CTA-PE: negative Chest x-ray: multifocal peribronchovascular and peripheral bandlike groundglass opacities involving all lobes, in keeping with COVID 19 pneumonia.
Aktuelle Erkrankungen: none reported
Vorgeschichte: alopecia, dibetes mellitus type 2, hypertension, hypothyroidism, asthma
Andere Medikamente: albuterol, vitamin C, azelastine, vitamin B12, vitamin D, finsteride, Synalar, griseofulvin, HCTZ, letoconazole shampoo, levothyroxine, losartan, loratadine, meclizine, meloxicam, metformin, metronidazole gel, multivitamin, omega-3, prednis
Allergien: cefaclor, codeine, lisinopril, sulfa
Vorherige Impfungen: -

VAERS 2521749

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 79,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Death

Symptomtext

Narrative: A 78yo with PMH of General Weakness, abnormal findings with diagnostng imaging of urinary organs, Primary Malignant Neoplasm of Prostate, Gout HTN, Onychomycosis and Dysphagia Received Pfizer Covid - 19 vaccine per policy and protocol without complications First dose on February 22, 2021 and the second dose March 15, 2021 NO ADE reported The system showed this patient passed away April 9, 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1989050

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MT
Alter: 91,0
Geschlecht: F
Eingang: 29.12.2021
Impfdatum: 11.03.2021
Beginn: 13.11.2021
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Asthenia Blood lactic acid COVID-19 COVID-19 pneumonia Confusional state Delirium Drug tolerance decreased Infection Lactic acidosis Metabolic encephalopathy Multiple organ dysfunction syndrome SARS-CoV-2 RNA SARS-CoV-2 test positive Somnolence Viral sepsis

Symptomtext

Case was hospitalized for Covid 8 months after completing primary series of Pfizer Covid vaccine. Hospitalized at: Hospital. Discharging physician: MD. * Acute hypoxemic respiratory failure due to COVID-19 Assessment & Plan Diagnosed at MC 11/10 and started on dexamethasone for at that time. Presented to Hospital 11/13 with worsening weakness, confusion. Had difficulty tolerating PO dexamethasone 2/2 GI upset. Continued on dexamethasone on admission in addition to supportive therapies. With worsening weakness, confusion, elected to transition to comfort care 11/19. - Discharged with hospice to the Facility Severe sepsis with acute organ dysfunction Assessment & Plan 4:31 PM 11/30/2021 Source of Infection: Viral Sepsis (including COVID-19) SIRS Criteria: Temp >38 C or < 36 C, HR > 90 and RR > 20 Acute Organ Dysfunction: Acute Respiratory Failure, Acute Metabolic Encephalopathy and Lactic Acidosis (Lactate > 2.0) Shock: Not Present Based on the above findings, the patient has evidence of: Severe sepsis (Sepsis + Acute organ dysfunction) Less than 30ml/kg bolus was ordered given p/w COVID PNA and no evidence of shock physiology. In addition, lactate normalized with 1L IVF in the ER. - Physiology has long since resolved. Weakness Assessment & Plan Due to cvoid-19 pneumonia. Now on comfort care. Acute metabolic encephalopathy Assessment & Plan Suspect initially driven by COVID and steroid use. Since then, ongoing hypoactive delirium. Mostly lays in bed sleepy. Suspect close to her new baseline. Now on comfort care

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 18,0
Labordaten: Ordered Test: SARS-CoV-2 RNA Resp Ql NAA+probe (SARS CoV-2 PCR (In House)) Ordered Test Codes: (L LOCAL) Status: Final Accession Number: Specimen Source: Nasopharynx Specimen Site: Specimen Collection Date/Time: 2021-11-10 09:21:00.0 Results: * Resulted Test: SARS-CoV-2 RNA Resp Ql NAA+probe (SARS CoV-2 PCR (COVID-19)) Coded Result: Positive (LOCAL) Numeric Result: Units: Text Result: Reference Range From: Negative Reference Range To: Performing Facility Details: Date/Time: 2021-11-10 10:06:49.0 Performing Facility: Med Cntr Facility ID: Interpretation: Abnormal Result Method: (Xpert Xpress SARS-Co) Status: Final Test Code: (L LOCAL) Result Code: (SCT/Positive (L LOCAL) Result Comments: Positive results are indicative of active infection with SARS-CoV-2. Positive results do not rule out bacterial infection or co-infection with other viruses
Aktuelle Erkrankungen: ? HLD (hyperlipidemia) 11/1/2017 ? Hypothyroidism 11/1/2017 ? Macular degeneration 11/1/2017 ? Non-healing ulcer of lower extremity, right, with unspecified severity 11/1/2017 ? Osteoarthritis 11/1/2017 ? Peripheral neuropathy 11/1/2017 ? PVD (peripheral vascular disease) 11/1/2017 ? Venous insufficiency of both lower extremities 11/1/2017 Extensive venous procedures in past per Dr.
Vorgeschichte: ? HLD (hyperlipidemia) 11/1/2017 ? Hypothyroidism 11/1/2017 ? Macular degeneration 11/1/2017 ? Non-healing ulcer of lower extremity, right, with unspecified severity 11/1/2017 ? Osteoarthritis 11/1/2017 ? Peripheral neuropathy 11/1/2017 ? PVD (peripheral vascular disease) 11/1/2017 ? Venous insufficiency of both lower extremities 11/1/2017 Extensive venous procedures in past per Dr.
Andere Medikamente: Polyethelene Glycol Powder qd Gabapentin 300 Mg tid
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1989039

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 70,0
Geschlecht: F
Eingang: 29.12.2021
Impfdatum: 23.03.2021
Beginn: 26.10.2021
Tage bis Beginn: 217,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Arthralgia COVID-19 Death Diarrhoea Dyspnoea Endotracheal intubation Intensive care Mechanical ventilation Pyrexia Renal impairment SARS-CoV-2 test positive

Symptomtext

pt admitted to hospital; found to be positive for COVID 7 days prior; presents to hosp with increasing SOB, fever, joint pains, diarrhea; O2 supplementation via NC and face mask, O2 sats between 70 - 80 % depending on exertion); worsening renal function; worsening O2 requirements; required intubation with mechanical vent; placed on antibiotics and steroids; pt's condition worsened and she died in the ICU

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, OSA, CAD
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1988768

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 81,0
Geschlecht: M
Eingang: 29.12.2021
Impfdatum: 19.03.2021
Beginn: 16.08.2021
Tage bis Beginn: 150,0
Dosis: 2
Route/Site: IM / OT

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Agitation COVID-19 pneumonia Cough

Symptomtext

Admit for COVID 19 Pneumonia with acute hypoxic respiratory failure--with cough as presenting symptom.On IV solumedrol, zinc, singulair, pepcid, Remdesivir 8/18-8/27. Toci given 8/19/21. Rocephin/doxy d/c'd. His O2 requirements worsened with worsening agitation. Family elected to pursue hospice care. DC to HCF. Disposition:He will be dischargedtodayto inpatient hospiceHCF

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 39,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1984702

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 28.12.2021
Impfdatum: 13.03.2021
Beginn: 27.12.2021
Tage bis Beginn: 289,0
Dosis: 1
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Asthenia COVID-19 Mental status changes Nasopharyngitis Sepsis

Symptomtext

Pt has a history of recurrent lung cancer, CAD, COPD, and CKD. Pt came to ER due to weakness and altered mental status. She started with cold like symptoms one week prior. Pt admitted for acute hypoxic respiratory failure due to COVID and sepsis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1981923

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TN
Alter: 70,0
Geschlecht: M
Eingang: 27.12.2021
Impfdatum: 21.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 157,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Death Dyspnoea Endotracheal intubation SARS-CoV-2 test positive

Symptomtext

EMS transported pt to hospital with c/o SOB; O2 sats in 50s on RA; placed on NRB and O2 sats were in the 70s; pt intubated; positive for COVID; treated with remdesivir, decadron, lovenox; per death certificate pt died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1971472

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 65,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 17.03.2021
Beginn: 18.09.2021
Tage bis Beginn: 185,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute kidney injury Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: six months after vaccination patient hospitalized for COVID-19 infection, acute hypoxic respiratory insufficiency, and acute kidney injury. Received steroids and antiviral agents and improved. Discharged to home medically stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 4,0
Labordaten: SARS-CoV-2: positive
Aktuelle Erkrankungen: UTI
Vorgeschichte: Hyperlipidemia, hypertension, type 2 diabetes mellitus, glaucoma, cataract, kidney transplant, anemia, seizure disorder, TIA, CVA.
Andere Medikamente: Aspirin, vitamin D3, finasteride, insulin, latanoprost, levothyroxine, lovastatin, magnesium hydroxide, mycophenolate, omeprazole, prednisone, tacrolimus, tamsulosin
Allergien: None reported
Vorherige Impfungen: -

VAERS 1971401

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 59,0
Geschlecht: F
Eingang: 22.12.2021
Impfdatum: 11.03.2021
Beginn: 06.05.2021
Tage bis Beginn: 56,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure COVID-19 Pneumonia

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: two months after vaccination patient hospitalized with COVID-19 acute hypoxemic respiratory failure and pneumonia. Received steroids, oxygen, and antimicrobials. Patient improved and discharged to home medically stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Waldenstrom macroglobulinemia, hypogammaglobulinemia, osteopenia, scoliosis, insomnia, chronic fatigue
Andere Medikamente: acyclovir, benzonatate, escitalopram, multivitamin, ondansetron, trazodone
Allergien: None reported
Vorherige Impfungen: -

VAERS 1955128

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: 25.03.2021
Beginn: 11.11.2021
Tage bis Beginn: 231,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 COVID-19 pneumonia Condition aggravated Death Dyspnoea Endotracheal intubation Intensive care Respiratory acidosis Respiratory failure SARS-CoV-2 test positive

Symptomtext

patient presented to emergency department on 11/11/21 with shortness of breath patient was admitted for further management of pneumonia due to covid-19 patient did require treatment for symptoms associated with covid-19 infection. treatment included dexamethasone, remdesivir and baricitinib patient required intubation on 11/17/21 and transferred to intensive care unit patient expired on 12/6/21 due to hypoxemic respiratory failure and compensated respiratory acidosis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 25,0
Labordaten: tested at hospital: covid-19 test positive on 11/11/21
Aktuelle Erkrankungen: unknown
Vorgeschichte: Cardiac and Vasculature Hyperlipidemia, unspecified hyperlipidemia type HTN (hypertension) Venous stasis Essential hypertension Endocrine and Metabolic Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) Gastrointestinal and Abdominal GERD (gastroesophageal reflux disease) Inguinal hernia, left Hematology and Neoplasia Mantle cell lymphoma (HCC) H/O prostate cancer Mantle cell lymphoma, unspecified body region (HCC) Other TIA (transient ischemic attack) Edema Diabetic polyneuropathy associated with type 2 diabetes mellitus (HCC) Pneumonia due to COVID-19 virus Pneumonia of right middle lobe due to infectious organism Pneumonia of left lower lobe due to infectious organism Hypoxia
Andere Medikamente: atorvastatin (LIPITOR) 20 MG tablet clopidogrel (PLAVIX) 75 MG tablet lisinopril (PRINIVIL) 10 MG tablet metoprolol succinate (TOPROL XL) 50 MG SR tablets omeprazole (PRILOSEC) 20 MG DR capsule ondansetron, disintegrating, (ZOFRAN ODT)
Allergien: aspirin
Vorherige Impfungen: -

VAERS 1954925

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

kritisch

Staat: WI
Alter: 78,0
Geschlecht: M
Eingang: 16.12.2021
Impfdatum: -
Beginn: 07.05.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

fully vaccinated-covid releated death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1952654

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 79,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 28.02.2021
Beginn: 20.07.2021
Tage bis Beginn: 142,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Pulmonary embolism Sudden death

Symptomtext

On July 20, 2021 I found my mother deceased in her home. She was not sick and died suddenly and unexpectedly of a cardiopulmonary embolism.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: COPD
Andere Medikamente: No
Allergien: No
Vorherige Impfungen: -

VAERS 1951325

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 12.03.2021
Beginn: 12.12.2021
Tage bis Beginn: 275,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute myocardial infarction

Symptomtext

NSTEMI (non-ST elevated myocardial infarction)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1951256

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 77,0
Geschlecht: F
Eingang: 15.12.2021
Impfdatum: 18.03.2021
Beginn: 11.12.2021
Tage bis Beginn: 268,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia

Symptomtext

Acute hypoxemic/failure, secondary to COVID-19 viral pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1947895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 68,0
Geschlecht: F
Eingang: 14.12.2021
Impfdatum: 17.03.2021
Beginn: 23.11.2021
Tage bis Beginn: 251,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Death Mechanical ventilation Oxygen saturation decreased SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 2/24/2021 and 3/17/2021 .68/F PMHx DMII, HTN, morbidly obese, hypo and hyperthyroidism, asthma and depression. Covid-19 + was going to get monoclonal antibody infusion but sats were in the low 80's subsequently told to report to the ED. Presented with acute hypoxic respiratory failure 2/2 Covid-19 PNA. Tx'd w/decadron, Tocilizumab, remdisivir, Lovenox and O2. Per pt. request care not escalated beyond non-invasive ventilation. Expired 12/09/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Depression, DM Type 2, GERD, Hypertension, Hyperlipidemia, Hypothyroidism, Asthma, Anxiety
Andere Medikamente: Albuterol MDI PRN, Amlodipine 5 mg QD, Benazepril 10 mg QD, Additional information for Item 9: Biotin QD, Calcipotriene cream BID, Cholecalciferol 125 mcg QD, Duloxetine 30 mg QD, Furosemide 40 mg QD, Icosapent ethyl 2 grams BID, Levothyro
Allergien: Celecoxib, Kiwi, Terconazole, Poria Mushroom, Sulfanilamide, Additional information for Item 10: Tetracyclines, Zucchini, Buproprion, Cefdinir, Sulfa antibiotics 68/F PMHx DMII, HTN,morbidly obese, hypo and hyperthyroidism, asthma and depression was going to get monoclonal antibody infusion but sats were in the low 80's. She was told to report to the ED. Presented with acute hypoxic respiratory failure 2/2 Covid-19 PNA. Tx'd w/decadron, Tocilizumab, remdisivir, Lovenox and O2. Per pt. request care not escalated beyond non-invasive ventilation. Expired 12/09/21.
Vorherige Impfungen: -

VAERS 1943660

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 58,0
Geschlecht: F
Eingang: 13.12.2021
Impfdatum: 01.04.2021
Beginn: 05.12.2021
Tage bis Beginn: 248,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic obstructive pulmonary disease Condition aggravated Cough Decreased appetite Diarrhoea Fatigue Hypoxia N-terminal prohormone brain natriuretic peptide abnormal Nasopharyngitis Nausea Procalcitonin normal SARS-CoV-2 test positive Synovial cyst

Symptomtext

Hospitalized 12/5/2021; COVID-19 positive 12/5/2021; fully vaccinated BRIEF OVERVIEW: Admission Date: 12/5/2021 Discharge Date: 12/8/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia Pneumonia due to COVID-19 virus HOSPITAL COURSE BY PROBLEM: * Pneumonia due to COVID-19 virus Assessment & Plan Patient is a 59-year-old female with a history of AFib on Xarelto, OSA on BiPAP, hypertension, morbid obesity, diastolic congestive heart failure, chronic obstructive pulmonary disease, bariatric surgery, presenting to our institution with cough and fatigue. She had associated nausea, poor appetite and vomiting, she also reported diarrhea. Symptom onset is approximately 1 week before presentation though she was having cold-like symptoms around Thanksgiving. In the emergency department she was found to be mildly hypoxic with O2 saturations 89%. She tested positive for COVID-19, the patient had been vaccinated but had not had booster. Chest x-ray concerning for bilateral infiltrates. She was admitted to the general medicine service for management of COVID-19 pneumonia. She was started on dexamethasone 6 mg daily as well as remdesivir. Patient rapidly weaned off of supplemental oxygen, remaining on room air at rest and with activity. In regards to her chronic obstructive pulmonary disease she likely had a mild exacerbation with good response to bronchodilator therapy and dexamethasone 6 mg daily. Her CRP was trended, improving from 77 to 29.3. Procalcitonin was negative. NT proBNP was normal. Doppler ultrasound of the lower extremities revealed no evidence of DVT, though she does have a left-sided popliteal cyst. Symptoms improved, she worked with physical therapy and occupational therapy and was felt to be safe for home with assist. She is weaned off of oxygen. Will continue dexamethasone 6 mg daily to complete a 10 day course. Is advised to return to the hospital she has any worsening symptoms or swelling in the lower extremities. She is advised to pursue a COVID-19 booster when she recovers from her COVID-19 illness and is out of isolation, she should also receive an influenza vaccination and be considered for Prevnar 13. She will discuss this with her primary care physician

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA (obstructive sleep apnea) COPD (chronic obstructive pulmonary disease) Pneumonia due to COVID-19 virus Atrial fibrillation Mitral regurgitation PFO (patent foramen ovale) Chronic diastolic congestive heart failure Essential hypertension Morbid obesity with BMI of 45.0-49.9, adult GERD (gastroesophageal reflux disease) Morbid obesity due to excess calories Diverticular disease Arthritis of knee, left Anemia, unspecified type Chronic bilateral low back pain with sciatica, sciatica laterality unspecified Syncope, unspecified syncope type Abdominal pain Bilateral sciatica Hyperlipidemia Hypomagnesemia Prediabetes Chronic gout without tophus Hx of bariatric surgery Vertigo Depression with anxiety Preop cardiovascular exam Long QT interval
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL, VENTOLIN, PROAIR) 108 (90 Base) MCG/ACT inhaler atorvastatin (LIPITOR) 40 MG tablet dexamethasone (DECADRON) 6 MG tablet fexofenadine (ALLEGRA) 60 MG tablet flecainide (TAMBOCOR) 5
Allergien: NKA
Vorherige Impfungen: -

VAERS 1936517

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 48,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 30.03.2021
Beginn: 24.10.2021
Tage bis Beginn: 208,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Distributive shock Respiratory failure SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is an instance of breakthrough COVID-19 disease after which a death occurred. The individual was vaccinated with the Pfizer product on 03/09/2021 and 03/30/2021. The individual became symptomatic on 10/18/2021 and a PCR test on 10/19/2021 was negative. However, an additional test done on 10/24/2021 was positive via PCR. The individual was admitted to the hospital on 10/24/2021 and discharged on 10/30/2021. However, they were re-admitted on 11/11/2021. Another additional PCR test was positive on 11/13/2021. They remained hospitalized until their death on 11/23/2021. Death certificate details are as follows: Part I Cause of Death A: Hypoxemic Respiratory Failure B: COVID 19 Part II Other Significant Conditions: Distributive Shock, Multiple Sclerosis

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 18,0
Labordaten: Positive COVID-19 PCR tests x2 despite being fully vaccinated.
Aktuelle Erkrankungen: -
Vorgeschichte: Multiple Sclerosis
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1935653

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 09.12.2021
Impfdatum: 15.03.2021
Beginn: 08.12.2021
Tage bis Beginn: 268,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute myocardial infarction Atrial fibrillation COVID-19 COVID-19 pneumonia Dyspnoea exertional Hypomagnesaemia

Symptomtext

Pneumonia due to COVID-19 virus; Hypomagnesemia; Type 2 MI (myocardial infarction); Paroxysmal atrial fibrillation with RVR; Dyspnea on minimal exertion

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1933583

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 08.12.2021
Impfdatum: 15.03.2021
Beginn: 05.12.2021
Tage bis Beginn: 265,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Agitation Anaemia Angiogram abnormal Anticoagulant therapy Arterial catheterisation Atrial fibrillation Bladder catheterisation Blood creatinine increased Blood culture negative Blood lactic acid increased Blood pressure systolic decreased Brain natriuretic peptide increased Bronchitis Bundle branch block right Chills Cholelithiasis Condition aggravated

Symptomtext

Patient currently admitted at (3) days for inpatient treatment. H& P: Patient is a 80 y.o. male with past medical history chronic thromboembolic pulmonary hypertension after saddle embolus in 2016 on 2 L of oxygen baseline, recently diagnosed myelodysplastic syndrome and type 2 diabetes who presented with acute hypoxic respiratory failure due to COVID-19 pneumonia. Patient reports that 3 days prior to presentation he started having significant shortness of breath, cough as well as having diarrhea for couple of days. He also notes chills and significantly decreased appetite and fatigue. On the day admission he called EMS who found him at home with oxygen saturation 50%. Of note on 12/1 patient was diagnosed with bronchitis started on prednisone 20 mg for 5 days. He notes that this would be the last day of steroid treatment. When brought to the emergency room he was initially started on high-flow nasal cannula, however he did not tolerate this well and became agitated and said there put on BiPAP. He is also given DuoNeb treatment due to wheezing heard on exam and 10 mg Decadron. The patient was febrile on presentation and tachycardic. Chest x-ray was obtained which was consistent with COVID pneumonia and COVID PCR was positive. Lab evaluation was significant for BNP elevated to 7000 when previously was normal, initial lactic was elevated to 2.6 but then decreased to 1.5. Also noted was a low hemoglobin of 7.3, however patient has been recently diagnosed with myelodysplastic syndrome and this lab finding has been stable since August. White blood cell count was not significantly elevated at 4.14. Troponins were collected and had a delta 103. The emergency department did discuss with Cardiology who recommended ordering an echo and starting high-intensity heparin drip for a possible PE. EKG showed atrial fibrillation with right bundle-branch block with no significant ST elevation or depression. CTA was not obtained due to elevated creatinine. The patient reports feeling significantly improved after the initiation BiPAP and son confirms that patient looks more comfortable. Of note the patient had received 2 COVID vaccines. He was waiting to receive the booster vaccine until he was able to talk with hematologist in light of his recent diagnosis of myelodysplastic syndrome. Unfortunately, he became ill before this discussion could take place. Plan: Patient is an 80 male with past medical history chronic thromboembolic pulmonary hypertension after saddle embolus in 2016 on 2 L of oxygen baseline, recently diagnosed myelodysplastic syndrome and type 2 diabetes who presented with acute hypoxic respiratory failure due to COVID-19 pneumonia. Acute on chronic Hypoxic Respiratory failure secondary to COVID-19 pneumonia Prior saddle embolus in 2016 leading to chronic thromboembolic pulmonary hypertension on long term xarelto and requiring 2L of O2 with activity and nightly CPAP. Now with hypoxia requiring BIPAP secondary to COVID-19 infection. - BiPAP, wean as tolerated - Methylprednisolone 40 mg BID, can wean to decadron 6mg as patient improves - Remdesivir 200mg now and then 100mg daily for 5 days total - Daily CMP, CBC, CRP, D-dimer - NPO, on IVF (1mL/kg/hr) while on BiPAP due to concern for decompensation - blood cultures pending CTEPH (Chronic thromboembolic pulmonary hypertension) Concern for possible PE Elevated Troponin Patient with in 2016 leading to CTEPH requiring supplemental oxygen at baseline. Now with hypoxia down to 50% saturation requiring BiPAP. Due to significant hypoxia as well slightly elevated D-dimer to 590, significant history of prior PE, significantly elevated troponin, concerned that he could PE now. - Trend troponins q6 hours, can discontinue once improving - Obtain CTA - Per cardiology recommendations, start heparin gtt - Echo pending - Cardiology consult in light of elevated troponins and concern for right heart strain - continue home Adempas Anemia due to myelodysplastic syndrome Patient being followed with Hematology due to various cytopenias including low hemoglobin. Recently diagnosed with myelodysplastic syndrome the bone marrow biopsy. Hemoglobin on admission 7.3 which is stable over the last several months. - Follow with daily CBCs - transfuse if less than 7 Hypertension - Hold home losartan in setting lower systolic blood pressures in 130s and with slightly elevated creatinine CKD stage 3 Elevated creatinine Creatinine on admission 1.67, previously on 11/10 was 1.69 and in 08/2021 was 1.54. Creatinine not significantly elevated from baseline. Does not meet criteria for AKI - will monitor daily in light of remdesivir and receiving contrast with CTA - hold home losartan for now Diabetes Mellitus type 2 Last HbA1c on 11/10/21 4.9. On metformin at home - 24 hour corrective insulin Fluids: Normal Saline at 100 mL/hr (being cautious in light of pulmonary hypertension and lower extremity edema) Diet: NPO while on BIPAP Lines/Tubes/Drains: PIV DVT Ppx: treatment heparin gtt Code Status: full Dispo: Admit to inpatient

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: USV Venous Lower Extremity Duplex Bilateral Collected: 12/08/21 1337 Order Status: Completed Updated: 12/08/21 1451 Narrative: EXAMINATION: Complete Right and Left Lower Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 12/8/2021 1:37 PM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left lower extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: COVID positive, non-ambulatory due to desaturation, D-Dimer increase COMPARISON: None _____________________ Right Lower Extremity Findings: Right Common Femoral Vein: No DVT. Right Femoral Vein: No DVT. Right Popliteal Vein: No DVT. Right Posterior Tibial Veins: Not well visualized. Right Peroneal Veins: No DVT. Right Gastrocnemius Veins: Occlusive acute DVT is present. Right proximal Greater Saphenous Vein: No thrombus. Left Lower Extremity Findings: Left Common Femoral Vein: No DVT. Left Femoral Vein: No DVT. Left Popliteal Vein: No DVT. Left Posterior Tibial Veins: No DVT. Left Peroneal Veins: No DVT. Left proximal Greater Saphenous Vein: No thrombus. Duplex Doppler: Spectral Doppler demonstrates bilateral normal respirophasic waveforms in the common femoral veins. Additional Findings: None. _____________________ Impression: Acute occlusive DVT is demonstrated within the right gastrocnemius veins. No deep venous thrombosis is demonstrated within the left lower extremity. The orange significant findings protocol was initiated at 12/8/2021 2:10 PM. The presence of a significant findings result is to be communicated with a clinician and/or clinical staff by support staff. * USV Venous Upper Extremity Duplex Bilateral Resulted: 12/08/21 1416 Order Status: Completed Updated: 12/08/21 1418 Narrative: EXAMINATION: Complete Bilateral Upper Extremity Venous Duplex Doppler Ultrasound EXAM DATE: 12/8/2021 1:38 PM TECHNIQUE: Real-time B-mode imaging with and without compression was used to evaluate the right and left upper extremity for deep venous thrombosis (DVT). Duplex Doppler with color and spectral Doppler was used. INDICATION: COVID positive, non-ambulatory due to desaturation, D-dimer elevation COMPARISON: None _____________________ Right Upper Extremity Findings: Right Internal Jugular Vein: No thrombus. Right Subclavian Vein: No thrombus. Right Axillary Vein: No thrombus. Right Brachial Vein: No thrombus. Right Radial Vein: No thrombus. Right Ulnar Vein: No thrombus. Superficial Veins: Right Basilic Vein: No thrombus. Right Cephalic Vein: No thrombus. Left Upper Extremity Findings: Left Internal Jugular Vein: No thrombus. Left Subclavian Vein: No thrombus. Left Axillary Vein: No thrombus. Left Brachial Vein: No thrombus. Left Radial Vein: No thrombus. Left Ulnar Vein: No thrombus. Superficial Veins: Left Basilic Vein: No thrombus. Left Cephalic Vein: A small amount of thrombus is seen in the cephalic vein just above the level the elbow. Median Antecubital Vein: Thrombus is demonstrated in the medial and antecubital vein at the site of the IV. ADDITIONAL FINDINGS: Normal cardiac pulsatility is present in the subclavian veins. _____________________ Impression: Acute superficial thrombophlebitis is demonstrated in the left cephalic vein. There is no evidence of deep venous thrombosis in the visualized veins of the deep system in the left and right upper extremity. DR CHEST SINGLE VIEW Resulted: 12/08/21 0851 Order Status: Completed Updated: 12/08/21 0853 Narrative: EXAMINATION: Single View Chest EXAM DATE: 12/8/2021 7:05 AM TECHNIQUE: Single view chest INDICATION: COVID COMPARISON: 12/5/2021 ENCOUNTER: Not applicable _________________________ FINDINGS: The heart is enlarged. There is obscuration of the pulmonary vasculature. Diffuse bilateral groundglass opacities which appears slightly improved compared to the prior examination. No large pleural effusion or definite pneumothorax. _________________________ Impression: Slightly improved bilateral opacities. DR CHEST SINGLE VIEW Resulted: 12/06/21 0119 Order Status: Completed Updated: 12/06/21 0121 Narrative: EXAMINATION: Single View Chest EXAM DATE: 12/6/2021 12:09 AM TECHNIQUE: Single view chest INDICATION: hemopytsis. Covid positive. COMPARISON: 12/5/2021, 0857 hours ENCOUNTER: Not applicable _________________________ FINDINGS: Increasing diffuse bilateral hazy groundglass opacities with short segment areas of mild nodularity new from prior. The new opacities are most pronounced on the right within the upper lobe and on the left within both the lower lung field and upper lung field. Heart size is within normal limits. Pulmonary vascularity is the most part obscured. No sizable effusion or discernible pneumothorax. _________________________ Impression: Worsening appearance of the chest as discussed. Findings may be on the basis of progression of the patient's Covid pneumonia but given elements of minimal background nodularity suggestive of minimal areas of alveolar filling, pulmonary hemorrhage in these locations is also a possibility. CV Echo Limited Collected: 12/05/21 1550 Order Status: Completed Updated: 12/05/21 1646 Narrative: Heart Center LIMITED ECHOCARDIOGRAPHY REPORT Name: Study Date: 12/05/2021 MRN: Patient Location: DOB: Patient Class: Inpatient Gender: Male Ordering Physician: Age: 80 yrs Height: 180 cm Performed By: RDCS Weight: 94 kg Resting HR: 53 BSA: 2.1 m2 Resting BP: 125/62 mmHg Reason For Study: Chest pain/anginal equiv, ECGs or troponins abnormal, Dyspnea on exertion (DOE), rising troponins, covid positive History/Symptoms: Covid positive, Pulmonary embolism, Hyperlipidemia, Hypertension, Obstructive sleep apnea, Pulmonary hypertension, Chronic kidney disease, Shortness of breath, Ascending aortic aneurysm Electronically signed by: MD on 12/05/2021 04:46 PM Interpretation Summary The LV ejection fraction is mildly decreased. The left ventricular ejection fraction is 40%. There is mild global hypokinesis of the left ventricle. The right ventricular systolic function is normal. Trivial pericardial effusion. The estimated right ventricular systolic pressure is 62 mmHg. The IVC is dilated (>2.1 cm) with less than 50% collapse during patient sniff. The estimated RA pressure is 15 mm Hg (10-20 mm Hg). Today's study was compared to one performed on 9/2/2016. The LVEF was 66% on the prior report. STUDY PERFORMED/QUALITY: TRICUSPID VALVE: A two-dimensional transthoracic There is mild tricuspid regurgitation. echocardiogram with color flow and The estimated right ventricular spectral flow Doppler was performed in systolic pressure is 62 mmHg. limited views only. The technical quality of the exam was fair. The study was done portable in the ER. LEFT VENTRICLE: The left ventricle is normal in size. The left ventricular ejection fraction is 40%. The LV ejection fraction was determined utilizing visual estimation. The LV ejection fraction is mildly decreased. Abnormal (dyssynchronous) septal motion consistent with conduction abnormality. There is mild global hypokinesis of the left ventricle. LEFT ATRIUM: The left atrium is normal in size. RIGHT VENTRICLE: Tricuspid annular plane systolic excursion is 24 mm. The right ventricular systolic function is normal. PERICARDIUM/PLEURAL: Trivial pericardial effusion. INFERIOR VENA CAVA: The IVC is dilated (>2.1 cm) with less than 50% collapse during patient sniff. The estimated RA pressure is 15 mm Hg (10-20 mm Hg). Left Ventricle Right Ventricle EF(MOD-Avg): 47 % RV FAC: 23 % EDV(MOD-sp4): 122.7 ml RVD1: 4.0 cm ESV(MOD-sp4): 64.8 ml SV(MOD-Avg): 58.6 ml IVSd: 0.89 cm LVPWd: 1.0 cm LVIDd: 5.4 cm LVIDs: 4.0 cm EDV(MOD-sp2): 129.5 ml ESV(MOD-sp2): 70.2 ml ______________________________________________________________________________ Tricuspid Valve Great Vessels RVSP(TR): 61.5 mmHg IVC diam: 2.6 cm TR max vel: 3.41 m/sec TR max PG: 46.5 mmHg RVFW S' Max Vel: 0.12 m/sec RAP systole: 15.0 mmHg ______________________________________________________________________________ Reference Table: Normal Mild ModerateSevere Men LVEF > 52% 41-51% 30-40% <30% Women LVEF > 54% 41-53% 30-40% <30% Men LVIDd 4.2-5.8 5.9-6.3 6.4-6.8 >6.8 Women LVIDd 3.8-5.2 5.3-5.6 5.7-6.1 >6.1 LA Volume (ml/m^2) < 34 35-41 42-48 >48 ______________________________________________________________________________ Electronically signed by: MD on 12/05/2021 04:46 PM All sources of data reside in the Cardiology PACS EJECTION FRACTION ECHO Collected: 12/05/21 1550 Order Status: Completed Updated: 12/05/21 1646 EJECTION FRACTION ECHO 40 % CT ANGIO THORAX WITH IV CONTRAST Resulted: 12/05/21 1455 Order Status: Completed Updated: 12/05/21 1458 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 12/5/2021 2:12 PM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, low/intermediate prob, positive D-dimer, Evaluate for PE in setting of COVID in patient with prior saddle embolism. COMPARISON: 6/3/2018 ENCOUNTER: Not applicable ____________________ FINDINGS: Base of Neck & Axillae: There is no lymph node enlargement. Mediastinum & Hila: Moderate mediastinal adenopathy. A few of the lymph nodes are calcified but most are not. The largest single lymph node is subcarinal measuring up to 24 x 33 mm Cardiovascular: Heart is mildly enlarged. There is a small pericardial effusion The thoracic aorta is not aneurysmal and there is no dissection. There is no evidence for right heart strain. Pulmonary Arteries: No pulmonary embolism is present. Lungs & Airways: Severe infiltrates are present particularly in the right upper and lower lobes. There is interstitial disease present in left upper and lower lobe well. There is a background of COPD. Pleural Space: Tiny bilateral effusions Upper Abdomen: Small gallstones without cholecystitis Chest Wall & Musculoskeletal: No significant abnormality. ____________________ Impression: 1. Severe bilateral infiltrates with primarily interstitial but also alveolar components. 2. Moderate mediastinal adenopathy, possibly reactive. Follow-up imaging after resolution of inflammatory process is recommended 3. No evidence of dissection or pulmonary embolism DR CHEST SINGLE VIEW Resulted: 12/05/21 0919 Order Status: Completed Updated: 12/05/21 0921 Narrative: EXAMINATION: Single View Chest EXAM DATE: 12/5/2021 8:58 AM TECHNIQUE: Single view chest INDICATION: shortness of breath, hypoxia, crackles COMPARISON: None ENCOUNTER: Not applicable _________________________ FINDINGS: Moderate cardiomegaly without vascular distention Moderate bilateral peripheral infiltrates, greater on the right. No effusions _________________________ Impression: Moderate Covid pneumonitis Peripheral Blood Culture Collected: 12/05/21 0842 Order Status: Completed Specimen: Blood, Venous Updated: 12/08/21 1001 Cult Blood Peripheral No Growth 3 Days Peripheral Blood Culture Collected: 12/05/21 0836 Order Status: Completed Specimen: Blood, Venous Updated: 12/08/21 1001 Cult Blood Peripheral No Growth 3 Days MRSA Screen PCR (Normal) Collected: 12/06/21 1252 Order Status: Completed Specimen: Swabbed Collection from Nares, Bilateral Updated: 12/06/21 1732 MRSA Screen PCR Not Detected Legionella Antigen, Urine (Normal) Collected: 12/06/21 0421 Order Status: Completed Specimen: Urine, catheter Updated: 12/06/21 0601 Legionella Ag Urine Negative Negative Streptococcus Pneumoniae Antigen, Urine (Normal) Collected: 12/06/21 0421 Order Status: Completed Specimen: Urine, catheter Updated: 12/06/21 0601 STREPTOCOCCUS PNEUMONIAE ANTIGEN Negative Negative, Invalid COVID-19, Influenza A/B, RSV PCR (BW ED and HDVCH ED Use Only) (Abnormal) Collected: 12/05/21 0823 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 12/05/21 0952 COVID-19 PCR Detected
Aktuelle Erkrankungen: -
Vorgeschichte: HTN (hypertension) Type 2 diabetes mellitus Pneumonia due to COVID-19 virus Acute HFrEF (heart failure with reduced ejection fraction) Elevated troponin MDS (myelodysplastic syndrome) History of pulmonary embolism Hyperlipemia Major depressive disorder, recurrent episode Decreased libido OSA on CPAP Left carotid artery occlusion Intracranial aneurysm Multiple rib fractures Abdominal pain Fall from ground level Closed wedge compression fracture of second thoracic vertebra with routine healing, subsequent encounter Closed wedge compression fracture of third thoracic vertebra with routine healing, subsequent encounter Femur fracture, left Hip fracture Closed fracture of left olecranon process with routine healing, subsequent encounter CTEPH (chronic thromboembolic pulmonary hypertension) Right heart failure due to pulmonary hypertension Hypoxemia Chronic respiratory failure with hypoxia Primary pulmonary hypertension SOB (shortness of breath) Bradycardia Other pulmonary embolism without acute cor pulmonale, unspecified chronicity Cerebral aneurysm CKD (chronic kidney disease) Arteriosclerosis of both carotid arteries Valvular heart disease Abdominal aortic aneurysm (AAA) without rupture Pain in both lower extremities Chronic diastolic heart failure Pancytopenia
Andere Medikamente: B Complex Vitamins (VITAMIN B COMPLEX) tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) capsule doxazosin (CARDURA) 2 MG tablet furosemide (LASIX) 20 MG tablet losartan (COZAAR) 50 MG tablet metFORMIN (GLUCOPHAGE) 500 MG tablet omeprazo
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1932403

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 81,0
Geschlecht: M
Eingang: 08.12.2021
Impfdatum: 10.03.2021
Beginn: 04.12.2021
Tage bis Beginn: 269,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute myocardial infarction Endotracheal intubation Mechanical ventilation Pneumonia Respiratory failure

Symptomtext

Hospitalized: NSTEMI intubated and ventilated for respiratory failure pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute myocardial infarction
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1925008

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 81,0
Geschlecht: F
Eingang: 06.12.2021
Impfdatum: 08.04.2021
Beginn: 29.11.2021
Tage bis Beginn: 235,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Cardiomegaly Chest X-ray abnormal Condition aggravated Dyspnoea Glomerular filtration rate decreased Hypoxia Oxygen saturation decreased SARS-CoV-2 test positive Sputum culture

Symptomtext

Hospitalized 11/29/2021-still admitted currently; COVID-19 positive 11/29/2021; fully vaccinated CHIEF COMPLAINT: Shortness of breath Assessment/Plan ASSESSMENT / PLAN: COVID-19 pneumonia Acute on chronic respiratory failure with hypoxia -- > Symptom onset: 11/23 -- > COVID 19 positive: 11/29 -- > Vaccination status: Not vaccinated - Requires 2-3 L of oxygen at baseline, stable on 2 L at rest, desaturated in the ER with ambulation - Chest x-ray (11/29): Cardiac silhouette mildly enlarged, no overt pulmonary edema. - NT-BNP and procalcitonin pending - Check sputum culture Plan: - Will not start remdesivir given onset of symptoms 7 days ago and borderline adequate renal function with an eGFR of 37 - Start Decadron 6 mg IV daily for 10 days - DVT prophylaxis with subcutaneous heparin - Prone positioning as tolerated, incentive spirometry hourly - Trend CRP and D-dimer daily for 3 days - Supportive measures - Monitor continuous pulse oximetry, wean oxygen as able Care Management note 12/6/2021: Plan: transfer tomorrow 12/7/2021 to Facility at 1pm with transport pending insurance authorization

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HTN (hypertension) Hypothyroidism (acquired) Diabetes mellitus Tobacco abuse, in remission OSA (obstructive sleep apnea) Pulmonary HTN COPD (chronic obstructive pulmonary disease) Pneumonia due to COVID-19 virus Acute on chronic respiratory failure with hypoxia Hypokalemia Hyponatremia Transaminitis Stage 3b chronic kidney disease PBC (primary biliary cirrhosis) Thyroid mass Edema Hoarseness of voice Gastroesophageal reflux disease Sleep related hypoxia Diabetes mellitus type 2 without retinopathy Myopia of both eyes Senile nuclear cataract, left Low-tension glaucoma of both eyes, mild stage Intermediate stage nonexudative age-related macular degeneration of both eyes Chronic rhinitis On supplemental oxygen therapy Circadian rhythm sleep disorder, delayed sleep phase type Essential tremor Exudative age-related macular degeneration of right eye with active choroidal neovascularization Type 2 diabetes mellitus with other diabetic ophthalmic complication
Andere Medikamente: Accu-Chek FastClix Lancets albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler amLODIPine (NORVASC) 5 MG tablet aspirin 81 MG tablet atenolol (TENORMIN
Allergien: Environmental Daliresp
Vorherige Impfungen: -

VAERS 1921218

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 91,0
Geschlecht: F
Eingang: 03.12.2021
Impfdatum: 18.03.2021
Beginn: 16.11.2021
Tage bis Beginn: 243,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Fatigue SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 11/21/2021 with fatigue. She was diagnosed with COVID-19 infection on 11/16/2021. Patient was admitted for management of COVID-19 infection. She was treated with dexamethasone, barcitinib, and supplemental oxygen. Patient was not improving with treatment and decided against aggressive treatment. She was discharged to hospice on 11/30/2021 and expired on 12/2/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: COVID-19 test positive on 11/16/2021.
Aktuelle Erkrankungen: None known
Vorgeschichte: Hyperlipemia; Hypothyroid; HTN (hypertension), benign; Functional diarrhea CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC); Stroke of unknown cause (HCC); Cerebral microvascular disease; Pneumonia due to infectious organism; Coarse tremors; Gait instability; Generalized weakness; Metabolic encephalopathy; Acute deep vein thrombosis (DVT) of calf muscle vein of left lower extremity (HCC); Thoracic aortic aneurysm (HCC)
Andere Medikamente: atropine (ATROPISOL) 1 % ophthalmic solution; bisacodyl (BISACODYL LAXATIVE) 10 MG suppository; LORazepam (ATIVAN) 0.5 MG tablet; morphine (ROXANOL CONCENTRATE) 20 MG/ML oral solution; ondansetron, disintegrating, (ZOFRAN ODT) 4 MG dispersi
Allergien: latex, bactrim, phenylephrine-guaifenesin, lamisil, lotrimin, neosporin, adhesive tape, azithromycin, amoxicillin
Vorherige Impfungen: -

VAERS 1917712

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 83,0
Geschlecht: F
Eingang: 02.12.2021
Impfdatum: 18.03.2021
Beginn: 29.11.2021
Tage bis Beginn: 256,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Accelerated hypertension Acute left ventricular failure Acute respiratory failure Anticoagulant therapy Arteriosclerosis Asthenia Atrial fibrillation Blood gases abnormal Blood lactic acid normal Blood pH decreased Chest X-ray abnormal Chronic left ventricular failure Computerised tomogram head abnormal Condition aggravated Cough COVID-19 COVID-19 pneumonia Cardiomegaly

Symptomtext

Patient currently inpatient at (3) days admission. The patient is a 84 y.o. female with a past medical history significant for chronic diastolic heart failure, atrial fibrillation, CVA, DVT, diabetes mellitus type 2, carotid artery disease s/p endarterectomy, essential hypertension and hyperlipidemia who presents today with a chief complaint of shortness of breath. Patient was a limited historian at the time of exam. She reports that she presented to the ER because ?her husband was worried about her.? When questioned, she does admit to some mild shortness of breath and intermittent cough. Patient also admits to some fatigue and generalized weakness. She denies any other complaints at this time. Specifically, she denies fevers, rigors, anorexia, nausea, vomiting, abdominal pain or diarrhea. She denies chest pain, palpitations, diaphoresis, lightheadedness or dizziness. Patient reports that her legs are always swollen at baseline, and do not seem much more swollen. She states that she does not weigh herself daily. Endorses good medication compliance with her Lasix 20 mg every other day. Denies orthopnea or paroxysmal nocturnal dyspnea. Patient reports that she has been vaccinated for COVID-19. Upon arrival to Emergency Department, the patient was noted to be hypertensive at 187/72. She was also hypoxic on room air requiring 2 L nasal cannula. CMP was grossly unremarkable. Complete blood count was significant for hemoglobin of 10.4. Lactate was normal. High sensitivity troponins were flat. NT-BNP elevated at 4286. VBG revealing a pH of 7.47 with a normal pCO2. COVID-19 PCR was positive. Chest x-ray demonstrating cardiomegaly with pulmonary vascular congestion. Additionally, hazy pulmonary opacities in the mid and lower lungs, right greater than left. CT head without IV contrast was negative for acute intracranial hemorrhage. Probable moderate chronic small-vessel ischemic disease was noted. No evidence for acute large territorial infarction. EKG demonstrating normal sinus rhythm with a normal QTC. Patient received Lasix 40 mg IV as well as Decadron 10 mg IV in the ER. Patient was then transferred to the hospital for admission as inpatient status in stable condition for further workup, monitoring and treatment. COVID-19 pneumonia -- > Symptom onset: 11/26 -- > COVID-19 (+): 11/29 -- > Vaccination status: Vaccinated, 2 doses of Pfizer Stable on 2 L nasal cannula Chest x-ray: Hazy pulmonary opacities in the mid and lower lungs, right greater than left. Plan: - Start remdesivir with loading dose now, followed by maintenance dosing - Start Decadron 6 mg IV daily for 10 days - DVT prophylaxis with Xarelto - Albuterol p.r.n. - Trend CMP daily for 7 days - Trend CRP and D-dimer daily for 3 days - Supportive measures Acute on chronic diastolic heart failure exacerbation Perhaps exacerbated by uncontrolled essential hypertension verses cardiomyopathy related to COVID-19 pneumonia Chest x-ray: Cardiomegaly with pulmonary vascular congestion. NT-BNP 4286 High sensitivity troponins flat Prior Echocardiogram (05/2021) at heart and vascular specialists showing LVEF 66% with mild right ventricular dilatation, moderate right atrial dilatation and moderate left atrial dilatation. Moderate tricuspid regurgitation. Moderate pulmonary hypertension. Diuresed with Lasix 40 mg IV in the ER Hold home Lasix 20 mg every other day Start diuresis with Lasix 40 mg IV 2 times a day Update echocardiogram 2 L fluid, 2 g sodium restriction Daily weights with I's and O's every 4 hours Acute respiratory insufficiency with hypoxia Multifactorial in the setting of COVID pneumonia and acute on chronic diastolic heart failure exacerbation Stable on 2 L nasal cannula Chest x-ray: Cardiomegaly with pulmonary vascular congestion. Hazy pulmonary opacities in the mid and lower lungs, right greater than left. Management as outlined above Monitor continuous pulse oximetry, wean as able Altered mental status Suspect related to COVID-19 infection Alert, oriented x3, however "off" according to husband per review of ER note, unable to reach husband via telephone to discuss baseline mentation CT head without IV contrast: Negative for acute intracranial hemorrhage. Probable moderate chronic small-vessel ischemic disease was noted. No evidence for acute large territorial infarction. UA pending, follow Closely monitor with neuro checks Q4 STAT CT head with any neurological changes Accelerated hypertension Renal artery calcifications Continue lisinopril-hydrochlorothiazide and carvedilol Prior office visit in June, blood pressure 138/86, however SBP's 180-190 on admission Continue home antihypertensives lisinopril-hydrochlorothiazide and carvedilol Will add hydralazine 25 mg orally 3 times a day p.r.n. for SBP greater than 180 mmHg If difficulty with blood pressure control, consider renal artery ultrasound Persistent atrial fibrillation on Xarelto Rates currently well controlled Continue carvedilol 2 times a day Continue Xarelto Monitor electrolytes and replace p.r.n. History of TIA versus CVA Continue baby aspirin and statin History of DVT Continue chronic anticoagulation with Xarelto Non-insulin-dependent diabetes mellitus type 2 Updated hemoglobin A1c pending Hold Metformin Will start low-dose Humalog, adjust as needed given administration of Decadron for COVID-19 PNA Goal blood sugar less than 180 Obesity BMI 37 Plaquenil use? Unclear as to why patient is taking Plaquenil Patient unreliable historian and unable to reach husband overnight Hyperlipidemia Carotid artery disease s/p endarterectomy Continue baby aspirin and rosuvastatin CODE: Full DVT Prophylaxis: Chronic anticoagulation with Xarelto DIET: Heart healthy, 2 L fluid, 2 g sodium The above assessment and plan was discussed with medical group attending and he/she agrees with the treatment plan.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Varicose veins of lower extremity with other complication Esophageal reflux Vocal cord paralysis History of left-sided carotid endarterectomy DVT of deep femoral vein, left (HCC)
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler aspirin 81 MG tablet carvedilol (COREG) 25 MG tablet cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) tablet fexofenadi
Allergien: Levaquin -Hives
Vorherige Impfungen: -

VAERS 1913670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 71,0
Geschlecht: U
Eingang: 01.12.2021
Impfdatum: 07.04.2021
Beginn: 01.12.2021
Tage bis Beginn: 238,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

fully vaccinated, complications of covid-19 death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM; CKD stage 3; a-fib; Hx of CVA
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1905950

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 71,0
Geschlecht: F
Eingang: 29.11.2021
Impfdatum: 15.03.2021
Beginn: 18.11.2021
Tage bis Beginn: 248,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Ageusia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Cough Decreased appetite Dyspnoea exertional Headache Laboratory test normal Respiratory tract congestion SARS-CoV-2 test positive Transaminases increased

Symptomtext

Hospitalized 11/21/2021; COVID-19 positive 11/18/2021; fully vaccinated BRIEF OVERVIEW: Discharge Provider: DO Primary Care Provider: MD Admission Date: 11/21/2021 Discharge Date: Nov 23, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure with hypoxia (HCC) [J96.01] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 72-year-old female with a past medical history of dyslipidemia, depression, obesity, OSA who presented secondary to a chief complaint of headache, loss of taste, decreased appetite, coughing congestion. She also started noting shortness of breath with exertion. She received both doses of Pfizer vaccine in March 2021. When EMS arrived she was 80% on room air. She was placed on 4 L nasal cannula. In the emergency department she was otherwise hemodynamically stable. Her labs were unremarkable. Her chest x-ray showed findings consistent with COVID-19 infection. She was known to be COVID positive on 11/18/2021. She was admitted for COVID-19 pneumonia. She was started on Decadron and was out of the window for remdesivir and monoclonal antibodies. She weaned to 3 L nasal cannula with activity per Pulmonary rehab evaluation. She was noted to have mildly elevated transaminases secondary to COVID-19. She had improvement of her symptoms and was discharged home on 11/23/2021 with home oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: OSA (obstructive sleep apnea) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Essential hypertension PAD (peripheral artery disease) (HCC) Duodenitis Colon polyps Class 1 obesity with serious comorbidity and body mass index (BMI) of 33.0 to 33.9 in adult, unspecified obesity type Unspecified severe protein-calorie malnutrition (HCC) Senile nuclear cataract, bilateral Lattice degeneration of both retinas Posterior vitreous detachment, bilateral Dyslipidemia
Andere Medikamente: aspirin 81 MG tablet atorvastatin (LIPITOR) 10 MG tablet B Complex-C (SUPER B COMPLEX) TABS benzonatate (TESSALON) 100 MG capsule Cholecalciferol (VITAMIN D3) 1000 UNITS TABS dexamethasone (DECADRON) 6 MG tablet famotidine (PEPCID) 20 MG ta
Allergien: Codeine PCN
Vorherige Impfungen: -

VAERS 1905648

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 88,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 15.03.2021
Beginn: 17.11.2021
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Angiopathy Aspiration Asthenia Asymptomatic COVID-19 Asymptomatic bacteriuria Blood culture negative Blood lactic acid normal Bradycardia COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chronic kidney disease Condition aggravated Drug level Gait disturbance Hypotension

Symptomtext

Hospitalized 11/23/2021-currently still admitted; COVID-19 positive 11/17/2021; fully vaccinated ASSESSMENT / PLAN: Patient is an 89 year old male with past medical history significant for CKD stage 3, chronic afib not on anticoagulation, CAD, chronic combined systolic and diastolic heart failure, and HTN. He was recently admitted 11/17 - 11/20 with fever and AKI. COVID positive but without respiratory symptoms. Discharged in prn 2L nasal cannula (felt to be more related to underlying OSA than COVID). ED reported patient was brought in for SOB although patient denied this. He was noted to have difficulty with ambulation in the ED and then became hypotensive requiring vasopressors. Labs were significant for AKI on CKD, troponin 301, procal .28, and mild leukocytosis. UA was unremarkable. Chest XR diffuse bilateral infiltrates (COVID vs bacterial pneumonia vs vascular congestion). He was started on vancomycin and Zosyn. NE weaned off shortly after arrival to ICU. Sepsis: Etiology likely pneumonia given chest XR findings COVID positive 11/17 (but patient reports no symptoms) Procalcitonin mildly elevated at .28 LA WNL Blood cultures NGTD Legionella and strep pneumo pending MRSA screen pending Sputum culture ordered NE for MAP >65mmHg, weaned off shortly after arrival to ICU Vancomycin and Zosyn for empiric coverage COVID: Vaccinated in March COVID positive 11/17 Has denied current symptoms Chest XR with bilateral infiltrates Decadron 6mg daily 11/29/2021 note: Assessment & Plan: # Septic Shock (Resolved) # Aspiration PNA Presented 11/23 with fever and hypotension and presumed respiratory etiology. Placed on vasopressors Norepi (11/24) and weaned the same day. UA unremarkable. Started on Zosyn and Vancomycin while in ICU and Vancomycin discontinued as MRSA screen negative. Strep pneumonia and legionella antigen negative. Unable to provide sputum sample ---follow peripheral blood cultures x2 (11/23) and no growth to date, maintain MAP >65 ---IV Zosyn (3.375 mg q6 day #6) and continue for now given worsening hypoxia and plan for 5-7 days ---SLP consulted and recommending NPO until respiratory status improves, aspiration precautions ---consult nutrition and likely if respiratory status not improved by tomorrow will need CorPak # COVID-19 PNA with Acute Hypoxic Respiratory Failure Admitted to hospital (11/17-11/20) with fever and AKI. Treated with UTI at the time with Fosfomycin. Tested positive for COVID-19 (11/17). CXR (11/23) with diffuse bilateral airspace opacities (worsening when compared to prior). Remdesivir (11/18-11/19), Decadron (11/17-11/20). States he is vaccinated against COVID-19, received 2 vaccines a couple months ago. ---Decadron (6 mg IV daily day #6 - did receive prior to hospitalization), ---continous pulse oximetry, hold on further lasix at this time given given NPO status Discharge Coordination/Progress: Pt is currently on high flow O2, per nursing pt continues to aspirate Plan: Pt to d/c when medically stable, to return to assisted living

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: Discharge Physician: Doctor Primary Care Physician: Doctor Date of Admission: 11/17/2021, Hospital Day: 4 Discharge Date: 11/20/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Generalized weakness AKI (acute kidney injury) COVID-19 virus infection COVID-19 HOSPITAL COURSE: 89-year-old male past medical history CKD stage 3, peripheral tibial disease, chronic combined systolic and diastolic CHF, permanent atrial fibrillation, coronary artery disease presents with weakness. In the emergency department, patient noted to be febrile. COVID-19 PCR positive. UA with evidence of increased WBC and was administered IV fosfomycin. Patient also noted to have AKI on CKD stage 3. He was not hypoxic and did not require supplemental oxygen. Hospitalist service consulted for admission further evaluation. Patient asymptomatic was not continued on antibiotics for abnormal finding on UA as likely asymptomatic bacteriuria. Medications were renally dosed. Patient was administered gentle IV fluid monitor closely given COVID-19 status. He had improvement of AKI with return to baseline CKD. PT/OT evaluated and initial advised SAR after additional days recommendations were updated to return to assisted living with PT/OT. Case management/MSW consulted to arrange for outpatient services and discharge planning. Patient was noted to be slightly bradycardic and digoxin was held with digoxin levels within normal limits. Bradycardia resolved and was continued on home medications. Respiratory therapy performed home oxygen evaluation as patient had on and off 1-2 L nasal cannula 1-2 L at night possibly related to underlying OSA. Respiratory therapy performed home oxygen evaluation patient did not qualify for continuous supplemental oxygen. Patient has a known establish order for supplemental oxygen 2 L p.r.n which he may continue. Patient clinically improved and hemodynamically stable for discharge. Discussed plan of care discharge with patient including outpatient follow-up PCP within 7 days. Patient voiced understanding was agreeable with plan of care discharge.
Vorgeschichte: Acute kidney injury Permanent atrial fibrillation Cardiomyopathy, ischemic Essential hypertension with goal blood pressure less than 140/90 Stage 3a chronic kidney disease Pressure injury of right foot, stage 3 COVID-19 virus infection Septic shock Chronic pain Coronary artery disease due to lipid rich plaque Dyslipidemia BPH (benign prostatic hyperplasia) GERD (gastroesophageal reflux disease) Lumbar spinal stenosis DJD (degenerative joint disease) Radicular syndrome of left leg-severe Congestive heart failure, NYHA class 2, chronic, combined PSA elevation Closed nondisplaced fracture of lateral malleolus of left fibula with routine healing Pressure injury of right ankle, stage 3 Physical deconditioning PAD (peripheral artery disease)
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet aluminum, magnesium & simethicone (ANTACID) 200-200-20 MG/5ML SUSP suspension aspirin 81 MG tablet atorvastatin (LIPITOR) 10 MG tablet benzonatate (TESSALON) 100 MG capsule bisacodyl (DULCOLAX) 10 MG su
Allergien: Valium Levofoxacin Morphine Fentanyl
Vorherige Impfungen: -

VAERS 1694810

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 80,0
Geschlecht: M
Eingang: 29.11.2021
Impfdatum: 13.03.2021
Beginn: 15.08.2021
Tage bis Beginn: 155,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Anticoagulant therapy COVID-19 COVID-19 pneumonia Cardiac disorder Death Deep vein thrombosis Chest X-ray abnormal Chronic kidney disease Computerised tomogram thorax abnormal Endotracheal intubation General physical health deterioration Dyspnoea Intensive care Pulmonary embolism Renal failure Hypoxia Mechanical ventilation

Symptomtext

pt diagnosed positive for COVID on 8/15/2021; admitted to hosp for AHRF secondary to COVID pneumonia from 8/17 - 8/23/21; treated with dexamethasone, remdesivir, antibiotics; dc'd to home on supplemental O2; admitted back into hosp on 8/25/21 with worsening dyspnea and hypoxia; admitted to ICU on OptiFlow on NRB; required intubation on 8/28; developed PE and bilat DVTs right and left LE; developed subcutaneous emphysema; worsening renal failure; was transitioned to comfort care due to worsening condition and died in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 17,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1897883

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 80,0
Geschlecht: F
Eingang: 24.11.2021
Impfdatum: 17.11.2021
Beginn: 23.11.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Blood creatinine normal Blood glucose normal C-reactive protein increased COVID-19 Chest X-ray abnormal Culture stool Dyspnoea exertional Fibrin D dimer Full blood count Laboratory test abnormal Lung opacity Metabolic function test SARS-CoV-2 test positive White blood cell count decreased

Symptomtext

Hospitalized 11/23/2021-still admitted currently; COVID-19 positive 11/23/2021; fully vaccinated plus booster CHIEF COMPLAINT: COVID ASSESSMENT / PLAN: Acute Respiratory Failure, secondary to COVID-19 o COVID-19 Infection - confirmed on 11/23/2021. o Vaccine Status: Fully vaccinated (Pfizer). Booster: Yes, dose on 11/17/2021 o Outpatient CXR (11/8/2021) suspicious for CAP - treated with Augmentin and Azithromycin o CTA Thorax (11/23/2021) - bilateral ground glass opacities, negative for PE o Abnormal Labs: ? Glucose - 61 ? Corrected in ER ? Cr - 1.10 ? WBC - 3.94 o Plan for Admission to Blodgett ? Hold Decadron as patient is not requiring O2. Did desaturate with ambulation but otherwise normal. Start if hypoxia occurs. ? Hold ABX, secondary to questionable Cdiff. ? Procalitonin ordered ? Not eligible for Remdesivir ? Trend CBC, CMP, D-Dimer, CRP ? Follow stool cultures ? Acapella, mucinex BID and Albuterol BID ? Encourage prone positioning, tessalon perles PRN, albuterol PRN ? Continuous O2 monitoring - not currently on O2. ? Respiratory Isolation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Bipolar 2 disorder DM (diabetes mellitus), type 2 with renal complications Chronic kidney disease (CKD), stage III (moderate) HTN (hypertension) Restless leg syndrome IBS (irritable bowel syndrome) Hyperlipidemia PAD (peripheral artery disease) Gastroparesis Coronary artery disease due to lipid rich plaque History of pulmonary embolism Osteoporosis Morbid obesity with BMI of 40.0-44.9, adult S/P total knee arthroplasty Binswanger's encephalopathy Back pain Carotid artery disease Thyroid nodule Colonoscopy refused Urge incontinence of urine Impaired mobility Dyspnea on exertion Chronic diastolic heart failure
Andere Medikamente: amoxicillin-clavulanate (AUGMENTIN) 875-125 MG per tablet Ascorbic Acid (VITAMIN C PO) aspirin 81 MG tablet benzonatate (TESSALON) 200 MG capsule betamethasone dipropionate 0.05 % cream clonazePAM (KLONOPIN) 0.5 MG tablet clotrimazole (LOTR
Allergien: Statins Clonidine Dyazide Norvasc Prilosec
Vorherige Impfungen: -

VAERS 1897236

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 65,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 18.03.2021
Beginn: 20.11.2021
Tage bis Beginn: 247,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Alcohol withdrawal syndrome Balance disorder Bursitis COVID-19 Cognitive disorder Computerised tomogram thorax abnormal Lung opacity Muscular weakness Pleural effusion Polyneuropathy SARS-CoV-2 test positive Spinal stenosis Tremor

Symptomtext

Hospitalized (11.22.21); COVID-19 positive (11.20.21); Fully Vaccinated Diagnosis: COVID-19, Acute respiratory failure with hypoxia Discharge Provider: MD Primary Care Provider at Discharge: MD Admission Date: 11/22/2021 Discharge Date: 11/23/2021 DETAILS OF HOSPITAL STAY PRESENTING PROBLEM: Hypoxic [R09.02] COVID-19 [U07.1] Acute respiratory failure with hypoxia [J96.01] HOSPITAL COURSE: Patient is a 66 y.o. male with a past medical history of liver cirrhosis secondary to alcohol abuse, chronic obstructive pulmonary disease, hypertension and obstructive sleep apnea who with hypoxia, COVID-19 positive. Patient was admitted to the medical service. He was started on dexamethasone and remdesivir. His clinical condition improved overnight. The patient was had no evidence of hypoxia on ambient air. Vital signs were stable. He did receive Ativan for tremors thought to be secondary to alcohol withdrawal. The patient's wife is a nurse. The patient was discharged on 11/23/2021 in stable condition. He was asked to return to the hospital if he had worsening fever chills or evidence of hypoxia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: 11.8.21 - CT thorax with contrast: Small to moderate left pleural effusion, new from previously. Minimal groundglass opacities in the left lung, nearly resolved from previously. No evidence for metastatic disease in the chest. 11.9.21 - outpatient neurology visit (He presents for post-hospital follow-up regarding lower extremities weakness and cognitive concerns. Agree with inpatient team that weakness and imbalance was likely multifactorial and related to polyneuropathy, spinal stenosis, bursitis, and deconditioning.) Alcohol-induced polyneuropathy / alcohol abuse / cirrhosis
Vorgeschichte: Unspecified essential hypertension Former smoker Pulmonary nodules Chronic rhinitis Alcohol abuse Cancer of true vocal cord OSA (obstructive sleep apnea) Prediabetes Neuromuscular weakness Cardiomyopathy
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Bacillus Coagulans-Inulin (PROBIOTIC FORMULA PO) Calcium Carbonate-Vit D-Min (CALTRATE 600+D PLUS PO) cholecalcifero
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1897098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 63,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 08.04.2021
Beginn: 12.11.2021
Tage bis Beginn: 218,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Confusional state Dyspnoea Emotional distress Feeling abnormal Haemoptysis Laboratory test abnormal Productive cough

Symptomtext

Patient was fully vaccinated with Pfizer. Doses received 3/18/21 and 4/8/21. Patient was admitted approximately 1 week ago for acute hypoxic respiratory failure due to COVID-19. Patient was admitted for COVID at a different facility and discharged , he has declined. He continued to feel worse each day and developed a coughing fit. He called his granddaughter who came to see him and said he was acting confused and appeared to be in distress. She states that he said he felt like he was dying. She called the ambulance and they brought him to the hospital. Patient endorses shortness of breath and productive cough with some specks of blood. Patient was admitted 11/19/21 and is still in hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: + 11/12/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1897018

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 79,0
Geschlecht: M
Eingang: 24.11.2021
Impfdatum: 29.03.2021
Beginn: 23.11.2021
Tage bis Beginn: 239,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Dyspnoea

Symptomtext

Pneumonia due to COVID-19 virus; Shortness of breath; Acute respiratory failure with hypoxia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1893982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 56,0
Geschlecht: F
Eingang: 23.11.2021
Impfdatum: 02.04.2021
Beginn: 10.11.2021
Tage bis Beginn: 222,0
Dosis: 1
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Chest X-ray abnormal Condition aggravated Cough Death Diarrhoea Dyspnoea Endotracheal intubation Hypervolaemia Intensive care Oedema Oxygen saturation decreased Paralysis Polyuria Positive airway pressure therapy SARS-CoV-2 test positive

Symptomtext

Deceased 11/17/2021; Hospitalized 11/10/2021; COVID-19 positive 11/10/2021; fully vaccinated BRIEF OVERVIEW: Admission Date: 11/10/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Acute respiratory failure [J96.00] COVID [U07.1] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 57 y.o. female who initially presented on 11/10 for 3-4 days of worsening shortness of breath, diarrhea, and nonproductive cough. She had pitting edema and signs of fluid overload on CXR and was diagnosed with COVID on arrival. She is on 5 L oxygen at baseline and was started on high-flow nasal cannula and initially admitted to hospitalist service. She was diuresed aggressively. She was started on steroids; did not qualify for Remdesivir due to kidney function.Her oxygen requirements continued to increase and she was transitioned to 100% high-flow nasal cannula with non-rebreather mask. Overnight on 11/11, she desated into low 80s and was placed on BIPAP and transferred to ICU service due to concern for impending intubation. Her respiratory status declined and was intubated on 11/13. We had multiple conversations about her likely poor prognosis considering her baseline respiratory status, and patient elected to proceed with intubation at that time. She was sedated and paralyzed, and she subsequent required initiation of norepinephrine. Her respiratory status continued to worsen and we began proning on 11/14. She responded to proning and was continued on a 20:4 proning schedule. Palliative care was consulted on 11/15 after family expressed concern about patient's grim prognosis and likelihood of tracheostomy and long-term care even if she survived this illness. On 11/16, palliative spoke with all first-degree relatives, and they decided to transition to DNR and comfort care. Paralytics turned off and patient pronounced dead on 11/17/21 at 12:45AM. Family at bedside, condolences offered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Obstructive sleep apnea Chronic respiratory failure with hypoxia Chronic obstructive pulmonary disease, unspecified COPD type Acute respiratory failure Hypertension Acute on chronic diastolic heart failure Neuropathy Diabetic neuropathic arthropathy Acute hip pain, left Type 2 diabetes mellitus with diabetic nephropathy History of smoking 30 or more pack years Anasarca Decubitus ulcer of left buttock, stage 3 Decubitus ulcer of right buttock, stage 3 Venous stasis ulcer of other part of right lower leg limited to breakdown of skin without varicose veins Pelvic ring fracture with routine healing
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROVENTIL) (2.5 MG/3ML) 0.083% nebulization ALBUTEROL 108 (90 Base) MCG/ACT inhaler aspirin 81 MG EC tablet atorvastatin (LIPITOR) 20 MG tablet busPIRone (BUSPAR) 15 MG tablet Calcium Carbona
Allergien: morphine
Vorherige Impfungen: -

VAERS 1889901

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 22.11.2021
Impfdatum: 18.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 217,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Death Fall Fatigue SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 10/21/2021 following a fall and generalized fatigue. He was found to be COVID-19 positive. His symptoms were relatively mild during admission. He was treated with dexamethasone and albuterol inhaler. He was discharged to home with home health care on 11/2/2021. He was readmitted on 11/4/2021 for increased weakness and rehab placement. He was treated with dexamethasone and supplemental oxygen and discharged on 11/9/2021 to a rehab facility. Patient expired on 11/15/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 17,0
Labordaten: COVID-19 positive on 10/21/2021.
Aktuelle Erkrankungen: None known
Vorgeschichte: H/O heart valve replacement with bioprosthetic valve for AS with 21 Magna Valve Hypercholesteremia Chronic fatigue History of permanent cardiac pacemaker placement; Medtronic July 2017 Florid cirrhosis OSA on CPAP Cerebellar infarct Mobitz type 1 second degree AV block Bilateral carotid artery disease; bilat; 50-69% stenosis Vertigo, central Abnormality of gait due to impairment of balance Malignant neoplasm of urinary bladder, unspecified site Blind left eye BPH (benign prostatic hyperplasia) Carotid stenosis GERD (gastroesophageal reflux disease) Glaucoma Essential hypertension Hyperlipidemia Acquired hypothyroidism Actinic keratosis Vitamin D deficiency Acquired urinary meatal stenosis Rheumatoid arthritis involving multiple sites with positive rheumatoid factor Idiopathic chronic gout of multiple sites without tophus Cirrhosis Thrombocytopenia Acute on chronic congestive heart failure, unspecified heart failure type Acute respiratory failure due to COVID-19 Injury due to fall, initial encounter Acute kidney injury
Andere Medikamente: albuterol (VENTOLIN HFA) 108 (90 BASE) MCG/ACT HFA inhaler aspirin (HALFPRIN) 81 MG tablet dorzolamide (TRUSOPT) 2 % ophthalmic solution ferrous sulfate (FEOSOL, 65 FE,) 325 (65 FE) MG tablet furosemide (LASIX) 40 MG tablet guaiFENesin (ROB
Allergien: -
Vorherige Impfungen: -

VAERS 1884868

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

kritisch

Staat: MI
Alter: 55,0
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: 15.03.2021
Beginn: 14.11.2021
Tage bis Beginn: 244,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Adrenal mass Ageusia Angiogram Angiogram pulmonary abnormal Anosmia Anticoagulant therapy Atelectasis Blood glucose increased Blood sodium decreased COVID-19 Condition aggravated Cough Decreased appetite Diarrhoea Dyspnoea Fibrin D dimer increased Full blood count normal Hepatic steatosis

Symptomtext

Inpatient - 4 days 11/14-11/18/21 Patient is a woman with past medical history significant for acute PE July 2021 currently morbid obesity, OSA on CPAP presenting with progressive shortness of breath. Patient states that over the past 3 days, she has experienced increasing shortness of breath. Patient also has persistent dry cough, intermittent fevers, body aches, diarrhea as well as nausea vomiting. Patient has also lost her sense of taste and smell. Patient has also had a poor appetite and has lost around 10 lb. In the emergency department, T-max 38.2?. Heart rate 113. O2 sat was 90% on room air with respiratory rate around 20. Lab showed a sodium 113, blood glucose 335 and the rest of her CMP was within normal limits. Complete blood count unremarkable. D-dimer elevated at 670. CT angiogram performed but read is pending at the time of this note. COVID-19 PCR was positive. Patient was given a dose of Decadron and transfer the hospitalist service. During the hospitalization initially was on empiric antibiotic of ceftriaxone, azithromycin as well as dexamethasone, antibiotics were discontinued as there was low clinical concern of bacterial pneumonia, her dexamethasone was discontinued because her oxygen requirement improved she was satting 100% on room air. Otherwise hospital course was mostly unremarkable, shortness of breath improved, doing well discharge home today in stable condition, recommended getting COVID booster shot in next 3-4 weeks, instruction discussed in detail with patient she verbalized understanding.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: Procedure Component Value Ref Range Date/Time CT ANGIO THORAX WITH IV CONTRAST [339034615] Resulted: 11/14/21 0601 Order Status: Completed Updated: 11/14/21 0604 Narrative: EXAMINATION: CT Angiography of the Thorax EXAM DATE: 11/14/2021 4:36 AM TECHNIQUE: Standard protocol CT angiogram images were obtained through the chest following the administration of intravenous contrast. Coronal and sagittal MIP 3-D reformations were performed. CONTRAST: The amount and type of contrast are recorded in the medical record. QPP DOCUMENTATION: At least one of the following dose reduction techniques was utilized: Iterative reconstruction, and/or Automatic Exposure Control, and/or mA/kV adjustment based on body size. INDICATION: PE suspected, high prob. COVID-19 positive. Shortness of breath. COMPARISON: 7/23/2021 ENCOUNTER: Not applicable ____________________ FINDINGS: Pulmonary Artery: No acute pulmonary embolism. Pulmonary web at the bifurcation of the right lower lobe pulmonary artery due to incomplete recanalization of the previously visualized pulmonary embolism. Aorta: No thoracic aortic aneurysm or dissection. Right Heart Strain: None. Heart: Normal. Mediastinum and Hilum: Borderline reactive adenopathy. Lung Parenchyma: Mosaic attenuation of the lungs. Alternating areas of air trapping and atelectasis from small airway disease. Moderate multifocal patchy parenchymal opacification in the left upper lobe. 2 small foci of peripheral groundglass opacity in the left lower lobe. Minimal involvement of the right lower lobe. Central Airways: Normal. Pleural Space: No pleural effusion or pneumothorax. Upper Abdomen: Limited evaluation due to the arterial phase of contrast. Hepatic steatosis. Stable small adrenal gland nodules. Musculoskeletal and Chest Wall: Moderate thoracic spine degenerative disc disease. ____________________ Impression: 1. No acute pulmonary embolism. 2. Moderate left upper lobe pneumonia with minimal bilateral lower lobe pneumonia. Given the history, COVID-19 pneumonia is most likely but the asymmetry atypical for COVID-19 pneumonia and a bacterial or atypical pneumonia is not excluded. Procedure Component Value Ref Range Date/Time COVID-19 PCR - Rapid [339034605] (Abnormal) Collected: 11/14/21 0341 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 11/14/21 0433 COVID-19 PCR Detected
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory DOE (dyspnea on exertion) Chronic cough OSA on CPAP Pneumonia due to COVID-19 virus Circulatory Multiple subsegmental pulmonary emboli without acute cor pulmonale (HCC) Bilateral pulmonary embolism (HCC) Digestive Morbid obesity (HCC) Gastroesophageal reflux disease without esophagitis Diverticulosis Hematologic Protein C deficiency (HCC) Nervous Syncope Endocrine/Metabolic Type 2 diabetes mellitus without complication, with long-term current use of insulin (HCC)
Andere Medikamente: Outpatient Medications acetaminophen (TYLENOL) 500 MG tablet albuterol (PROAIR HFA) 108 (90 BASE) MCG/ACT inhaler buPROPion (WELLBUTRIN XL) 150 MG 24 hr tablet clonazePAM (KLONOPIN) 0.5 MG tablet cloNIDine (CATAPRES) 0.1 MG tablet DUL
Allergien: MorphineItching, Nausea and Vomiting Lipitor [Atorvastatin] LisinoprilCough Statins [Hmg-coa-r Inhibitors]Myalgia
Vorherige Impfungen: -

VAERS 1869860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 69,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 23.02.2021
Beginn: 12.11.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 pneumonia Encephalopathy Respiratory failure Septic shock

Symptomtext

Hospitalized with COVID pneumonia, septic shock, encephalopathy, hypoxemic respiratory failure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Septic shock
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1641622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 57,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 31.03.2021
Beginn: 29.06.2021
Tage bis Beginn: 90,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acidosis Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Bacterial test positive COVID-19 COVID-19 pneumonia Cough Death Bilevel positive airway pressure Blood lactic acid Blood pH decreased Chest X-ray abnormal Convalescent plasma transfusion Culture Culture urine positive Dyspnoea Echocardiogram

Symptomtext

DC: COVID-19 PNEUMONIA____VRE BACTEREMIA____ACUTE RESPIRATORY FAILURE 7/28/2021 S/S SHORTNESS OF BREATH, COUGH, WHEEZING, DIFFICULTY BREATHING. HX OF DIABETES, HYPERTENSION, COPD, CURRENT SMOKER, SUBSTANCE ABUSE, ANXIETY/DEPRESSION, HYPERLIPIDEMIA. PATIENT DECEASED ON 7/26/2021. CRM Non-LTCF. PCR (+) 07/21/2021. S/S: SOA, Cough, Wheezing. PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD. Vaccinated (Pfizer): 03/10/2021, 03/31/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1641622

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 57,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 31.03.2021
Beginn: 29.06.2021
Tage bis Beginn: 90,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Acidosis Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Bacterial test positive COVID-19 COVID-19 pneumonia Cough Death Bilevel positive airway pressure Blood lactic acid Blood pH decreased Chest X-ray abnormal Convalescent plasma transfusion Culture Culture urine positive Dyspnoea Echocardiogram

Symptomtext

DC: COVID-19 PNEUMONIA____VRE BACTEREMIA____ACUTE RESPIRATORY FAILURE 7/28/2021 S/S SHORTNESS OF BREATH, COUGH, WHEEZING, DIFFICULTY BREATHING. HX OF DIABETES, HYPERTENSION, COPD, CURRENT SMOKER, SUBSTANCE ABUSE, ANXIETY/DEPRESSION, HYPERLIPIDEMIA. PATIENT DECEASED ON 7/26/2021. CRM Non-LTCF. PCR (+) 07/21/2021. S/S: SOA, Cough, Wheezing. PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD. Vaccinated (Pfizer): 03/10/2021, 03/31/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: PMH: DM, HTN, COPD, current smoker, Substance abuse disorder, Anxiety/depression, HLD.
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1865510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 81,0
Geschlecht: M
Eingang: 12.11.2021
Impfdatum: 18.03.2021
Beginn: 09.11.2021
Tage bis Beginn: 236,0
Dosis: 2
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Alveolar lung disease Blood creatinine increased Blood culture negative Blood pressure decreased COVID-19 Chest X-ray abnormal Computerised tomogram head normal Cough Dyspnoea Head injury Headache Hypophagia Laboratory test abnormal Lung opacity Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient is a very pleasant 82yo M admitted for orthostatic syncope as well as brief acute respiratory failure with hypoxia in setting of COVID19. He has a PMH of CKD G3a and HTN as well as likely vaso-vagal events. Patient presented after having viral syndrome symptoms and poor PO intake for ~ 5 days with syncope after standing up to let dog out. Patient did not have any alarm symptoms to suggest arrhythmia. On arrival patient had fever but VS were largely normal at rest but he had marked drop in BP w/ standing. Labs revealed an AKI on his known CKD. COVID19 PCR was positive. He was admitted for monitoring and briefly was hypoxic and required supplemental O2 so was started on steroids and remdesivir; he was given fluid for AKI. Patient symptomatically improved rapidly and was able to tolerate much more PO intake than before, O2 was titrated off, and he was hopeful for DC, however he became febrile again, Cr increased, and repeat orthostatics remained positive. Patient was given further fluids and monitored. The following day patient felt significant further improvement and felt close to his baseline. Orthostatics were minimally positive and patient had no symptoms with standing. He was discharged off his BP meds and will f/u with PCP to evaluate their need for reinitiation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 2,0
Labordaten: Procedure Component Value Ref Range Date/Time DR CHEST 2 VIEWS FRONTAL AND LATERAL [351908498] Resulted: 11/09/21 1654 Order Status: Completed Updated: 11/09/21 1656 Narrative: EXAMINATION: Frontal and Lateral View Chest EXAM DATE: 11/9/2021 4:23 PM TECHNIQUE: Frontal and lateral views INDICATION: cough, dyspnea, fever. COMPARISON: 11/24/2019 ENCOUNTER: Not applicable _________________________ FINDINGS: The cardiomediastinal silhouette is within normal limits. The lung volumes are low, accentuating the bronchovascular markings. Mild patchy left basilar opacities. The right lung is grossly clear. No pleural abnormality is evident. _________________________ Impression: Low lung volumes. Mild left basilar airspace disease, may relate to atelectasis and/or pneumonia. CT HEAD WITHOUT IV CONTRAST [351908499] Resulted: 11/09/21 1627 Order Status: Completed Updated: 11/09/21 1629 Narrative: EXAMINATION: CT Head without Contrast EXAM DATE: 11/9/2021 4:11 PM TECHNIQUE: Multiple axial images were obtained from the skull base to the vertex without contrast. Coronal and sagittal reformatted images were generated for review. INDICATION: syncope, headache, head trauma. COMPARISON: None ENCOUNTER: Not applicable HAND DOMINANCE: Right. _________________________ FINDINGS: The ventricles are normal in size. There is no evidence of mass, mass effect, midline shift, acute intracranial hemorrhage, acute transcortical infarct, or extra-axial fluid collection. There are no depressed calvarial fractures. Visualized paranasal sinuses are clear. ___________________________ Impression: No acute intracranial abnormality. Procedure Component Value Ref Range Date/Time Peripheral Blood Culture [351908500] Collected: 11/09/21 1739 Order Status: Completed Specimen: Blood, Venous Updated: 11/11/21 2102 Cult Blood Peripheral No Growth 48 hours Peripheral Blood Culture [351908501] Collected: 11/09/21 1534 Order Status: Completed Specimen: Blood, Venous Updated: 11/11/21 1801 Cult Blood Peripheral No Growth 48 hours COVID-19 PCR - Rapid BL and Regionals [351908497] (Abnormal) Collected: 11/09/21 1534 Order Status: Completed Specimen: Swabbed Collection from Nasopharynx Updated: 11/09/21 1622 COVID-19 PCR Detected
Aktuelle Erkrankungen: -
Vorgeschichte: Circulatory Unspecified essential hypertension Digestive GERD (gastroesophageal reflux disease) Infectious/Inflammatory Hand arthritis COVID Nervous Low back pain Syncope and collapse Genitourinary Chronic kidney disease (CKD), stage I Other S/P right hemicolectomy
Andere Medikamente: ciprofloxacin-dexamethasone (CIPRODEX) otic suspension ciprofloxacin-dexamethasone (CIPRODEX) otic suspension Multiple Vitamins-Minerals (CENTRUM SILVER ADULT 50+) TABS neomycin-polymyxin-hydrocortisone (CORTISPORIN) otic solution
Allergien: Viagra Vicodin [Hydrocodone-acetaminophen]
Vorherige Impfungen: -

VAERS 1864918

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 74,0
Geschlecht: F
Eingang: 12.11.2021
Impfdatum: 18.03.2021
Beginn: 13.09.2021
Tage bis Beginn: 179,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 COVID-19 pneumonia Death Dyspnoea Mechanical ventilation Multiple organ dysfunction syndrome SARS-CoV-2 test positive

Symptomtext

pt with end stage renal disease, on hemodialysis; presents to ED with SOB; positive for COVID, COVID pneumonia; during the pt's stay, required ventilation support; condition worsened; multi-organ failure; expired in the hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1722958

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 65,0
Geschlecht: F
Eingang: 12.11.2021
Impfdatum: 09.04.2021
Beginn: 05.08.2021
Tage bis Beginn: 118,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Blood glucose decreased COVID-19 Chest X-ray Computerised tomogram thorax Cough Chronic obstructive pulmonary disease Death Electrolyte substitution therapy Refusal of treatment by patient Dyspnoea Full blood count Metabolic function test Muscular weakness Nausea Physical deconditioning SARS-CoV-2 test positive Spinal X-ray Vomiting

Symptomtext

pt presents to ED with dyspnea and cough x 2 days; recently diagnosed with small cell lung CA but refuses to go for treatment; states she's "given up"; recent COPD exacerbation, refused to take antibiotics; tested positive for COVID; O2 supplementation via NC; given antibiotics, steroids, IV fluids, electrolyte replacement; dexamethasone; OptiFlow; DNR/DNI; comfort measures and hospice care requested; pt's condition worsened and she died in inpatient hospice care

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1851133

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 68,0
Geschlecht: F
Eingang: 08.11.2021
Impfdatum: 24.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 211,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Alanine aminotransferase normal Anion gap normal Anticoagulant therapy Aspartate aminotransferase increased Band neutrophil count decreased Blood bilirubin normal Blood chloride normal Blood creatinine increased Blood culture Blood glucose normal Blood lactic acid normal Blood potassium decreased Blood sodium decreased Blood urea increased Brain natriuretic peptide normal C-reactive protein normal COVID-19

Symptomtext

Date of Admission: 10/21/2021 ? Date of Discharge: 10/30/2021 69 yo female h/o of past smoking, moderqte COPD/emphysema, HTN, gout, pre-DM, vit D deficiency. She was vaccinated x2 with Pfizer vaccine, admitted on 10/21/21?with severe sepsis with mild acute hypoxic respiratory failure from COVID-19 PNA. ? ? Plan: 1)Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia. Symptom onset on 10/18/21COVID positive on 10/19/21. - Patient required oxygen via nasal cannula and received Decadron 6 mg daily during hospitalization and Remdesivir 200mg IV x1, followed by 100mg IV daily until clinical improvement (last day on 10/26/21). Patient received course of PO Levofloxacin which was started on 10/22/21 for possible superimposed pneumonia. I discussed with inpatient pharmacist on 10/27/21 and plan for last dose on Thurs 10/28/21.; patient will need follow up CXR in 6 weeks Patient received DVT prophylaxis with Heparin 5,000 units SQ q12h during hospitalization. I discussed patient with doctor of Pulmonary on 10/28/21 who recommended Prednisone taper on discharge (30 mg PO daily for 3 days, then 20 mg PO daily for 3 days, then 10 mg PO daily for 3 days, then stop). Patient was hypoxic with 02 sat decreased to 87% RA during ambulation on 10/29/21. ? It has been arranged for home 02 with instructions to use 2 liters with activity. ?Patient will have follow-up with Home Health and econsult sent for follow-up oxygen clinic. placed referral for COVID Transitions team follow-up. Isolation through 11/7/21. ? ?2) s/p AKI (Cr increased to 1.51 on 10/21/21); on Lisinopril as outpatient which was held during hospitalization. Cr improved to 0.97 on 10/30/21. It has been arranged for Home Health to draw follow-up chem 7 in 2-3 days. ? 3) HTN; On Lisinopril as outpatient which was held during hospitalization in setting of AKI. Patient continued on Amlodipine 2.5 mg PO daily. BP's have been stable on Amlodipine and patient was instructed to hold Lisinopril on discharge and PCC has arranged for HHRN for BP check and patient to follow-up with doctor to discuss with patient if Lisinopril should be resumed ? 4) H/o COPD; stable. Continue Stiolto and Rx for Albuterol MDI PRN shortness of breath/wheezing ? ? 5)H/o prediabetes; stable. ?Prior HbAIC 6.0% from 5/20/21. ?Patient not on medications as outpatient. ? 6) History of gout; stable. ?On Allupurinol ? Primary Procedures: None ? Secondary Procedures: 10/21/21 XR Chest ? ? Reason for Hospital Admission (Admitting Diagnosis): Severe sepsis and acute hypoxemic respiratory failure due to COVID pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: Results as of 11/8/2021 13:04 10/21/2021 17:20 NA: 134 (L) K: 3.4 (L) CL: 99 (L) CO2: 21 (L) BUN: 32 (H) CREAT: 1.51 (H) ANION GAP4 SERPL: 14 GLUC: 198 (H) TROPONIN I: 0.03 BNP: 34 ALT: 29 AST: 48 (H) ALKP: 64 LIPASE: 28 TBILI: 0.5 GFR-AFRAM: 40 (L) GFR NONAFR AMER: 35 (L) COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 9.6 (H) LACTATE: 1.8 WBC: 4.4 RBC'S: 4.84 HGB: 14.2 HCT: 42.2 MCV: 87 RDW, RBC: 13.9 PLT: 175 PLT'S, BLD QL, MAN: ADEQUATE NRBC: 0 NEUTROPHILS % MAN CNT: 81 (H) BAND'S % MAN CNT: 2 LYMPHS % MAN CNT: 15 MONOS % MAN CNT: 2 RBC'S MORPH: NORMAL PLT'S MORPH: NORMAL DIFF PANEL: MAN DIFF PT: 13.9 INR: 1.1 D-DIMER: 2.79 (H) BLD CULT RSLT: Final Report...
Aktuelle Erkrankungen: -
Vorgeschichte: hx of past smoking, mod COPD/emphysema, HTN, gout, pre-DM, vit D deficiency.
Andere Medikamente: Outpatient medications : confirmed with patient Prior to Admission Medications Outpatient Home Medications Taking? Albuterol (PROAIR/PROVENTIL/VENTOLIN) 90 mcg/actuation Inhl HFAA Takes Occasionally Sig: Inhale 2 Puffs by mouth every 4 hour
Allergien: nkda
Vorherige Impfungen: -

VAERS 1850851

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 73,0
Geschlecht: F
Eingang: 08.11.2021
Impfdatum: 21.03.2021
Beginn: 15.10.2021
Tage bis Beginn: 208,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Basophil percentage decreased Blood alkaline phosphatase normal Blood bilirubin decreased Blood chloride normal Blood creatinine normal Blood culture Blood glucose increased Blood lactate dehydrogenase increased Blood lactic acid Blood magnesium normal Blood potassium normal Blood sodium decreased Blood urea increased Brain natriuretic peptide normal

Symptomtext

73 Y female with a past medical history of CAD with stents, DM2 with hyperlipidemia, HTN, osteopenia, atherosclerosis of aorta, PAD presents with progressive shortness of breath and cough with sputum production and declining O2 sats, admitted for acute hypoxemic respiratory failure 2/2 likely COVID Pneumonia COVID PNEUMONIA // ACUTE HYPOXEMIC RESPIRATORY FAILURE Patient fully vaccinated with two doses Pfizer. Patient attended wedding 10/2 and noticed mild symptoms shortly after. Developed a cough 10/6 managed by Robitussin. Tested positive at home 10/8, and tested positive again 10/9. 10/14, symptoms worsened considerably with productive cough with green sputum, and home pulse ox showed SpO2 in high 80s. Used supplemental O2 at home which mildly relieved symptoms and was told to present to ED by PCP. In ED, patient comfortably speaking on 2LNC. 6mg Decadron x 3, Remdesivir 200mg in ED, and Remdesivir 100mg x1. Patient oxygen requirements improved from 2L NC to 1L NC to RA. HYPONATREMIA On presentation, patient with Na of 134 10/15, decreased to 132 10/16 and improved to 136 10/17. Stable at time of discharge Reason for Hospital Admission (Admitting Diagnosis): COVID Pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: Results as of 11/8/2021 11:07 10/15/2021 15:50 NA: 134 (L) K: 4.1 CL: 98 (L) CO2: 29 BUN: 25 CREAT: 1.04 ANION GAP4 SERPL: 7 GLUC: 103 TROPONIN I: <0.02 BNP: 45 ALT: 33 AST: 26 ALKP: 73 TBILI: 0.2 GFR-AFRAM: >60 GFR NONAFR AMER: 53 (L) COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 1.0 (H) LACTATE: 0.9 WBC: 6.7 RBC'S: 4.68 HGB: 13.7 HCT: 42.7 MCV: 91 RDW, RBC: 13.4 PLT: 330 IMMAT GRANULO % AUTO: 0 NRBC: 0 NEUTROPHILS % AUTO: 60 ANC: 4.1 LYMPHS % AUTO: 24 MONOS % AUTO: 11 EOS % AUTO: 3 BASO'S % AUTO: 0 DIFF PANEL: AUTO DIF BLD CULT RSLT: Final Report... 10/15/2021 16:25 BLD CULT RSLT: Final Report... 10/15/2021 17:01 EKG 12 OR MORE LEADS W INT & RPT: Rpt HEART RATE: 66 PR: 144 QRS: 92 QT: 403 QT CORRECTED: 423 10/15/2021 17:31 XR CHEST: Rpt 10/15/2021 21:20 D-DIMER: 0.88 (H) 10/15/2021 22:17 GLUC BLD GLUCOMETER: 304 (H) 10/16/2021 06:05 LDH: 205 CRP, SER QL: 0.9 WBC: 6.9 RBC'S: 4.26 HGB: 12.1 HCT: 38.9 MCV: 91 RDW, RBC: 13.2 PLT: 299 IMMAT GRANULO % AUTO: 0 NRBC: 0 NEUTROPHILS % AUTO: 82 (H) ANC: 5.7 LYMPHS % AUTO: 13 (L) MONOS % AUTO: 5 EOS % AUTO: 0 BASO'S % AUTO: 0 D-DIMER: 0.90 (H) 10/16/2021 06:05 NA: 132 (L) K: 4.6 CL: 99 (L) CO2: 25 BUN: 20 CREAT: 0.66 ANION GAP4 SERPL: 8 MG: 1.8 GLUC: 199 (H) LDH: 231 ALT: 28 AST: 22 ALKP: 66 TBILI: 0.2 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE FERRITIN: 240 10/16/2021 11:27 GLUC BLD GLUCOMETER: 94 10/16/2021 16:01 OSMO UR: 356 NA UR: 28 10/16/2021 17:36 GLUC BLD GLUCOMETER: 281 (H) 10/16/2021 21:55 GLUC BLD GLUCOMETER: 109 10/17/2021 05:54 NA: 136 K: 4.6 CL: 101 CO2: 30 BUN: 21 CREAT: 0.64 ANION GAP4 SERPL: 5 MG: 2.0 GLUC: 102 ALT: 26 AST: 18 ALKP: 62 TBILI: 0.2 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE OSMO: 297 WBC: 10.8 RBC'S: 4.29 HGB: 12.4 HCT: 38.7 MCV: 90 RDW, RBC: 13.3 PLT: 344 IMMAT GRANULO % AUTO: 1 NRBC: 0 NEUTROPHILS % AUTO: 77 (H) ANC: 8.3 (H) LYMPHS % AUTO: 14 (L) MONOS % AUTO: 8 EOS % AUTO: 0 BASO'S % AUTO: 0 10/17/2021 18:50 GLUC BLD GLUCOMETER: 146 10/17/2021 21:51 GLUC BLD GLUCOMETER: 225 (H) 10/18/2021 05:54 NA: 135 K: 4.5 CL: 100 CO2: 29 BUN: 23 CREAT: 0.68 ANION GAP4 SERPL: 6 MG: 2.0 GLUC: 81 LDH: 200 ALT: 27 AST: 18 ALKP: 60 TBILI: 0.2 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 0.2 FERRITIN: 263 WBC: 10.2 RBC'S: 4.41 HGB: 12.7 HCT: 39.6 MCV: 90 RDW, RBC: 13.4 PLT: 374 IMMAT GRANULO % AUTO: 1 NRBC: 0 NEUTROPHILS % AUTO: 69 ANC: 7.0 LYMPHS % AUTO: 22 MONOS % AUTO: 9 EOS % AUTO: 0 BASO'S % AUTO: 0 D-DIMER: 0.73 (H) 10/18/2021 07:52 GLUC BLD GLUCOMETER: 77
Aktuelle Erkrankungen: -
Vorgeschichte: PMHx of CAD (s/p PCI to RCA in 2019 and 2007), HTN, HLD, diet controlled DMII (last A1c 6.8 in 9/2021
Andere Medikamente: Prior to Admission Medications Outpatient Home Medications Taking? Aspirin (ECOTRIN LOW STRENGTH) 81 mg Oral TBEC DR Tab Sig: TAKE 1 TABLET ORALLY DAILY Patient taking differently: takes 325mg PO daily CALCIUM ORAL Sig: None Entered Not
Allergien: Lipitor - Foot pain Lovastatin - Muscle pain Penicillins Class - rash Simvastatin - Tingling in feet
Vorherige Impfungen: -

VAERS 1842829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 83,0
Geschlecht: M
Eingang: 04.11.2021
Impfdatum: 17.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: UN / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Cardiac imaging procedure abnormal Cardiac stress test Condition aggravated Cough Death Dysphagia Dyspnoea Endoscopy Joint swelling Oedema Peripheral swelling Productive cough Pulmonary fibrosis Rash Regurgitation SARS-CoV-2 test negative Weight decreased

Symptomtext

83-year-old man comes to an appointment for skin condition - rash. He is currently not on any medications. He does have some swelling in his ankles and a previous years-older history of swelling on his knee. He is diagnosed with scleroderma for the first time and also given his first COVID vaccine, lot #EN6207 on 3/17/21. He comes back for a return appointment and check up on 4/7/21 and receives his second dose of COVID vaccine, lot #EW015D on 4/7/21. As the months go forward his skin rashes increase, his ankles become more swollen and he has increasingly more difficulty upon swallowing food without large amounts of mucus needing to be coughed up soon afterwards, often bringing some or most of his food back up. This mucus accumulation problem continues, worsening through the months which causes and large amount of weight loss. He visited his doctor around July or August 2021 about the problem. They want to check his heart even though it is made clear that he has a swallowing and mucus problem. He completes a stress test and is scheduled for an angiogram. He schedules with a GI doctor to get an endoscopy to help understand the swallowing and mucus issues as this issues is currently the most distressing and he is losing more weight each week. It is cancelled by the heart doctor until the angiogram takes place. He has a lung evaluation that indicates that his lungs have a lot of scar tissue. He smoked for 20 years, 40 years ago and never had any known pulmonary issues to date. He sees a new doctor regarding the heart angiogram and it is completed - 4 areas where stents could be helpful are recommended but the new heart doctor says he needs to be able to swallow a blood thinner for a few months first so schedules the endoscopy. The endoscopy takes place, no cancerous cells noted and they stretch his esophagus in at least one place. Initially the swallowing is improved but soon, more mucus and difficulty swallowing resumes. He is scheduled for heart stents as his doctor suggests. His ankles and feet are increasingly swollen with pitting edema. His cough is productive but getting weaker and more strained, his weight is dangerously low at 155 for a 6'1" man. He is on a water pill and blood thinners. Just a few days before stent surgery is to be done, he passes away as he wakes in the morning in bed after a night of labored breathing. He was tested 2 times for COVID in the recent months before his passing and both were negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Negative COVID scar tissue in lungs Possible CHF Angiogram Endoscopy Stress test
Aktuelle Erkrankungen: March 2021 diagnosis of scleroderma - the reason for the appointment upon which he also received his first COVID vaccine.
Vorgeschichte: Rash, occasional hair loss, possibly a few years history of scleroderma without diagnosis. Chronic alcohol use, no liver issues noted however upon last recent blood test.
Andere Medikamente: occasional black licorice extract, occasional milk thistle extract supplement
Allergien: None
Vorherige Impfungen: -

VAERS 2602076

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 56,0
Geschlecht: F
Eingang: 02.11.2021
Impfdatum: 18.03.2021
Beginn: 01.08.2021
Tage bis Beginn: 136,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Acute respiratory failure Atelectasis Back pain Blood bicarbonate decreased Blood fibrinogen normal Blood gases abnormal Blood pH normal Brain natriuretic peptide normal C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Cough Dyspnoea Electrocardiogram Fibrin D dimer Lipase normal Lung infiltration

Symptomtext

Narrative: COVID infection following COVID vaccine series 02/25, Pfizer, dose #1 03/18, Pfizer, dose #2 08/01 pt cc: cough, dyspnea, malaise, wheezing, chest congestion, low backache unknown exposure: unknown 08/09 COVID swab, result: detected 08/12 SARS-COV-2 TOTAL AB SPIKE SEMI QN>2500.00 08/09 ekg sr 84, qtc 441, no acute changes 08/09 ABG i-pH 7.40, i-PCO2 30.6, i-PO2 50, i-HCO3 19.1, SpO2 84 08/09 Admit to medicine dx: Acute Hypoxic Respiratory Failure due to Covid 19 Pneumonia LOS: 8 days 08/09 BNP 12.1 08/09 LIPASE 28 08/09 CRP 10.970 08/09 PROCALCITONIN <0.05 08/09 CXR impression: The exam is limited by poor timing of the contrast bolus and respiratory motion artifact. Given these limitations, no central pulmonary embolism is visualized. -Patchy and groundglass opacities in the mid/lower lungs, most compatible with multifocal infection. Imaging features of Covid-19 pneumonia are present. Other processes such as influenza pneumonia and organizing pneumonia, as can be seen with drug toxicity and connective tissue disease, can cause a similar imaging pattern. 08/09 CXR impression: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: Left lower lobe infiltrate is identified. Small infiltrate versus atelectasis in the right lower lobe is seen. Clinical correlation is recommended. Bones: Unchanged 08/10 SARS-COV-2-IgG 0.07 08/10 FIBRINOGEN 491 08/10 ESR 81 08/10 DDIMER 0.24 08/18 FIBRINOGEN 212 08/18 DDIMER <0.22 08/18 ESR 44 08/31 CXR impression: No acute cardiopulmonary abnormality. Interval resolution of LEFT lower lobe pneumonia identified earlier this month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: 08/09 COVID swab, result: detected 08/09 ekg sr 84, qtc 441, no acute changes 08/09 BNP 12.1 08/09 LIPASE 28 08/09 CRP 10.970 08/09 PROCALCITONIN <0.05 08/09 CTA impression: The exam is limited by poor timing of the contrast bolus and respiratory motion artifact. Given these limitations, no central pulmonary embolism is visualized. -Patchy and groundglass opacities in the mid/lower lungs, most compatible with multifocal infection. Imaging features of Covid-19 pneumonia are present. Other processes such as influenza pneumonia and organizing pneumonia, as can be seen with drug toxicity and connective tissue disease, can cause a similar imaging pattern. 08/09 CXR impression: Support devices: None identified Mediastinum: Normal cardiac size. No central pulmonary vascular enlargement. Lungs and pleura: Left lower lobe infiltrate is identified. Small infiltrate versus atelectasis in the right lower lobe is seen. Clinical correlation is recommended. Bones: Unchanged 08/10 SARS-COV-2-IgG 0.07 08/10 FIBRINOGEN 491 08/10 ESR 81 08/10 DDIMER 0.24 08/18 FIBRINOGEN 212 08/18 DDIMER <0.22 08/18 ESR 44 08/31 CXR impression: No acute cardiopulmonary abnormality. Interval resolution of LEFT lower lobe pneumonia identified earlier this month.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1833143

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 76,0
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: 17.03.2021
Beginn: 04.09.2021
Tage bis Beginn: 171,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia COVID-19 Death Dyspnoea General physical health deterioration Hypoxia SARS-CoV-2 test positive

Symptomtext

6 days prior to hosp admission, pt diagnosed positive for COVID in the ED; left AMA to home; admitted to hosp with increase in weakness and SOB; O2 sats in the 70s; placed on NRB and NC; treated with remdesivir and dexamethasone; PMH renal transplant, HTN, monoclonal gammopathy; DNI/DNR; optiflow therapy for hypoxia; condition worsened; pt transferred to palliative care; pt's condition continued to decline and she expired in the hosp

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1825641

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 28.10.2021
Impfdatum: 15.03.2021
Beginn: 21.10.2021
Tage bis Beginn: 220,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Angiogram pulmonary abnormal Anticoagulant therapy Aortic dilatation COVID-19 Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Cough Dyspnoea Echocardiogram abnormal Left ventricular hypertrophy Lung opacity Pain in extremity Pulmonary embolism SARS-CoV-2 test positive Scan with contrast abnormal

Symptomtext

Hospitalized (10.21.21); COVID-19 positive (10.21.21); Fully vaccinated Admission Date: 10/21/2021 Discharge Date: 10/24/2021 DETAILS OF HOSPITAL STAY: HOSPITAL COURSE: 83 y.o. male who presented with worsening cough, shortness of breath found to be COVID 19 positive on date 10/21 with pulmonary embolism. He was treated with decadron, 4 day course of remdesivir as well as home inhalers. He initially required 2L NC but was weaned to room air. He improved both clinically and in lab findings. He was discharged home in stable condition to complete decadron course. CT as above regarding PE. Patient initially started on heparin for PE for suspicion of failed anticoagulation with Xarelto. Home xarelto had been held for upcoming biopsy prior to admission, indicating PE not due to treatment failure. Patient transitioned to loading dose of Xarelto. Echo limited in quality but did not show clear evidence of right heart strain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: PROCEDURES 10/21/21: - CT angio thorax w/ contrast: 1. Segmental and subsegmental pulmonary emboli involving the right upper, middle, and lower lobes as well as the lingula. No CT evidence of right heart strain. 2. Similar appearance of a spiculated density within the right upper lung near the apex. This remains concerning for lung cancer and the patient is currently scheduled for CT-guided biopsy. 3. There are scattered areas of groundglass opacity are nonspecific but can be seen with Covid-19 pneumonia. 4. Ectasia of the ascending thoracic aorta measuring up to 44 mm. -CXR: 1. No acute cardiopulmonary process. 2. Redemonstration of an area of architectural distortion in the peripheral right upper lung zone corresponding to a solid spiculated density on the recent comparison CT. This remains concerning for lung cancer. 10/22/21 Echocardiogram: Technical quality limited. LV normal in size. Mild concentric LVH. LV systolic function normal. RV not well visualized. RV systolic pressure normal
Aktuelle Erkrankungen: 9.23.21: ED: Leg pain 9.24.21: ED: Left leg pain
Vorgeschichte: CAD (coronary artery disease) PVD (peripheral vascular disease) with claudication (HCC) Diabetes mellitus, type II (HCC) Dyslipidemia Left Diaphragm paralysis OSA (obstructive sleep apnea) COPD, severe (HCC) Preop cardiovascular exam CKD (chronic kidney disease) stage 3, GFR 30-59 ml/min (HCC) Right inguinal hernia Abscess, intra-abdominal, postoperative History of Recurrent Pulmonary Embolism Edema, unspecified type Ascending aorta dilatation (HCC) Abnormal CT of the chest
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler allopurinol (ZYLOPRIM) 300 MG tablet aspirin 81 MG EC tablet atenolol (TENORMIN) 50 MG tablet colchicine (COLCRYS) 0.6 MG tablet dexamethasone (DECADRON)
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1821558

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IA
Alter: 75,0
Geschlecht: F
Eingang: 27.10.2021
Impfdatum: 14.03.2021
Beginn: 05.08.2021
Tage bis Beginn: 144,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure Anticoagulant therapy Asthenia COVID-19 Chills Computerised tomogram abnormal Cough Dyspnoea Echocardiogram abnormal Escherichia infection Fatigue Pericardial effusion Peripheral swelling Pneumonia Pyrexia SARS-CoV-2 test positive Urinary tract infection

Symptomtext

Pfizer Dose 1 2/21/21 (EN6200) Pfizer Dose 2 3/14/21 (EN6207) COVID Positive 8/7/21 8/7/21: Presented to ED. This is a 75-year-old female with rheumatoid arthritis on methotrexate, Parkinson disease, tremors who presented with generalized body weakness and fatigue that has been worsening over the last 2 days. Patient has recently noted bilateral lower leg fullness and swelling of about 1 week duration. Since yesterday she started to have fever, chills and cough for which she came to the emergency room and tested positive for COVID-19 infection. She has been fully vaccinated with Moderna COVID-19 vaccine. She takes methotrexate for her rheumatoid arthritis. She denies any history of cancer, COPD, heart disease, trauma, thromboembolism, strokes. She has no chest pain or known now history of coronary artery disease or congestive heart failure. CT scan showed large pericardial effusion. ED attending discussed with on-call Cardiology Patient's symptoms at this time a not attributed to her pericardial effusion. Cardiology and pulmonology team is consulted and will additionally follow the patient 8/17/21: Patient is a very pleasant 75-year-old female who presented to the emergency department with complaint shortness of breath found to have bilateral community-acquired pneumonia secondary to COVID-19 infection complicated by acute hypoxic respiratory failure, although patient received COVID-19 vaccine however she was immunocompromised secondary to rheumatoid arthritis on methotrexate, echocardiogram was suggestive of large pericardial effusion however cardiogram ruled out tamponade, cardiology were consulted, patient was monitored. There was no need for any intervention. She received COVID-19 specific treatment. She was on Rocephin and doxycycline to cover for pneumonia and E coli UTI. Her symptoms significantly improved, for some time she was on heparin drip then transition to Lovenox and upon discharge will discharge with Xarelto. Start evaluated by Cardiology who recommended follow-up with Cardiology as an outpatient and echocardiogram 3 months. Patient did very well throughout hospitalization, worked with physical therapy and they recommended placement on patient was discharged in a stable condition without oxygen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 11,0
Labordaten: see above
Aktuelle Erkrankungen: rheumatoid arthritis on methotrexate Parkinson's disease tremors
Vorgeschichte: rheumatoid arthritis on methotrexate Parkinson's disease tremors
Andere Medikamente: amantadine 100 mg PO TID carbidopa-levodopa 25-100 mg PO QID clopidogrel 75 mg PO QD Breo 1 inh QD furosemide 20 mg PO QD losartan-HCTZ 100-25 mg PO QD hydroxychloroquine 200 mg PO QD methotrexate as instructed rivaroxaban 20 mg PO HS
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1815217

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 68,0
Geschlecht: M
Eingang: 25.10.2021
Impfdatum: 13.03.2021
Beginn: 21.09.2021
Tage bis Beginn: 192,0
Dosis: 2
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory distress syndrome Acute respiratory failure Asthenia COVID-19 COVID-19 pneumonia Condition aggravated Death Diarrhoea Dyspnoea Fatigue Malaise Metabolic encephalopathy Oropharyngeal pain SARS-CoV-2 test positive Vaccine breakthrough infection

Symptomtext

This is a case of breakthrough COVID-19 disease that resulted in death. The patient became symptomatic while on a trip out of state. Several other people on this trip were also ill with COVID-19. This case was vaccinated with the Pfizer product on 02/19/2021 and 03/13/2021. The case became symptomatic for COVID-19 on 09/21/2021 and experienced symptoms of diarrhea, general weakness, fatigue, and sore throat. The exact timeline here is not clear, but over the course of the following days, the case developed difficulty breathing and was admitted to the hospital on 09/27/2021.. The case subsequently died on 10/01/2021. The death certificate details are as follows: Part I Cause of Death A: Acute Hypoxic Respiratory Failure B: COVID 19 Pneumonia; Adult Respiratory Distress Syndrome Part II Other Significant Conditions: Acute Kidney Failure; Acute Metabolic Encephalopathy

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: PCR positive for COVID-19 on 09/27/2021 despite being fully vaccinated against COVID-19.
Aktuelle Erkrankungen: -
Vorgeschichte: Acute kidney failure; acute metabolic encephalopathy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1808237

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 62,0
Geschlecht: F
Eingang: 22.10.2021
Impfdatum: 01.04.2021
Beginn: 19.10.2021
Tage bis Beginn: 201,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Bacterial test positive Blood creatine phosphokinase increased Blood glucose normal Blood potassium increased Blood urea increased Bone pain C-reactive protein increased COVID-19 COVID-19 pneumonia Chest pain Computerised tomogram head normal Cough Diarrhoea Dizziness Dizziness postural Dyspnoea

Symptomtext

Hospitalized 10/19/2021; COVID-19 positive 10/19/2021; fully vaccinated HISTORY OF PRESENT ILLNESS: PT is a 62 y.o. female who presents today with not feeling well with shortness of breath and feeling sick. Her husband had covid and he is recovering now. Has chest pain with cough. No abdominal pain. She has had diarrhea. Her symptoms started on last Wednesday. No leg swelling. She recently had left foot fracture. CT angio was negative for PE. She has type 2 DM as well. ASSESSMENT / PLAN: # Acute hypoxic respiratory failure: # Covid 19 pneumonia: - Decadron and remdesevir as symptoms are ongoing for 5 days - fully vaccinated - not a candidate for MAB due to hypoxia - continuous pulse ox 10/22/2012 note: CHIEF COMPLAINT: Hypoxia ASSESSMENT / PLAN: Acute hypoxic respiratory failure Covid 19 pneumonia - Symptom onset 10/14; COVID positive 10/19 - Decadron started 10/19 - On remdesivir through 10/24 - Fully vaccinated with Pfizer March and April 2021 - not a candidate for MAB due to hypoxia - Today desatting on 95% high flow. Requiring NRB. If continues to decline will need to reach out to ICU for possible intubation - Continuous pulse ox - CTA 10/19 no definitive PE, diffuse ground glass opacities -CRP 80.3->28.1 -ddimer 460->680 -Will trial IV lasix

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: 10/7/2021 ED note: MEDICAL DECISION MAKING Patient is a 62 y/o female hx of DM II with neuropathy, Hypertension, presents to the ED from urgent care following a syncopal fall around 1500 yesterday, unknown down time. LOC+, denies anticoagulation, unsure of head injury. She endorses L foot pain and worsened positional lightheadedness since fall. She is mentating appropriately, did not show any neurological deficit on exam. She was significantly tender to left metatarsals. EKG noted normal sinus rhythm at 83 bpm, non-specific changes noted in leads V3, V4, V5 when compared to previous EKG this morning. Initial troponin was elevated at 16, 2 hr troponin 17. CBC noted leukocytosis at 14 with a left shift and CMP noted potassium of 5.3, glucose of 173 and BUN of 28 that is not baseline. UA was positive for nitrates and bacteria with <1 squamous epithelial cells. COVID-19 was not detected. Creatinine kinase elevated at 208. XR of foot noted acute displaced comminuted fractures present involving the base of the second and third metatarsals, likely medial cuneiform, and potential base first metatarsal fracture with moderate soft tissue swelling. XR of ankle noted intact. CT of head showed no acute intracranial abnormalilty. Spoke with Dr. Foot and Ankle specialist, recommended CT of foot and non-weight bearing. A posterior short splint was placed on left leg with sensation intact distally and good capillary refill. Per orthopedics, recommended outpatient follow-up with non-weight bearing restrictions. Patient was discharged home in stable condition.
Vorgeschichte: OSA (obstructive sleep apnea) Excessive sleepiness Generalized anxiety disorder Diabetic Neuropathy Essential hypertension, benign Chronic bilateral low back pain without sciatica Dyslipidemia Traumatic incomplete tear of left rotator cuff, subsequent encounter Spinal stenosis, lumbar region without neurogenic claudication Spondylolisthesis, lumbar region Lumbar stenosis with neurogenic claudication Routine adult health maintenance Diabetic neuropathy (HCC) Diabetic retinopathy (HCC) Vitamin D deficiency NAFLD (nonalcoholic fatty liver disease) Class 3 severe obesity due to excess calories with serious comorbidity and body mass index (BMI) of 40.0 to 44.9 in adult (HCC) Diabetes mellitus, type II, insulin dependent (HCC) Hypoxia
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet Alpha-Lipoic Acid 300 MG TABS Ascorbic Acid (VITAMIN C PO) atorvastatin (LIPITOR) 20 MG tablet B-D UF III MINI PEN NEEDLES calcipotriene (DOVONEX) 0.005 % ointment Contour Next Test Strips dulaglutide (
Allergien: NKA
Vorherige Impfungen: -

VAERS 1807869

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 58,0
Geschlecht: M
Eingang: 22.10.2021
Impfdatum: 21.04.2021
Beginn: 15.08.2021
Tage bis Beginn: 116,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Back pain Computerised tomogram thorax Coronary arterial stent insertion Coronary artery occlusion Dizziness Electrocardiogram Myocardial infarction Paraesthesia

Symptomtext

I was in the shower. I got a dizzy, my arm started tingling, and my whole back started hurting. I went to ER. They did a EKG and a CT scan of my heart, and found out that one of my artery's was blocked. So they put a stent in right then and there. I had a heart attack. I was hospitalized for 2 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 2,0
Labordaten: EKG CT scan
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1797721

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 80,0
Geschlecht: F
Eingang: 19.10.2021
Impfdatum: 15.03.2021
Beginn: 15.10.2021
Tage bis Beginn: 214,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19

Symptomtext

Patient was fully vaccinated for COVID (dose 1 = 2/22/21, dose 2 = 3/15/21), but was hospitalized on 10/15/21 with COVID and is in acute resp. failure.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1591251

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 64,0
Geschlecht: F
Eingang: 19.10.2021
Impfdatum: 12.05.2021
Beginn: 19.08.2021
Tage bis Beginn: 99,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure COVID-19 Cough Death Dyspnoea SARS-CoV-2 test positive General physical health deterioration Impaired self-care Pulmonary oedema

Symptomtext

pt presented to ED with SOB and cough, unable to care for self; hx of AKI, DMT2, CVA, HTN; tested positive for COVID; acute respiratory failure with hypoxia; fluid build up in lungs; requiring 100% Vapotherm consistently with decompensation; pt's condition began to deteriorate; body began to shut down; discharged to hospice where she passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 21,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1795017

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 83,0
Geschlecht: M
Eingang: 18.10.2021
Impfdatum: 24.03.2021
Beginn: 11.10.2021
Tage bis Beginn: 201,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

PATIENT EXPIRED ON 10/11/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DM HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1790860

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NH
Alter: 78,0
Geschlecht: U
Eingang: 16.10.2021
Impfdatum: 25.03.2021
Beginn: 01.07.2021
Tage bis Beginn: 98,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebrovascular accident

Symptomtext

I have a stroke in July; This is a spontaneous report from a contactable consumer (patient). A 78-year-old patient of an unspecified gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 2 via an unspecified route of administration at the age of 78-year-old on 25Mar2021 (Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history included High blood pressure (on High blood pressure medicine), blood disorder (on blood thinners), immunisation. Concomitant medications included influenza vaccine taken for immunisation, start and stop date were not reported; acetylsalicylic acid (ASPIRIN) taken for an unspecified indication, start and stop date were not reported; on blood thinners medication (unspcified), on High blood pressure medicine (unspcified). The patient previously took first dose bnt162b2 (The LOT# for first is EL9266) at the age of 78-year-old on 26Feb2021 for COVID-19 immunisation and experienced arm is sore. The patient experienced 'I have a stroke in july' in Jul2021. The outcome of event was unknown. No follow-up attempts are needed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood disorder (on blood thinners); Blood pressure high (on High blood pressure medicine); Immunisation
Andere Medikamente: INFLUENZA VACCINE; ASPIRIN [ACETYLSALICYLIC ACID]
Allergien: -
Vorherige Impfungen: -

VAERS 1786357

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 91,0
Geschlecht: M
Eingang: 14.10.2021
Impfdatum: 16.03.2021
Beginn: 04.10.2021
Tage bis Beginn: 202,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Adenovirus test Agitation Angiogram pulmonary abnormal Arrhythmia Asthenia Atelectasis Blood test Body temperature increased Bordetella test negative Bradycardia Brain natriuretic peptide increased COVID-19 COVID-19 pneumonia Cardiac failure congestive Chest X-ray abnormal Chlamydia test negative Chronic kidney disease

Symptomtext

91 year old (deceased) Male. Communication details: Call to PCP office to report patient up all night with a cough, elevated temp this morning. Poor appetite today and fatigue. SOB, +DOE, diarrhea. They will call the patient after speaking to the MD. Office Visit Family Medicine Chronic diastolic congestive heart failure +4 more Dx Cough ? Shortness of Breath ? Insomnia ? Poor Appetite Reason for Visit Patient was seen today for cough, shortness of breath, insomnia and poor appetite. Diagnoses and all orders for this visit: Chronic diastolic congestive heart failure - CBC and differential; Future - B-type natriuretic peptide; Future - Basic metabolic panel; Future - X-ray chest 2 views; Future Stage 3a chronic kidney disease - CBC and differential; Future - B-type natriuretic peptide; Future - Basic metabolic panel; Future Suspected COVID-19 virus infection - COVID-19 PCR; Future - COVID-19 PCR Bradycardia - ECG 12-lead: IN OFFICE Patient Instructions I am not entirely sure what is causing your shortness of breath. I think it is going to turn out to be a combination of things. Your pulse is a little bit low. EKG does not show anything that would make me insist upon a pacemaker but you do have an irregular rhythm with some "supraventricular" beats. Chest x-ray Blood work Today when you get home take an extra furosemide 20 mg pill You do not want to go to the emergency department. If you change your mind at any time call 911 Visit time 40 minutes including obtaining history, physical exam, placing orders and, interpreting past test results, communicating to pt/family and dictating. Daughter was a bit frustrated that he did not agree to go to the emergency department. She thought it would be in her dad's best interest but he strongly and consistently refused emergency department evaluation. He did say that he is dying and his time is limited even if they would elect for hospitalization Return for Next scheduled follow up. Patient is here with wife and daughter due to cough, shortness of breath, decreased appetite. He is known to have interstitial lung disease, COPD, diastolic heart failure, pulmonary hypertension. He was hospitalized a little bit over a week ago for similar symptoms. He was felt to be in heart failure due to an elevated BNP at 503. He was given IV Lasix but that adversely affected his kidney function. He was transitioned and discharged to 20 mg of Lasix daily. He is on chronic oxygen. Since being at home he has not been doing well. He has cough productive of clear sputum, shortness of breath and yesterday he had a fever of 100.6. Yesterday and earlier today when we heard of his difficulties we recommended that he go to the emergency department. He and his wife absolutely refused. They are well aware that emergency department is the most rapid and efficient way of getting testing done. In spite of this they wanted to come into the office to see me today. Patient arrives in a wheelchair. He appears to be in moderate respiratory distress. He appears weak and frail. I confirmed with patient and his wife their desire to return to the hospital. They are again very clear that they do not want emergency department evaluation. They would like for me to do what I can in the outpatient setting. ROS: Patient denies headache, vision changes, chest pain, chest pressure, lightheadedness, dizziness, shortness of breath at rest, nausea, vomiting, melena, bright red blood per rectum, abdominal pain, dysuria, hematuria, focal neurologic deficit, fever, unexplained weight loss ED to Hosp-Admission Discharged 10/6/2021 - 10/10/2021 (4 days) Last attending ? Treatment team Severe sepsis Principal problem Hospital Course:Patient is a 91 y.o. male with past medical history of pulmonary fibrosis and ILD with chronic respiratory failure on home oxygen 2 L per nasal cannula, hypothyroidism, BPH, chronic diastolic heart failure was admitted to Hospital with severe sepsis secondary with associated acute on chronic respiratory failure with hypoxia secondary to COVID-19 pneumonia. He has been undergoing treatment with dexamethasone and Remdesevir for COVID-19 pneumonia. He did receive IV Tocilizumab treatment per ID for worsening acute on chronic respiratory failure with hypoxia requiring maxed out high flow nasal cannula oxygen. He also required empiric antibiotics for possible superimposed community-acquired pneumonia. Over the past 24 hours he developed worsening acute on chronic respiratory failure with hypoxia requiring maxed out high flow nasal cannula oxygen and nonrebreather. The patient also developed worsening acute metabolic encephalopathy and end-stage agitation that did not respond to lorazepam, Zyprexa, or haloperidol. The patient's breathing and confusion continued to worsen. After further discussion with the patient's wife, the family has agreed to transition the patient's goals of care to comfort measures only. The patient was seen by hospice and community care and consents were signed to transition the patient to inpatient hospice. Admission Discharged Acute on chronic respiratory failure with hypoxia Principal problem Details of Hospital Stay Presenting Problem/History of Present Illness/Reason for Admission Acute on chronic respiratory failure with hypoxia Severe sepsis secondary to COVID-19 pneumonia Acute metabolic encephalopathy Patient is a 91 y.o. male with past medical history of pulmonary fibrosis and ILD with chronic respiratory failure on home oxygen 2 L per nasal cannula, hypothyroidism, BPH, chronic diastolic heart failure was admitted to Hospital with severe sepsis secondary with associated acute on chronic respiratory failure with hypoxia secondary to COVID-19 pneumonia. He has been undergoing treatment with dexamethasone and Remdesevir for COVID-19 pneumonia. He did receive IV Tocilizumab treatment per ID for worsening acute on chronic respiratory failure with hypoxia requiring maxed out high flow nasal cannula oxygen. He also required empiric antibiotics for possible superimposed community-acquired pneumonia. Over the past 24 hours he developed worsening acute on chronic respiratory failure with hypoxia requiring maxed out high flow nasal cannula oxygen and nonrebreather. The patient also developed worsening acute metabolic encephalopathy and end-stage agitation that did not respond to lorazepam, Zyprexa, or haloperidol. The patient's breathing and confusion continued to worsen. After further discussion with the patient's wife, the family has agreed to transition the patient's goals of care to comfort measures only. The patient was seen by hospice and community care and consents were signed to transition the patient to inpatient hospice. The patient was readmitted under inpatient hospice. He was started on continuous IV morphine infusion at 2 mg/hr. he did rest comfortably on the morphine drip and passed comfortably in the late afternoon. The family was present at the bedside and were very grateful for the excellent care the patient had received. All of our best wishes were offered to the family at this time. Condition at Discharge Discharge Condition: Expired

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: 10/05/2021 1528 COVID-19 (SARS CoV-2,RNA Molecular Amplification) Collected: 10/05/21 1528 | Final result | Specimen: Swab from Nasopharynx COVID-19 SARS-CoV-2 Overall Result Detected Critical Results Procedure Component Value Ref Range Date/Time CT angiogram chest pulmonary embolism with and without contrast [3307542570] Resulted: 10/08/21 1304 Order Status: Completed Updated: 10/08/21 1305 Narrative: CTA CHEST PULMONARY EMBOLISM W WO CONTRAST IMPRESSION: Underlying pattern of panlobular emphysema and chronic interstitial inflammatory change with overall marked increase of opacities from the CT of 9/22/2012. Cannot differentiate between progressive interstitial disease versus superimposed infiltrate or edema. Minimal left effusion. No definite pulmonary embolus. See above. RV/LV Ratio: N/A END OF IMPRESSION: INDICATION: Shortness of breath and sepsis and history of Covid positivity Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2 mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. CONTRAST: 80mL of IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. Quality of contrast opacification was adequate. COMPARISON: 9/22/2012 FINDINGS: There is a background pattern of severe interstitial disease which has progressed since 9/22/2012. Panlobular emphysema. Minimal left effusion. There certainly may be a superimposed diffuse inflammatory changes but I cannot differentiate from interval chronic changes worsening or superimposed edema or infiltrate. Within the mediastinum there are some small but very stable nodes present. There is an excellent bolus and there is no central or mid lung zone pulmonary embolus but peripherally very difficult to identify due to the underlying emphysema and chronic interstitial lung disease. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. X-ray chest 1 view [3305321890] Resulted: 10/06/21 0731 Order Status: Completed Updated: 10/06/21 0731 Narrative: XR CHEST 1 VW PORT IMPRESSION: No significant interval change. Redemonstrated diffuse bilateral interstitial markings consistent with pulmonary fibrosis/ILD. Superimposed infection cannot be excluded. Clinical correlation recommended. END OF IMPRESSION: INDICATION: sob. TECHNIQUE: Single AP projection of the chest is acquired. COMPARISON: Chest radiograph from October 5, 2021 and priors FINDINGS: Redemonstrated diffuse bilateral interstitial opacities with a lower lobe predominance, which is more prominent on the left side and not significantly changed compared to prior studies. Opacity at the right lower lung zone is also not significantly changed and likely represents atelectasis. The heart appears borderline enlarged on this single AP projection. The mediastinal contours are unchanged. No large pleural effusion. There is no evidence of pneumothorax. There are no significant bony findings. 10/05/2021 1528 COVID-19 PCR Collected: 10/05/21 1528 | Final result | Specimen: Swab from Nasopharynx 10/06/2021 0734 Respiratory virus detection panel Collected: 10/06/21 0734 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result Detected Critical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Syncytial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected
Aktuelle Erkrankungen: -
Vorgeschichte: Respiratory Allergic rhinitis Chronic obstructive pulmonary disease Hypoxia Postinflammatory pulmonary fibrosis Shortness of breath Acute on chronic respiratory failure with hypoxia Circulatory Benign essential hypertension Mitral regurgitation Pulmonary hypertension Digestive Tubular adenoma of colon Vitamin D deficiency Diverticulosis of large intestine without hemorrhage Genitourinary Benign prostatic hyperplasia (BPH) with straining on urination Chronic kidney disease, stage 3 Musculoskeletal Arthritis of shoulder region, degenerative Squamous cell carcinoma of upper extremity Basal cell carcinoma of skin Atypical fibroxanthoma of skin Actinic keratosis Squamous cell cancer of skin of right forearm Endocrine/Metabolic Hypercholesterolemia Hypocalcemia Acquired hypothyroidism Prediabetes Hematologic Anemia Immune Severe sepsis Other Anxiety Edema Right inguinal hernia Squamous cell carcinoma
Andere Medikamente: UNKNOWN
Allergien: Advair Diskus [Fluticasone Propion-salmeterol]Palpitations EscitalopramConfusion / Delirium SimvastatinMyalgia / Muscle Pain FenofibrateOther (document details in comments) PravastatinOther (document details in comments)
Vorherige Impfungen: -

VAERS 1782687

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

kritisch

Staat: MO
Alter: 87,0
Geschlecht: M
Eingang: 13.10.2021
Impfdatum: 17.03.2021
Beginn: 13.09.2021
Tage bis Beginn: 180,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Intensive care

Symptomtext

admitted to Hospital 9/13/2021 directly to ICU. No interview was done. At last communication on 9/23/2021, hospital said he was still in the ICU. Passed away on 9/24/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1768982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 97,0
Geschlecht: F
Eingang: 07.10.2021
Impfdatum: 23.03.2021
Beginn: 15.09.2021
Tage bis Beginn: 176,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain Acute respiratory failure COVID-19 Death Decreased appetite Depressed level of consciousness Diarrhoea Dyspnoea Fatigue Hypoxia Pneumonia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: COVID-19 case resulting in Hospitalization / Death. Patient received Pfizer Vaccines on 3/5/2021 and 3/23/2021. Presented to ED on 9/18/2021 with reports decreased appetite over the last 3 days, diarrhea and abdominal pain 2 days duration, shortness of breath, and fatigue. She was found to have pneumonia secondary to COVID-19. She was hypoxic and admitted to the hospital. She was started on dexamethasone and determined to not be a candidate for remdesivir. She rapidly decompensated and required high-flow nasal cannula. By September 24th she had become relatively obtunded and stop taking all oral medications. On maximum high-flow she was only maintaining O2 saturations in the 86-89% range. Palliative Care evaluated the patient on that evening and on the morning of the 26th she was transitioned to comfort care. On September 26 at 3:16 a.m. the patient passed away.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: Positive COVID-19 test on 9/18/2021 using the Roche LIAT SARS assay platform using PCR or equivalent technology.
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension, Left bundle branch block, Hypothyroidism, Dementia, Atrial Fibrillation, Benign neoplasm of kidney, Nodular lymphoma, Angiomyolipoma, Follicular lymphoma, 1st degreee AV block, Bigeminy, SIADH,
Andere Medikamente: Acetaminophen prn, Amlodipine 5 mg QD, Carvedilol 12.5 mg BID, Levothyroxine 37.5 mcg QD, Lisinopril 10 mg QD, Rivastigmine 4.6 mg/24hr Patch QD.
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1768470

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 71,0
Geschlecht: F
Eingang: 07.10.2021
Impfdatum: 31.03.2021
Beginn: 20.09.2021
Tage bis Beginn: 173,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure Angiogram Angiogram pulmonary abnormal Blood creatinine Blood glucose Bradycardia Brain natriuretic peptide increased C-reactive protein COVID-19 Cardiac failure congestive Chest discomfort Chills Condition aggravated Cough Dyspnoea Fibrin D dimer Hypotension Hypoxia

Symptomtext

Date of Admission: 9/20/2021 Date of Discharge: 9/28/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 8,0
Labordaten: 71F with HTN, HLD, OSA, asthma, ILD, hypersensitivity pneumonitis, chronic hypoxemic failure (normally 2-3L home O2), HFpEF, CKD (creat 1.4) and DM2 who present with shortness of breath ongoing x 2 weeks. Increased lasix to 40mg daily 9/14. Covid postive on 9/16 during visit to the oxygen clinic. Developed chills, dry cough, chest tightness, and increased SOB on 9/19 and came to the ED on 9/20. Noted to have O2 sat 64%, BNP 805. Acute on chronic respiratory failure due to HFpEF, ILD and covid - admitted directly to ICU and managed with tocilizumab x 1 9/20, solumedrol 100mg IV BID (9/20-22), then 250mg IV q6hr (9/22-24), iNO given on 9/23 with some improvement in hemodynamics. HF component managed with IV lasix and spironolactone. Not given remdesivir due to renal function. Per I/O documentation she has diuresed a total of 18.8L. Weight down to 174lbs at discharge. (last clinic weight 195lbs on 8/16/21). CRP/Ddimer low so unclear how much covid is contributing to hypoxia. FiO2 returned to baseline 2 lpm. Received empiric cefepime 9/22-25. Solumedrol was weaned to prednisone 40mg daily 9/26 with plan to decrease by 10mg every 5 days. Lasix switched to PO on 9/27. PTA atenolol and losartan were continued at lower doses than home and amlodipine was stopped (bradycardia and low BP). Continued on PTA wixela and prn albuterol. Referral sent to follow up in pulmonary clinic. DM - managed with NPH/lipsor with ongoing titration. BS's were elevated and labile due to ongoing titration of steroids. Transitioned back to lantus for discharge. CKD - creatinine has improved with diuresis and is below recent basleine Mediastinal adenopathy - seen on CTA, f/u CXR in 6 weeks OSA - on CPAP q HS Primary Procedures: None Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis): CHF, ILD, covid, acute on chronic respirtory failure
Aktuelle Erkrankungen: -
Vorgeschichte: PMH HTN, HLD, OSA, asthma, ILD, hypersensitivity pneumonitis, chronic hypoxemic failure (normally 2-3L home O2), HFpEF, and DM2 who presents with shortness of breath
Andere Medikamente: ASPIRIN 81 MG ORAL TBEC DR TAB Sig: TAKE 1 TABLET ORALLY DAILY Albuterol (PROAIR/PROVENTIL/VENTOLIN) 90 mcg/actuation Inhl HFAA Sig: Inhale 2 puffs by mouth every 4 hours as needed for quick relief of asthma symptoms . 100 days suppl
Allergien: Hydrochlorothiazide -makes gout worse Salonpas-hot ---Rash Simvastatin - Nausea/Vomiting Tetracycline - Vomiting
Vorherige Impfungen: -

VAERS 1220292

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: ME
Alter: 65,0
Geschlecht: M
Eingang: 06.10.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Aortic dilatation Blood test Computerised tomogram Echocardiogram Muscle spasms Aortic disorder Condition aggravated Pulmonary embolism Parosmia Product odour abnormal

Symptomtext

having bilateral ankle cramping and a weird smell in his nose. (pin to top)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: non
Aktuelle Erkrankungen: none
Vorgeschichte: no
Andere Medikamente: no
Allergien: no
Vorherige Impfungen: -

VAERS 1753324

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 56,0
Geschlecht: M
Eingang: 01.10.2021
Impfdatum: 08.04.2021
Beginn: 09.09.2021
Tage bis Beginn: 154,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Asthenia COVID-19 Chest X-ray abnormal Cough Death Deep vein thrombosis Dyspnoea Endotracheal intubation Extubation Gait disturbance Hypoxia Jugular vein occlusion Lung opacity Oxygen saturation decreased Peripheral coldness Physical deconditioning Positive airway pressure therapy

Symptomtext

Patient has expired / died (9.28.21); Hospitalized (9.15.21); COVID positive (9.9.21); fully vaccinated Discharge Provider: Admission Date: 9/15/2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: COVID-19 virus infection [U07.1] COVID-19 [U07.1] Acute respiratory failure with hypoxia [J96.01] Acute respiratory failure due to COVID-19 [U07.1, J96.00] HOSPITAL COURSE: Patient is a 57 year old with asthma, MS (ocrelizumab q 6 months), tobacco abuse (30pkyr), and congenitally absent left kidney. He was COVID (+) 9/9 (was vaccinated in the spring). He presented 9/15 with 10 days cough/SOB/fevers. In the ED, he was hypoxemic and would desaturate with activity. CXR showed patchy bilateral opacities. He was admitted and treated with Decadron, remdesivir, and empiric antibiotics. On 9/18, he was transferred requiring HFNC/NRB. On 9/19, he required intubation, NMB (until 9/22), and proning (until 9/21). Doppler US 9/20 showed acute right IJ and right SC DVTs. He was extubated 9/26 and initially tolerated low-flow NC oxygen but was profoundly weak. He decompensated requiring BiPAP. He had been made DNR by family then comfort measures. He passed away on 9/28 while this attending was off service and at home Date of Death: 9/28/21 Time of Death: 8:07 PM Preliminary Cause of Death: Acute respiratory failure due to COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: 9.2.21 - office visit - annual physical - MS, HTN, asthma, polyps, knee pain, difficulty walking / cold legs Symptoms started 9.5.21. COVID-19 positive 9.9.21 (weak, coughing, difficulty walking)
Vorgeschichte: Kidney congenitally absent, left Acute deep vein thrombosis (DVT) of right subclavian and IJ vein, noted 9/20/21 Acute allergic rhinitis Multiple sclerosis diagnosis in 1997. Fatigue Depression due to multiple sclerosis Neurogenic bladder Erectile disorder due to medical condition in male Anxiety Insomnia related to another mental disorder Gastroesophageal reflux disease without esophagitis Mild persistent asthma without complication Hypersomnia Chronic anemia Dyspnea on exertion At risk for falls Benign essential hypertension Pulmonary nodules History of adenomatous polyp of colon Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia, secondary to COVID-19 pneumonia Asthma Shock
Andere Medikamente: acetaminophen (TYLENOL) 500 MG tablet albuterol (PROAIR HFA) 108 (90 BASE) MCG/ACT inhaler ALPRAZolam (XANAX) 0.5 MG tablet aspirin 81 MG chewable tablet CALCIUM PO CANNABIDIOL PO Cholecalciferol (VITAMIN D-3 PO) CRANBERRY PO Dalfampridine
Allergien: CatsAsthma/Shortness of Breath DogsAsthma/Shortness of Breath PenicillinsNausea Only, Rash
Vorherige Impfungen: -

VAERS 1753250

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 65,0
Geschlecht: F
Eingang: 01.10.2021
Impfdatum: 18.03.2021
Beginn: 31.08.2021
Tage bis Beginn: 166,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Acute respiratory failure Anticoagulant therapy Anxiety Arthralgia Blood culture negative Bursitis COVID-19 COVID-19 pneumonia Coronary artery thrombosis Culture negative Death Dyspnoea Endotracheal intubation General physical health deterioration Hypervolaemia Intensive care Laboratory test normal

Symptomtext

Deceased (9.26.21); Hospitalized due to COVID-19 (9.2.21); COVID-19 positive (8.31.21); Fully vaccinated Admission Date: 9/2/2021 Died 9/26/21 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Hypoxia [R09.02] Pneumonia due to COVID-19 virus [U07.1, J12.82] Acute hypoxemic respiratory failure (HCC) [J96.01] COVID-19 [U07.1] HOSPITAL COURSE: Patient is a 65 y.o. female with a PMHx of COPD not on home oxygen, HTN, Hypothyroid, RA on immunomodulator therapy who was admitted for AHRF secondary to Covid pneumonia. Completed 4 days of dexamethasone, 3 days of remdesivir so far. Bcx, other infectious work-up have been negative. Going intermittently between HFNC and BiPAP, stays relatively comfortable without additional work of breathing. She has been responding well to once/day diuresis. Multiple conversations at that time were held with the patient, who has elected to be DNR/DNI - okay with vasopressor medications if needed. After transfer out of the ICU she completed dexamethasone, remdesivir, diuresis as needed- she developed an AkI that resolved. She was able to alternate between HFNC and BiPAP but developed hypoxia despite continuous BiPAP at 100%. She was readmitted to the ICU on 9/11 and was unsure of her code status to be DNR or FULL. Overnight she remained on continuous BiPAP with O2 sats in the high 80s. A CTA to rule out PE was unable to be performed given her respiratory status, U/S showed no signsof DVT. On 9/12 Patient had increased work of breathing and anxiety, especially with repositioning and requested to be FULL CODE and was electively intubated for hypoxic respiratory failure 2/2 COVID-19 PNA. Following intubation, the patient did develop worsening urine output and AKI. She ultimately was started on CRRT for volume overload. With volume overload, her O2 requirement did improve somewhat, but she still had significant ventilatory needs due to her COVID-19 pneumonia. Patient also had persistent tachycardia during her hospital stay. Her serotonergic medications were held to rule out serotonin syndrome, repeat cultures were obtained without any growth, and extremity ultrasounds were performed which did show equivocal left coronal DVT. Patient was started on heparin drip for this possible DVT. Due to the persistent high ventilatory needs, goals of care were discussed with the family. It was agreed that tracheostomy tube placement was not in line with the patient's goals of care, and due to her persistent refractory hypoxemia requiring high ventilatory needs, plan was made to transition patient to comfort care on Monday, 09/27/2021. On Sunday 9/26 patient had acute worsening in clinical status with decreasing oxygen levels. Based on patient's families wishes for the patient to be with her husband upon passing the patient was made comfort care and passed away at 1108 AM. Date of Death: 9/26/21 Time of Death: 11:08 AM Preliminary Cause of Death: COVID-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 25,0
Labordaten: -
Aktuelle Erkrankungen: 8.11.21: Office visit - plans to schedule - rotator cuff repair 8.16.21: Office visit - left hip pain (trochanteric bursitis, lumbar radiculopathy) COVID-19 positive 8.31.21
Vorgeschichte: Rheumatoid arthritis involving multiple sites (HCC) Fibromyalgia HTN (hypertension) Tremor, essential Fatigue Morbid obesity (HCC) OSA (obstructive sleep apnea) Nocturnal hypoxemia Knee pain OA (osteoarthritis) of knee S/P total knee arthroplasty Pinguecula of both eyes Myopia of both eyes Hypothyroidism, unspecified type Bilateral hip joint arthritis Need for vaccination Screening, lipid Obesity hypoventilation syndrome (HCC) Pneumonia due to COVID-19 virus Acute respiratory failure with hypoxia (HCC) Obesity hypoventilation syndrome (HCC)
Andere Medikamente: albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler ALPRAZolam (XANAX) 1 MG tablet atenolol (TENORMIN) 100 MG tablet benzonatate (TESSALON) 100 MG capsule busPIRone (BUSPAR) 10 MG tablet DULoxetine (CYMBALT
Allergien: Dilaudid
Vorherige Impfungen: -

VAERS 1749953

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: GA
Alter: 56,0
Geschlecht: F
Eingang: 30.09.2021
Impfdatum: 23.02.2021
Beginn: 01.04.2021
Tage bis Beginn: 37,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Catheterisation cardiac abnormal Chest X-ray Chest discomfort Chest pain Coronary artery occlusion Dyspnoea Echocardiogram Fatigue Inappropriate schedule of product administration Insomnia Laboratory test Myocardial infarction Pericarditis

Symptomtext

I received the Pizer Covid-19 Vaccine on February 23, 2021 and March 23, 2021. Shortly thereafter, in April of 2021, I started experiencing fatigue, chest tightness, breathing issues and sleeplessness. I thought these symptoms were indications of acid reflux and stress, and took Tylenol and over-the-counter acid reflux medication, Omeprazole. On July 31, 2021, I went to Hospital due to shortness of breath and chest pain. I was then transferred to another hospital, where they ran blood work and tests. I stayed in the hospital until August 3, 2021 and was told that I had inflammation around my heart. Later, I followed-up with Dr., a Cardiologist, on August 18, 2021 and was told that I had in fact, suffered a Heart Attack! Hence, I have been on seven (7) different medications (Omeprazole 20 mg, Aspirin 81 mg, Colchicine 0.6 mg, Isosorbide Mononitrate 30 mg, Atorvastatin 80 mg, Lisinopril 2.5 mg, and Metoprolol ER Succinate 25 mg) for my conditions in order for the inflammation to subside and have a stent placed in a blocked artery. On September 27, 2021, I was informed by Dr. that a stent would be too risky to perform, since the artery is blocked 100%. Therefore, I will have to live with this "permanent injury" for the rest of my life. Consequently, I have been told I have a rare case of inflammation. Therefore, I certainly believe it is Covid-19 vaccine related, and have filed a VAERS report (Vaccine Adverse Event Reporting System) with the CDC. Thus, I do not have a family history of Heart Disease and never have been on ANY prescription medications other than for very brief illnesses. These are some of the symptoms and/or side effects that I have experienced from my medications, since August 5, 2021 to date: 1.) Sore throat/cold 2.) Headaches/migraines 3.) Diarrhea 4.) Chills/hot and cold 5.) Stomach aches 6.) Light-headedness 7.) Low energy 8.) Unstable on feet; fell on September 15, 2021 around 12:30 p.m. 9.) Sleeplessness 10.) Loss of appetite 11.) Tightness in left calf area 12.) Cramping in both legs 13.) Fever 14,) Feeling depressed 15.) Woozy and dizzy 16.) Constipation 17.) Excessive coughing 18.) Body aches, specifically, back, arms and legs 19.) Nausea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 4,0
Labordaten: Blood work, Heart X-rays, MKGs, Heart Ultrasound, and Heart Cather from July 31, 2021 through August 3, 2021.
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1745371

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MO
Alter: 81,0
Geschlecht: F
Eingang: 29.09.2021
Impfdatum: 06.04.2021
Beginn: 17.09.2021
Tage bis Beginn: 164,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

SARS COV 2 listed as cause of death on death certificate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Death Certificate Confirmaiton
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1726783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 73,0
Geschlecht: M
Eingang: 23.09.2021
Impfdatum: 09.03.2021
Beginn: 02.09.2021
Tage bis Beginn: 177,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

COVID-19 Confusional state Death Decreased appetite Hypoxia Musculoskeletal pain SARS-CoV-2 test positive

Symptomtext

seen in ED after a dr's appointment for complaint of pain in L buttock area, COVID test done - positive; confusion, decreased appetite and drinking x 2days; mildly hypoxic; pt wanted to go home; dc'd to home with O2; pt died at home 5 days later

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1726380

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 23.09.2021
Impfdatum: 08.04.2021
Beginn: 16.09.2021
Tage bis Beginn: 161,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute left ventricular failure Acute respiratory failure Ageusia Alanine aminotransferase increased Anosmia Aspartate aminotransferase increased Asthenia Blood albumin decreased Blood alkaline phosphatase increased Blood creatinine increased Blood glucose increased Blood sodium decreased Blood urea increased C-reactive protein increased COVID-19 COVID-19 pneumonia Chest X-ray abnormal Chest pain

Symptomtext

Hospitalized (9.21.21 - present); COVID-19 positive (9.16.21); fully vaccinated HISTORY OF PRESENT ILLNESS: Patient is a 65 y.o. female with a past medical history of sarcoidosis, OSA not on CPAP, CKD 3B, MGUS, and morbid obesity who presents today with hypoxia. Her current symptoms started on 9/14. Symptoms include fevers, chills, rigors, anorexia, dysgeusia, cough, weakness and diarrhea. She has not taken the majority of her medications in 1 week. She confirmed that she had not taken her Lasix in 1 week. The patient received a COVID test on 09/16 which was positive. She was to have the monoclonal antibody infusion today. When she went to her appointment, her oxygen level was noted to be in the 60s on room air and was sent to the ER. The patient arrived on 6 L of oxygen by nasal cannula. Her oxygen level at arrival was 77% on the 6 L. she was placed on non-rebreather at 15 L. She was transitioned to high-flow nasal cannula with an FiO2 of 90%. She was noted to be tachypneic in the ER with a respiratory rate of 30. She was also tachycardic with pulse of 107. Labs significant for sodium 133, BUN 25, creatinine 1.66, glucose 234, alk-phos 159, albumin 2.9, AST 137 ALT 100. CRP was 152.8. D-dimer 470. CXR with bilateral perihilar and left basilar opacities. This could represent central pulmonary edema. An atypical infection would be a differential consideration, although the distribution would be atypical for Covid 19 pneumonia. Patient was given 6 mg of Decadron as well as 40 mg of IV Lasix. ASSESSMENT / PLAN: Pneumonia due to COVID-19 virus Acute Respiratory failure with Hypoxia Lung Sarcoidosis Acute Systolic Congestive Heart Failure -CXR with bilateral perihilar and left basilar opacities. This could represent central pulmonary edema. An atypical infection would be a differential consideration, although the distribution would be atypical for Covid 19 pneumonia. Symptom onset: 9/14 - positive COVID-19 test 9/16 Symptoms: Chills, fevers, rigors, myalgias, head aches, anorexia, loss of taste and smell, productive cough, dizziness, chest pain, diarrhea, chest pain. Treatment: Remdesivir (starting 9/21 - will need to monitor kidney function and liver function daily), Decadron (started 9/21), Pulmonology consult (hx of Sarcoidosis), VTE prophylaxis with weight based Heparin, Prone PRN, IS, continuous pulse oximetry, supportive care with PRN Imodium, PRN anti-tussives, PRN anti-emetics, PRN albuterol inhaler. Given abnormal appearance of chest X-ray will continue IV Lasix 40 mg daily (adjust as necessary) -Not on current treatment for Sarcoidosis - has not taken her Lasix in one week 2/2 to poor oral intake/diarrhea -Daily weights with I/O, monitor urine output -Given reported chest pain - will obtain EKG now and place on telemetry -Pulm note 8/2021 regarding Sarcoidosis: Multiorgan involvement of sarcoidosis: liver, renal, lung. PET ct in July 2020 w/o evidence of sarcoidosis in heart. MTX stopped July 2020 and her PFTs have been stable since this. NOte from 9.23.21: Pneumonia due to COVID-19 virus Acute Respiratory failure with Hypoxia H/o pulmonary Sarcoidosis - CXR showed bilateral perihilar and left basilar opacities. - Symptom onset: 9/14, positive COVID test 9/16 - Remdesivir started 9/21 - plan to complete 5 day course - Decadron started 9/21 - plan to complete 10 days - Pulmonology consulted (hx of Sarcoidosis) - VTE prophylaxis with weight based Heparin - Encourage prone positioning and IS - Supportive care with anti tussives and anti emetics - Lasix decreased to 40mg IV daily Acute on chronic Systolic Congestive Heart Failure - ECHO from 2019 with LVEF 45-50%, normal diastolic function - LHC from 2020 without any significant arterial disease. EF not noted. - Takes Lasix 40mg PO daily at home - has not taken in one week - Pro BNP normal though may be falsely low due to BMI. CXR suggestive of pulmonary edema. - Continue on Lasix IV as above - Monitor daily weights, I&Os Pulmonary sarcoidosis - Per pulm note 8/2021 regarding Sarcoidosis: Multiorgan involvement of sarcoidosis: liver, renal, lung. PET ct in July 2020 w/o evidence of sarcoidosis in heart. MTX stopped July 2020 and her PFTs have been stable since this. - Not on active treatment - Pulm following - no need for an acute treatment. - Albuterol INH PRN CKD IIIB - Follows with Nephrology as outpatient - Creatinine is near baseline at 1.6 - GFR 38 - Monitor closely while diuresing and on Remdesivir - Lasix dosing as above - Daily weights, I/O

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: 9.15.21 - called with symptoms 9.16.21 - COVID-19 positive 9.21.21 - antibody infusion
Vorgeschichte: Non-Hospital Anxiety Retinal neovascularization Degenerative progressive high myopia Dyslipidemia Gastroesophageal reflux disease Granuloma present on biopsy of liver Migraine headache Posterior vitreous detachment Histoplasmosis Hematuria CHF, chronic (HCC) MGUS (monoclonal gammopathy of unknown significance) Gout of left foot, unspecified cause, unspecified chronicity
Andere Medikamente: Outpatient Medications acetaminophen (TYLENOL) 500 MG tablet albuterol sulfate (PROAIR RESPICLICK) 108 (90 Base) MCG/ACT inhalation powder allopurinol (ZYLOPRIM) 100 MG tablet aspirin 81 MG tablet atorvastatin (LIPITOR) 40 MG tablet brimoni
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1723815

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SD
Alter: 66,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: 16.03.2021
Beginn: 14.04.2021
Tage bis Beginn: 29,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Breast pain Breast tenderness Chest X-ray normal Gynaecomastia Mammogram abnormal

Symptomtext

Xray and Mammo Symtoms showed up shortly after second shot. Pain in right breast continued to get worse. Went to the doctor and had an xray and mammo. Pain source was not found, pain continues. Nothing is being done for treatment and pain continues. This coinsides with problems my other family members have had. My Mother died March 2 2021 three weeks after her second covid shot. Moderna My Mothers sister died March 21 2021 three weeks after her second shot. Moderna My younger brother had congested heart failure three weeks after his second shot. Moderna And my breast pain started about three weeks after my second shot. Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Gynaecomastia
Hospital-Tage: -
Labordaten: Procedure: MAMMOGRAM TOMO DIGITAL DIAGNOSTIC BIL Date of Service: 09/10/2021 There is no component information for this result. Procedure: XRAY CHEST PA AND LATERAL Date of Service: 09/09/2021 EXAM: XRAY CHEST PA AND LATERAL INDICATION: Breast pain, right COMPARISON(S): None Available DISCUSSION: Clear lungs without pleural effusion or pneumothorax. Heart size and pulmonary vasculature are within normal limits. Date of service: 01/10/2021 EXAM: MAMMOGRAM TOMO DIGITAL DIAGNOSTIC BIL INDICATION: Breast pain 66 year old male with a gynecomastia and two months of tenderness to palpation over the superior areola. Also request ultrasound if felt to be indicated by radiologist. . COMPARISON(S): Baseline exam TECHNIQUE: Computer aided detection used. Interpretation was made with the benefit of tomosynthesis imaging. DENSITY: The breasts are almost entirely fatty. Mild right retroareolar flame-shaped density compatible with gynecomastia. No significant masses, calcifications or other abnormalities are seen. ASSESSMENT: BI-RADS: 2 - Benign RECOMMENDATION: Manage patient on a clinical basis for symptoms. Verbal results given.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Levothyroxin, Rosuvastatin
Allergien: Bactrim, Sulfer
Vorherige Impfungen: -

VAERS 1723399

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 78,0
Geschlecht: M
Eingang: 22.09.2021
Impfdatum: 19.03.2021
Beginn: 13.09.2021
Tage bis Beginn: 178,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute respiratory failure Angiogram pulmonary abnormal Atelectasis Blood culture Blood gases abnormal COVID-19 COVID-19 pneumonia Cardiomegaly Computerised tomogram thorax abnormal Cough Dyspnoea exertional Headache International normalised ratio increased Lung consolidation Oropharyngeal pain Oxygen saturation decreased PO2 decreased Painful respiration

Symptomtext

He went out recently to a football game where most people were not wearing a mask, started to have sore throat, cough and headache going on for about 2-3 days and on 9/17/21 he had dyspnea on exertion and therefore came to emergency room. In the beginning he was saturating well. He did test positive for COVID-19 and the plan was for the ER to send him home after they give him Regeneron. However, when the patient tried to go to the restroom his saturations dropped to 88% on room air. His 1st ABG done in the ER showed a pO2 of 84.7%. I am not sure whether it was on room air or on oxygen, but the 2nd one repeated on room air showed a pO2 of only 58.8, and then the hospitalist service was called for admission. I have started the patient on Decadron and remdesivir since his onset of symptoms is just 2-3 days. His CT of the chest was done in the ER which is showing bibasilar pneumonia/consolidation, so the patient was started on Rocephin and Zithromax which I am going to continue. Blood cultures have already been sent. Sputum cultures have also been ordered. Patient will be admitted as an inpatient with a diagnosis of acute hypoxemic respiratory failure secondary to COVID-19 pneumonia. Pulmonary consult will be obtained in the morning as well. Please note, the patient is already on anticoagulation with Coumadin with INR of 1.8. He takes it for history of PEs and DVTs. Patient denies any chest pain except occasionally when he tries to take a deep breath. He is unable to produce any sputum when he coughs. Says he has chronic right lower extremity swelling, which he attributes after surgery on that leg and the fact that he has had DVT in the right lower extremity as well. Was admitted on 9/17/21. Dexamethasone, remdesivir, vitamin C, vitamin D, ceftriaxone, and azithromycin started.Was placed on 3 L of oxygen via nasal cannula and was saturating well. He denies any significant complaints of breathing. Remained afebrile. Was also treated with remdesivir and Decadron. He continued to remain stable. He did complete 5 day course of remdesivir. Oxygen walk was performed on 09/21/2021. Required no oxygen at rest, 3 L with exertion. Discharged on 9/22/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: 9/16/21 COVID19: positive 9/16/21 Chest: 1. Cardiomegaly. Right basilar consolidation could represent atelectasis or pneumonia. Correlate clinically. 9/17/21 CTA chest: Findings compatible with COVID-19 pneumonia
Aktuelle Erkrankungen: -
Vorgeschichte: Morbid obesity, hypertension, hyperlipidemia, history of PE and DVT on chronic Coumadin, BPH, gout, CKD stage 3, history of right humerus fracture, history of small bowel obstruction, history of avascular necrosis of the right femur status post surgery, chronic venous insufficiency, hypothyroidism but not on any current medication. Fully vaccinated against COVID-19 with two doses of Pfizer vaccine, last 1 in April; history of elevated PSA, history of colonoscopy and sigmoidoscopy, history of prostate biopsy, history of right hip fracture surgery, history of left inguinal hernia repair, remote tonsillectomy, remote surgery for varicose veins.
Andere Medikamente: Allopurinol, finasteride, pravastatin, verapamil, enalapril, warfarin
Allergien: None
Vorherige Impfungen: -

VAERS 1715588

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 78,0
Geschlecht: F
Eingang: 20.09.2021
Impfdatum: 19.03.2021
Beginn: 19.09.2021
Tage bis Beginn: 184,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 Cardiac arrest Death Dyspnoea Intensive care Mechanical ventilation Oxygen saturation decreased Pulseless electrical activity SARS-CoV-2 test positive

Symptomtext

Patient is a 78 y.o. female with a history of HTN, DMII, anxiety and depression presenting with worsening shortness of breath over the past 1 week. Pt went to PCP on 9/13 and was ordered curb-side rapid COVID test, and was notified the following day that it was positive. Pt underwent Regeneron infusion on 9/15. When symptoms worsened pt came to ED for further evaluation and treatment. Patient was admitted to the COVID-19 cool floor. Patient was placed on AV APS for acute hypoxic respiratory failure. It appears her mask was dislodged, oxygen saturations to dropped patient went into PEA cardiac arrest. ROSC obtained patient was transferred to the ICU where she was coded again. Once again, ROSC regained. Patient was placed on an epinephrine followed by norepinephrine and vasopressin. hydrocortisone followed by hydrocortisone every 8 hr. Family was at bedside they were notified of patient's poor prognosis. They asked patient remains a full code. Once again patient coded, asystole. ACLS protocols were started, family was updated in a asked patient"s status to DNR patient expired soon after. time of death240hr

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1708822

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 74,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 18.03.2021
Beginn: 10.09.2021
Tage bis Beginn: 176,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Agitation Asthenia Blood culture negative Blood lactic acid increased COVID-19 Cough Culture urine negative Culture urine positive Death Delirium COVID-19 pneumonia Chest X-ray abnormal Chills Cognitive disorder Condition aggravated Dementia Hypomagnesaemia Hypoxia

Symptomtext

Hospitalization (9.10.21) --- > patient deceased (9.15.21) due to COVID-19 pneumonia; COVID-19 positive 9.10.21; fully vaccinated Date of Death: 9/15/21 Time of Death: 1:29 PM Preliminary Cause of Death: Pneumonia due to COVID-19 virus Discharge Disposition: expired DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia due to COVID-19 virus COVID-19 HOSPITAL COURSE: 74 yo male presented with the complaint of fever and weakness. He had been admitted on 9/6/21 with fever and weakness and had tested negative for covid. He had a UTI and was discharged home on the 8th. He returned 2 days later and was positive for covid and had hypoxia with CXR findings. He was admitted for the treatment of covid pneumonia dn started on dexamethasone. Over the course of his stay his baseline dementia was worse with note sun downing and associated agitation. He did not like having oxygen on or pulse ox monitoring. Family stayed with him which did not help. They decided to change his goals of care and talked to hospice. He was changed to comfort care and passed away with his family at bedside. (at admission: HISTORY OF PRESENT ILLNESS: Patient is a 74 y.o. male who presents today with fever and weakness . Recently discharged 9/8/2021 with febrile illness meeting sepsis criteria with elevated lactic, wbc, fever . Started with empiric abx With zosyn. Infectious work up neg for covid, film array , cxr, blood and urine cultures neg . Op urine culture growing serratia. He improved clinically and was dc to complete x2 more days cipro. Per wife still having low grade fever on dc . He progressively became more generally weak . continued with higher fever and chills taking tylenol for relief. With fever and weakness brought back in to ed where tested pos for covid 19 . In ed lactic elevated initially then trended down . Per wife he has become more and more wean . Still able to stand and walk to bathroom . Notes increasing urine incontinence now utilizing depends. No co chest pain and really has not been sob significantly . Minimally cough. No dysuria other wise . No diarrhea . No co ha vision changes. Notes progressive decline in cognitive function over last several months. occasionally wit hand tremors . No other sz like movements .)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: Hospital admission 9.6.21 - 9.8.21: diagnosis - SIRS; hypomagnesemia; recent UTI (COVID negative during this hospitalization) Worsened and COVID-19 positive 9.10.21
Vorgeschichte: OSA on CPAP Polyneuropathy in diabetes Essential hypertension HLD (hyperlipidemia) Type 2 diabetes mellitus with hyperglycemia, with long-term current use of insulin Actinic keratosis Medial meniscus, posterior horn derangement, right Mild dementia NSTEMI (non-ST elevated myocardial infarction) Coronary artery disease involving native coronary artery of native heart with other form of angina pectoris Cardiomyopathy, ischemic Shortness of breath Lower abdominal pain Pneumonia due to COVID-19 virus Generalized weakness Metabolic encephalopathy Advanced care planning/counseling discussion Acute respiratory failure with hypoxia
Andere Medikamente: adapalene (DIFFERIN) 0.1 % gel Ascorbic Acid (VITAMIN C PO) aspirin 81 MG chewable tablet atorvastatin (LIPITOR) 80 MG tablet B Complex-C (SUPER B COMPLEX PO) benzonatate (TESSALON) 100 MG capsule Cholecalciferol (VITAMIN D3) 2000 UNITS TAB
Allergien: Ranexa [Ranolazine]
Vorherige Impfungen: -

VAERS 1708656

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: GA
Alter: 82,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 18.02.2021
Beginn: 29.07.2021
Tage bis Beginn: 161,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Chest pain Death Dyspnoea Fatigue

Symptomtext

Shortness of breath or difficulty breathing Chest pain Fatigue or tiredness Hospitalization and death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 15,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes Hypertension Cardiovascular condition
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1700618

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 83,0
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 17.03.2021
Beginn: 01.09.2021
Tage bis Beginn: 168,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 COVID-19 pneumonia Hypoxia SARS-CoV-2 test positive

Symptomtext

Patient admitted as inpatient on 9/1 due to acute respiratory failure with hypoxia due to COVID pneumonia. Patient was tested for COVID-19 and was positive on 9/1.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 12,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: amLODIPine, finasteride, gabapentin, Omeprazole
Allergien: Statins-hmg-coa Reductase Inhibitors, Codeine, Dilantin, Fentanyl, Ibuprofen, Niacin, Lipitor [Atorvastatin], Pravastatin, Simvastatin, Rosuvastatin
Vorherige Impfungen: -

VAERS 1700099

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 59,0
Geschlecht: M
Eingang: 15.09.2021
Impfdatum: 18.03.2021
Beginn: 03.09.2021
Tage bis Beginn: 169,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Alpha tumour necrosis factor Aspergillus infection Aspergillus test COVID-19 COVID-19 pneumonia Candida infection Computerised tomogram thorax abnormal Condition aggravated Diarrhoea Dyspnoea Endotracheal intubation Immunodeficiency Intensive care Myalgia Pain Productive cough Pulmonary mass

Symptomtext

Hospitalized (9.2.21 - still admitted); COVID-19 positive (8.30.21; 9.3.21); fully vaccinated HISTORY OF PRESENT ILLNESS: Patient is a 59 y.o. male who presents today with 7 day history of fever, muscle aches, dyspnea, diarrhea, productive cough and body aches. Patient has a history of RA and is currently on Humira, Plaquenil and Sulfasalazine. He follows with rheumatology. Patient states he has been full vaccinated with Pfizer COVID-19 vaccination (completed in March) and denies any tobacco use. He states he possible contracted virus possible at a wedding and his wife also is currently being admitted for COVID-19. He tested positive on 8/30 but due to progressive symptoms presented to the ED today. ASSESSMENT / PLAN: # Acute Hypoxic Respiratory Failure Secondary to COVID-19 PNA -symptom onset 8/27 and tested positive on 8/30 per patient (unable to locate in EMR) -fully vaccinated with Pfizer vaccination (completed in March 2021) & CXR personally reviewed -continuous pulse oximetry and target oxygen saturation >90% -decadron 6 mg daily x 10 days, Remdesivir and monitor LFT's and renal function -check CRP and if >75 and not improving with decadron consider Tocilizumab -maintain net negative fluid balance (fluid restriction, 20 mg PO lasix daily) -given immunocompromised state high risk for secondary bacterial PNA -check pro-calcitonin and will cover with IV Rocephin (1 gm daily) for now -if pro-calcitonin negative and improving consider discontinuation of antibiotics Aspergillus fumigatus Assessment & Plan Presented with respiratory failure secondary to COVID pneumonia. Course complicated with increasing oxygenation requirement as result was subsequently brought to the intensive care unit and intubated on 09/11. Remains afebrile since completion of antibiotic therapy for 5 days empirically with Rocephin/azithromycin on 09/07. Furthermore, sputum cultures obtained on 09/11-aspergillus fumigatus and 0 9/12-identified isolated fungal species with Candida. He is a high risk for fungal pneumonia in the setting of COVID -19 along with this history of immune suppression with TNF alpha inhibitor/humeral for his rheumatoid arthritis and CT evidence of subpleural nodules in bilateral lung fields, left greater than right are all reasonable indications in the clinical setting to initiate antifungal therapy. Monotherapy with IV Voriconazole loaded with 6 mg/kg IV BID on 09/14. Plan: -Will Follow: Fungitell, Aspergillus serum antigen, Repeat Sputum Cx with Aspergillus PCR -Continue Voriconazole 4mg/kg BID for atleast 7 days. Stop dates placed. Will transition to orally when able. Anticipate total duration of therapy 6-12 weeks, will reassess the need of chronic prophylaxis oral therapy. -Will check through levels 4-7 days into the therapy with goals serum concentration 1-5.5 mcg/ml. And trough level 1-1.5 mcg/kg. Trough level check ordered for 09/17 am.. -Daily CMP to monitor for hepatotoxicity and nephrotoxicity -Agree with holding DMARDs * Pneumonia due to COVID-19 virus Assessment & Plan Vaccinated fully with Pfizer vaccine in March 2021 (immune compromised); Sx onset 08/27, tested positive 8/30 admitted on 09/02. Has finished appropriate 5 day therapy with remdesivir, dexamethasone from 09/02-09/11 x 9 days. CAP coverage completed w/ Rocephin/Azithromycin 09/02-09/07

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: Hospital Pneumonia due to COVID-19 virus Rheumatoid arthritis Acute hypoxemic respiratory failure due to COVID-19 Aspergillus fumigatus
Andere Medikamente: Hospital Medications L1 acetaminophen (TYLENOL) tablet 1,000 mg L1 acetaminophen (TYLENOL) tablet 500 mg artificial tears ophthalmic ointment 3.5 g L2 chlorhexidine (PERIDEX) 0.12 % solution 15 mL L2 chlorhexidine (PERIDEX) 0.12 % solution
Allergien: NA
Vorherige Impfungen: -

VAERS 1685561

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 79,0
Geschlecht: M
Eingang: 09.09.2021
Impfdatum: 11.03.2021
Beginn: 12.08.2021
Tage bis Beginn: 154,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy COVID-19 Cardiac arrest Chills Death Disease risk factor Hypotension Intensive care Myalgia Oxygen saturation decreased Pyrexia SARS-CoV-2 antibody test positive SARS-CoV-2 test positive Therapeutic response decreased

Symptomtext

Presented to the ED with chief complain of fever, myalgia and noted low oxygen saturation. He was possibly exposed to the coronavirus at his bar during a hosted festival from 8/6-8/8 where one attendant called to inform him he tested positive to the coronavirus. His symptoms started with fever, myalgia, chills about 1-2 weeks prior to his admit on 8/24/21, In the ED, he was desaturating to the 50s and placed on a HFNC. His code status is DNR/DNI. He has received remdesivir, decadron, 2 doses of barticinib and therapeutic anticoagulation for being at high thrombotic risk from the coronavirus infection. Patient was managed in the ICU from the time of admission. On the night of 9/5/21 patient became hypotensive and not responding adequately to IV fluids. Patient was found to have asystole at 3:06 AM on 9/6/21. Pronounced dead at 3:06 AM.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 13,0
Labordaten: COVID Anti-Spike IgG Positive, COVID Anti-Spike Nucleocapsid IgG Negative, COVID Rapid Molecular Positive,
Aktuelle Erkrankungen: UTI
Vorgeschichte: Bladder Cancer 2004, Hypertension, Renal Cancer (Nephrectomy 2004)
Andere Medikamente: Lisinopril, Amiodipine,quin
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1684691

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 82,0
Geschlecht: M
Eingang: 09.09.2021
Impfdatum: 18.03.2021
Beginn: 19.08.2021
Tage bis Beginn: 154,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death Dyspnoea Endotracheal intubation General physical health deterioration Hypoxia Intensive care Multiple organ dysfunction syndrome SARS-CoV-2 test positive

Symptomtext

Patient presented to emergency department on 8/19/2021 with shortness of breath. He was found to be COVID-19 positive and admitted for further management. He was transferred to the ICU on 8/23/2021 due to worsening hypoxia. He was intubated on 8/28/2021. Patient's condition further deteriorated into multisystem organ failure. He was placed on comfort measures on and expired on 9/8/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 20,0
Labordaten: COVID-19 test positive on 8/19/2021
Aktuelle Erkrankungen: None known
Vorgeschichte: Hyperlipidemia Mitral regurgitation HTN (hypertension) Gout Depression Rotator cuff arthropathy Obesity (BMI 30-39.9) Gastroesophageal reflux disease without esophagitis IFG (impaired fasting glucose) Bilateral wrist pain Thrombocytopenia CAD S/P percutaneous coronary angioplasty S/P cardiac cath 08/21/20 Osteoarthritis of right knee, unspecified osteoarthritis type S/P TKR (total knee replacement), right Memory loss Tremor
Andere Medikamente: allopurinol (ZYLOPRIM) 100 MG tablet amLODIPine-benazepril (LOTREL) 10-20 MG capsule ascorbic acid (VITAMIN C) 250 MG tablet aspirin (HALFPRIN) 81 MG tablet Calcium Carbonate-Vitamin D (CALTRATE 600+D PO) clopidogrel (PLAVIX) 75 MG tablet o
Allergien: Latex (contact dermatitis), Celebrex (rash), lipitor (dizziness), penicillins
Vorherige Impfungen: -

VAERS 1678840

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

kritisch

Staat: CA
Alter: 91,0
Geschlecht: F
Eingang: 07.09.2021
Impfdatum: 22.03.2021
Beginn: 30.08.2021
Tage bis Beginn: 161,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Agitation Alanine aminotransferase normal Anion gap Aspartate aminotransferase normal Basophil percentage decreased Blood alkaline phosphatase normal Blood bilirubin normal Blood chloride normal Blood creatinine increased Blood glucose normal Blood potassium increased Blood sodium normal Blood urea increased C-reactive protein increased COVID-19 COVID-19 pneumonia Carbon dioxide decreased

Symptomtext

92 Y F with history of mixed dementia, HTN, CKD3, fully vaccinated against COVID-19, recent exposure to COVID 19 (son passed away from COVID 2 days ago and daughter who lives with her is also has COVID-19), who started having sx of slight cough, fatigue, raspy voice and diarrhea as of 8/19. COVID-19 + on 8/26. Pt lived in own home with daughter staying with her, but pt needed help with some ADLs. Baseline was could go to BR, take her own bath, feeds self, uses a FWW sometimes. Pt lives in her own home, her daughter lives with her. Son is main contact COVID Pneumonia, Acute hypoxemic Respiratory failure - Symptom onset on 8/19. COVID positive on 8/26. Pt completed a course of remdesivir 8/31-9/4 and received decadron for which she will be discharged on a tapering course. Patient was never symptomatic from a respiratory standpoint, symptoms mainly manifested as sleepiness. Her overall clinical condition improved with increased alertness and po intake. She was able to ambulate with only standby assist from RN staff. Her oxygen measured with ambulation was 90% on 9/4. Hx HTN/HLD: on amlodipine and statin. Stable. Initially BPs were low but they began rising and she will restart amlodipine on discharge. Hx mixed dementia: pt was sleepy initially and had received 2.5 mg po zyprexa in ED on admission, presumably for agitation, but for the bulk of hospitalization was forgetful but answered simple questions and was cooperative and pleasant with no agitation. Primary Procedures: None Secondary Procedures: None Reason for Hospital Admission (Admitting Diagnosis): Covid Pneumonia

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: Results for PT (MRN 110001574201) as of 9/7/2021 09:49 8/31/2021 06:27 NA: 137 K: 5.3 CL: 105 CO2: 20 (L) BUN: 29 (H) CREAT: 1.16 (H) ANION GAP4 SERPL: 12 GLUC: 164 (H) ALT: 8 AST: 17 ALKP: 66 TBILI: 0.4 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE FERRITIN: 649 (H) WBC: 4.6 RBC'S: 4.73 HGB: 15.0 HCT: 44.6 MCV: 94 RDW, RBC: 13.1 PLT: 405 (H) IMMAT GRANULO % AUTO: 2 (H) NRBC: 0 NEUTROPHILS % AUTO: 84 (H) ANC: 3.9 LYMPHS % AUTO: 12 (L) MONOS % AUTO: 2 (L) EOS % AUTO: 0 BASO'S % AUTO: 0 9/1/2021 06:12 NA: 139 K: 4.7 CL: 105 CO2: 23 (L) BUN: 44 (H) CREAT: 1.48 (H) ANION GAP4 SERPL: 11 GLUC: 144 ALT: 11 AST: 13 ALKP: 75 TBILI: 0.4 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 9.9 (H) WBC: 16.8 (H) RBC'S: 4.79 HGB: 15.0 HCT: 45.1 MCV: 94 RDW, RBC: 13.3 PLT: 572 (H) IMMAT GRANULO % AUTO: 2 (H) NRBC: 0 NEUTROPHILS % AUTO: 84 (H) ANC: 14.0 (H) LYMPHS % AUTO: 9 (L) MONOS % AUTO: 5 EOS % AUTO: 0 BASO'S % AUTO: 0 D-DIMER: 1.50 (H) 9/2/2021 06:04 NA: 138 K: 5.1 CL: 106 CO2: 23 (L) BUN: 40 (H) CREAT: 1.17 (H) ANION GAP4 SERPL: 9 GLUC: 174 (H) ALT: 11 AST: 11 ALKP: 60 TBILI: 0.3 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE FERRITIN: 753 (H) WBC: 15.7 (H) RBC'S: 4.17 HGB: 13.2 HCT: 39.1 MCV: 94 RDW, RBC: 13.2 PLT: 472 (H) IMMAT GRANULO % AUTO: 2 (H) NRBC: 0 NEUTROPHILS % AUTO: 86 (H) ANC: 13.5 (H) LYMPHS % AUTO: 5 (L) MONOS % AUTO: 7 EOS % AUTO: 0 BASO'S % AUTO: 0 9/3/2021 07:08 NA: 134 (L) K: 5.0 CL: 104 CO2: 22 (L) BUN: 35 (H) CREAT: 1.08 ANION GAP4 SERPL: 8 GLUC: 126 ALT: 15 AST: 18 ALKP: 58 TBILI: 0.4 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE CRP, SER QL: 2.3 (H) WBC: 14.2 (H) RBC'S: 4.39 HGB: 13.6 HCT: 41.2 MCV: 94 RDW, RBC: 13.0 PLT: 444 (H) IMMAT GRANULO % AUTO: 2 (H) NRBC: 0 NEUTROPHILS % AUTO: 82 (H) ANC: 11.7 (H) LYMPHS % AUTO: 7 (L) MONOS % AUTO: 8 EOS % AUTO: 0 BASO'S % AUTO: 0 D-DIMER: 0.82 (H) 9/4/2021 07:05 NA: 137 K: 5.1 CL: 105 CO2: 25 BUN: 38 (H) CREAT: 1.13 (H) ANION GAP4 SERPL: 7 GLUC: 129 ALKP: 63 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE FERRITIN: 1,018 (H) WBC: 16.8 (H) RBC'S: 4.59 HGB: 14.6 HCT: 42.8 MCV: 93 RDW, RBC: 13.1 PLT: 452 (H) IMMAT GRANULO % AUTO: 2 (H) NRBC: 0 NEUTROPHILS % AUTO: 84 (H) ANC: 14.1 (H) LYMPHS % AUTO: 6 (L) MONOS % AUTO: 8 EOS % AUTO: 0 BASO'S % AUTO: 0 9/5/2021 06:36 NA: 137 K: 5.1 CL: 108 CO2: 22 (L) BUN: 39 (H) CREAT: 1.05 ANION GAP4 SERPL: 7 GLUC: 144 COMMENT, GLOMERULAR FILTRATION RATE: SEE NOTE WBC: 16.7 (H) RBC'S: 4.43 HGB: 14.0 HCT: 41.5 MCV: 94 RDW, RBC: 13.2 PLT: 409 (H) IMMAT GRANULO % AUTO: 1 NRBC: 0 NEUTROPHILS % AUTO: 85 (H) ANC: 14.2 (H) LYMPHS % AUTO: 5 (L) MONOS % AUTO: 8 EOS % AUTO: 0 BASO'S % AUTO: 0
Aktuelle Erkrankungen: -
Vorgeschichte: history of mixed dementia, HTN, CKD3, fully vaccinated against COVID-19, recent exposure to COVID 19 ( son passed away from COVID 2 days ago and daughter who lives with her is also has COVID-19
Andere Medikamente: Outpatient medications :confirmed w patient's son Prior to Admission Medications Outpatient Home Medications Taking? Aspirin (ECOTRIN LOW STRENGTH) 81 mg Oral TBEC DR Tab Sig: Take 81 mg by mouth daily Atorvastatin (LIPITOR) 10 mg Oral
Allergien: nkda
Vorherige Impfungen: -

VAERS 1623081

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 65,0
Geschlecht: M
Eingang: 07.09.2021
Impfdatum: 17.03.2021
Beginn: 17.08.2021
Tage bis Beginn: 153,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 SARS-CoV-2 test positive Sepsis Vaccine breakthrough infection

Symptomtext

COVID pos 8/19/2021 admitted to hospital 8/19/2021 trated with oxygen, remdesivir and dexamethasone discharged in room air on 8/25/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: cerebral aneurysm, nonruptured
Vorgeschichte: GERD, COPD, tobacco abuse, chrnic pain, cough, seizures, hyperglycemia
Andere Medikamente: APAP, albuterol, amlodipine, ASA, bezonatate, cyclobenzaprine, dicyclomine, HCTZ, insulin, levetiracetam, metformin, omeprazole,
Allergien: Claritin
Vorherige Impfungen: -

VAERS 1233385

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 67,0
Geschlecht: F
Eingang: 29.08.2021
Impfdatum: 01.03.2021
Beginn: 07.04.2021
Tage bis Beginn: 37,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Cardiac failure Death Diarrhoea Endoscopy Abdominal pain Cardiogenic shock Faeces discoloured Hypotension Mental status changes Lung neoplasm malignant Renal failure Vomiting Multiple organ dysfunction syndrome Pyrexia Sepsis

Symptomtext

Diahrrea, vomiting, stomach pain, then emergency hospitalization. Heart failure, lung failure, kidney failure, and death within 6 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 6,0
Labordaten: Endoscopy led to heart failure, then death.
Aktuelle Erkrankungen: cirrhosis of the liver
Vorgeschichte: Liver damage, overweight
Andere Medikamente: Ammonia reducer, morphine for pain
Allergien: N/A
Vorherige Impfungen: -

VAERS 1632595

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: KY
Alter: 70,0
Geschlecht: M
Eingang: 25.08.2021
Impfdatum: 16.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 162,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac arrest Death Endotracheal intubation General physical health deterioration Intensive care Mechanical ventilation Renal impairment Respiration abnormal Resuscitation

Symptomtext

Patient was initially admitted to the medical COVID floor. He was initiated on remdesivir and dexamethasone. He was transferred to the ICU on 8/17/2021 due to worsening respiratory status and need for noninvasive ventilatory support. Due to his worsening renal function, remdesivir was discontinued as it is known to potentially contribute to worsening renal function. He was initiated on CRRT on 8/18/2021. Patient's respiratory status continued to worsen and he was intubated on 8/21/2021. Unfortunately, over the next several days, patient's condition worsened overall. He was unable to be weaned from high ventilatory support needs. CRRT was optimized to insure diuresis to try to optimize ventilator conditions. Unfortunately, on the morning of 8/25/2021, the patient did suffer a sudden cardiac arrest. CPR and ACLS interventions were initiated without success. Nursing staff was in contact with the patient's family via telephone during the cardiac arrest and resuscitation. They did advise that they did not want to continue ongoing resuscitative efforts and further efforts were terminated. Unfortunately, patient did pass on the morning of 8/25/2021 at 0150 hr

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1592122

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 46,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 10.03.2021
Beginn: 14.08.2021
Tage bis Beginn: 157,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Pt admitted to hospital 8/18/21 due to acute hypoxic respiratory failure. Per H&P, tested positive at drive-up testing site on 8/14/21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: Positive COVID-19 test 8/14/21 - completed Pfizer series on 3/10/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1591931

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 67,0
Geschlecht: M
Eingang: 20.08.2021
Impfdatum: 26.03.2021
Beginn: 26.07.2021
Tage bis Beginn: 122,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia COVID-19 Death Dyspnoea General physical health deterioration Pneumonia Renal transplant SARS-CoV-2 antibody test negative SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA: Fully Vaccinated Expired Patient received Pfizer Vaccines on 3/5/2021 and 3/26/2021. Patient had a history of ESRD secondary to diabetes and hypertension, renal transplant on 7/13/2021, and was admitted on 7/26/2021 through ED for worsening shortness of breath, weakness and dyspnea. Patient found to be positive for COVID-19 and pneumonia. Patient was treated with remdesivir, dexamethasone, and piperacillin+Tazobactam. Patient continued to decline and expired on 8/11/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 16,0
Labordaten: Positive COVID-19 test 07/27 @ 1827 using PCR Positive COVID-19 test 07/30 @ 1220 using PCR Negative SARS CoV2 Antibodies
Aktuelle Erkrankungen: -
Vorgeschichte: Hyperlipidemia, Hypertension, Anemia in ESRD, Retinal Edema, Chronic venous hypertension w/ ulcer, Mild intermittent asthma, Seasonal allergies, Type 2 diabetes mellitus, End Stage Renal Disease, Chronic Dialysis, OSA on CPAP, Metabolic bone disease, secondary hyperparathyroidism, hyperkalemia, history fo CVA with residual effects, diverticulosis of colon without diverticulitis, Obesity, Coronary artery disease, GERD, History of Junctional dysrhythmia
Andere Medikamente: fluconazole 100 mg QD, furosemide 80 mg QD, gabapentin 100 mg BID, Insulin Lispro sliding scale TID, Mycophenolate 720 mg BID, Oxycodone 5 mg Q4h PRN, Polyethylene glycol 17 grams PRN, Prednisone 5 mg QD, Senna+Docusate PRN, Sulfamethoxazol
Allergien: Chlorhexidine (Dermatitis)
Vorherige Impfungen: -

VAERS 1591249

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 94,0
Geschlecht: F
Eingang: 20.08.2021
Impfdatum: 12.03.2021
Beginn: 08.08.2021
Tage bis Beginn: 149,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient passed away on 08/08/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Ativan, Roxanol, albuterol, Gas-X, Mylanta, Tylenol, Maalox, Lopressor, Docusate sodium, miralax
Allergien: Bacitracin, Beef-derived products, Codeine, Loperamide, Neomycin, pork derived products, vicodin, percocet
Vorherige Impfungen: -

VAERS 1431265

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 73,0
Geschlecht: M
Eingang: 19.08.2021
Impfdatum: 19.04.2021
Beginn: 01.08.2021
Tage bis Beginn: 104,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Bacterial infection COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram neck Computerised tomogram normal Computerised tomogram thorax abnormal Condition aggravated Cough Death Fatigue Hypoxia Pneumonia SARS-CoV-2 test positive Dyspnoea exertional Echocardiogram abnormal Ejection fraction decreased Endotracheal intubation

Symptomtext

Deceased. Date of Death: 8/11/21 Time of Death: 4:29 PM Preliminary Cause of Death: Respiratory failure with hypoxia Discharge Disposition: Deceased DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: Pneumonia of both lungs due to infectious organism, unspecified part of lung [J18.9] Acute hypoxemic respiratory failure [J96.01] a 73 year old male with PMH significant for follicular lymphoma, squamous cell carcinoma of face, recent COVID-19 pneumonia, pulmonary fibrosis, DVT hx s/p IVC filter on warfarin, HTN, hypothyroidism, who presented to the ED on 8/1 for evaluation following a syncopal episode, dyspnea on exertion and cough. Patient recent COVID-19 infection 6/15/21. Had remdesivir, steroids and antibiotic therapy, followed by pulm. He was placed on dexamethasone with taper 7/21. Started on Augmentin on 7/30. He had the syncopal episode on 8/1 and was found down by his wife. Negative CT after fall. Had desaturation to 83% in the emergency department. Started on vanc/zosyn. MRSA screen negative and vanc d/c'ed. CT chest in the emergency department showed no evidence of pulmonary embolism, did show prefer ground-glass infiltrates possible COVID-19 infection, also underlying interstitial lung disease. Pulmonology was consulted. He tested positive for COVID on 08/03/2021. ID was consulted. Thought to be new acute COVID infection rather than viral shedding. Started on dexamethasone 6 on 8/2. Received tocilizumab on 8/4. Due to worsening respiratory status, patient was transferred to ICU on 8/7. He was initially DNI. After conversation with patient and family on 8/8, he decided to be full code and pursue intubation. He was intubated on 8/8 and underwent bronch. Vancomycin was added. On 8/9 bactrim was started for empiric PJP treatment and zosyn was changed to meropenem for broader coverage. Patient developed DIC and was treated supportively with transfusions. Due to worsening respiratory status and poor prognosis, family decided to make patient DNR on 8/10. Decision was made to make patient comfort care on 8/11. Paralytics were held at 2:15 pm. Patient was terminally extubated at 3:49pm with comfort measures. Time of death 4:29pm. a 73 year old male with PMH significant for follicular lymphoma, squamous cell carcinoma of face, recent COVID-19 pneumonia, pulmonary fibrosis, DVT hx s/p IVC filter on warfarin, HTN, hypothyroidism, who was admitted on 8/1 for management of AHRF 2/2 repeat COVID-19 pneumonia. #Acute hypoxic respiratory failure #COVID-19 infection #idiopathic pulmonary fibrosis - AHRF etiology COVID vs ILD flare vs bacterial infection. Unlikely CHF exacerbation given echo with EF 62%. - pt volume up which may be contributing to respiratory status - possibility of PE. Known DVT in July, on warfarin. Will treat dvt with heparin which also treats possible PE. - d-dimer >35,000 since 8/5 - on 3 L O2 baseline - Recent covid infection on 6/15. Thought to be acute reinfection. - s/p tocuilizumab on 8/4 - diurese as needed to achieve net negative 1-2 L /24 hours - IV lasix 40 mg today - increase to decadron 6 mg BID #superimposed bacterial pna - CXR on 8/1 suggestive of bacterial pna - started on vanc/zosyn in ED - vanc d/c'ed after MRSA screen negative - continue zosyn (first dose 8/2) - given leukopenia and steroid use, consider addition bactrim for PCP prophylaxis. Will discuss with ID. #pancytopenia - likely related pt's prior chemo treatments - transfuse for hgb < 7, plts < 10

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: history of COVID in June 2021. Decreased O2 sats and sick visit scheduled with Pulmonary 7.21.21. . Hx of COVID-19 6/15/2021, with admission 6/17-6/20, in an immunocompromised host - He experienced initial improvement in symptoms with dexamethasone, but then worsening/persistent cough and exertional dyspnea symptoms since discontinuation of the steroids. Here today with new hypoxia. - Most recent CT imaging of the neck was reviewed from 6/28, which does provide some available slices of the bilateral upper lobes. There has been interval development of peripherally located GGO on top of pre-existing subpleural fibrotic changes. These findings are consistent with COVID-19 viral pneumonia, and I suspect his hypoxia is due to these changes on top of his chronic fibrotic lung disease. - His exertional hypoxia, as demonstrated on today's ambulatory pulse ox assessment, does qualify him for home oxygen therapy. Given his current symptomatology and ongoing hypoxia, will re-start steroids. I recommended prednisone taper, however, pt and his wife preferred dexamethasone as he had tolerated this previously without any adverse side effects. - Will start dexamethasone, 6 mg daily x 10 days, then 3 mg daily x 10 days. If feeling improved with steroids, can stop after completion, however, he may require a more prolonged steroid taper. Will forward message to his hematologist so he is aware. - Repeat CXR ordered - He did not have cough prior to COVID. If cough not improving with steroids, consider starting Atrovent inhaler 4 times daily. - Pt and his wife are scheduled to go out of town for 3 weeks in September, from 9/3-9/24. We will schedule him for follow up after return from their trip. I have ordered home oxygen to be used with ambulation in the interim, 3L per today's titration, however, if he still requires supplemental oxygen at the time of his trip, he will likely need oxygen during his flight and during travel, and we will discuss about getting him a portable oxygen concentrator. I have asked him to call and speak with one of the RN's in 20 days to give an update. 2. Chronic hypoxic respiratory failure - As above
Vorgeschichte: AKI (acute kidney injury) Pancytopenia Diverticulosis of sigmoid colon Family history of colon cancer Indolent non-Hodgkins lymphoma Hypothyroidism Chronic anticoagulation S/P insertion of IVC (inferior vena caval) filter Hypertension History of DVT (deep vein thrombosis) Erectile dysfunction, unspecified erectile dysfunction type Low testosterone in male Chronic venous stasis Chronic cough Dyslipidemia IPF (idiopathic pulmonary fibrosis) Agranulocytosis secondary to cancer chemotherapy Ankle impingement syndrome, left Arthritis of left ankle Exostosis of left tibia Squamous cell carcinoma, face COVID-19 virus infection Non-healing surgical wound Chemotherapy-induced peripheral neuropathy Chronic deep vein thrombosis (DVT) of right popliteal vein Platelets decreased Acute hypoxemic respiratory failure Syncope Left leg pain Elevated liver enzymes Goals of care, counseling/discussion
Andere Medikamente: acetaminophen (TYLENOL) 325 MG tablet acyclovir (ZOVIRAX) 400 MG tablet albuterol HFA (PROVENTIL HFA, VENTOLIN HFA, PROAIR HFA) 108 (90 Base) MCG/ACT inhaler Ascorbic Acid (VITAMIN C) 500 MG CAPS B Complex Vitamins (B COMPLEX 1 PO) dexameth
Allergien: amlodipine
Vorherige Impfungen: -

VAERS 1577926

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

kritisch

Staat: MO
Alter: 87,0
Geschlecht: M
Eingang: 17.08.2021
Impfdatum: 01.05.2021
Beginn: 06.08.2021
Tage bis Beginn: 97,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Death Intensive care

Symptomtext

Sxs onset 7/26. -Death Disease Report says that the patient was admitted to ICU. Admitted to hospital on 8/6 and died on 8/10. *Death DIsease Report said he was NOT admitted to hospital due to COVID. *Death Disease Report said his death was NOT related to COVID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1541117

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 83,0
Geschlecht: F
Eingang: 10.08.2021
Impfdatum: 23.03.2021
Beginn: 30.07.2021
Tage bis Beginn: 129,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Acute kidney injury Ageusia COVID-19 Death Delirium Dyspnoea Intensive care Muscular weakness Myalgia Pyrexia SARS-CoV-2 test positive

Symptomtext

Pfizer BioNTech COVID-19 Vaccine EUA Patient received Pfizer Vaccines on 3/5/2021 and 3/23/2021. Presented to urgent care on 7/24 and had a positive COVID test, started on azithromycin and benzonatate. Patient presented to ED on 7/30 with fever, dyspnea, myalgia, loss of taste, muscle weakness. Patient was initially admitted to the medical floor, on 4 L nasal cannula, but quickly escalated to high-flow nasal cannula and was then transferred to the ICU. The patient required high levels of oxygen and also developed delirium, as well as had acute kidney injury. Patient was treated with dexamethasone, terbutaline, remdesivir. In discussion with the patient's primary medical decision makers, including the patient's husband and son, the patient/s status was made a do not attempt resuscitation, but may continue the treatments. The patient was transferred to the medical wards on high levels of oxygen 60 L and 90% FiO2. Unfortunately, the patient continued to decompensate and passed away the evening of 8/3/2021. Additional information for Item 9: Atorvastatin 10 mg QD, Azithromycin 250 mg QD, Benzonatate 100 mg TID prn, Cholecalciferol 1000 units QD, Furosemide 40 mg QD, MagOx QD, Metoprolol 25 mg QD, Mycolog cream BID.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 5,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Morbid obesity, Diabetes, Hypertension, Congestive heart failure, Obstructive sleep apnea, Pulmonary Hypertension, fibromyalgia, psoriasis, history of breast cancer.
Andere Medikamente: Acetaminophen PRN, Albuterol 2 puff Q6H Prn, Aspirin 81 mg QD
Allergien: Penicillins (Rash)
Vorherige Impfungen: -

VAERS 1536043

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MO
Alter: 63,0
Geschlecht: M
Eingang: 09.08.2021
Impfdatum: 11.03.2021
Beginn: 19.07.2021
Tage bis Beginn: 130,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death

Symptomtext

Death from Covid-19

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1528887

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 68,0
Geschlecht: M
Eingang: 05.08.2021
Impfdatum: 12.03.2021
Beginn: 03.08.2021
Tage bis Beginn: 144,0
Dosis: 1
Route/Site: UN / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure COVID-19 pneumonia Condition aggravated Cough Dizziness Dyspnoea Myalgia Nausea Pyrexia SARS-CoV-2 test positive

Symptomtext

Patient in ER w/difficulty breathing and cough. Onset was 08/02/2021. The symptoms are worsening during course. Fever, SOB, dizziness, muscle pain and nausea.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: SARS-CoV-2 (COVID-19) PCR (GeneXpert) - POSITIVE* Acute Respiratory Failure with hypoxia Pneumonia due to COVID-19 virus
Aktuelle Erkrankungen: NO KNOWN ILLNESSES
Vorgeschichte: NONE
Andere Medikamente: UNKNOWN
Allergien: NO KNOW ALLERGIES
Vorherige Impfungen: -

VAERS 1515707

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 59,0
Geschlecht: M
Eingang: 05.08.2021
Impfdatum: 15.04.2021
Beginn: 14.07.2021
Tage bis Beginn: 90,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Heart rate abnormal Intracardiac thrombus Joint swelling Peripheral swelling Pulmonary embolism Pulmonary thrombosis Red blood cell count Surgery Thrombectomy Thrombosis

Symptomtext

On July 15 I had surgery to remove significant blood clots from my heart and lungs as a result from a saddle pulmonary embolism. I have done testing to eliminate Cancer, Hereditary and red blood cells; On July 15 I had surgery to remove significant blood clots from my heart and lungs as a result from a saddle pulmonary embolism. I have done testing to eliminate Cancer, Hereditary and red blood cells; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EW0153; Expiry date: unknown) via an unspecified route of administration, administered in arm right on 15Apr2021 13:00 (at age of 59-year-old) as dose 2, single for COVID-19 immunization. Medical history included chronic low back pain from multiple back surgeries and allergy to sulfa from an unknown date and unknown if ongoing. Concomitant medications included magnesium sulfate, Vitamin D Nos taken for an unspecified indication. The patient had previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN6207; Expiry date: unknown) on 25Mar2021 at 13:00 (at age of 59-year-old) as dose 1 single for COVID-19 immunization. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. It was reported that, on July 15 patient had surgery to remove significant blood clots from his heart and lungs as a result from a saddle pulmonary embolism which was reported on 14Jul2021 (at 04:00). patient had done testing to eliminate cancer, hereditary and red blood cells for as a cause 8 days. The adverse event resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The patient was hospitalized due to adverse event. Therapeutic measures were taken as a result of adverse event as patient underwent surgery (to remove significant blood clots from heart and lungs as a result from a saddle pulmonary embolism) on 15Jul2021 and unspecified medication. The outcome of events was resolving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 8,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Pain back; Sulfonamide allergy
Andere Medikamente: MAGNESIUM SULFATE; VITAMIN D NOS
Allergien: -
Vorherige Impfungen: -

VAERS 1470499

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: -
Geschlecht: F
Eingang: 04.08.2021
Impfdatum: 17.03.2021
Beginn: 30.03.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: - / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute megakaryocytic leukaemia Biopsy bone marrow COVID-19 Contusion Death Acute myeloid leukaemia Biopsy bone marrow abnormal Chemotherapy Chest X-ray abnormal Drug ineffective Granulocytes abnormal Haemoglobin decreased Mechanical ventilation Haemoglobin Platelet count Pneumothorax SARS-CoV-2 test White blood cell count

Symptomtext

Pneumothorax; Acute megakaryocytic leukaemia; passed away; Diagnosed with COVID; bruises; This is a spontaneous report from a contactable consumer. A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1, via an unspecified route of administration on 17Mar2021 (Batch/Lot number was not reported) as DOSE 1, SINGLE for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient's husband stated, "Your vaccine killed my wife. She received her first dose of your COVID vaccine on 17Mar2021." The patient received her COVID vaccine on 17Mar2021 at a local clinic. She developed bruises within days after the shot on 30Mar2021. She pursued care and diagnosis and reporting with the vaccine administrator, but finally had to see PCP. After multiple visits, patient was sent to Hospital in the city was diagnosed with AML on 10Apr2021 (hospitalized 5 days: April 6-10, 2021) and started chemotherapy (outpatient on 19Apr2021). She returned to hospital on 25Apr2021 in distress and was diagnosed with COVID. The patient was put on a ventilator with pressor support on 01May2021 and passed away on 10May2021. The outcome of the events was unknown. The course of the event was as follows: The patient received her COVID vaccine and developed bruises within days after the shot. She pursued care and diagnosis and reporting with vaccine administrator, but finally had to see PCP. After multiple visits, she was sent to a hospital in the city. She was diagnosed with AML (hospitalized 6 days) and started chemotherapy (outpatient). Then returned to the hospital 25Apr2021 in distress and diagnosed with COVID. On 17Mar2021, Pfizer vaccine. On 17Mar2021, immediate reactions to vaccine, physical and emotional distress. On 20Mar2021, 24 bruises by 30Mar2021. On 06Apr2021, hospital admission for AML diagnosed 10Apr2021. On 08Apr2021, bone marrow biopsy completed with report of 29% blasts, hypercellular bone marrow (60-70%) with significant granulocytic dysplasia and occasional diserythropoiesis. On 19Apr2021, first outpatient chemotherapy. On 25Apr2021, hospital admission and positive covid test: Labs were remarkable for Hgb 4.3, WBC 1.3, and PI-TK 10. Transfusion of 3 units pRBCs and 2 units PLT was ordered. After 2 units pRBC, Hgb up-trended from 4.3 to 6.0. Plan was for admission to P2, but the patient tested positive for COVID-19. Chest x ray was obtained and showed evidence of early multilobar pneumonia. On 30Apr2021, full oxygen mask ('trying to save her life'). On 01May2021, ventilator DSO. On 07May2021, subcutaneous emphysema, Family meeting at hospital, drug treatments discontinued. On 10May2021, pneumothorax, Ventilator discontinued, patient passed away. Prior to vaccination, the patient was a healthy 64 year old woman planning a vacation. The vaccination was intended to make the trip safer. Information on the lot/batch number has been requested.; Reported Cause(s) of Death: passed away

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: Test Date: 20210408; Test Name: Bone Marrow Biopsy; Test Result: 29 %; Comments: 29% blasts; Test Date: 20210408; Test Name: Bone Marrow Biopsy; Result Unstructured Data: Test Result:60-70 %; Comments: Hypercellular bone marrow; Test Name: Hgb; Result Unstructured Data: Test Result:4.3-6.0; Test Date: 20210408; Test Name: Hgb; Result Unstructured Data: Test Result:4.3; Test Date: 20210408; Test Name: PLT; Result Unstructured Data: Test Result:<10; Test Date: 20210408; Test Name: Covid test; Result Unstructured Data: Test Result:Positive; Test Date: 20210408; Test Name: WBC; Result Unstructured Data: Test Result:1.3
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1519817

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NM
Alter: 60,0
Geschlecht: M
Eingang: 02.08.2021
Impfdatum: 31.03.2021
Beginn: 09.07.2021
Tage bis Beginn: 100,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy Blood test Cardiac ventricular disorder Chest X-ray Computerised tomogram thorax abnormal Condition aggravated Dyspnoea Echocardiogram abnormal Protein total normal Pulmonary embolism Ultrasound Doppler normal

Symptomtext

Shortness of breath began 7/9/2021; went to urgent care center 7/11/2021, then hospital; CatScan diagnosis of multiple pulmonary embolisms in nearly every lobe of both lungs. No leg pain typically associated with DVTs; ultrasound of both lower extremities negative for signs of DVT. Patient noticed higher than normal use of albuterol inhaler 2-3 weeks prior to incident. Physicians indicated that PEs likely accumulated over several days prior to incident. No other signs, indications of origin of clots outside of lungs. Because of tetralogy history, echocardiogram of heart performed; indication of additional stress on right ventricular wall; follow-up with patient's cardiologist, assessment that heart ===>

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: Several blood tests, 7/11-7/13/2021; chest X-ray, cat-scan 7/11; ultrasound of legs, echocardiogram 7/12; blood tests indicated protein levels in proper range, ===>
Aktuelle Erkrankungen: None
Vorgeschichte: Surgically-repaired tetralogy of Fallot, asthma, Feb. 2013 DVT/PE incident
Andere Medikamente: Albuterol, Pulmicort, Losartan, Lovastatin, Montelukast, aspir
Allergien: Grasses, weeds, pollens, wasp stings
Vorherige Impfungen: The day after 3/31 COVID vaccine, patient had 100F fever, body aches for one day.

VAERS 1442714

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NE
Alter: 40,0
Geschlecht: F
Eingang: 28.07.2021
Impfdatum: 04.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiac failure Computerised tomogram Intensive care Mechanical ventilation Medical induction of coma Resuscitation

Symptomtext

I died at home in the morning of April 10th at approx. 10:30 am my husband had to give me CPR and revive me. Then in rescue squad I died again and the EMTs had to revive me. Then at the hospital i was in the Trauma room, they sent me to get a CT Scan and I died for 5 minutes on the CT table. Then spent 3 days in a medical comma on a ventilator in ICU, then 4 days in a hospital room.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Medical induction of coma
Hospital-Tage: 6,0
Labordaten: Unknown hospital would have these.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Prilosec, and normal vitamins
Allergien: None except pain meds make me nausea
Vorherige Impfungen: -

VAERS 1474311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 50,0
Geschlecht: M
Eingang: 15.07.2021
Impfdatum: 16.03.2021
Beginn: 06.04.2021
Tage bis Beginn: 21,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Patient died 04/06/2021 Covid vaccine #1 Pfizer 03/16/2021 Lot #EN6207 Covid Vaccine #2 Pfizer 03/19/2021 Lot # N/A

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1470106

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NC
Alter: 74,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 12.04.2021
Beginn: 25.06.2021
Tage bis Beginn: 74,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 pneumonia Death Respiratory distress SARS-CoV-2 test positive

Symptomtext

PATIENT ADMITTED TO HOSPITAL ON 6/25/21 DUE TO RESP DISTRESS. COVID TESTING POSITIVE. DIAGNOSED WITH COVID PNEUMONIA. ON 6/25/21 NAD 6/26/21. PATIENT DIED ON 7/8/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 13,0
Labordaten: 6/25/201 AND 6/26/2021 COVID TESTING = DETECTED.
Aktuelle Erkrankungen: -
Vorgeschichte: INFLAMMATORY BOWEL DISEASE, HTN,
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1466009

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

kritisch

Staat: CA
Alter: 16,0
Geschlecht: M
Eingang: 13.07.2021
Impfdatum: 03.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 27,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Autopsy Death

Symptomtext

My son died, while taking his math class on Zoom. We are waiting for the autopsy because the doctors did not find anything. He was a healthy boy, he had a good academic index, he wanted to be a civil engineer. He was the best thing in my life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 8,0
Labordaten: He had no previous symptoms. I was with him one hour before and my assistant saw him 20 minutes prior and he did not show any irregularities.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1147210

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

kritisch

Staat: AZ
Alter: 61,0
Geschlecht: M
Eingang: 13.07.2021
Impfdatum: 17.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Myocardial infarction Pulse absent Syncope

Symptomtext

Death. Patient received vaccine on 3/17/2021. Patient died on 3/22/2021. Initially presumed cause of death was heart attack. Patient collapsed at home, spouse called 911. Never revived with CPR or ACLS. Pronounced dead in emergency department. (No physician at that point have been informed of his COVID-19 immunization? The patient?s spouse informed me of his COVID-19 immunization today 7/13/2021)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, hyperlipidemia, obesity, peripheral neuropathy, gout, fatty liver disease, vitamin D deficiency, heart disease
Andere Medikamente: Aspirin, fish oil, allopurinol, vitamin D, nortriptyline, tresiba, pioglitazone, metformin, atorvastatin, gemfibrozil, ozempic
Allergien: Isothiazolinone
Vorherige Impfungen: -

VAERS 1454630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: TX
Alter: 57,0
Geschlecht: M
Eingang: 07.07.2021
Impfdatum: 05.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Autopsy Sudden death

Symptomtext

Sudden death 5 days after second vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sudden death
Hospital-Tage: -
Labordaten: Autopsy on April 12, 2021
Aktuelle Erkrankungen: Dyspnea on exertion, atrial fibrillation with palpitations, shortness of breath and tachycardia, gout flare up
Vorgeschichte: Hypertension Obesity Gout Hyperlipidemia Atrial fibrillation
Andere Medikamente: Sotolol, xarelto, carvedilol, furosemide, indomethacin, lisinopril
Allergien: Iodine (anxiety)
Vorherige Impfungen: -

VAERS 1449542

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 53,0
Geschlecht: F
Eingang: 06.07.2021
Impfdatum: 17.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anxiety Cerebrovascular accident Chest discomfort Eyelid ptosis Mass Pain in extremity Panic attack Paraesthesia

Symptomtext

She was advise to go to the ER because it could be a stroke.; Tingling in her arms post vaccination/ tingling started in her face and then spread; Her right eye lid was drooping a little.; She noticed a pressure on her chest including panic attacks and anxiety.; She noticed a pressure on her chest including panic attacks and anxiety.; She noticed a pressure on her chest including panic attacks and anxiety.; Soreness in arm; Lump; This is a spontaneous report from a contactable consumer (Patient) or other non health care professional from Pfizer sponsored program. A 53-years-old female patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE, solution for injection, Lot Number: EN6207 ), dose 1 via an unspecified route of administration, administered in top of the Arm Left on 17Mar2021 as DOSE 1, SINGLE, dose 2 via an unspecified route of administration, administered in top of the Arm Right on 08Apr2021 (Batch/Lot number was not reported) as DOSE 2, SINGLE for covid-19 immunisation. Prior vaccinations within 4 weeks were None. Reporter then stated she did not receive any of the vaccines and she thinks she just had the tests to confirm you had it. Medical history included pain in extremity and visual impairment. There were no concomitant medications. The patient experienced she was advise to go to the ER because it could be a stroke on an unspecified date, tingling in her arms post vaccination/ tingling started in her face and then spread ( It was within 48 to 72 hours of receiving the vaccine). it initially started at the jaw bone and down into her arm midway to forearm then continued to left side of hip and down leg and stopped right above her knee, her right eye lid was drooping a little, she noticed a pressure on her chest including panic attacks and anxiety, soreness in arm, lump. It was reported that reporter has asked certain questions Has Pfizer provided a statement on the need for a booster dose (3rd dose)? Is Pfizer investigating the need for a booster dose. My pediatrician told me the vaccine is only 95 % effective against the variant. Response: The emergency use authorization for the Pfizer-BioNTech COVID-19 Vaccine has been expanded to include individuals 12 to 15 years of age. In the Phase 3 pivotal trial, there were 2,260 individuals in this age group who received either the vaccine or placebo. The dose in 12 to 15 years of age is the same dose as currently available for adults (30 mcg per 0.3 mL dose as a series of two doses). Topline results showed a vaccine efficacy of 100% in participants with or without prior SARS-CoV-2 infection and the vaccine was also generally well-tolerated. These individuals will continue to be monitored for an additional two years after their second dose. Also, Pfizer has submitted this information for publication in a scientific journal for peer-review and potential publication. Pfizer and BioNTech started a Phase 2/3 study to further evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) in children aged 5 to 11 years. This is part of the Phase 1/2/3 dose-escalation study in healthy children 6 months to 11 years was designed to evaluate the safety, tolerability, and immunogenicity of the Pfizer-BioNTech COVID-19 vaccine on a two-dose schedule (approximately 21 days apart) in three age groups:o 5 to 11 yearso 2 to 5 yearso 6 months to 2 yearsAdditional information about the study can be found at www.clinicaltrials.gov under the identifier NCT04816643. The Pfizer-BioNTech COVID-19 Vaccine is not authorized for use in individuals less than 12 years of age. References:Pfizer-BioNTech COVID-19 Vaccine EUA Prescribing Information Pfizer-BioNTech COVID-19 Vaccine Authorized Product Monograph. Pfizer Press Pelease. withheld 10May2021.Pfizer-BioNTech COVID-19 Vaccine. Data on file (155). Pfizer. The need for a booster dose of Pfizer-BioNTech COVID-19 vaccine based on duration of protection or impact of variant strains has not yet been determined. On February 25, Pfizer and BioNTech announced they initiated an evaluation of the safety and immunogenicity of a potential third dose of the Pfizer-BioNTech COVID-19 vaccine (BNT162b2) to understand the effect of a booster on immunity against COVID-19 caused by the currently circulating and potential newly emerging variants. It is important to have a vaccine technology that allows us to both provide boosting doses if needed and to address potential changes in the virus itself if a new variant emerges that the vaccine does not protect against. While we have not seen any evidence that the circulating variants result in a loss of protection provided by our vaccine in our laboratory studies, we are taking multiple steps to be ready in case a strain becomes resistant to the vaccine. The administration of more than a 2-dose series of Pfizer BioNTech COVID-19 Vaccine is not approved. She had asked her doctor confirmed the vaccine can cause demyelination in adults post vaccination. Response: There were no other notable patterns or numerical imbalances between treatment groups for specific categories of serious adverse events (including neurologic, neuro-inflammatory, and thrombotic events) that would suggest a causal relationship to Pfizer-BioNTech. She asked What are the ingredients of the vaccine. Response: Informed caller to retrieve the list of ingredients on the following website. Sending the attached document via e-mail for reference. She was sure she does not have a stroke . Response was sent tot her to speak to her HCP. Reporter stated she had the adverse events after both the first and second doses. The outcome of she was advise to go to the ER because it could be a stroke on an unspecified date, tingling in her arms post vaccination/ tingling started in her face and then spread. it initially started at the jaw bone and down into her arm midway to forearm then continued to left side of hip and down leg and stopped right above her knee, She noticed a pressure on her chest including panic attacks and anxiety , Soreness in arm and Lump was unknown. The outcome of Her right eye lid was drooping a little was not recovered. She has to see when she goes to the doctor next week.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Pain in arm; Visual disturbance
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1233465

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 84,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 31.03.2021
Beginn: 03.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Death Unevaluable event

Symptomtext

Patient was hospitalized and died within 60 days of receiving a COVID vaccine series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1410894

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MT
Alter: 75,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 18.02.2021
Beginn: 11.03.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Death SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized due to COVID-19 from May 19, 2021 to May 22, 2021. Patient was then placed on hospice on 6/5/2021 and expired on 6/7/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 3,0
Labordaten: Positive SARS-CoV-2 PCR test collected on 5/19/2021 and resulted out on 5/19/2021.
Aktuelle Erkrankungen: diffuse large B cell lymphoma, cardiovascular disease, diabetes mellitus type 2, hypertension.
Vorgeschichte: diffuse large B cell lymphoma, cardiovascular disease, diabetes mellitus type 2, hypertension.
Andere Medikamente: allopurinol 300 mg PO DAILY amoxicillin 500 mg PO 2 caps prior to dental appt then 2 caps BID the following day. ; apixaban (Eliquis) 5 mg PO BID aspirin 81 mg PO QHS cholecalciferol (vitamin D3) 2,000 units PO DAILY coenzyme Q10 30 mg PO
Allergien: streptomycin
Vorherige Impfungen: -

VAERS 1358250

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 79,0
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 16.03.2021
Beginn: 25.05.2021
Tage bis Beginn: 70,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute respiratory failure Angiogram pulmonary abnormal Anticoagulant therapy Atypical pneumonia Bacterial test Adverse event COVID-19 SARS-CoV-2 test positive Vaccine breakthrough infection Blood bicarbonate increased Blood calcium decreased Blood chloride normal Blood creatinine increased Blood culture negative Blood glucose increased Blood potassium normal Blood sodium decreased Blood urea normal

Symptomtext

Patient presented to the ED on 5/25/21 w/worsening cough, fatigue and fever. He had been sick for approx 4 days and hadreportedly tested positive for SARS-CoV-2 on 5/19. He had a known exposure to a grandson w/COVID.. His was sent home from the ED initially and returned several hours later stating that his home pulse ox was 75%. In the ED he had a temp of 103.3 and a RA pulse ox of 88% CTA of the chest showed subacute pulmonary emboli and ground glass infiltrates consistent w/ atypical pneumonia. The pt was admitted. Acute hypoxic respiratory failure Combination of COVID-19 pneumonia with pulmonary embolism Required transfer to stepdown requiring OptiFlow FiO2 50%, flow rate 50 L Suspect secondary to fluid congestion. Significant improvement overnight diuresis Was able to wean down to 2 L of NC Pulmonology followed in the hospital. Appreciate help Checked O2 requirement prior to discharge and qualified for 2L via NC C/w pul toilette OP f/u with pulmonary Doctor and PCP as instructed 2. COVID 19 pneumonia Date of onset of symptoms: 5/19/21 Date of covid positive test: 5/21/2021 (outside facility), here positive from 5/26/21 Symptoms: shortness of breath, fever, fatigue Special isolation precautions implemented: yes Imaging: Chest x-ray-bibasilar and alveolar infiltrates Left >Right with probable small left pleural effusion Oxygen requirements as outlined above Medical therapy: Continue Decadron, completed remdesivir Continue pulmonary toilet, bronchodilators Inflammatory markers improving DC on Decadron 6 mg daily for 2 more days to complete 10 days course Pulmonary followed and felt stable for discharge OP f/u with Doctor/pul for PFT in 3 months 3. Pulmonary emboli,bilateral CTA chest with b/l submassive pulmonary emboli Most likely secondary to COVID-19 pneumonia Continue Eliquis, will need 3 months therapy Patient and spouse educated to check D-dimer level towards end of 3 month before stopping Eliquis, and they acknowledged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 9,0
Labordaten: 5/25/21 Na 133, K+ 3.9, Cl 99, HCO3 22, BUN 16, Cr 10.3, glucose 141 Ca 8.1, WBD 3.83, Hgb11.7, Hct 33.9, Plt 146 5/26/21 NP swab positive for SARS-CoV-2 CTA chest : Subocclusive filling defects in both lower lobes and in the left upper lobe are compatible with subacute pulmonary emboli. 2. Negative for right heart strain. 3. Ground-glass infiltrates in both lungs have developed since CT pulmonary angiogram of 03/25/2021, compatible with atypical pneumonia 5/27 CPR 1148, blood cultures x 2 negative, Hep C Ab neg, urine Legionella and strep pneumo antigens negative, T-spot negative, Hep B screen negative, HIV negative 5/30 HgbA1c 6.3%
Aktuelle Erkrankungen: none
Vorgeschichte: asthma benign prostatic hypertrophy hyperlipidemia
Andere Medikamente: Albuterol MDI 2 puffs QID prn SOB ASA 81mg daily cinnamon bark niacin 500mg TID omega 3/fish oil 300-1000 2gm daily Psyllium simvastatin 40mg QHS tamsulosin 08mg daily MVI daily
Allergien: NKA
Vorherige Impfungen: -

VAERS 1395826

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 64,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 30.03.2021
Beginn: 17.05.2021
Tage bis Beginn: 48,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary abnormal Computerised tomogram thorax Deep vein thrombosis Dyspnoea Peripheral swelling Pulmonary embolism Ultrasound Doppler Ultrasound scan abnormal

Symptomtext

Presented to Emergency Department with LLE swelling and dyspnea

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: 05/17 2012 Ultrasound duplex venous legs bilateral = Acute deep vein thrombosis in the distal femoral, popliteal, posterior tibial and peroneal veins of the left lower extremity. 2118 CT Pulmonary Arteries = Acute PE seen in the right lower lobe pulmonary arterial vasculature and also minimally in the right middle lobe, right upper lobe, and left upper lobe pulmonary arterial vasculature.
Aktuelle Erkrankungen: Suspected Pulmonary HTN per CTPA
Vorgeschichte: Factor V Leiden, Mild OSA, Primary osteoarthritis of both knees, BPH, Aortic Atherosclerosis
Andere Medikamente: Escitalopram 10mg po Daily
Allergien: No KNown Drug Allergies
Vorherige Impfungen: -

VAERS 1395556

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PR
Alter: 53,0
Geschlecht: M
Eingang: 14.06.2021
Impfdatum: 14.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Hypertensive heart disease Myocardial ischaemia Resuscitation

Symptomtext

Death. Ischemic and Hypertensive Heart Disease. No signs. Active and athletic middle age man. Was riding bicycle on a trail, stopped pedaling and dropped dead. Died instantly. CPR was performed. No vitals upon arrival.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: No info available.
Aktuelle Erkrankungen: Hypertension
Vorgeschichte: none
Andere Medikamente: Irbesartan 150mg Fenofibrate 160mg
Allergien: none
Vorherige Impfungen: -

VAERS 1374688

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 59,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 02.04.2021
Beginn: 14.04.2021
Tage bis Beginn: 12,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Pulmonary embolism

Symptomtext

I26.99 - Subacute massive pulmonary embolism (CMS/HCC) I26.99 - Other pulmonary embolism without acute cor pulmonale

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1368830

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 58,0
Geschlecht: M
Eingang: 02.06.2021
Impfdatum: 04.04.2021
Beginn: 20.05.2021
Tage bis Beginn: 46,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Acute respiratory failure COVID-19 SARS-CoV-2 test positive

Symptomtext

Patient contracted COVID-19 after receiving two COVID-19 vaccine doses (Pfizer series completed on 4/4/21). Patient was admitted to the hospital on 4/9/21 for acute hypoxic respiratory failure and was ultimately diagnosed with PJP and HIV/AIDS. On 5/20 patient had tested positive for SARS-CoV-2 and received treatment with monoclonal antibody.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: -
Labordaten: SARS-CoV-2 positive on 5/20 SARS-CoV-2 AB (Spike Assay) - 7 on 5/21
Aktuelle Erkrankungen: None
Vorgeschichte: None - Dx w/ PJP and HIV/AIDS on this hospital admission (4/9/21 to 5/24/21)
Andere Medikamente: Vitamin B-12, metformin, pantoprazole, bictegravir/emtricitabine/tenofovir alafenamide, TMP/SMX
Allergien: Pollen extracts
Vorherige Impfungen: -

VAERS 1368764

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 77,0
Geschlecht: M
Eingang: 02.06.2021
Impfdatum: 19.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Acute kidney injury Blood pH decreased Brain injury Cardiac arrest Computerised tomogram head abnormal Death Hyperkalaemia Intensive care Ischaemic hepatitis Mechanical ventilation Metabolic acidosis Resuscitation Unresponsive to stimuli

Symptomtext

Cardiac arrest at home, EMS performed CPR. Return of spontaneous circulation in the field after 2 rounds of epinephrine, In ED unresponsive, placed on a ventilator, required high doses epi to maintain perfusing blood pressure. Has acute kidney injury with hyperkalemia, shock liver and severe metabolic acidosis with arterial pH 7.04. CT of the head showed early findings of anoxic brain injury. Admitted to ICU and treated with aggressively with vasopressors, bicarbonate drip, heparin drip and empiric broad spectrum antibiotics. Very poor medical and neurologic prognosis, discussed with family and patient was transitioned to comfort care and passed away on 03/21/21 at 1626

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 2,0
Labordaten: N/A
Aktuelle Erkrankungen: Edema, unspecified type
Vorgeschichte: Diabetes, COPD, Chronic Hypoxemic Respiratory Failure, Hyperlipidemia, Thrombocytopenia, Unspecified, Atherosclerosis of Aorta, DM2 w/microalbuminuria, secondary polycythemia, chronic O2
Andere Medikamente: Simvastatin, glipizide, metformin, Spiriva, lisinopril, Ventolin
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1368497

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OK
Alter: 65,0
Geschlecht: F
Eingang: 02.06.2021
Impfdatum: 15.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test normal Coma Delusion Fall Gait disturbance Hallucination Incontinence Loss of personal independence in daily activities Memory impairment Seizure like phenomena Transient ischaemic attack Tremor

Symptomtext

She started having delusions and hallucinations, body tremors like epileptic seizure, she was falling down and using the bathroom on herself, her walk was a shuffled gate, she didn't remember almost 3 months in hospital, coma for 5 days and had a mini stroke. Her psych doctor thought maybe the vaccine could have triggered this type of reaction. She gained consciousness and was sent to a rehab nursing home where she's learning to walk to feed herself and getting stronger now that she's home. There's a long road to recovery.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Coma
Hospital-Tage: 21,0
Labordaten: Blood test for her psych medicine and her blood came back fine.
Aktuelle Erkrankungen: No
Vorgeschichte: Bipolar,
Andere Medikamente: Ibuprofen
Allergien: No
Vorherige Impfungen: -

VAERS 1354872

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 64,0
Geschlecht: M
Eingang: 27.05.2021
Impfdatum: 31.03.2021
Beginn: 21.04.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Death

Symptomtext

Patient was hospitalized multiple times and died within 60 days of receiving a COVID vaccine series

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1331812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 79,0
Geschlecht: M
Eingang: 19.05.2021
Impfdatum: 15.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Acute kidney injury Acute respiratory failure Adenovirus test Angiogram pulmonary abnormal Blood creatinine increased COVID-19 pneumonia Chest X-ray abnormal Condition aggravated Coronavirus test negative Dyspnoea Enterovirus test negative Fibrin D dimer increased Human metapneumovirus test Human rhinovirus test Influenza A virus test negative Influenza B virus test Lung opacity Pyrexia

Symptomtext

Inpatient Discharge Summary Admission Date: 3/22/2021 Discharge Date: 3/27/2021 Principal Problem: COVID-19 virus infection Hospital Course s a 79 y.o. male who presented to the hospital with a complaint of 1 week of shortness of breath and fever. He was managed for- COVID19 pneumonia with acute hypoxic respiratory failure, POA - CTA negative for PE; there is evidence of COVID19 pneumonia - given a unit of convalescent plasma - Remdesivir daily x 5 days (last day 3/26) -Will be sent on 4 days of Decadron to finish total of 10 days of Decadron. - inflammatory markers have improved - procalcitonin is negative x 2 - Mucinex/is/opep - wean oxygen as able, encourage patient to prone. - patient weaned down to room air. Home oxygen evaluation was done he did not qualify for O2 at home. AKI - Cr 1.36 upon presentation, improved to 1.0. - avoid nephrotoxic agents- d/c mobic. Did get contrast on 3/23 - continue to monitor renal function 5 beat run vtach - Patient does have hx of osa and was using CPAP machine - electrolytes were normal - continue telemetry monitoring - discussed outpatient ECHO Transaminitis - ?secondary to remdesivir vs covid virus Commend to repeat the LFTs in 3 days and follow the results with the PCP.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 5,0
Labordaten: 03/22/21 1347 Respiratory virus detection panel Collected: 03/22/21 1206 | Final result | Specimen: Swab from Nasopharynx Adenovirus Not Detected Mycoplasma pneumoniae Not Detected Chlamydophila pneumoniae Not Detected Parainfluenza Not Detected COVID-19 SARS-CoV-2 Overall Result DetectedCritical Enterovirus/Rhinovirus Not Detected Coronavirus Not Detected Respiratory Synctial Virus Not Detected Influenza A Not Detected Bordetella pertussis Not Detected Influenza B Not Detected Bordetella parapertussis Not Detected Metapneumovirus Not Detected X-ray Chest 1 View Result Date: 3/22/2021 XR CHEST 1 VW PORT IMPRESSION: 1. Bibasilar reticular opacities, likely secondary to subsegmental atelectasis. Consider follow-up imaging, as clinically directed. 2. No pleural effusion or pneumothorax. END OF IMPRESSION: INDICATION: Concern for COVID infection. TECHNIQUE: AP upright portable projection of the chest is acquired. COMPARISON: Chest radiographs performed on November 6, 2020. FINDINGS: Reticular opacities within bilateral lower lobes, most likely secondary to subsegmental atelectasis, however consider follow-up imaging as clinically directed. Minimal prominence of the central interstitial markings is noted. No pleural effusion or pneumothorax identified. Calcification of the aortic arch is noted. The cardiac silhouette is unremarkable. Redemonstrated is diffuse idiopathic skeletal hyperostosis. Mild right shoulder degenerative arthropathy is noted. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ultrasound Lower Extremity Venous Bilateral Result Date: 3/23/2021 US LOWER EXTREMITY VENOUS BILATERAL IMPRESSION: There is no evidence of deep venous thrombosis involving the bilateral lower extremities END OF IMPRESSION: INDICATION: Covid 19 positive, elevated d-dimer, concern for deep venous thrombosis. TECHNIQUE: Multiple longitudinal and transverse 2D real-time ultrasound images were performed from groin to knee, and at the calf and ankle. Color and grayscale and duplex Doppler imaging was also performed. Permanently recorded images were obtained and stored. COMPARISON: None available. FINDINGS: No evidence of deep venous thrombosis. On each side, there is normal flow, compressibility and augmentation in the common femoral, greater saphenous, superficial and deep femoral veins and popliteal veins. There is also normal flow, compressibility and augmentation in the posterior tibial veins, peroneal veins and small saphenous veins in the calves. This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient. Ct Angiogram Chest Pulmonary Embolism With And Without Contrast Result Date: 3/22/2021 CTA CHEST PULMONARY EMBOLISM W CONTRAST IMPRESSION: 1. No aortic aneurysm or dissection. 2. No pulmonary embolus. The study is very limited due to respiratory motion artifacts and suboptimal opacification of pulmonary arteries in both lungs. 3. There are bilateral peripheral and pleural-based interstitial groundglass opacities both lungs in the upper, mid and lower lung fields and bibasal atelectasis consistent with Covid infection. END OF IMPRESSION: INDICATION: covid. Shortness of breath. Assess for pulmonary artery embolism. TECHNIQUE: Enhanced helical CT scan of the chest was performed from the lung apices to below the diaphragm. 2mm axial reconstruction with MPR coronal, oblique and sagittal images were created. 3D shaded surface images also created on a separate workstation and permanently stored. CONTRAST: 80mL of IODIXANOL 320 MG IODINE/ML INTRAVENOUS SOLUTION administered INTRAVENOUS. COMPARISON: None available. FINDINGS: The study is very limited due to respiratory motion artifacts and suboptimal opacification of pulmonary arteries in both lungs. The visualized portion of the thyroid gland appears unremarkable. Evaluation of the thoracic aorta demonstrates unremarkable course and caliber. There is no evidence of aortic aneurysm or aortic dissection. The visualized central main and first order segmental branches of pulmonary arteries demonstrate unremarkable opacification with IV contrast. No focal filling defect is identified. No pathologic mediastinal, perihilar, or axillary adenopathy is identified. There are bilateral peripheral and pleural-based interstitial groundglass opacities both lungs in the upper, mid and lower lung fields and bibasal atelectasis consistent with Covid infection. There is no evidence of pleural effusion or pneumothorax. Minimal dependent atelectasis is present. No pulmonary nodules are identified. Visualized structures below the level of the diaphragm demonstrate no acute abnormality. Evaluation of dedicated bone windows reveals no acute osseous abnormality. None This report was created using Voice Recognition software. Thank you for allowing us to participate in the care of your patient.
Aktuelle Erkrankungen: -
Vorgeschichte: Nervous Lumbar radiculopathy Sacral back pain Respiratory Obstructive sleep apnea Circulatory Essential hypertension Digestive Esophageal reflux Change in bowel habits Chronic idiopathic constipation Genitourinary Prostate cancer (CMS/HCC) BPH (benign prostatic hyperplasia) BPH with obstruction/lower urinary tract symptoms Malignant neoplasm of prostate (CMS/HCC) Acute cystitis with hematuria Complicated UTI (urinary tract infection) Musculoskeletal Lumbar spondylosis Osteoarthritis Facet arthropathy, lumbar Sacroiliitis (CMS/HCC) Endocrine/Metabolic Hyperlipidemia LDL goal <130 Infectious/Inflammatory MRSA infection COVID-19 virus infection Other Personality disorder (CMS/HCC) Lumbar canal stenosis MDD (major depressive disorder), recurrent severe, without psychosis (CMS/HCC) Somatic symptom disorder Anxiety Neurofibroma Squamous cell carcinoma Medication management
Andere Medikamente: acetaminophen 650 mg oral 8 hr tablet atorvastatin (LIPITOR) 10 mg tablet(Expired) diclofenac sodium (VOLTAREN GEL) 1 % gel finasteride (PROSCAR) 5 mg tablet FLUoxetine (PROzac) 40 mg capsule irbesartan (AVAPRO) 300 mg tablet loratadine (CL
Allergien: Mercurial AnaloguesSwelling TamsulosinPalpitations Tramadol Bee PollenOther (document details in comments) Cymbalta [Duloxetine]Anxiety Norvasc [Amlodipine]Fatigue Toprol Xl [Metoprolol Succinate]Fatigue
Vorherige Impfungen: -

VAERS 1320662

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 46,0
Geschlecht: M
Eingang: 15.05.2021
Impfdatum: 17.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Acute respiratory failure Blood culture COVID-19 pneumonia Chest X-ray Condition aggravated Sepsis

Symptomtext

Acute respiratory failure with hypoxia sepsis secondary to COVID-19 pneumonia.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Acute respiratory failure
Hospital-Tage: 6,0
Labordaten: Blood Culture, Peripheral #1 Preliminary result Blood Culture, Peripheral #2 X-ray Chest 1 View
Aktuelle Erkrankungen: None
Vorgeschichte: Nervous Ankle pain Respiratory Acute respiratory failure with hypoxia Asthma Hypoxia Circulatory Hypertension Digestive Esophageal reflux Peptic ulcer Musculoskeletal Osteochondral defect of ankle Bone spur of right foot Sprain of right ankle, unspecified ligament, initial encounter Infectious/Inflammatory COVID-19 Other Depression Orthopedic aftercare
Andere Medikamente: amLODIPine (NORVASC) 10 mg tablet bupivacaine HCl/0.9 % NaCl/PF (BUPIVACAINE IN NACL,PF,) 0.125 % 750 mL elastomeric pump,hi var rate cetirizine (ZyrTEC) 10 mg tablet lisinopril-hydrochlorothiazide (PRINZIDE,ZESTORETIC) 20-12.5 mg per table
Allergien: Sulfa (Sulfonamide Antibiotics)Hives / Urticaria AmoxicillinNausea and Vomiting AzithromycinDiarrhea DoxycyclineDiarrhea
Vorherige Impfungen: -

VAERS 1314382

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 69,0
Geschlecht: F
Eingang: 13.05.2021
Impfdatum: 01.04.2021
Beginn: 06.04.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cerebrovascular accident

Symptomtext

Patient presented to the ED and subsequently hospitalized on 4/14/21 with CVA.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1302134

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 66,0
Geschlecht: M
Eingang: 10.05.2021
Impfdatum: 01.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Cardiac arrest Death

Symptomtext

Patient had several ED visits within 6 weeks of receiving COVID vaccination. He first presented to the ED on 4/8/21, was admitted on 4/9/21 for 2 days. He was admitted again on 4/20/21 for 6 days. He presented to the ED on 5/8/21 with cardiac arrest and died.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1299139

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NC
Alter: 65,0
Geschlecht: M
Eingang: 08.05.2021
Impfdatum: 22.03.2021
Beginn: 27.03.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Chest X-ray Computerised tomogram head Echocardiogram Magnetic resonance imaging head Magnetic resonance imaging heart Ultrasound abdomen Ultrasound chest

Symptomtext

Stroke; This is a spontaneous report from a contactable consumer. A 65-year-old male patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), via an unspecified route of administration on 22Mar2021 09:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history included ongoing high blood pressure, bleeding ulcer and helicobacter pylori infection both from 15Feb2021, and ongoing tumor on his heart. Concomitant medication included lisinopril taken for high blood pressure. The patient previously took the first dose of bnt162b2 in the left arm on 26Feb2021 (lot number: EN6203) for COVID-19 immunisation. Right before he had his first shot, he was in the hospital on 15Feb2021 with a bleeding ulcer and a helicobacter pylori infection. He had been in the hospital and isn't sure what all they gave him then. The patient started lisinopril 4 or 5 years ago when he was diagnosed with high blood pressure. His blood pressure was under control with the lisinopril but the patient is no longer on it. The patient's father had a stroke when he was 42 but he had high blood pressure and didn't get it treated. The patient got up around 07:00 in the morning on 27Mar2021. The patient's wife got up at 08:30 when she realized something was wrong. The patient said when he got up around 07:00, he experienced his right side being numb. The patient went to the emergency room and was treated there. He had a stroke. The patient was hospitalized from 27Mar2021 to 30Mar2021. The patient's wife doesn't know if it has anything to do with the shot. After his stroke, they put him on "carvilo". When the patient was in the hospital for the stroke, they found other issues. He has a tumor in his heart that's a pretty good size and the doctor said it had been there for awhile. So, they put her husband on "carvilo" to help with his blood pressure and his heart. She doesn't think the tumor had anything to do with the shot because the doctor did say the size of the tumor was as big as it was because it had been there a while. They found the tumor while trying to find out why he had the stroke. They still haven't found a reason as to why he had the stroke. The tumor is on the right side of his heart and they said they didn't think that had anything to do with the stroke. The tumor was found on 28Mar2021. They did an MRI and a CT scan on his head when he was in the emergency room (ER) on 27Mar2021. They also did an ultrasound on his heart, chest, and abdomen. Since he's been out, they did an MRI on his heart. They also did X-rays on his lungs. He is getting ready to go back to the hospital for open heart surgery on 07May2021. Outcome of the event was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Date: 20210327; Test Name: X-Ray of lungs; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: Head CT; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: ultrasound on heart; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: Head MRI; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: MRI on heart; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: ultrasound on abdomen; Result Unstructured Data: Test Result:unknown result; Test Date: 20210327; Test Name: ultrasound on chest; Result Unstructured Data: Test Result:unknown result
Aktuelle Erkrankungen: Blood pressure high; Cardiac neoplasm unspecified
Vorgeschichte: Medical History/Concurrent Conditions: Helicobacter pylori infection; Ulcer bleeding
Andere Medikamente: LISINOPRIL
Allergien: -
Vorherige Impfungen: -

VAERS 1293454

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 89,0
Geschlecht: M
Eingang: 06.05.2021
Impfdatum: 01.04.2021
Beginn: 01.04.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cerebral haemorrhage Fall Fatigue Hypoxia

Symptomtext

he felt tired the day of but continued doing his daily activities, on april 6 morning a friend couldn't reach him by phone and went to his home and found him on the floor, the hospital said he had a brain bleed, acute hypoxia, the bleed was on the left side of his brain, the doctor stated it was a cerebral bleeding that cause him to fall.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral haemorrhage
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: terazosin HCL, levothyroxine sodium, benazepril HCL, atorvastatin calium, latanoprost, clopidogrel,
Allergien: -
Vorherige Impfungen: -

VAERS 1289416

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NH
Alter: 50,0
Geschlecht: F
Eingang: 05.05.2021
Impfdatum: 30.03.2021
Beginn: 04.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time shortened Angiogram pulmonary abnormal Chest X-ray Dyspnoea Dyspnoea exertional Haematocrit normal Haemoglobin normal International normalised ratio normal Prothrombin time shortened Pulmonary embolism Pulmonary hypertension Ultrasound scan normal White blood cell count increased

Symptomtext

Shortness of breath, DOE, worsening daily from time of shot to now. PCP on 4/13, CXRAY 4/16, Pulmonology 4/26/21, ER 5/3/21 and admitted.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CT Angio, Positive for bilateral segmental and subsegmental pulmonary emboli noted in lungs and bilateral upper lobes, right middle lobe and also bilateral lower lobes. Reflux of contrast noted in hepatic veins, early pulmonary hypertension, no septal bowing or cardiomegaly. US BLE is clear. WBC 11.16 H+H 14.7/44.4. PT 9.5, INR 1.0 PTT 19.6
Aktuelle Erkrankungen: -
Vorgeschichte: Hasimoto's hypothyroidism, perimenopause, anxiety, osteoarthritis.
Andere Medikamente: estradiol, imipramine, levothyroxine, medroxyprogesterone, naproxen, sumatriptan succinate, albuterol Sulfate
Allergien: None known.
Vorherige Impfungen: -

VAERS 1283410

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 85,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 10.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: UN / -

Tod: ja Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Cerebral thrombosis Cerebrovascular accident Death

Symptomtext

Patient had a stroke on March 15, 2021 as described as a blood clot in her brain. Medical personnel were unable to correct it surgically and she passed away that evening in the hospital. Death was the final result.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: Asthma - emphagsema
Vorgeschichte: Anxiety
Andere Medikamente: Levothyroxine Alprozalan Combivent Serevent Incruse Montelucart Qvar
Allergien: Aspirin Penicillin
Vorherige Impfungen: -

VAERS 1156845

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 72,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 23.03.2021
Beginn: 27.03.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Death

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Autism
Andere Medikamente: None
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1278155

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 42,0
Geschlecht: M
Eingang: 01.05.2021
Impfdatum: 23.03.2021
Beginn: 21.04.2021
Tage bis Beginn: 29,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Magnetic resonance imaging head Thrombosis

Symptomtext

Stroke caused by blood clot. Spent 6 days in medical facility as a result. Unknown if vaccine and blood clot are related - but it seemed wise to report for further investigation

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 6,0
Labordaten: MRI of brain w/o contrast 4/22/2021
Aktuelle Erkrankungen: None
Vorgeschichte: Depression
Andere Medikamente: Effexor, famotidine, buspirone
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1274835

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: GA
Alter: 60,0
Geschlecht: F
Eingang: 30.04.2021
Impfdatum: 29.04.2021
Beginn: 30.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Anxiety Cardiac arrest Resuscitation

Symptomtext

Cardiac Arrest at 1:30 pm on 4/30/2021. . Arrest was witnessed by family and Emergency Medical Personnel. Cardiopulmonary Resuscitation was initiated. Pt was very anxious when EMS arrived.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Diabetes
Vorgeschichte: Liver transplant August 2020 at Emory University Hospital, Decatur GA
Andere Medikamente: ?
Allergien: Mushrooms
Vorherige Impfungen: -

VAERS 1257772

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 61,0
Geschlecht: M
Eingang: 26.04.2021
Impfdatum: 01.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: SYR / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Malaise

Symptomtext

Patient started not feeling well and told friends and family that he was not feeling well and that his doctor believed he was having a side effect to the 2nd dose of his COVID-19 Vaccine. He died 11 days after receiving his vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Speak to Physician. None known to family other than high blood pressure.
Vorgeschichte: Elevated Blood Pressure
Andere Medikamente: Speak to Physician
Allergien: Speak to Physician
Vorherige Impfungen: -

VAERS 1248176

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 55,0
Geschlecht: M
Eingang: 23.04.2021
Impfdatum: 21.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood electrolytes normal Blood fibrinogen Cerebral atrophy Cerebral microangiopathy Cerebrovascular accident Computerised tomogram head normal Computerised tomogram neck Dizziness Full blood count normal Gaze palsy International normalised ratio normal Lacunar infarction Magnetic resonance imaging head Pulse abnormal

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: two days after vaccination patient presented to the emergency department with impaired vertical gaze and dizziness. Vital signs within normal ranges except pulse 49 beats per minute. Diagnosed with CVA, administered tPA, admitted to the hospital. Discharged two days later to home in good condition.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: CTA head/neck: no acute intracranial abnormality, no arterial occlusion or significant stenosis in the head or neck, chronic right MCA territory infarct CT brain: no acute intracranial findings MRA brain: no acute large vessel occlusion; unchanged chronic occlusion of a right M2 segment MR brain: acute lacunar infarct in the left midbrain, chronic right MCA territory infarct, cerebral volume loss and scattered T2 white matter hyperintense lesions, likely reflecting chronic microvascular angiopathy CBC, electrolytes, INR, and fibrinogen all within normal ranges
Aktuelle Erkrankungen: -
Vorgeschichte: CAD, STEMI (2016) with stents placed, pre-diabetes mellitus, hearing loss
Andere Medikamente: aspirin, atorvastatin, clopidogrel, fish oil, lisinopril, multivitamin, nitroglycerin,
Allergien: none reported
Vorherige Impfungen: -

VAERS 1245272

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: -
Alter: 19,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 16.03.2021
Beginn: 14.04.2021
Tage bis Beginn: 29,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Chest pain Dyspnoea Echocardiogram normal Haemoptysis Pulmonary embolism Tachycardia

Symptomtext

Patient transferred from medical group practice for b/l PE. Patient reports chest pain and SOB x 4 days ago. Patient has also been having hemoptysis for the past couple days as well. Physical exam is remarkable for tachycardic heart rate and rhythm is regular. Patient given heparin bolus and infusion and admitted to hospital for acute large main vessel pulmonary embolism. 2D echocardiogram showing no signs of right heart strain. Patient was transitioned to oral Eliquis and given a 1 month supply on discharge. Patient told to stop birth control and avoid NSAIDS. Patient instructed to F/U with PCP and hematology.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1224897

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IL
Alter: 67,0
Geschlecht: F
Eingang: 18.04.2021
Impfdatum: 03.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Hypoxia

Symptomtext

Hypoxia; cardiac arrest; This is a spontaneous report from a contactable physician. A 67-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via intramuscular route of administration on 03Apr2021 at 15:15 (at the age of 67 years) at a single dose in the left arm for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 13Mar2021 (at the age of 67 years) for COVID-19 immunization. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not pregnant at the time of vaccination. On 05Apr2021, the patient experienced hypoxia and subsequent cardiac arrest. The events resulted in Emergency room/department or urgent care and hospitalization. The events were considered life threatening. Therapeutic measures were taken as a result of the events which included CPR and intubation. It was unknown if patient has been tested for COVID-19. The outcome of the events was unknown.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events hypoxia and cardiac arrest cannot be excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1224639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MD
Alter: 73,0
Geschlecht: F
Eingang: 18.04.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Computerised tomogram Fatigue Loss of personal independence in daily activities Magnetic resonance imaging Migraine Scan with contrast

Symptomtext

Could understand words but could not answer back; Her symptoms came out as if she was having a stroke.; Bad headache/migraine; Extremely tired; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EN6207, expiry date: Jul2021), via an unspecified route of administration, administered in left arm on 19Mar2021 10:45 at single dose for COVID-19 immunization. The patient's medical history included diabetes from Jun2001 and ongoing. The patient's concomitant medication included metformin taken for diabetes from Jun2001 and ongoing. The patient previously received flu shot from immunization (she had the flu shot 20 years ago had bad reaction to). Facility where the most recent COVID-19 vaccine was administered was at the hospital. The vaccine was not administered at military facility. The patient received the vaccine on 19Mar2021 and she felt fine that Friday. On 20Mar2021 (Saturday), she started having a bad headache and took Aleve. She took Aleve 3 times 4 hours apart because she still had a bad headache. She started losing the ability to bring out words. She stated that her headache was gone. On 21Mar2021 (around 4 o clock), her husband was in the kitchen and asked her a question but could not understand her and asked again. She could not say the words but she could spell them. Her husband asked her another question, she tried to talk but she could not answer back. At that point her husband said they were going to the hospital. She was admitted for 3 days from 21Mar2021 to 23Mar2021. The doctor told her she was having a migraine because it had lasted for 2 days. She also spoke with her primary care provider, who looked it up and said this could be a side effect. She was told the migraine may take away the ability to talk. Her headache has been gone but continues to feel very tired (extremely tired since 19Mar2021). Her symptoms came out as if she was having a stroke on an unspecified date. The event 'could not understand words but could not answer back' required an emergency room visit.The patient underwent lab tests and procedures which included CAT scan, MRI, and contrast test, all with negative result on 22Mar2021. The outcome of the event 'could understand words but could not answer back' was recovered on 22Mar2021, the event 'bad headache/migraine' was recovered on 21Mar2021, not recovered for extremely tired, and unknown for the event 'stroke'.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Date: 20210322; Test Name: CAT scan; Result Unstructured Data: Test Result:Negative; Test Date: 20210322; Test Name: MRI; Result Unstructured Data: Test Result:Negative; Test Date: 20210322; Test Name: Contrast test; Result Unstructured Data: Test Result:Negative
Aktuelle Erkrankungen: Diabetes
Vorgeschichte: -
Andere Medikamente: METFORMIN
Allergien: -
Vorherige Impfungen: -

VAERS 1224144

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

kritisch

Staat: CA
Alter: 79,0
Geschlecht: M
Eingang: 17.04.2021
Impfdatum: 23.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac arrest Death Dyspnoea Life support Multiple organ dysfunction syndrome Nausea Pyrexia Resuscitation Septic shock Syncope Vomiting

Symptomtext

Developed fever, nausea and vomiting about 24 hours later. Symptoms lasted two days and began to subside, at which time shortness of breath began. Patient drove himself to the hospital for evaluation and treatment on Saturday, March 27th where he collapsed in cardiac arrest. he was resuscitated and stabilized on life support. He died of multiple organ failure on Monday March 29th. The official diagnosis was Severe Septic Shock. It is unclear if any infective agent was identified. It should be noted that sepsis is a condition in which immune dysregulation is inherent and includes cytokine storm activity. The possible correlation between vaccination and the subsequent development of sepsis should be investigated.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: The hospital refuses to provide medical records to next of kin at this time.
Aktuelle Erkrankungen: NONE
Vorgeschichte: Prior heart attack on or before 2017
Andere Medikamente: Albuterol Inhaler as needed, Sertraline 50 mg/day, Allopurinol 300 mg, Atorvastatin 20 mg
Allergien: None or unknown
Vorherige Impfungen: -

VAERS 1219334

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MO
Alter: 64,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 17.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death Unresponsive to stimuli

Symptomtext

Death on 3/22. Unknown cause. Family found him unresponsive. Did not pursue autopsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: no autopsy performed
Aktuelle Erkrankungen: hypertension, uncontrolled type 2 diabetes, hyperlipidemia, COPD, sleep apnea, tobacco use, alcohol abuse, cocaine abuse
Vorgeschichte: hypertension, uncontrolled type 2 diabetes, hyperlipidemia, COPD, sleep apnea, tobacco use, alcohol abuse, cocaine abuse
Andere Medikamente: acetaminophen, amlodipine, aspirin, atorvastatin, cholecalciferol, diphenhydramine, glipizide, melatonin
Allergien: tramadol, lisinopril
Vorherige Impfungen: -

VAERS 1218835

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 63,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 31.03.2021
Beginn: 07.04.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Angiogram pulmonary abnormal Anticoagulant therapy Computerised tomogram thorax Deep vein thrombosis Pelvic venous thrombosis Pulmonary embolism Ultrasound Doppler abnormal

Symptomtext

CTA showed extensive bilateral PE involving R and L-pulmonary arteries with extension into lobar, segmental and subsegmental branches with questionable heart strain. LE US showed L-DVT in L-femoral vein, popliteal vein, posterior tibial veins, gastrocnemius vein. He denies any prior COVID diagnosis and reports 2nd dose of Pfizer vaccine on 3/31. Patient treated with heparin infusion and subsequently discharged on xarelto. No urgent mechanical thrombectomy or catheter thrombolysis was done.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: CTA showed extensive bilateral PE involving R and L-pulmonary arteries with extension into lobar, segmental and subsegmental branches with questionable heart strain. Bilateral LE US showed L-DVT in L-femoral vein, popliteal vein, posterior tibial veins, gastrocnemius vein.
Aktuelle Erkrankungen: none
Vorgeschichte: BPH
Andere Medikamente: Anusol HC-1 Rectal BID PRN for rectal pain Avodart 0.5mg daily CoQ10 200mg daily Glucosamine Chondroitin 1 cap per day omeprazole 40mg daily vitamin B12 1000mcg daily
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1218147

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: SC
Alter: 71,0
Geschlecht: F
Eingang: 16.04.2021
Impfdatum: 18.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 10,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram Angiogram abnormal Anticoagulant therapy Blood creatinine increased Blood urea increased Brain natriuretic peptide increased Bundle branch block right Chest X-ray normal Diastolic dysfunction Dyspnoea Echocardiogram abnormal Electrocardiogram ST-T segment abnormal Electrocardiogram abnormal Fibrin D dimer increased Pulmonary arterial hypertension Pulmonary embolism Right ventricular dilatation SARS-CoV-2 test negative

Symptomtext

Patient is a 71-year-old female with history of hypertension, hyperlipidemia, and obesity who presents with complaint of acute onset shortness of breath. She reports she was walking around her house earlier when she suddenly became short of breath. She denies any chest pain, numbness or tingling but states that shortness of breath persisted. She denies any tobacco, alcohol or drug use and states she has never had any symptoms similar to this before. Denies any lung disease or heart disease previously. She does have hypertension and hyperlipidemia and is on metoprolol and rosuvastatin respectively which she reports good compliance. Denies family history of MI or strokes. She also denies other symptoms such as nausea, vomiting, abdominal pain, fevers or lower extremity edema. In the ED vitals were found to be within normal limits. EKG was obtained showing diffuse T wave inversions, right bundle branch block, no ST changes, no hypertrophy. Troponin found to be elevated at 0.137, creatinine elevated at 1.3, BUN 26. Chest x-ray was within normal limits. Otherwise lab work was unremarkable. She was given aspirin and Nitropaste Hospital Course: Patient was admitted to the medical floor and remained hemodynamically stable throughout her stay. She actually remained asymptomatic and had no further shortness of breath. She was not hypoxic, at no point required supplemental oxygen. Her troponins however continued to uptrend to 0.389. Cardiology consulted, she was medically optimized with increased statin dose, therapeutic lovenox, and aspirin. Original plan was for cardiac catheterization. However, a d-dimer was ordered which returned elevated to 13.7. CTA was performed which revealed extensive bilateral pulmonary emboli with large clot burden and concern for right heart strain. Echocardiogram showed mildly dilated and hypokinetic RV with mild diastolic dysfunction with impaired relaxation. She was deemed not to be candidate for EKOS. Troponin elevation was felt to be type II NSTEMI 2/2 PE. PE was classified as unprovoked as she has no definite risk factors for this: no prior DVT/PE, no family history of clotting disorder, no evidence of malignancy (UTD with cancer screenings and visits PCP q6m for health maintenance), no cell line abnormalities, no prolonged immobility or long trips or surgeries, no trauma, no hormone or steroid therapies or even antidepressants. She is obese, and has mild CKD. She tested negative for COVID-19 by antigen testing. The only identifiable change in her health habits recently was receiving the first COVID-vaccine dose on 3/18. We discharged her with Eliquis with instructions to taper from 10BID to 5BID after 7 days. As she will be on anticoagulation, the benefit will likely outweigh the risk of receiving the second COVID dose. She will follow up with her PCP and hematology/oncology.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 2,0
Labordaten: 03/28/2021: Chest CTA - Extensive bilateral pulmonary emboli with overall large clot burden and suggestion of pulmonary arterial hypertension and right heart strain. 03/29/2021: Cardiac echocardiogram - Conclusion - The left ventricle is normal size. The left ventricular systolic function is normal. LVEF is 60-65%. There is normal LV segmental wall motion. Mild diastolic dysfunction is present (impaired relaxation pattern). Right ventricle is mildly dilated. Right ventricle is mildly hypokinetic. Trace tricuspid regurgitation. 003/29/2021: Vascular ultrasound: Conclusion - This study is negative for thrombus in the deep and superficial venous system in both lower extremities Labs: 03/28/2021: D-Dimer 13.7 Troponin 0.389 BNP: 3430
Aktuelle Erkrankungen: -
Vorgeschichte: hypertension, hyperlipidemia, obesity
Andere Medikamente: Rosuvastatin 5mg, metoprolol 100mg
Allergien: n/a
Vorherige Impfungen: -

VAERS 1214072

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

kritisch

Staat: NY
Alter: 69,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 18.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 10,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pulmonary embolism

Symptomtext

Pulmonary embolism

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: 3/30/2021 emergency room
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Paxil 20mg Losartan 50mg Simvastitan 40mg Motelelast 10mg Somnapure sleep aid 1 a day Colace 2 a day Prebiotic Fiber 2 a day Baby aspirin 1 a day
Allergien: Penicillin Clyndamicin
Vorherige Impfungen: -

VAERS 1205829

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en 6207

kritisch

Staat: HI
Alter: 56,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 20.03.2021
Beginn: 04.04.2021
Tage bis Beginn: 15,0
Dosis: 1
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Cerebrovascular accident

Symptomtext

STROKE. ACCORDING TO PATIENT'S WIFE, HE IS DOING OK. ONLY WAS HOSPITALIZED FOR A FEW DAYS AND WENT HOME. NO RECORDS OF HIS HOSPITALIZATION ARE AT ; HE WENT TO MEDICAL CENTER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: DIABETES HTN
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1203725

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: IN
Alter: -
Geschlecht: U
Eingang: 13.04.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: ja

Aphasia Atrial septal defect Cerebrovascular accident Computerised tomogram thorax normal Echocardiogram Echocardiogram normal Electrocardiogram normal Magnetic resonance imaging head abnormal Scan with contrast normal Thrombosis

Symptomtext

10 days after receiving my first Pfizer shot I suffered a stroke that was caused by a blood clot. I was unable to speak for a short time the morning of 4/1/2021 and went to emergency room at. My speech had already returned and I was no longer having symptoms. There were numbers tests and scans run and it was confirmed that I had a stroke that was caused by a blood clot. There were no obvious issue present to why I would have had this happen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 2,0
Labordaten: 4/1/2021 numerous blood tests that all saw results in normal ranges, ECG's normal, CAT Scan, CAT Scan w/Contrast (all veins & arteries were normal with no blockage) , MRI (This is the test that confirmed an actual stroke). Echocardiogram (all results normal). 4/2/2021 - Transesophageal Echocardiogram - found small PFO but nothing abnormal. Performed bubble test with very minimal bubbles through the PFO.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1197923

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 71,0
Geschlecht: M
Eingang: 12.04.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood glucose increased Cardiac arrest Death Resuscitation

Symptomtext

He was found down in cardiac arrest- EMS called CPR done and taken to Emergency room, unsuccessful CPR, patient died

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: blood sugar 259. I do not have any additional test results available
Aktuelle Erkrankungen: had URI symptoms 3/8/21 and 3/13/21 - took azithromycin, refused COVID-19 testing had 1st COVID-19 (Pfizer) vaccine 2/26/21
Vorgeschichte: CAD, aortic stenosis, hx of CABG, hx of asbestos exposure, HTN, HL, interstitial lung disease, smoker
Andere Medikamente: Aspirin, prinzide, plavix, atorvastatin, metoprolol, may have been taking albuterol, benzonatate and guaifenasin.
Allergien: codeine, penicillin
Vorherige Impfungen: -

VAERS 1186951

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 65,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 23.03.2021
Beginn: 04.04.2021
Tage bis Beginn: 12,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Angiogram pulmonary Deep vein thrombosis Pulmonary embolism Ultrasound Doppler

Symptomtext

Saddle Pulmonary embolism and right lower extremity DVT

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 3,0
Labordaten: CT angiogram of chest 4/6/2021 vascular lev to r/o DVT
Aktuelle Erkrankungen: none
Vorgeschichte: Hypertension, hyperlipidemia
Andere Medikamente: lisinopril 20 q daily
Allergien: no known drug allergy
Vorherige Impfungen: -

VAERS 1175716

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MN
Alter: 72,0
Geschlecht: F
Eingang: 07.04.2021
Impfdatum: 17.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebrovascular accident Echocardiogram Facial paralysis Magnetic resonance imaging head abnormal Muscular weakness Scan with contrast Thrombosis Ultrasound Doppler

Symptomtext

1st symptom 3/19/21 at 5:30 am - Weakness in fingers on right hand. Called nurse line, they recommended calling EMT. EMT said no stroke but could go to urgent care for further evaluation. Urgent care recomended ER. ER recommended appointment with Neurology 2nd symptom 3/21/21 slight droop on right side of mouth. Went to ER in Hospital. MRI revealed clot. Additional ultra sound of heart and carotid arteries clear. Final diagnosis: Subacute CVA-Lt Centrum Semiovale w/ right facial droop and right hand deficits. Recomendations: Nuerology evaluation, Outpatient PT/OT for right hamd deficits. Hospitilization: 1 day Hospital Name: Unnamed City: Unnamed State: Unnamed

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: -
Labordaten: MR Brain Without Contrast 3/21/21 MR Brain With Contrast 3/21/21
Aktuelle Erkrankungen: None
Vorgeschichte: Type 2 diabeties Hypertention
Andere Medikamente: -
Allergien: None
Vorherige Impfungen: -

VAERS 1173865

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 73,0
Geschlecht: F
Eingang: 07.04.2021
Impfdatum: 15.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood pressure measurement Cerebrovascular accident Computerised tomogram head Magnetic resonance imaging Thrombosis Cerebral infarction Computerised tomogram head normal Intensive care Magnetic resonance imaging head abnormal

Symptomtext

developed a clot which led to a left frontal cerebral vascular accident (CVA)/stroke; developed a clot which led to a left frontal cerebral vascular accident (CVA)/stroke; This is a spontaneous report from a contactable nurse. A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in left arm on 15Mar2021 11:00 (lot number: EN6207) at single dose for COVID-19 immunisation. The patient's medical history included ongoing slightly elevated blood pressure (diagnosis about 5 years ago). The patient's concomitant medication included metoprolol taken for slightly elevated blood pressure from 2017 and ongoing. The patient previously took second dose of influenza vaccine on Sep2019 and experienced flu like symptoms for 24hours. The vaccine facility type was clinic. Prior vaccinations (within 4 weeks) was none. On 22Mar2021, the patient developed a clot which led to left frontal cerebral vascular accident (CVA)/stroke on 22Mar2021 that resulted to an Emergency Room visit. The patient was hospitalized for from 22Mar2021 to 25Mar2021 (3 days) due to the events. The patient does not have any left or right arm deficits. Her speech has came back. She was cognizant right now. She had no other factors that would have contributed to this. She has no other pre-existing conditions or co-morbidities. The patient underwent lab tests and procedures which included blood pressure: within normal limits prior to the events on an unspecified date, head CT: unknown result, and MRI: left frontal lobe infarct, both on 23Mar2021. The outcome of the events were recovered on an unspecified date. The reporter was inquiring about correlation between vaccine and clot formation, cerebrovascular accidents, strokes. Seriousness criteria of the events were hospitalization, life-threatening.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Cerebrovascular accident and Clot blood cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:normal limits; Comments: within normal limits prior to this event; Test Date: 20210323; Test Name: Head CT; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210323; Test Name: MRI; Result Unstructured Data: Test Result:left frontal lobe infarct
Aktuelle Erkrankungen: Blood pressure increased (Diagnosis about 5 years ago.)
Vorgeschichte: -
Andere Medikamente: METOPROLOL
Allergien: -
Vorherige Impfungen: -

VAERS 1173865

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 73,0
Geschlecht: F
Eingang: 07.04.2021
Impfdatum: 15.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Blood pressure measurement Cerebrovascular accident Computerised tomogram head Magnetic resonance imaging Thrombosis Cerebral infarction Computerised tomogram head normal Intensive care Magnetic resonance imaging head abnormal

Symptomtext

developed a clot which led to a left frontal cerebral vascular accident (CVA)/stroke; developed a clot which led to a left frontal cerebral vascular accident (CVA)/stroke; This is a spontaneous report from a contactable nurse. A 73-year-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), intramuscular, administered in left arm on 15Mar2021 11:00 (lot number: EN6207) at single dose for COVID-19 immunisation. The patient's medical history included ongoing slightly elevated blood pressure (diagnosis about 5 years ago). The patient's concomitant medication included metoprolol taken for slightly elevated blood pressure from 2017 and ongoing. The patient previously took second dose of influenza vaccine on Sep2019 and experienced flu like symptoms for 24hours. The vaccine facility type was clinic. Prior vaccinations (within 4 weeks) was none. On 22Mar2021, the patient developed a clot which led to left frontal cerebral vascular accident (CVA)/stroke on 22Mar2021 that resulted to an Emergency Room visit. The patient was hospitalized for from 22Mar2021 to 25Mar2021 (3 days) due to the events. The patient does not have any left or right arm deficits. Her speech has came back. She was cognizant right now. She had no other factors that would have contributed to this. She has no other pre-existing conditions or co-morbidities. The patient underwent lab tests and procedures which included blood pressure: within normal limits prior to the events on an unspecified date, head CT: unknown result, and MRI: left frontal lobe infarct, both on 23Mar2021. The outcome of the events were recovered on an unspecified date. The reporter was inquiring about correlation between vaccine and clot formation, cerebrovascular accidents, strokes. Seriousness criteria of the events were hospitalization, life-threatening.; Sender's Comments: Based on the current available information and the plausible drug-event temporal association, a possible contributory role of the suspect product BNT162B2 to the development of events Cerebrovascular accident and Clot blood cannot be totally excluded. The case will be reassessed if additional information becomes available. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:normal limits; Comments: within normal limits prior to this event; Test Date: 20210323; Test Name: Head CT; Result Unstructured Data: Test Result:Unknown result; Test Date: 20210323; Test Name: MRI; Result Unstructured Data: Test Result:left frontal lobe infarct
Aktuelle Erkrankungen: Blood pressure increased (Diagnosis about 5 years ago.)
Vorgeschichte: -
Andere Medikamente: METOPROLOL
Allergien: -
Vorherige Impfungen: -

VAERS 1171391

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 60,0
Geschlecht: M
Eingang: 06.04.2021
Impfdatum: 17.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Death on 3/24/21 reported to vaccination clinic by family member. No additional details given.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Death reported to vaccination clinic by family member. Date of death 3/24/2021. No other details given.
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1153376

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: OH
Alter: 37,0
Geschlecht: F
Eingang: 31.03.2021
Impfdatum: 19.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Exposure during pregnancy Fatigue Foetal death Foetal heart rate abnormal Pain in extremity Ultrasound foetal abnormal

Symptomtext

Pain in arm and fatigue 1-2 days after receiving vaccination. Was 12 weeks 2 days pregnant on vaccination date, estimated due date of 9/27/2021. Fetus confirmed healthy day prior to vaccination via ultrasound on 3/18/2021. Had routine prenatal check on 3/31/2021 and fetal heartbeat could not be found. Fetal demise confirmed via ultrasound the same day, 3/31/2021. Estimated fetus age at demise was 13 weeks 1 day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Foetal death
Hospital-Tage: 1,0
Labordaten: Ultrasound 3/18/2021 Ultrasound 3/31/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma
Andere Medikamente: 10mg singulair 10mg Zyrtec 20mg lexapro Prenatal vitamin
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1151639

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 69,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 18.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 5,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram Angiogram abnormal Diastolic dysfunction Dyspnoea Dyspnoea exertional Echocardiogram abnormal Fluid overload Intensive care Oedema peripheral Pain in extremity Pulmonary embolism Systolic dysfunction

Symptomtext

Patient is a 69 y.o. male patient who originally presented to the hospital on 3/23/2021 due to shortness of breath. Patient had 1 week of shortness of breath. He starts experiencing 2 weeks of pain in edema right lower extremity. Did notice increasing dyspnea on exertion. Was noted to have bilateral PEs with evidence of RV strain on CT scan. She admitted to the ICU on heparin drip he did undergo tPA. Echocardiogram documented to be improving. Patient now baseline ambulatory in the room without oxygen stable.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: 4,0
Labordaten: o CTA chest large quantity of septic mental type bilateral pulmonary arterial embolism. Positive RV strain. o Echocardiogram x2 ? First echocardiogram with ejection fraction 55% and grade 1 diastolic dysfunction with notable moderately dilated RV with markedly reduced RV systolic function ? Second echocardiogram was limited look at the right ventricle positive discharge in neck motion consistent with RV volume and pressure overload. RV was dilated systolic function now low normal
Aktuelle Erkrankungen: Adenocarcinoma of prostate (HCC) 8/17/2018 - Present Acute submassive pulmonary embolism (HCC) 3/23/2021 - Present Elevated troponin 3/23/2021 - Present AKI (acute kidney injury) 3/23/2021 - Present HTN (hypertension) 3/23/2021 - Present HLD (hyperlipidemia) 3/23/2021 - Present DM2 (diabetes mellitus, type 2) 3/23/2021 - Present RESOLVED: Acute respiratory failure with hypoxia 3/23/2021 - 3/25/2021 Prostate CA (HCC) 3/23/2021 - Present
Vorgeschichte: Adenocarcinoma of prostate (HCC) 8/17/2018 - Present Acute submassive pulmonary embolism (HCC) 3/23/2021 - Present Elevated troponin 3/23/2021 - Present AKI (acute kidney injury) 3/23/2021 - Present HTN (hypertension) 3/23/2021 - Present HLD (hyperlipidemia) 3/23/2021 - Present DM2 (diabetes mellitus, type 2) 3/23/2021 - Present RESOLVED: Acute respiratory failure with hypoxia 3/23/2021 - 3/25/2021 Prostate CA (HCC) 3/23/2021 - Present
Andere Medikamente: Alogliptin-Metformin HCl 12.5-500 MG TABS ALPRAZolam (XANAX) 0.25 mg tablet (Expired) amLODIPine (NORVASC) 10 mg tablet apixaban (ELIQUIS) 5 mg atorvastatin (LIPITOR) 40 mg tablet glimepiride (AMARYL) 4 mg tablet tamsulosin (FL
Allergien: none known
Vorherige Impfungen: -

VAERS 1147151

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 66,0
Geschlecht: M
Eingang: 30.03.2021
Impfdatum: 10.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Received email from Public Health Nurse that patient had passed away on 3-16-21. The coroner did not believe it was associated with the vaccine, just reporting the death. Requested VAERS form still be filled out.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1144362

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CO
Alter: 62,0
Geschlecht: F
Eingang: 29.03.2021
Impfdatum: 12.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 8,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram thorax abnormal Deep vein thrombosis Dyspnoea Heart injury Pain in extremity Pulmonary embolism Ultrasound scan abnormal

Symptomtext

1 week later, left calf pain, SOB

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary embolism
Hospital-Tage: -
Labordaten: US lower extremity revealed DVT, fu CT chest showed + PE and ? Rt heart strain
Aktuelle Erkrankungen: GERD
Vorgeschichte: HTN, GERD, h/o UTIs
Andere Medikamente: losartan 100 mg, hctz 12.5, metoprolol 25 mg XL, estradiol cream topically 3 x weekly, D-mannose, Vit D 5000 IU
Allergien: soy, grass, mold
Vorherige Impfungen: -

VAERS 1116661

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

kritisch

Staat: OH
Alter: 62,0
Geschlecht: F
Eingang: 29.03.2021
Impfdatum: 09.03.1959
Beginn: 19.03.2021
Tage bis Beginn: 22.656,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Agonal respiration Blood lactic acid normal Body temperature increased Endotracheal intubation Imaging procedure abnormal Cardiac arrest Encephalopathy Mechanical ventilation Nephrolithiasis Platelet count decreased Sepsis Thrombocytopenia Ureteric obstruction Unresponsive to stimuli White blood cell count increased

Symptomtext

Went to sleep with husband evening after vaccine and in the morning was found unresponsive with agonal breathing. Intubated in the field by EMS and taken to the hospital. At this time is still encephalopathic, on ventilator, s/p cardiac arrest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1139812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: CA
Alter: 60,0
Geschlecht: M
Eingang: 27.03.2021
Impfdatum: 17.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 3,0
Dosis: UNK
Route/Site: IM / LA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Death

Symptomtext

Patient was found expired in his home on 3/20/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: -
Labordaten: None (patient was taken to mortuary from home after police investigation)
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes with chronic kidney disease stage 3B, proliferative retinopathy, and neuropathy, hypertension, and severe obesity
Andere Medikamente: Lantus Insulin, Humulog Insulin, Victoza, carvedilol, lisinopril, spironolactone, atorvastatin, amlodipine, gabapentin, omeperazole,
Allergien: NSAIDS avoided due to kidney disease
Vorherige Impfungen: -

VAERS 1135594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 27.03.2021
Impfdatum: 10.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Cardiac stress test Echocardiogram Myocardial infarction Fatigue Heart injury Investigation Stress echocardiogram Palpitations Tremor Troponin I increased

Symptomtext

Heart Attack: taken by ambulance to hospital ER: symptoms were weakness, pounding, racing heart, uncontrollable shaking

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 4,0
Labordaten: blood test with an elevated Troponin 1, ECHO and Stress Test
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lopressor, Klonopin
Allergien: Contrast dye, PCN, Latex
Vorherige Impfungen: -

VAERS 1135594

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: MI
Alter: 73,0
Geschlecht: F
Eingang: 27.03.2021
Impfdatum: 10.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Asthenia Blood test Cardiac stress test Echocardiogram Myocardial infarction Fatigue Heart injury Investigation Stress echocardiogram Palpitations Tremor Troponin I increased

Symptomtext

Heart Attack: taken by ambulance to hospital ER: symptoms were weakness, pounding, racing heart, uncontrollable shaking

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocardial infarction
Hospital-Tage: 4,0
Labordaten: blood test with an elevated Troponin 1, ECHO and Stress Test
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Lopressor, Klonopin
Allergien: Contrast dye, PCN, Latex
Vorherige Impfungen: -

VAERS 1134751

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: WI
Alter: 66,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 10.03.2021
Beginn: 14.03.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Death

Symptomtext

Patient was hospitalized within 4 days of getting the vaccine and passed away 6 days after getting the vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Death
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1124794

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: NY
Alter: 31,0
Geschlecht: M
Eingang: 22.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cardiac arrest Chest pain Death Headache Pyrexia

Symptomtext

Extreme head ache, chest pain, fever 101 F. Gave 1000 mg Tylenol, albuterol via nebulizer Q4hr. Died 3/20/2021 approx 11:00 am from Cardiac Arrest.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: none known
Aktuelle Erkrankungen: Pulmonary inflammation
Vorgeschichte: MEDICAL SUMMARY: VATER?S SYNDROME ? Tetralogy of Fallot with LPA Atresia s/p repair (last conduit replacement 2/96) ? TE Fistula s/p repair 10/89 (Medical Center) ? Abnormal Ear Canals ? Absent right kidney ? Absent Corpus Colossus ? Abnormal Vertebrae (fissured) ? 7th Nerve Palsy ? Developmental Delays ? Nissen Fundoplication 11/89 (AMC), failed ? G-Tube placement 9/89 (AMC) ? J-Tube placement 3/95 (BCH) (complicated with fistulas) ? ? CVA 0-3mo. ? Reglan Reaction 12/90 (fever - 108.1F) ? Upper Right Lobectomy 10/93 (BCH) ? Poor Venous Access ? Seizure Disorder, controlled, out grown ? Growth on back of tongue (looks like ordinary tissue-benign-prone to bleeding if irritated) ? Enlarged Adenoids ? 6th digit left hand (ligated 9/89) ? Prone to Candida ? Pseudomonas Picetti lung infection 2/98, colonized ? History of bleeding duodenal ulcer ? MRSA 05/07, lungs, colonized ? Power Port placed 2/15 ? Power Port removed due to bacterial infection 6/15 ? Cardiac Cath, LPA Stent dilated, 20mm/100%, Melody valve placed, RV, 8/27/2015, (BCH)
Andere Medikamente: Ipratropium Bromide, (0.5mg/2.5ml) (Atrovent) Budesonide, (0.5mg/2ml) (Pulmicort) Tobi neb, (28 days on/28 Days off) Glycopyrolate, (2mg) (Robinol) Aspirin, (81 mg) Omeprazole, (20 mg) (Prilosec) Cimetidine, (300 mg) Azithromycin, (250
Allergien: Medication Allergies: REGLAN, Morphine, Droperidol, Intal, Keflex, Erythromycin, Augmentin, Latex FOOD ALLERGIES: Milk, NUTS ENVIRONMENTAL ALLERGIES: Evergreens, Dust, Mold, Dog and Cat dander, Spiders, ?Bugs?
Vorherige Impfungen: -

VAERS 1110152

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

kritisch

Staat: PA
Alter: 60,0
Geschlecht: F
Eingang: 18.03.2021
Impfdatum: 11.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 2,0
Dosis: UNK
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Cardiac arrest Corneal reflex decreased Death Diarrhoea Echocardiogram Endotracheal intubation Life support Nausea Pulse absent Pulseless electrical activity Pupil fixed Resuscitation Unresponsive to stimuli Vomiting

Symptomtext

This is a 60 year old female was brought into emergency department as cardiac arrest. Patient was seen at care now urgent care with the complain of epigastric pain associated with nausea vomiting and intermittent diarrhea. Patient received her initial COVID vaccine 2 days ago. History is obtained from urgent care chart. As per notes patient started nausea vomiting 6 hours post COVID vaccine administration. Patient was seen in urgent care for epigastric pain and nausea vomiting. Patient was found unresponsive at 0902 by tech. No carotid pulses palpated. CPR was started. Patient was brought into the emergency department with Lucas on. Patient was given 5 epinephrine prior to arrival. CPR was in progress. Patient was asystole. Resuscitation was continued in the ED. Patient was intubated in the ED by physician assistant 5 epinephrine 2 bicarb and 1 calcium chloride was given in the ED. Cardiac Ultrasound didn't show any cardiac activity. Asystole on the monitor. No corneal reflex people are fixed and dilated. Patient was pronounced at 1007 am

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cardiac arrest
Hospital-Tage: -
Labordaten: Cardiac Arrest Witnessed by: Healthcare provider Incident location: Urgent care. Time since incident: 35 minutes Time before BLS initiated: 3-5 minutes Time before ALS initiated: 5-8 minutes Condition upon EMS arrival: Unresponsive Pulse: Absent Initial cardiac rhythm per EMS: Asystole Treatments prior to arrival: ACLS protocol and vascular access Medications given prior to ED: Epinephrine
Aktuelle Erkrankungen: Medical History Past Medical History: Diagnosis Date ? Diabetes (HCC) ? Diabetes mellitus (HCC) ? Hypertension ? Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) 12/2/2019 Past Surgical History: Procedure Laterality Date ? CATARACT EXTRACTION ? CESAREAN SECTION ? RETINAL DETACHMENT SURGERY Left 1985 ? TONSILECTOMY, ADENOIDECTOMY, BILATERAL MYRINGOTOMY AND TUBES
Vorgeschichte: Medical History Past Medical History: Diagnosis Date ? Diabetes (HCC) ? Diabetes mellitus (HCC) ? Hypertension ? Type 2 diabetes mellitus without complication, without long-term current use of insulin (HCC) 12/2/2019 Past Surgical History: Procedure Laterality Date ? CATARACT EXTRACTION ? CESAREAN SECTION ? RETINAL DETACHMENT SURGERY Left 1985 ? TONSILECTOMY, ADENOIDECTOMY, BILATERAL MYRINGOTOMY AND TUBES
Andere Medikamente: MEDS Prescriptions Last Dose Informant Patient Reported? Taking? Empagliflozin-metFORMIN HCl (Synjardy) 12.5-500 MG TABS No No Sig: Take 1 tablet by mouth 2 (two) times a day Multiple Vitamins-Minerals (CENTRUM SILVER 50+WOMEN PO) Sel
Allergien: Allergies Ceclor [Cefaclor]Rash Adhesive [Medical Tape]Rash
Vorherige Impfungen: -

VAERS 1108885

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

kritisch

Staat: MN
Alter: 53,0
Geschlecht: F
Eingang: 17.03.2021
Impfdatum: 03.03.2021
Beginn: 14.03.2021
Tage bis Beginn: 11,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Cerebrovascular accident Fall Head injury Hemiparesis Magnetic resonance imaging abnormal Monoplegia Weight bearing difficulty

Symptomtext

12 hours after receiving a shot I woke up from a sleep and when I went to walk her right leg collapsed under her. She hit her head at that point. Her leg remained unable to bear weight and Monday morning we went to the emergency room where they diagnosed her with a stroke. Her right leg is paralyzed and her right side weak.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebrovascular accident
Hospital-Tage: 3,0
Labordaten: Had 2-3 MRI. The results are that she had a stroke . There were no obvious clots etc. Dr. Described it as acute onset paralysis. Blood work ?
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 2713678

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 70,0
Geschlecht: F
Eingang: 14.11.2023
Impfdatum: 17.03.2021
Beginn: 21.12.2021
Tage bis Beginn: 279,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation COVID-19 Cardiac failure congestive Chest X-ray abnormal Lung infiltration SARS-CoV-2 test positive Syncope

Symptomtext

Presented with syncope, CXR with bilat infiltrates, + covid; also CHF and afib; Tx- Vit C, Vit D3, Decadron, lovenox, zinc; O2 @ 2 LPM, then down to room air by dc

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2700724

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 77,0
Geschlecht: M
Eingang: 24.10.2023
Impfdatum: 17.03.2021
Beginn: 26.12.2021
Tage bis Beginn: 284,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Fatigue Flank pain Pneumonia SARS-CoV-2 test positive Syncope Ultrasound Doppler Ultrasound Doppler normal Urine odour abnormal

Symptomtext

Patient presented to the ER with c/o fatigue, flank pain and odorous urine x 5 days. Patient had a syncopal episode witnessed and documented in the ER. Patient found to have pneumonia. Patient experienced multiple syncopal events during admission. Patient was tested for Covid on 12.28.21 and tested positive. Patient received IV abx. Syncope was likely due to Covid-19 infection per Discharge Summary. No evidence of orthostatic htn, carotid ultrasound was unremarkable. Patient was discharged home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2683476

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 90,0
Geschlecht: F
Eingang: 19.09.2023
Impfdatum: 17.03.2021
Beginn: 29.12.2021
Tage bis Beginn: 287,0
Dosis: 2
Route/Site: IM / RA

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Atrial fibrillation C-reactive protein increased COVID-19 pneumonia Chest X-ray abnormal Dyspnoea Fibrin D dimer Haemodialysis Hypotension Pulmonary oedema Serum ferritin increased

Symptomtext

Presented with SOB, afib; dx bilat covid PNA; CXR with pulm edema; D-dimer 2.40; CRP 1.46 Ferritin 179; Tx: Maxipime, decadron, cardizem (afib), singulair, zinc 1/4 pt with poor intake 1/5 pt with continued afib 130's at times, increasing oxygen demand; placed on 100% NRB; pulmonary consult; pt with hypotension during HD; Family decided on comfort care;

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 7,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2680915

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 69,0
Geschlecht: M
Eingang: 11.09.2023
Impfdatum: 06.04.2021
Beginn: 12.02.2022
Tage bis Beginn: 312,0
Dosis: 2
Route/Site: IM / UN

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Arthritis bacterial Aspiration joint abnormal COVID-19 Central venous catheter removal Confusional state Device related infection Dialysis Embolic stroke Endotracheal intubation Fall Intensive care Joint debridement Magnetic resonance imaging head abnormal Pain Positive airway pressure therapy SARS-CoV-2 test positive Shoulder operation Staphylococcal sepsis

Symptomtext

c/o fell out of bed at home, severe pain. Sent to hosp from dialysis center due to pain, +COVID 5 days prior to admit requiring 4L O2 at home. No fractures on xrays. rt shoulder aspirate done (48 ml serosanguineous fluid removed). Steroid injection given. Remdisivir X 3 days and decadron (stopped) given. shoulder aspirate confiremed septic arthritis, going to OR. blood cultures +MRSA. Vanc for 6 weeks following shoulder surgery. MRSA sepsis from femoral dialysis cath. Cath removed. Shoulder Debribement completed. pt becoming more confused. moved to ICU due to confusion and tachypnea. On bipap with FiO2 at 40-50%, became unresponsive, Intubated. Unable to give Toci or Bari. MRI - shows multiple embolic CVA. sever

Weitere VAERSDATA-Felder

Praegender Schweregrund: Embolic stroke
Hospital-Tage: 10,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2675583

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 81,0
Geschlecht: M
Eingang: 23.08.2023
Impfdatum: 06.04.2021
Beginn: 27.01.2022
Tage bis Beginn: 296,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia COVID-19 SARS-CoV-2 test positive Syncope

Symptomtext

Presented after syncopal episode, prior to event had weakness. Covid + tx w/ Dexamethasone, Vit D/C and zinc

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2657059

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WI
Alter: 70,0
Geschlecht: F
Eingang: 17.07.2023
Impfdatum: 11.03.2021
Beginn: 31.12.2021
Tage bis Beginn: 295,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cardiac monitoring Cardiac stress test Chest X-ray Disturbance in attention Dizziness Fatigue Headache Laboratory test Loss of consciousness Magnetic resonance imaging Neurological symptom Syncope

Symptomtext

Fainting, blackouts,( stroke symptom of left eye blackout) , fatigue, dizziness, inability to focus , headaches

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: ER in Dec. 2021 - All tests MRI, chest X-ray, work, heart evaluation etc. etc. ER in Nov 2022 - All 16 emergency tests again, heart, chest brain etc. etc. Dec. 2022 and Jan 2023 - Heart monitor and stress test
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Vit B & D
Allergien: sulfurs and eucalyptus oil
Vorherige Impfungen: -

VAERS 2617630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WI
Alter: 75,0
Geschlecht: M
Eingang: 19.04.2023
Impfdatum: 06.10.2021
Beginn: 01.01.2022
Tage bis Beginn: 87,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Computerised tomogram Diaphragmatic paralysis Dyspnoea Magnetic resonance imaging Surgery X-ray

Symptomtext

See my comment above

Weitere VAERSDATA-Felder

Praegender Schweregrund: Diaphragmatic paralysis
Hospital-Tage: 10,0
Labordaten: X-rays, fluorescent X-ray, CAT scan, MRI, 6 minute walks, and many more from April 2022 thru February 2023. Too many blood tests to list here
Aktuelle Erkrankungen: None
Vorgeschichte: I began struggling with breathing issues in January 2022. April 4, 2022 I complained to by primary care doctor about difficulties breathing. By May 2022 I was diagnosed with a paralyzed diaphragm. October 13,2022 I had first surgery. January 2023 I had a secon open body surgery. I am breathing better but still struggling in recovery
Andere Medikamente: Atorvastatin, Venlafaxine, Ramipril, Clopidogrel, Levothyroxine, and Metformin.
Allergien: Dog dander and Phyzer booster shot(3rd vaccination)
Vorherige Impfungen: -

VAERS 2544790

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En 6207

schwer

Staat: NC
Alter: 52,0
Geschlecht: F
Eingang: 28.12.2022
Impfdatum: 15.03.2021
Beginn: 01.05.2021
Tage bis Beginn: 47,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood blister Blood test normal Burning sensation Chills Confusional state Cyanosis Depression Electric shock sensation Exposure to fungus Feeling abnormal Feeling hot Formication Haemorrhage Heart rate irregular Hypersensitivity Hypoaesthesia Immunisation reaction Neuropathy peripheral

Symptomtext

About a month after the shot I started getting sensitive to every ingredient in personal care products. I developed a moving symmetrical rash all over my body. I would scratch til I bled and was completely miserable. From there, I developed the following, many of which I still have. Brain fog, heartbeat irregular, and pounding at random times. Tingling, pins, and needles all over. Ice pick -bee sting pain all over. bloodshot eyes, uncontrollable shaking with teeth chattering chills-no fever. a wave of heat/burning/feeling of bugs crawling up my spine. I now have Raynauds and Mold toxicity. Right pointer finger turns blue every am for a couple hours. Brain zaps, mental confusion. numbness, and neuropathy. random spots that look like blood blisters popping up in different areas, like neck, hand, arm etc, gi issues, anxiety depression. I did have some anxiety pre-vax. skin crawling and I'm down 30 pounds and can't lose any more weight. Finally found a functional medical dr that diagnosed me with mold and vaccine injury. Something needs to be done. There are MILLIONS of people suffering because of this shot-it's not a vaccine. IT"S A SHOT. A shot that has ruined countless lives. I've had days where I just wished my life would be over because I can't live like this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Dr. has all my records of tests that were done. Oddly enough with all this going on most of my bloodwork looks normal. I still need to see an immunologist to see if there is anything else that can be done.
Aktuelle Erkrankungen: colitis that was manageable
Vorgeschichte: colitis flare maybe once a yr or every 2-3 yrs
Andere Medikamente: klonopin
Allergien: been taking allergy shots for mold dogs and cats and cockroach poop for about 6 years
Vorherige Impfungen: had chills for one night after second dose of shingles vaccine

VAERS 2530361

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NM
Alter: 78,0
Geschlecht: F
Eingang: 13.12.2022
Impfdatum: 11.12.2022
Beginn: 01.01.1900
Tage bis Beginn: -
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest X-ray Computerised tomogram head Computerised tomogram spine Dizziness postural Electrocardiogram Eye contusion Fall Full blood count Influenza virus test Loss of consciousness Metabolic function test Myalgia Myocardial necrosis marker Pyrexia Respiratory syncytial virus test SARS-CoV-2 test Skin laceration Wound closure

Symptomtext

I received my booster on Sunday 12/11/22 at 4:30 PM. During the night of 12/11 I had muscle aches throughout my body. I got up at 7:30 AM on 12/12/22. Muscles no longer ached. Went to the bathroom. When I attempted to stand up I was momentarily very dizzy, apparently blacked out (syncope), fell, and was brought back to consciousness by my husband calling me. EMT arrived and while trying to get me onto a stretcher I had another syncope. I was taken to the emergency room at hospital, where I received the tests indicated below. When I fell I apparently whacked my head, resulting in 3 staples in my scalp and a black eye. I have had a fever varying from 99-101.4 since the shot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: EKG 12-lead, XR chest, comprehensive metabolic panel, cardiac injury panel, complete blood count, CT head-brain, CT cervical spine, SARS cov-2, flu, RSV, laceration repair
Aktuelle Erkrankungen: none
Vorgeschichte: high cholesterol, Gilbert's Sndrome
Andere Medikamente: baby aspirin, fish oil, magnesium glycinate, multivitamin
Allergien: sulfa, shellfish
Vorherige Impfungen: -

VAERS 2466671

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MD
Alter: 64,0
Geschlecht: M
Eingang: 01.10.2022
Impfdatum: 21.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood test normal Computerised tomogram normal Memory impairment Seizure

Symptomtext

Patient had a seizure. He was hospitalized. NOTE: The patient has had two Pfizer shots and two boosters. He continue to have seizures and altered memory.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Various blood tests were performed and a CT scan. The results were negative and the patient was sent home.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Aspirin - 18mg CO Q10 - 100mg Fish Oil - 100mg Vitamin B-12 - 500mg Sildenafil - 100mg
Allergien: None
Vorherige Impfungen: -

VAERS 2284748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 87,0
Geschlecht: M
Eingang: 19.05.2022
Impfdatum: 21.12.2021
Beginn: 07.05.2022
Tage bis Beginn: 137,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood culture Bradycardia Brain natriuretic peptide increased COVID-19 Clostridium test negative Cough Culture urine Diarrhoea Dyspnoea Echocardiogram Emotional distress Gait disturbance Intensive care International normalised ratio increased Positive airway pressure therapy Pyrexia SARS-CoV-2 test positive Tachypnoea

Symptomtext

Hospitalized (05/07/2022-05/18/2022); COVID-19 positive 05/07/2022; fully vaccinated plus booster BRIEF OVERVIEW: Primary Care Physician at Discharge: MD Hematologist/Oncologist: Admission Date: 5/7/2022 Discharge Date: 05/18/2022 Patient's Discharge Disposition: Rehab in stable condition. Hospital course: 87 y/oM with pmHx bacterial endocarditis s/p MVR and ICD placement in 2007, CAD (50% occlusion of LAD), combined systolic and diastolic CHF with most recent EF 40%, multiple myeloma on Revlimid and bortezomib + decadron, afib on coumadin admitted with acute hypoxic respiratory failure and hypotension. Patient currently lives with his daughter. EMS was called after an episode of coughing and vomiting for which he became very dyspneic and distressed. He presented to the ED on NRB, tachypneic, febrile, and bradycardic. Labs confirmed + UA, + COVID-19 PCR, BNP 4,100, INR 3.1. BiPAP was initiated, patient received 2L IVF, blood and urine culture cultures obtained, and he was given a dose of ceftriaxone and azithromycin. Despite IVF he was started on NE and admitted to the ICU. Upon arrival, NE was weaned from .08 down to .02 and he was stable on BiPAP with normal RR. He was started on remdesivir and decadron, abx broadened to vancomycin and zosyn. He was able to wean off BiPAP and NE. Repeat ECHO stable. Patient evaluated by SLP and diet ordered. On 5/8, patient improved and able to transfer out of the ICU. Spoke with oncology service who accepted the patient under Dr. The patient completed a course of abx with Zosyn on 5/12, Remdesivir on 5/11, and a 10 day course of dexamethasone on 5/16. He developed diarrhea during his admission but was c diff neg. He was started on scheduled Imodium and PRN Lomotil. Diarrhea was starting to improve by time of discharge. PT/OT evaluated and recommended SAR. Staff assisted with arranging and the patient was able to discharge to a facility via ambulance. The patient was eating and ambulating with assistance at the time of discharge. Discharge medications and follow up as listed below. Answered all questions and the patient was comfortable with the discharge plan

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Posttraumatic respiratory failure (HCC) Acute hypoxemic respiratory failure due to COVID-19 (HCC) SBE (subacute bacterial endocarditis) CHF (congestive heart failure) Hypotension, unspecified CAD (coronary artery disease) Atrial fibrillation, persistent (HCC) Occlusion of right femoral artery (HCC) Cardiac pacemaker in situ Acute cystitis Macrocytic anemia Multiple myeloma not having achieved remission (HCC) Multiple myeloma (HCC) hx of CVA (cerebral infarction) Dementia without behavioral disturbance, unspecified dementia type (HCC) Obstructive uropathy Urinary retention Hypercholesteremia Severely underweight adult Shock (HCC) S/P MVR (mitral valve replacement) Statin intolerance Closed displaced fracture of fifth cervical vertebra with routine healing, unspecified fracture morphology, subsequent encounter Long term (current) use of anticoagulants History of total hip replacement History of endocarditis Closed rib fracture At risk of decubitus ulcer At risk for falls Scoliosis Traumatic rhabdomyolysis (HCC)
Andere Medikamente: acyclovir (ZOVIRAX) 400 MG tablet benzonatate (TESSALON) 100 MG capsule CALCIUM PO cholecalciferol (VITAMIN D3) 50 MCG (2000 UT) capsule cyanocobalamin 1000 MCG tablet dexamethasone (DECADRON) 4 MG tablet diphenoxylate-atropine (LOMOTIL) 2.
Allergien: Sulfadiazine Heparin Lipitor Statins Sulfa drugs
Vorherige Impfungen: -

VAERS 2277738

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: MO
Alter: 70,0
Geschlecht: F
Eingang: 14.05.2022
Impfdatum: 28.02.2021
Beginn: 01.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest X-ray Chest pain Computerised tomogram thorax Drain placement Dyspnoea Echocardiogram Pericarditis Pulmonary pain Surgery

Symptomtext

After each vaccine I received 2/28/2021, 3/21/2021 and 10/23/2021. I experienced severe chest pain in heart area, lung pain in both lungs and dyspnea. It went away after 2 days so I did not seek medical help. After each vaccine the adverse reaction was worse. After the 10/2022 vaccine I experienced repeated symptoms on and off until the beginning of May, 2022 at which time these symptoms did not go away. The became so severe that I went the the ER feeling like I was having a heart attack. I was given IV morphine, had a CT of the chest, a chest x-ray and multiple echocardiograms. Diagnosis - pericarditis. I had surgery on 5/9/2022 at which time a pigtail drain was inserted. This did not resolve the problem. On 5/13/2022 I had surgical subxiphoid pericardial drainage by a cardio vascular surgeon. I have now been hospitalized from 5/8/2022 through today 5/14/2022. I was told I will continue to stay inpatient for 2-3 may 4 more days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: CT of the Chest, Chest s-ray, multiple echocardiograms. beginning on 5/8/2022 and they continue as of today 5/14/2022
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: sulfa
Vorherige Impfungen: -

VAERS 2260180

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IA
Alter: 69,0
Geschlecht: M
Eingang: 02.05.2022
Impfdatum: 23.03.2021
Beginn: 20.11.2021
Tage bis Beginn: 242,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Alanine aminotransferase increased Alcohol poisoning Aspartate aminotransferase increased Blood alkaline phosphatase increased Blood creatine phosphokinase increased C-reactive protein increased COVID-19 COVID-19 pneumonia Condition aggravated Dyspnoea Hypercapnia Hyperglycaemia Hypertension Hypertransaminasaemia Hyponatraemia Hypoxia Lactic acidosis Left ventricular failure

Symptomtext

COVID Vaccine Breakout Case Pfizer Dose 1 3/2/21 (EN6203) Pfizer Dose 2 3/23/21 (EN6207) COVID Positive 11/20/21 11/20/21: Patient is a 69 year old male who presented to ED via EMS with complaints of shortness of breath. Per chart review EMS was called while the patient was drinking at a bar when he became acutely hypoxic. The patient had 1 episode of emesis and was noted to be hypoxic on room air at 80%. EMS placed the patient on BiPAP and he improved his oxygen saturations to 92%. He has a past medical history significant for atrial fibrillation anticoagulated on Eliquis, CHF, OSA, morbid obesity and hypertension. Patient is intoxicated and a poor historian at this time. He is unaware of all his medications. He does take Eliquis and a water pill but is unsure of dosing. He does not recall the events leading up to EMS being called. He denies daily ETOH use but admits he has been drinking daily for the past several days, a few beers per day. He has been Covid vaccinated. He denies tobacco use and does not report a history of COPD. He denies any recent fevers or body aches. He does endorse shortness of breath at this time. Denies chest pain. On arrival to ED the patient was hypertensive 148/105. Laboratory findings were significant for hyponatremia 128. Transaminitis ALT 222, AST 211 and ALP 124. Lactic acidosis 2.5. ProBNP 1400. CK 292. Hypoxemic/hypercapnic respiratory distress pCO2 62 and PO2 136. ALC 187. C-reactive 2.50. Rapid Covid positive. Patient was started on azithromycin and ceftriaxone in ED. Solu-Medrol 125 mg and DuoNeb treatment given in ED. Lasix 20 mg IV given in ED 11/23/21: Patient is a 69-year-old male with history of diastolic heart failure, atrial fibrillation on Eliquis, OSA, COPD, CPAP use, alcohol abuse, presented to the emergency department from bar after emesis and hypoxia. Diagnosed with COVID-19 pneumonia and possible bacterial pneumonia, treated for alcohol intoxication. Also had diastolic heart failure exacerbation for which he was on Lasix. He became euvolemic. Successfully weaned off oxygen. Had transient hyperglycemia most likely related to steroids use. Otherwise was back to baseline and was stable for discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: HTN a fib OSA cellulitis
Vorgeschichte: HTN a fib OSA cellulitis
Andere Medikamente: acetaminophen 650mg PO Q4h PRN apixaban 5 mg PO BID clonidine 0.1 mg PO BID diltaizem ER 240 mg PO QD fluoxetine 40 mg PO QD lisinopril 40 mg PO QD magnesium oxide 400 mg PO QD metoprolol 100 mg PO BID multivitamin 1 tab PO QD
Allergien: HCTZ - rash
Vorherige Impfungen: -

VAERS 2252198

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 66,0
Geschlecht: M
Eingang: 26.04.2022
Impfdatum: 16.03.2021
Beginn: 05.11.2021
Tage bis Beginn: 234,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram Lumbar puncture Magnetic resonance imaging Seizure

Symptomtext

I had a seizure in the emergency room of hospital November 5, 2021. I had never had a seizure before or since. I was hospitalized for four days and treated for a non-covid 19 virus.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 4,0
Labordaten: CT scan, MRI, and spinal tap. Was treated with IV antibiotics. Nothing conclusive was found
Aktuelle Erkrankungen: None
Vorgeschichte: Nasal allergies Ulcerative colitis Right bundle branch block Bicuspid aortic valve Aortic annurism
Andere Medikamente: Omega 3 ? 756mg EPA, 228mg DHA, 1000 I.U. Vitamin D3 Singulair Azelastine Nasal Spray Lialda Amlodipine Besylate Nasacort Allergy 24 Hour Vitamin C Panax Ginseng Psyllium husk L-Arginine Probiotic
Allergien: Feldene ? Throat ulcers Ketoconazole cream ? Intense rash
Vorherige Impfungen: Swine Flu vaccine 3/1977 - Flu like symptoms for three days Pneumonia vaccine 7/2013 - Flu like symptoms for three days Shingles

VAERS 2228754

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 71,0
Geschlecht: M
Eingang: 12.04.2022
Impfdatum: 18.03.2021
Beginn: 21.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Biopsy skin abnormal Computerised tomogram Dizziness Dysarthria Ear congestion Facial paralysis Magnetic resonance imaging abnormal Mastoid disorder Positron emission tomogram Soft tissue disorder Squamous cell carcinoma of skin

Symptomtext

A few days after the 1st shot, the discharge I have always had in my right ear stopped. The ear felt stuffy. Saw a local ENT doctor on 3/26/21, 4/5/21 and 4/19/21 . Was treated with steroids and had a CAT scan performed. Dr. referred me to hospital. Symptoms worsened from 4/19/21 to 5/10/21, started to slur speech, noticed facial paralysis and slight dizziness. Saw Dr. 5/10/21 and 5/26/21. Treated with steroid ear drops, two MRI scans performed. Abnormal soft tissue thickening detected in right mastoid sinus/ear. Biopsy performed by Dr. 6/3/21. Results are well defined squamous cell carcinoma.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: CAT scan 4/5/21, inconclusive, MRI scan5/26/21 abnormal soft tissue thickening, MRI scan 6/1/21 abnormal soft tissue thickening, Biopsy 6/3/21 squamous cell carcinoma, PET scan 6/17/21
Aktuelle Erkrankungen: Essential Tremors
Vorgeschichte: Loss of hearing right ear. Chronic ear infections in infancy. Mastoidectomy performed in my youth. Chronic ear discharge since youth.
Andere Medikamente: Propranolol ER80mg, Diclofenac Sodium 50mg, Zolpidem 10mg, Multi Vitamins, Vitamin E
Allergien: Sulfa Drugs, Latex
Vorherige Impfungen: -

VAERS 2196395

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 58,0
Geschlecht: F
Eingang: 24.03.2022
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthma Condition aggravated Feeling abnormal Nausea Pyrexia SARS-CoV-2 test negative Somnolence Syncope Vision blurred Vomiting

Symptomtext

The same day, I started running fever about 5:00pm (106) that night, and I fainted. My husband found me and took me to the doctor, not then, but the next day on the 20th. and slept all day and started having asthma and had to use my nebulizer. I did not do anything for the next couple of days. I was with nauseas, throwing one time, Brain fogs, did not see clearly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: COVID Test: Negative.
Aktuelle Erkrankungen: Pneumonia
Vorgeschichte: Asthma
Andere Medikamente: Singulair 10 mg daily; Stelara inhaler one time a day; Vitamin C 1000 mg daily; Vitamin D 50000 once a week.
Allergien: Shellfish; Shrimps; Augment (antibiotic); Sulfa
Vorherige Impfungen: -

VAERS 2184316

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 67,0
Geschlecht: F
Eingang: 17.03.2022
Impfdatum: 15.03.2021
Beginn: 16.10.2021
Tage bis Beginn: 215,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blood culture Chest X-ray Cough Dyspnoea Fall Headache Mobility decreased Oxygen saturation decreased Pneumonia Pulmonary function test Pulmonary thrombosis Respiratory tract congestion SARS-CoV-2 test

Symptomtext

Initially, I thought I had a sinus infection because I had congestion, shortness of breath, a light cough and a headache. After 3-4 days of my condition getting worse and OTC medicine not aiding me, I got up and put on clothes and went to get tested for COVID-19. As I was walking up to the clinic, I fell over outside walking towards the clinic doors. A nurse and gentleman walked over to assist me. They drew blood and found I had blood clots in both lungs and pneumonia in both lungs. They transported me to the Hospital on 10/20/2021 to 11/02/2021 and was discharged. Once I got home, I couldn't make it up the stairs because I still had shortness of breath. The next day, a nurse was sent over and thought I was fine, but I still had shortness of breath. That next night, I struggled breathing and called 911; the EMT came and checked my oxygen concentration and discovered my O2 levels dropped to 77%. They took me to the Hospital from 11/03/2021 to 11/06/2021 and conducted chest x-rays and was transported to a rehabilitation center for 22 days and was discharged. Since then, I'm slightly recovering but still having some shortness of breath periodically and just recently saw a pulmonary specialist who ordered tests to check the condition of my lungs on 03/15/2022.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 13,0
Labordaten: COVID 19 & blood culture: 10/20/2021, chest x-ray: 11/03/2021, breathing test & chest x-ray: 03/15/2022
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rheumatoid Arthritis, Pulmonary Hypertension, Fibromyalgia, Irritable Bowel Syndrome
Andere Medikamente: Magnesium 500mg, Aspirin 80mg, Prevagen, Cetirizine 10mg, Vitamin B12, Vitamin C, Vitamin D3, Vitamin E, Flaxseed, Calcium, Multivitamin Supplement, Ezetimibe 10mg, Olmesartan 20mg, Hydrocodone 200mg, Hydroxyzine 50mg , Gabapentin 800mg, Pr
Allergien: Eggs, Morphine
Vorherige Impfungen: -

VAERS 2086400

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 17,0
Geschlecht: M
Eingang: 24.02.2022
Impfdatum: 24.01.2022
Beginn: 28.01.2022
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Blood test abnormal Chest X-ray Chest pain Chills Delirium Blood test Dyspnoea Bradycardia Capillary nail refill test Chest discomfort Echocardiogram normal Echocardiogram Electrocardiogram Lethargy Myalgia Myocarditis Neuralgia Pain

Symptomtext

17 Y 7 M generally healthy male who presents with acute onset of chest pain/pressure worsening Friday. He received COVID booster on 1/24/22, had intense fevers, myalgias, "nerve pain" all over body the 24-36hours after the booster. He was pretty much recovering by Wednesday and went to school since Thursday. However, on Friday, by 11:30am, he was feeling very tired and out-of-it. He started feeling chest pressure and pain. Denies tingling/numbness/radiation. Currently, he says he feels a little pressure at the chest right above the epigastric area--more like pressure rather than sharp. At one point, he did feel sharp pain but the general sensation of pressure was more bothering. He was seen this afternoon and referred for labs. His troponin came back elevated at 0.4 and so he was directed to the emergency room for further evaluation. In ED: repeat troponin 0.44, bedside echocardiogram showed good LV function and no effusion. Rest of labs reassuring. After discussion with cardiology, patient admitted for further management. on 1/31/22:17 y.o. M with post COVID vaccine-related myocarditis, admitted with intermittent chest pain and elevated troponin, awaiting troponin level <0.5. Overall down-trended from peak troponin of 3.55 but with mild uptrend in troponin to 1.16 from 0.95. Chest pain improved with q8h motrin, now with only intermittent chest pain (at decr level from prior) and no SOB. Plan: Trending troponin q12h until trop <0.5. 1/28 EKG: NSR, RSR' in V1/V2 prob normal variant per Cards. Also on nicotine patch 14mg/24h started 1/29/22 in s/o hx vaping and desire to quit. Dispo plan & recs per Cardiology: Plan for outpt cards f/u appt, no strenuous activities for 30 days after discharge and no competitive sports for 3 months until he can be cleared with a normal treadmill test. Recheck troponin 1 week after discharge. Will need nicotine patch wean - should be on (14 mg/day) for 2 weeks then step down to step 3 (7 mg/day) for 2 weeks. Exam notable for CV: mildly bradycardic rate, normal rhythm, normal S1/S2, no point tenderness of chest on palpation. Cap refill < 2 sec, normal pulse. Pulm: CTAB. Abd: soft, NT, ND.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 3,0
Labordaten: Results for patient as of 2/24/2022 13:58 1/28/2022 16:48 TROPONIN I: 0.40 (H) 1/28/2022 20:40 TROPONIN I: 0.44 (H) 1/29/2022 04:15 TROPONIN I: 0.84 (H) 1/29/2022 16:25 TROPONIN I: 1.75 (H) 1/30/2022 03:40 TROPONIN I: 3.55 (H) 1/30/2022 15:35 TROPONIN I: 0.95 (H) 1/31/2022 03:50 TROPONIN I: 1.16 (H) 1/31/2022 16:30 TROPONIN I: 0.32 (H) 2/7/2022 16:35 TROPONIN I: <0.02
Aktuelle Erkrankungen: -
Vorgeschichte: h/o Vaping
Andere Medikamente: -
Allergien: Sulfur (not Sulfonamides)
Vorherige Impfungen: -

VAERS 1329452

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 68,0
Geschlecht: F
Eingang: 19.02.2022
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Brain natriuretic peptide Fall Full blood count Headache Investigation Fibrin D dimer Malaise Nausea Pain Pulmonary thrombosis Troponin I X-ray

Symptomtext

Didn't feel well; felt achy; nauseated; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A 68 year-old female patient received bnt162b2 (BNT162B2), administered in arm left, administration date 25Mar2021 10:00 (Lot number: EN6207) at the age of 68 years as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (First Dose), administration date: 16Apr2021, for COVID-19 immunization. The following information was reported: MALAISE (non-serious) with onset 25Mar2021, outcome "recovered" (27Mar2021), described as "Didn't feel well"; PAIN (non-serious) with onset 25Mar2021, outcome "recovered" (27Mar2021), described as "felt achy"; NAUSEA (non-serious) with onset 25Mar2021, outcome "recovered" (27Mar2021), described as "nauseated". The events "didn't feel well", "felt achy" and "nauseated" were evaluated at the emergency room visit. Relevant laboratory tests and procedures are available in the appropriate section. Additional information: She received her first dose on 25Mar2021 and for three days after that she didn't feel good. On 26Mar2021 and 27Mar2021 she didn't feel good. She felt achy and nauseated. But since she had COVID in DEC2020 her second dose of the COVID vaccine was the problem like how people's antibodies are already built up and had that reaction so that is why she was fine. She was just fearful of the new variants and wanted to be extra protected against those variants No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210427; Test Name: B-type natriuretic peptide; Result Unstructured Data: Test Result:looks like it lies within normal range; Test Date: 20210427; Test Name: d-timer; Result Unstructured Data: Test Result:1079; Test Date: 20210427; Test Name: Troponin I; Result Unstructured Data: Test Result:less than 0.03; Test Date: 20210427; Test Name: x-ray; Result Unstructured Data: Test Result:unknown
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2122914

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 66,0
Geschlecht: M
Eingang: 18.02.2022
Impfdatum: 25.03.2021
Beginn: 07.01.2022
Tage bis Beginn: 288,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Asthenia Blood creatinine normal Breath sounds abnormal C-reactive protein increased COVID-19 Chest X-ray normal Cognitive disorder Confusional state Dyspnoea Dyspnoea exertional Electrocardiogram abnormal Fall Fibrin D dimer increased Gait inability Laboratory test abnormal Positive airway pressure therapy Procalcitonin Pyrexia

Symptomtext

.Patient was initially presented on 1/9/2022 with a chief complaint of worsening shortness of breath and a fall. Patient was diagnosed to have COVID-19 infection 6 days ago. He was on 90% on home BiPAP upon EMS arrival. Patient also appeared to be more confused and had generalized weakness per MMR. Patient also have a history of chronic respiratory failure and is on 4 L of oxygen at baseline. Patient was started on doxycycline 2 days ago by his PCP. Upon evaluation in the ED, BP 116/76, heart rate 140, febrile at 100.4 and rectal temperature is 103 Fand SpO2 100% on BiPAP. Patient reportedly had respiratory distress with the using accessory muscles and high-pitched wheeze, left side more than right coarse breath sounds bilaterally. Patient was unable to speak in sentences per ED physician. EKG reported sinus tachycardia lab work abnormal for mildly elevated creatinine 1.1, CRP 4.39, procalcitonin 0.23, D-dimer elevated at 1408. Chest x-ray did not report any significant abnormalities. Patient was subsequently admitted for further evaluation and treatment under Hospital Medicine to moderate care with pulmonary service on consult. Patient received IV Bumex for coarse bilateral breath sounds as he received significant amount of IV fluid in the ECC prior to arrival to floor. Patient was placed on HF N/C of 50 L and 30% and BiPAP as needed. Patient is evaluated by Pulmonary service and recommended to continue Remdesivir and Decadron. Patient developed significant shortness of breath when he was moved from the bed to the chair. Patient also have cognitive impairment and confusion could be due to delirium in the setting of COVID-19 infection. Patient subsequently improved with oxygenation and is at baseline oxygen at 4 liter/minute via nasal cannula and a web setting is baseline as well. Pulmonary service recommended patient can be discharged from their point of view on 1/13/22 Per Family request he stayed additional 1/15/22 until able to ambulate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 6,0
Labordaten: COVID 19 positive on 01/07/2022
Aktuelle Erkrankungen: unknown
Vorgeschichte: Diabetes mellitus on long-term insulin Hyperthyroidism History of chronic diastolic failure History of CAD History of asbestos exposure Bipolar disorder 1 Morbidly obese Chronic steroid therapy
Andere Medikamente: albuterol (VENTOLIN HFA) 108 (90 BASE) MCG/ACT HFA inhaler aspirin (HALFPRIN) 81 MG tablet budesonide-formoterol (SYMBICORT) 160-4.5 MCG/ACT inhaler bumetanide (BUMEX) 1 MG tablet busPIRone (BUSPAR) 5 MG tablet calcium-vitamin D (OSCAL
Allergien: Nexium, xanax, omeprazole.
Vorherige Impfungen: -

VAERS 2112793

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WI
Alter: 72,0
Geschlecht: F
Eingang: 15.02.2022
Impfdatum: 10.11.2021
Beginn: 02.02.2022
Tage bis Beginn: 84,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Anticoagulant therapy Asymptomatic COVID-19 Blood sodium decreased COVID-19 Eye injury Eye operation Eye pain Eye swelling Facial bones fracture Fall Hyponatraemia Intraocular pressure test normal Orbital haematoma SARS-CoV-2 test positive Syncope

Symptomtext

Patient states she had a syncopal episode getting out of the shower 01/25/2022. Had a mild prodrome. Fell striking her right eye. Was seen at an outside facility where imaging showed zygomatic fractures. Ocular pressure stable. Also incidentally found COVID positive the same date. Asymptomatic. Is fully vaccinated. Has been following with Ophthalmology. As of this morning had increasing right eye swelling and pain so presented for cares. Imaging here showed retro-orbital hematoma. Warfarin reversed with Kcentra and 10 mg of vitamin K. Seen by Ophthalmology who performed Right lateral canthotomy/cantholysis. Eyedrops prescribed. Patient was also found to be hyponatremic at 123. She has run slightly hypo

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2104795

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 52,0
Geschlecht: F
Eingang: 11.02.2022
Impfdatum: 25.03.2021
Beginn: 15.05.2021
Tage bis Beginn: 51,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Alopecia Antibody test Antinuclear antibody Arthralgia Blood creatine phosphokinase Blood thyroid stimulating hormone C-reactive protein Complement factor Differential white blood cell count Full blood count Laboratory test Rash Respiratory distress Rheumatoid factor Sjogren's syndrome Thyroxine Urine analysis

Symptomtext

Scalp Hair loss, facial rash, large joint pain, respiratory distress

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: -
Labordaten: ALL LABS COMPLETED ON 09/10/2021 Urinalysis 9/10/2021 CBC w diff 9/10/2021 Sed rate 9/10/21 C reactive protein 9/10/21 CBC Ana w reflex tiger Sjogens syndrome A Sjogren's syndrome B Sm/rep antibodies Sm antibody DNA ANTI CRIT IFA REF TITER C3 COMPLEMENT COMPONENT C4 COMPLEMENT COMPONENT CENTROMERE ANTIBODY, EIA SCLERODERMA ANTIBODIES TSH W REFLEX TO FREE T4 RHEUMATOID FACTOR CYCLIC CITRULLINMATED PEPTIDE CREATINE KINASE, TOTAL
Aktuelle Erkrankungen: None
Vorgeschichte: +ANA(autoimmune antibody in serum blood)
Andere Medikamente: Naltrexone, disulfiram , calcium, multivitamin
Allergien: None
Vorherige Impfungen: -

VAERS 2075495

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 73,0
Geschlecht: M
Eingang: 31.01.2022
Impfdatum: 14.04.2021
Beginn: 19.01.2022
Tage bis Beginn: 280,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Anticoagulant therapy Respiratory distress

Symptomtext

Patient admitted for respiratory distress, Patient required up to 4L of nasal cannula. Patient received Lovenox 40 mg daily subQ.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: 11,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: dementia restless leg syndrome rheumatic multiple valve diseases iron deficiency
Andere Medikamente: None listed
Allergien: None
Vorherige Impfungen: -

VAERS 2068578

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 58,0
Geschlecht: M
Eingang: 27.01.2022
Impfdatum: 29.03.2021
Beginn: 20.01.2022
Tage bis Beginn: 297,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cardiovascular evaluation Chest X-ray normal Electrocardiogram SARS-CoV-2 test positive Sinus rhythm Syncope Vaccine breakthrough infection

Symptomtext

Breakthrough COVID at healthcare facility. Pt fully vaccinated and boostered on 10/27/21. Pt admitted to ED on 1/20/22 for syncopal episode. ED workup included sinus rhythm on EKG, significantly positive orthostatic vital signs, normal chest XR, positive COVID test. Pt admitted for cardiac workup.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Covid positive test on 1/20/2022
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, hyperlipidemia, GERD, neuropathy
Andere Medikamente: -
Allergien: No Known allergies
Vorherige Impfungen: -

VAERS 2058258

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 29,0
Geschlecht: F
Eingang: 24.01.2022
Impfdatum: 19.02.2021
Beginn: 19.02.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chills Dysstasia Fatigue Feeling abnormal Gait disturbance Headache Hyperhidrosis Hypoaesthesia Menstruation delayed Menstruation irregular Migraine Muscular weakness Nausea Paraesthesia Pyrexia Thrombosis Weight bearing difficulty

Symptomtext

After the 1st & 2nd dose within 10-15 minutes of it being administered I had sweats, chills, fever, nausea, tiredness, headache, tingling in my body, muscle weakness and extreme fatigue. I felt like I had got hit by a bus for over a week. After an hour I could barely bare weight and stand up. Walking was very hard. I still have numbness and tingling in my legs from the waist down. I have headaches that hav gradually turned into everyday ones and migraines. I have had delayed menstrual cycle and inconsistent periods. Some of which have small blood clots.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: before vaccine- No. after vaccine - Yes.
Andere Medikamente: -
Allergien: Shellfish, seasonal allergies
Vorherige Impfungen: -

VAERS 2052239

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: UT
Alter: 82,0
Geschlecht: M
Eingang: 20.01.2022
Impfdatum: 30.01.2021
Beginn: 11.12.2021
Tage bis Beginn: 315,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blindness Cerebellar stroke Cerebral thrombosis Colectomy Haemorrhagic disorder Intestinal ischaemia Laboratory test Stoma creation Thrombosis

Symptomtext

Hemorrhagic (blood clot) related brain stroke resulting in permanent loss of vision. Then patient experienced blood clots in intestines resulting in ischemic colon which had to be removed with stoma put in its place.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebellar stroke
Hospital-Tage: 21,0
Labordaten: Many tests were done but you'll have to ask the doctor for that information.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: Rosuvastin, Furosemide, Sertraline, Doxazosin, Omeprazole, Diltiazen, Donepezil, Ferrous Sulfate, Lovenox
Allergien: -
Vorherige Impfungen: -

VAERS 2043178

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 46,0
Geschlecht: F
Eingang: 18.01.2022
Impfdatum: 01.03.2021
Beginn: 21.04.2021
Tage bis Beginn: 51,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Antinuclear antibody increased Arteriogram carotid normal Blood pressure increased Cardiac monitoring Computerised tomogram head normal Double stranded DNA antibody positive Electrocardiogram ST segment depression Electrocardiogram normal Facial paralysis Facial paresis Fatigue Hypertension Laboratory test normal Neurological symptom Palpitations Stress echocardiogram abnormal Supraventricular tachycardia Tachycardia

Symptomtext

The patient was found to have an elevated ANA as well as double stranded DNA on her recent testing. 11.4.21 Patient present to ED on 4.27.21-for TIA symptoms of left sided facial weakness with drooping, elevated blood pressure 181/91, fatigue & tachycardia 119. Facial drooping-resolved-possible neurological side effect from vaccine

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: 2,0
Labordaten: Ongoing palpitations requiring cardiac follow up as well as a Zio patch monitor, labs & Stress echocardiogram In the emergency room the patient presented hypertensive at 181/91 and tachycardic at 119. Stroke work-up was initiated, laboratory studies and EKG were unremarkable. CT of head and CTA of head and neck were done and were also unremarkable. 4.24.21. The patient was found to have an elevated ANA as well as double stranded DNA on her recent testing. 11.4.21 Stress echo-SVT's & ST depression
Aktuelle Erkrankungen: -
Vorgeschichte: Asthma Chronic pain syndrome-Degeneration of intervertebral disc of lumbar region Anxiety
Andere Medikamente: albuterol sulfate Claritin Mobic Flexeril
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1370653

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 17,0
Geschlecht: F
Eingang: 13.01.2022
Impfdatum: 01.04.2021
Beginn: 04.04.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Angioedema Blood test Urticaria Arthralgia C-reactive protein increased Full blood count Histamine level Hypersensitivity Investigation Pyrexia Serum sickness Tryptase

Symptomtext

Anaphylaxis. Angioedema, hives

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Blood work
Aktuelle Erkrankungen: No
Vorgeschichte: Ulcerative colitis 22q.2
Andere Medikamente: Synthroid Vyvanse Prozac
Allergien: No
Vorherige Impfungen: -

VAERS 2026965

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PR
Alter: 63,0
Geschlecht: M
Eingang: 12.01.2022
Impfdatum: 13.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / -

Tod: ja Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain Anxiety Blood cholesterol Blood glucose Blood pressure measurement Cardiac failure Fall Hepatic pain Hepatomegaly Hyperhidrosis Hypertension Insomnia Seizure Tremor

Symptomtext

the cause of death was heart failure with no previous history of heart diseases; convulsed/seizures; however, at night he fell; Tremors/ trembling; excessive sweating; high blood pressure; anxiety; insomnia; pain in the liver; pain at the right side of the abdomen/pain in his right side of the belly; hepatomegaly; This is a spontaneous report received from a contactable reporter (nurse) from medical information team. A 63-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), administration date 13Mar2021 13:20 (Lot number: EN6207, Expiration Date: 21Jul2021) at the age of 63 years as dose 1, single for COVID-19 immunisation. Relevant medical history included: "controlled hypertension" (unspecified if ongoing), notes: He never had high pressure; "Liver Colitis" (unspecified if ongoing). The patient has a very nice diet. He had it from like 10 years ago. The patient took concomitant medications for hypertension which were not specified. The patient had no prior vaccinations within 4 weeks. The following information was reported: CARDIAC FAILURE (death, medically significant) with onset 16Mar2021, outcome "fatal", described as "the cause of death was heart failure with no previous history of heart diseases"; SEIZURE (medically significant) with onset 15Mar2021, outcome "unknown", described as "convulsed/seizures"; TREMOR (non-serious) with onset 13Mar2021, outcome "unknown", described as "Tremors/trembling."; HYPERHIDROSIS (non-serious) with onset 13Mar2021, outcome "unknown", described as "excessive sweating"; HYPERTENSION (non-serious) with onset 13Mar2021, outcome "unknown", described as "high blood pressure"; ANXIETY (non-serious) with onset 13Mar2021, outcome "unknown", described as "anxiety"; INSOMNIA (non-serious) with onset 13Mar2021, outcome "unknown", described as "insomnia"; HEPATIC PAIN (non-serious) with onset 13Mar2021, outcome "unknown", described as "pain in the liver"; ABDOMINAL PAIN (non-serious) with onset 13Mar2021, outcome "unknown", described as "pain at the right side of the abdomen/pain in his right side of the belly"; HEPATOMEGALY (non-serious) with onset 13Mar2021, outcome "unknown", described as "hepatomegaly"; FALL (non-serious) with onset 15Mar2021, outcome "unknown", described as "however, at night he fell". The patient underwent the following laboratory tests and procedures: blood pressure measurement: (13Mar2021) high; blood cholesterol: (unspecified date) fine; blood glucose: (unspecified date) fine. The patient date of death was 16Mar2021. The reported cause of death was cardiac failure. No autopsy was performed. Clinical course details: The reporter stated that her father (patient) received the first dose of the Pfizer vaccine on 13Mar2021 at 1:20 p.m. On 16Mar2021, her father died. She mentioned that after her father received the vaccine, he started with the following signs and symptoms: Tremors or trembling (all of his body was trembling), excessive sweating, high blood pressure, anxiety, insomnia, pain in the liver and right side of the abdomen, pain in his right side of the belly and hepatomegaly. All of this on the same day he received the vaccine (13Mar2021). Then on 14Mar2021, his father was calmer, but he still had the symptoms, as well as insomnia. On 15Mar2021, his father woke up, however, at night he fell, convulsed, had seizures and later died in the early morning of 16Mar2021. She also mentioned that her father had no previous history of heart diseases, and that everything happened after receiving the vaccine. In the death certificate, the cause of death was heart failure with no previous history of heart diseases. Autopsy performed or not: Reporter stated, the death certificate said that he had no autopsy made but didn't know how (further clarifications unknown). Causality: Reporter stated, Yes, totally. right after the first dose, it was only 2 days after and patient did not have any heart conditions. He also had, his cholesterol very fine and glucose, everything he was just fine. He never had high pressure and he didn't have arrhythmia.; Sender's Comments: Based on the currently available information and temporal relation the possibility of causal association between the event cardiac failure seizure and the suspect drug BNT162B2 cannot be ruled out. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, RA, as appropriate.; Reported Cause(s) of Death: the cause of death was heart failure with no previous history of heart diseases

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Name: cholesterol; Result Unstructured Data: Test Result:fine; Test Name: glucose; Result Unstructured Data: Test Result:fine; Test Date: 20210313; Test Name: blood pressure; Result Unstructured Data: Test Result:high
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Controlled hypertension (He never had high pressure); Hepatic disease
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 2009858

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 55,0
Geschlecht: M
Eingang: 05.01.2022
Impfdatum: -
Beginn: 17.03.2021
Tage bis Beginn: -
Dosis: UNK
Route/Site: SC / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Facial paralysis Headache Hemiplegic migraine Pupils unequal

Symptomtext

hemiplegic migraine. one hour after receiving my first Pfizer covid-19 vaccine, I developed severe left hemicranium and left facial droop and odd sized pupil

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: cetirizine
Allergien: none
Vorherige Impfungen: -

VAERS 1984642

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OK
Alter: 49,0
Geschlecht: F
Eingang: 28.12.2021
Impfdatum: 11.04.2021
Beginn: 16.04.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Angiogram abnormal Atrioventricular block Blood test normal Cardiac monitoring normal Cardiac stress test abnormal Dyspnoea Electrocardiogram normal Fatigue Heart rate increased Myocarditis Scan normal Stent placement

Symptomtext

FATIGUE, SHORTNESS OF BREATH, DIFFICULT BREATHING, MYCOCARDITIS, RAPID HEART RATE , STARTED 5 DAYS POST VACCINATION, SEVERE FATIGUE AND CONTINUE FOR 3 MOS BLOOD WORK, EKG, HEART SCANS, WORE HEART MONITOR, NORMAL UNTIL STRESS TEST PERFORMED IN JUNE. NO PRIOR HX OF DM, HYPERTENSION, OR HEART ISSUES UNITL AFTER 2ND VACCINE. HAD EMERGENCY ANGIOGRAM AND STENT PLACED DUE TO BLOCKAGE AN D CARDIAC REHAB WAS ORDERED . NEVER TOOK OR NEEDED ROUTINE MEDS PRIOR TO 06/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: LAB WORK PERFORMED 06/2021 EKG 6/2021 AND LAB WORK CARDIAC LAB WORK 07/2021 STRESS TEST 07/22 ANGIOGRAM AND STENT 07/26/21
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: PERCOCET
Vorherige Impfungen: -

VAERS 1984129

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 38,0
Geschlecht: F
Eingang: 28.12.2021
Impfdatum: 21.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Computerised tomogram thorax Electrocardiogram Full blood count Lipids Metabolic function test Thrombosis Thyroid function test Troponin Vitamin D

Symptomtext

Blood clot; Blood clot in my leg; Blood clot in my right leg; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient. A 39 year-old female patient received bnt162b2 (BNT162B2, Pfizer Covid 19 vaccine), administered in arm right, administration date 21Mar2021 (Lot number: EN6207) at the age of 38 years as dose 2, single for covid-19 immunisation. Not any prior vaccination (within 4 weeks). Family history included: "Factor V blood clotting disorder" (ongoing), notes: I have a family history of blood clotting disorder called Factor V. The patient's concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose, LOT# for the first shot: EN6200, Anatomical location: Left arm), administration date: 28Feb2021, when the patient was 38 years old, for COVID-19 Immunization. The following information was reported: THROMBOSIS (medically significant) with onset 2021, outcome "unknown", described as "Blood clot; Blood clot in my leg; Blood clot in my right leg". The patient underwent the following laboratory tests and procedures: blood test: blood clot, notes: I was diagnosed with a blood clot, it was just diagnosed that I had a blood clot in my leg; computerised tomogram thorax (CT of chest): unknown results; electrocardiogram (EKG): unknown results; full blood count (CBC): unknown results; lipids: unknown results; metabolic function test (CMP): unknown results; thyroid function test: unknown results; troponin: unknown results; vitamin D: unknown results. Therapeutic measures were taken as a result of thrombosis: Xarelto.Consumer (nurse) stated, "I am calling because I have like 2 things. I did get the Pfizer Covid vaccination and I got my first one in Feb2021 and my second one in Mar2021 and I was diagnosed with a blood clot and I just wanted to see if that is something I should report to you all, with it being that far like is it even like a risk. Also, I do have Factor V blood clotting disorder (history) as well and I was told it was okay to still get the shot and I did and I was having somethings going on (not clarified) and then it was just diagnosed that I had a blood clot in my leg. I have been put on Xarelto for the blood clot, for the next week pretty high dose (not clarified further) and then I will be on twice a day. So, I am trying to find out like I was given a free card and that helped me to get my first medicine, my insurance from the doctor just filled it for Jan like it is going to be like expensive and I just can't afford that. So, that was kind of two things I had, I would like to know if I should report that to you all that I do have a blood clot and I did get after I had the Covid vaccine and about the medication, the cost." Consumer further stated, "I had the first one in 28Feb2021 and the second one in Mar2021. The medicine that I was just put on, for the blood clot is Xarelto." When paraphrased the concern, consumer stated, "I want to report, I didn't know if I should report that to you all because I don't know, I just didn't know if there is something like, so many people say that like blood clots are risk with the virus or vaccine. So, I didn't know if I should report that to you or not." Consumer stated, "So, this happened, like some swelling for a couple of months but 2 weeks ago, I started having swelling in my right calf and I was diagnosed on Thursday, the 9th of this month, with a blood clot in my right leg." (not clarified further). Causality: Consumer stated, "No, I don't feel like, I just felt like I needed to report, I do have and you can note this too, I have Factor V, I have a family history of blood clotting disorder called Factor V (history). I did talk with my doctor before getting the shot and I was told that it was still recommended to go ahead and get the vaccination. So, I did the vaccination and then now, here I am diagnosed with the blood clot. So, I just wanted to make some type because I did not know and I just wanted to make some type of a report with you all or just talk to somebody about it and to let you all know that it has not been quite a year since I got the shot and I have never had any symptoms of blood clot before this and now here I am, I have a blood clot. So, I am a little reserved to get another third shot right now. So, that is why I wanted to call and just report it and see if this is something that other people has reported within a year of getting the shot because it is scary and they are not knowing, so that's why." (consumer was not sure, hence causality tab left unchecked). Other medications: Consumer stated "Now, I have been placed on Xarelto and I am taking two 5 mg tablet in the morning and two 5 mg tablets in evening. So, I am doing like a total 20 mg a day for 7 days and then I am going to go on 5 mg in the morning and 5 mg at the night after the week of taking it like this."; Sender's Comments: Based on the information currently available, a possible contribution of the suspect drug administration BNT162B2 to the reported event thrombosis cannot be totally excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Name: Blood test; Result Unstructured Data: Test Result:blood clot; Comments: I was diagnosed with a blood clot, it was just diagnosed that I had a blood clot in my leg; Test Name: CT of my chest; Result Unstructured Data: Test Result:Unknown results; Test Name: EKG; Result Unstructured Data: Test Result:Unknown results; Test Name: CBC; Result Unstructured Data: Test Result:Unknown results; Test Name: lipid; Result Unstructured Data: Test Result:Unknown results; Test Name: CMP; Result Unstructured Data: Test Result:Unknown results; Test Name: thyroid; Result Unstructured Data: Test Result:Unknown results; Test Name: troponin test; Result Unstructured Data: Test Result:Unknown results; Test Name: Vitamin D; Result Unstructured Data: Test Result:Unknown results
Aktuelle Erkrankungen: Factor V deficiency (I have a family history of blood clotting disorder called Factor V)
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1974826

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: MO
Alter: 83,0
Geschlecht: M
Eingang: 23.12.2021
Impfdatum: 15.03.2021
Beginn: 16.12.2021
Tage bis Beginn: 276,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Intensive care Kidney infection Pyrexia Renal disorder SARS-CoV-2 test positive

Symptomtext

fully vaccinated on 3/15/2021. admitted to hospital with kidney infection. Tested (+) COVID 12/16/2021. Only symptom was a fever > 100.4. Wife reported hospitalized due to kidney issues. Remains in ICU as of 12/23/2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 16,0
Labordaten: -
Aktuelle Erkrankungen: unknown
Vorgeschichte: chronic kidney condition, COPD
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 1971973

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 51,0
Geschlecht: M
Eingang: 22.12.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Diplopia Hypertension VIth nerve paralysis

Symptomtext

Cranial Nerve VI Palsy affecting left eye causing diplopia. I also had extreme hypertension.

Weitere VAERSDATA-Felder

Praegender Schweregrund: VIth nerve paralysis
Hospital-Tage: -
Labordaten: Went to Hospital- Emergency room per an Eye Center and PCP. Records can be obtained from another Dr.
Aktuelle Erkrankungen: None known.
Vorgeschichte: Type 2 Diabetes and Hypertension.
Andere Medikamente: Glipizide 5 24 hour tablet , Atorovastin10, Losartan-Hydrochlorothiazide 100-12.5 , Trazadone 50
Allergien: None known
Vorherige Impfungen: -

VAERS 1943791

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 78,0
Geschlecht: M
Eingang: 13.12.2021
Impfdatum: 15.03.2021
Beginn: 02.12.2021
Tage bis Beginn: 262,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Blood pressure orthostatic normal COVID-19 COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram head abnormal Computerised tomogram spine Condition aggravated Dizziness Echocardiogram normal Fall Head injury Hypophagia Musculoskeletal chest pain Nausea Respiratory failure SARS-CoV-2 test positive Skin laceration

Symptomtext

Hospitalized 12/2/2021; COVID-19 positive 12/2/2021; fully vaccinated BRIEF OVERVIEW: Discharge Provider: * Primary Care Provider: MD Admission Date: 12/2/2021 Discharge Date: Dec 8, 2021 DETAILS OF HOSPITAL STAY: PRESENTING PROBLEM: SAH (subarachnoid hemorrhage) [I60.9] Generalized weakness [R53.1] Syncope, unspecified syncope type [R55] COVID-19 [U07.1] Pneumonia due to COVID-19 virus [U07.1, J12.82] HOSPITAL COURSE: Patient is a 79-year-old male, presents to the hospital on 12/2 after he fell at home, syncope. Patient apparently was feeling weak on Thanksgiving Day and was walking to his bathroom and fell backwards hitting his head on the bathtub. Patient had been diagnosed with COVID-19 on the day prior to fall, he started to feel lightheaded, dizzy and nauseated after urinating and then proceeded to fall. Patient had his laceration on the scalp on the left side stapled with 4 staples (which have to be removed in about a week post discharge through PCP office.) Chest x-ray showed COVID pneumonia CT C-spine without any acute pathology but CT head questioned a possible subarachnoid hemorrhage. Trauma felt that he did not needed official consultation. Syncope: This is felt to be related to his poor oral intake secondary to his struggles with ongoing COVID infection. Orthostatics were negative. Echocardiogram was unremarkable. Bilateral carotid ultrasound were also normal. Patient tolerated out of bed activity, PT/OT recommending home with physical therapy. Subarachnoid hemorrhage: This was suspected on initial CT however not seen and repeat CT. COVID-19 pneumonia: Associated with hypoxic respiratory failure. Patient was previously vaccinated. Patient will finish 10 day course of dexamethasone. He was arranged with home oxygen at the time of discharge. Patient did complain of left-sided rib pain, however her rib view chest x-ray was negative for any rib fracture. Lidocaine provided some relief. Recommended him to follow-up with PCP in 1 week to have the staples removed and also discuss further need of oxygen. Because syncope was felt to be related to generalized weakness, poor oral intake driving restriction was felt not to be needed. More over patient had negative orthostatics while at hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 6,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Generalized weakness Scalp laceration
Andere Medikamente: amLODIPine (NORVASC) 5 MG tablet cetirizine (ZYRTEC) 10 MG tablet dexamethasone (DECADRON) 6 MG tablet lidocaine (LIDODERM) 5 % patch losartan (COZAAR) 50 MG tablet Multiple Vitamins-Minerals (CERTAVITE SENIOR/ANTIOXIDANT) tablet raNITIdine
Allergien: NKA
Vorherige Impfungen: -

VAERS 1929477

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: MO
Alter: 75,0
Geschlecht: M
Eingang: 07.12.2021
Impfdatum: 01.05.2021
Beginn: 15.11.2021
Tage bis Beginn: 198,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Intensive care

Symptomtext

Admitted to the hospital on 11/15/2021. Still in ICU as of 12/02/2021. Attempted to call family phone # 3x on different days and no answer.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: unknown
Vorherige Impfungen: -

VAERS 2564245

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 51,0
Geschlecht: M
Eingang: 03.12.2021
Impfdatum: 23.03.2021
Beginn: 20.07.2021
Tage bis Beginn: 119,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Ageusia Anosmia Asthenia Audiogram abnormal Back pain Blood glucose increased COVID-19 Chest X-ray abnormal Chills Cough Deafness Diarrhoea Dizziness Dyspnoea Fatigue Headache Inner ear disorder Intensive care

Symptomtext

Narrative: COVID infections following completion of COVID vaccine series 03/05/21 COVID vaccine dose #1 03/29/21 COVID vaccine dose #2 06/22/21 Pt reports inner ear problemx12 days that has made him very sick from vertigo 06/25/21 Pt states ear problem was treated with steroids by allergy doctor; reports dizziness, but slowly getting better and is worse with head movement; unable to hear from right ear, still has nausea on and off, no fever, speech or swallow problems, or focal weakness, c/o worsening tinnitus associated with blurred vision, and headache 07/20/21 Pt presents to ED with elevated glucose and reports n/v/d x4 days, cough, congestion, weakness, back pain and body aches, chills, fatigue, fever, headache, dyspnea; COVID POSITIVE; admitted to ICU 07/22/21 Pt transferred to stepdown 07/23/21 Pt medically stable and is discharged with rx for zinc, ondansetron, dextromethorphan/guaifenesin, ascorbic acid, albuterol, acetaminophen 07/24/21 Pt reports doing very well with very mild respiratory symptoms and fatigue, no fever 07/25/21 Pt reports headache, cough, and loss of taste or smell 07/27/21 Pt reports no symptoms and no fever for past 7 days since ER visit

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: 06/25/21 COVID NEGATIVE 07/06/21 Audiogram show an asymmetrical hearing loss 07/20/21 COVID POSITIVE; VARIANT SEQUENCING PENDING 07/20/21 Chest, single view: Hyperlucent upper lobes, suggesting underlying emphysema. No radiographic evidence of acute cardiopulmonary disease. 07/21/21 CT Chest: patchy parenchymal ground glass airspace opacities indicative of bilateral pneumonia including viral infection
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1912847

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 72,0
Geschlecht: F
Eingang: 01.12.2021
Impfdatum: 17.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 15,0
Dosis: 2
Route/Site: IM / AR

Tod: ja Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: unbekannt Erholt: nein

Blood glucose fluctuation Cardiac disorder Heart rate irregular Malignant melanoma Myocarditis Sepsis

Symptomtext

After the 2nd vaccine, patient was diagnosed with a rare malanoma in her vagina. Started treatment for cancer. Got booster on 9/18/2021 (Pfizer, Lot # FF2588). Hospitalized with heart problem , eratic heartbeat. Fluxuating suger number. Diagnosed with mayocarditis. and septis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes, Beast Cancer Survivor- Double Mastectomy, Hystorectomy
Andere Medikamente: Glargine 100 unit, Insulin Lispro, Cardizim, Prognozone, Lasix, Cardizium, Eliquis, Fish Oil, Vitamin D3, Cholecaleiferol, Prvachol, Tricor, Flexpin injection
Allergien: -
Vorherige Impfungen: -

VAERS 1241703

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MN
Alter: 93,0
Geschlecht: M
Eingang: 01.12.2021
Impfdatum: 08.03.2021
Beginn: 29.11.2021
Tage bis Beginn: 266,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angiogram pulmonary Blood test Computerised tomogram Jugular vein thrombosis Subclavian vein thrombosis Cough Rhinorrhoea Peripheral swelling Ultrasound scan abnormal Ultrasound scan normal Ultrasound scan

Symptomtext

runny nose and cough starting 11/28/2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Jugular vein thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: Paroxysmal atrial fibrillation/flutter. S/P pacemaker placement. Congestive heart failure. Hypertension. BPH. Intussusception at age 2.
Andere Medikamente: Eliquis 5 MG Tablet 1 tablet Oral two times a day Amiodarone HCl 200 MG Tablet 1 tablet Orally once a day Hydrochlorothiazide 25 mg Tablet 1 tablet in the morning for swelling Orally Once a day Metoprolol Tartrate 25 mg Tablet 1 ta
Allergien: ACE INHIBITOR DRUGS: cough - Side Effects
Vorherige Impfungen: -

VAERS 1890113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 41,0
Geschlecht: F
Eingang: 22.11.2021
Impfdatum: 11.11.2021
Beginn: 18.11.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Blood test Computerised tomogram Painful respiration Pulmonary thrombosis Thrombosis Ultrasound Doppler normal X-ray

Symptomtext

A week after the booster, I experienced severe pain when breathing. I went to the ER the next day and was diagnosed with multiple blood clots in my lungs (a subsequent doppler of my legs showed no clots there). They immediately started blood thinners. I was admitted to the hospital and stayed one night.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 1,0
Labordaten: multiple blood panels, x-ray, CT scan, doppler
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: oral birth control, zoloft, calcium, vitamin d, prenatals
Allergien: n/a
Vorherige Impfungen: -

VAERS 1484015

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 57,0
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: 22.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Antinuclear antibody positive Arthralgia Asthenia Back pain Bordetella test negative Distractibility Dysgeusia Dyspnoea Electric shock sensation Epstein-Barr virus antibody positive Pruritus Epstein-Barr virus test negative Facial discomfort Feeling abnormal Feeling hot Headache Hypertension Hypoacusis

Symptomtext

Itching; An "electrical whooshing feeling" down through my whole body; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6207), intramuscular, administered in left arm on 22Mar2021 10:15 (at the age of 57 years old) as dose 1, single for COVID-19 immunization. Medical history included urinary tract infection (UTI). The patient is not pregnant at the time of vaccination and has not had COVID prior to vaccination. The patient has no known allergies. Concomitant medications included aciclovir sodium (ACYCLOVIR); nitrofurantoin (NITROFURANTOIN MONO/MAC) for urinary tract infection (UTI); fish oil; st john's wort; and curcuma longa root (TURMERIC CURCUMIN). No other vaccines were given in four weeks. On 22Mar2021 11:15, the patient experienced an "electrical whooshing feeling" down through her whole body, followed by itching. No difficulty breathing. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Unspecified treatment was given in response to the events. The outcome of the events was not recovered. The events were assessed as serious (Disability or permanent damage). The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in left arm on 12Apr2021 10:00 as dose 2, single.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: UTI
Andere Medikamente: ACYCLOVIR [ACICLOVIR SODIUM]; NITROFURANTOIN MONO/MAC; FISH OIL; ST JOHN'S WORT; TURMERIC CURCUMIN
Allergien: -
Vorherige Impfungen: -

VAERS 1484015

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 57,0
Geschlecht: F
Eingang: 19.11.2021
Impfdatum: 22.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Antinuclear antibody positive Arthralgia Asthenia Back pain Bordetella test negative Distractibility Dysgeusia Dyspnoea Electric shock sensation Epstein-Barr virus antibody positive Pruritus Epstein-Barr virus test negative Facial discomfort Feeling abnormal Feeling hot Headache Hypertension Hypoacusis

Symptomtext

Itching; An "electrical whooshing feeling" down through my whole body; This is a spontaneous report from a contactable consumer. A 57-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN6207), intramuscular, administered in left arm on 22Mar2021 10:15 (at the age of 57 years old) as dose 1, single for COVID-19 immunization. Medical history included urinary tract infection (UTI). The patient is not pregnant at the time of vaccination and has not had COVID prior to vaccination. The patient has no known allergies. Concomitant medications included aciclovir sodium (ACYCLOVIR); nitrofurantoin (NITROFURANTOIN MONO/MAC) for urinary tract infection (UTI); fish oil; st john's wort; and curcuma longa root (TURMERIC CURCUMIN). No other vaccines were given in four weeks. On 22Mar2021 11:15, the patient experienced an "electrical whooshing feeling" down through her whole body, followed by itching. No difficulty breathing. The events resulted in Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care, Disability or permanent damage. Unspecified treatment was given in response to the events. The outcome of the events was not recovered. The events were assessed as serious (Disability or permanent damage). The patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) intramuscular, administered in left arm on 12Apr2021 10:00 as dose 2, single.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: UTI
Andere Medikamente: ACYCLOVIR [ACICLOVIR SODIUM]; NITROFURANTOIN MONO/MAC; FISH OIL; ST JOHN'S WORT; TURMERIC CURCUMIN
Allergien: -
Vorherige Impfungen: -

VAERS 1869612

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: UT
Alter: 72,0
Geschlecht: F
Eingang: 15.11.2021
Impfdatum: 29.09.2021
Beginn: 30.10.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Asthenia Bronchitis Chest discomfort Cough Electric shock sensation Headache Pyrexia SARS-CoV-2 test

Symptomtext

Within 24 hours of having the Booster I became bedridden with a fever, headache, and electrical shocks running from my cranium all the way down to my fingers and toes. After a few days the fever and shocks subsided, but i got a terrible cough was weak. I treated with OTC DayQuil for several days and finally on Oct 18 called my family Dr. near closing time. She told me I should go to Urgent care. I did so and saw a PA-C. I told him I had not felt well since taking the covid booster and now had a painful cough. They did a covid test which was negative and did an X-ray it was determined that I had bronchitis and was Rx'd augmentin and a strong cough medicine. that helped the bronchitis, but I still suffer from weak spells and electrical shocks which leave me weak. It interferes with my ADL and I still don't feel normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Chest x-ray and covid test October 18,2021
Aktuelle Erkrankungen: none
Vorgeschichte: migraine headaches
Andere Medikamente: verapamil, magnesium, multi vitiamin,
Allergien: codeine
Vorherige Impfungen: -

VAERS 1837382

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 74,0
Geschlecht: M
Eingang: 02.11.2021
Impfdatum: 29.04.2021
Beginn: 27.10.2021
Tage bis Beginn: 181,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood lactate dehydrogenase increased C-reactive protein increased COVID-19 pneumonia Chest X-ray abnormal Computerised tomogram thorax abnormal Condition aggravated Cough Diarrhoea Dyspnoea Fatigue Fibrin D dimer normal Intensive care Lung infiltration Myalgia Pyrexia

Symptomtext

presents to ED on 11/1/2021 with 6 days of fevers, cough, myalgias, fatigue, worsening dyspnea and diarrhea. Unclear exposure but has been spending time with his spouse and adult daughter. Vaccinated in April 2021. He noticed today that his cough and dyspnea were getting worse and his spouse insisted he come to the hospital. Patient admitted to ICU for increased O2 requirements, is still admitted at the time of this entry.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 2,0
Labordaten: In the ED on 11/1/2021 vitals were notable saturations of 80s on RA at rest but O2 requirements escalated quickly and he is now on ~10L. Labs were significant for CRP~22, LDH 334, d-dimer wnl. Chest x-ray (extensive bilateral infiltrates consistent with COVID pneumonia), CT scan (negative for PE)
Aktuelle Erkrankungen: unknown
Vorgeschichte: prostate cancer (remission), radiation enteritis recurrent diarrhea (secondary to previous) asthma, mild intermittent alcohol abuse
Andere Medikamente: unknown
Allergien: NKA
Vorherige Impfungen: -

VAERS 1833135

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 39,0
Geschlecht: F
Eingang: 01.11.2021
Impfdatum: 19.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 4,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Anticoagulant therapy Blood test Pulmonary thrombosis Thrombosis Ultrasound Doppler abnormal X-ray

Symptomtext

Blood clots (2 in left leg, and 2 in each lung). Now on Warfrin 5mg daily.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary thrombosis
Hospital-Tage: 10,0
Labordaten: Blood work, X ray, Ultrasound
Aktuelle Erkrankungen: None
Vorgeschichte: Depression, Fibromyalgia, Osteoarthritis
Andere Medikamente: Gabaentin 400mg 3x daily, Carbamazepine 200ml 3x daily, Effexor extended release 150 ml nightly, Xanax 1mg 4x daily, Ambien 15mg nightly, Metoprolol extended release 150 mg 2x daily, Duloxetine 50 mg 2x daily, Bacoflen/Potassium 50 mg each,
Allergien: Vancomyasin, Naproxin
Vorherige Impfungen: -

VAERS 1827473

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 48,0
Geschlecht: M
Eingang: 29.10.2021
Impfdatum: 22.03.2021
Beginn: 27.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: ja

Blood test Cardiac flutter Electrocardiogram Feeling abnormal Heart rate increased Heart rate irregular Inflammation Investigation Loss of consciousness Migraine SARS-CoV-2 test

Symptomtext

He is on disability because he gets migraines so bad they put him down.; Felt like he was going to pass out; and he felt kind of weird, but they let him go. Next day, heart was feeling weird; Heart was fluttering in his chest/ was told his heart rhythm was off and his heart was doing butterflies; a slow gradual progression of my heart rhythm changing; irregular heart beat; 5 days later in ER for inflamed heart.; This is a spontaneous report from a contactable consumer (patient) from Pfizer-sponsored program with Regulatory Authority Support. A 48-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 22Mar2021 13:00 (Batch/Lot Number: EN6207; Expiration Date: 31Jul2021) as DOSE 1, SINGLE for covid-19 immunisation. Medical history included pre hypertensive and degenerative disc disease both from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported (also reported as It is a very low dose pulse reducer, not a beta blocker because his blood pressure is really nice (patient did not provide a product name). The patient previously took morphine and prednisone and experienced drug hypersensitivity (also reported as known allergies). The patient reported that "a slow gradual progression of my heart rhythm changing which lead me to the emergency day 6 days after shot, hospital couldn't find anything wrong with my heart but could only blame my recent shot, they would not give me second dosage at vaccine center in fear it may cause death" The event was reported to occur on 27Mar2021 06:00 PM that resulted in Emergency room/department or urgent care and no treatment was noted. It was also reported that 5 days later in ER for inflamed heart (also reported as was diagnosed with inflammation of the heart 5 days after getting the first dose of his Pfizer BioNTech Covid-19 Vaccine disappeared and asked how he is able to retrieve it). The patient asked is it recommended to get second dose or how should he continued? The patient told his experience after the first dose and the center contacted the hospital he had visited because of the issue he had with the first dosage. He met with the head of the vaccine center and the CDC. The representative told him they could not advise him to get the second dosage. When he goes to the doctor, he was told he will have to have the vaccine card if he wants to travel next year. He is going to have to have the second dose. The patient asked his primary care which one to take. Primary care advised he take Pfizer because it is the easiest one for his age group. The patient states he is caught in a conundrum because he needs the vaccine to do certain things. He is on disability because he gets migraines so bad they put him down. The patient also stated he only takes one thing heart related. It is a very low dose pulse reducer, not a beta blocker because his blood pressure is really nice (patient did not provide a product name). What happened after the COVID-19 Vaccine dosage, he was given it, and he felt kind of weird, but they let him go. Next day, heart was feeling weird. Felt like he was going to pass out. Heart was fluttering in his chest. Hospital did an EKG, was told his heart rhythm was off and his heart was doing butterflies. Hospital did a bunch of blood work and looked for clots. Told his blood work and urine looked as good as a 20-year-old. Hospital said the only thing they could tell him is the inflammation of the heart and irregular heart beat after the COVID-19 Vaccine shot. Stated it gradually passed after 2-2.5 weeks. Every day it felt less and less. He has no problems with his heart. It was the only think peaking after the shot. he needs to know what to do. The patient stated that he wasn't able to get his second dose of the Pfizer BioNTech Covid-19 Vaccine since his first dose last 22Mar2021 caused him heart inflammation. The patient wanted to know if he can still proceed with his second dose and if there is a change in the ingredient of the Pfizer BioNTech Covid-19 Vaccine between the first and the second dose. The patient also wanted to know if he would be contraindicated in getting the second dose of the Pfizer BioNTech Covid-19 Vaccine if he experienced inflammation of the heart 5 days after the first dose of the vaccine. The patient missed the 21 days recommended dosing schedule for the second dose. The patient underwent laboratory test which includes: covid test type post vaccination (Nasal Swab): Negative on 18Sep2021. The outcome of the event a slow gradual progression of my heart rhythm changing and irregular heart beat was recovered for all other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Name: blood work; Result Unstructured Data: Test Result: Unknown Results; Comments: Told his blood work and urine looked as good as a 20-year-old.; Test Name: EKG; Result Unstructured Data: Test Result: Unknown Results; Comments: was told his heart rhythm was off and his heart was doing butterflies; Test Name: urine; Result Unstructured Data: Test Result: Unknown Results; Comments: Told his blood work and urine looked as good as a 20-year-old.; Test Date: 20210918; Test Name: Nasal Swab; Test Result: Negative.
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Degenerative disc disease (other medical history: pre hypertensive, degenerative disc disease); Prehypertension (other medical history: pre hypertensive, degenerative disc disease).
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1816322

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 48,0
Geschlecht: F
Eingang: 25.10.2021
Impfdatum: 17.03.2021
Beginn: 01.04.2021
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: unbekannt Erholt: nein

Electric shock sensation Formication Immediate post-injection reaction Incorrect route of product administration Injection site bruising Injection site pain Injection site pruritus Shoulder injury related to vaccine administration

Symptomtext

After quite a painful injection on my upper L shoulder (I felt the needle quite sharply from the moment it went in, to the moment it came out, which seemed like a few minutes rather than seconds), I initially lived with a bruised upper arm/shoulder for about 3 weeks. During this time, colors ranging from purple to red to yellow were all visible in the vaccinated area, accompanied by pain and itching. The more long-term effect of the injection started, however, after this three-week period when it became clear that this was an incorrectly administered vaccine (SIRVA) due to the constant "crawling" and "electric-like sensations" felt on my left upper-back, lasting to this day! Having shared these symptoms with my PCP, I was advised to follow up with a neurologist (whom I will be seeing soon). In the meantime, I wanted to report my case in order to present a clear picture of what has happened to an area of my body during the past 7+ months, which was perfectly healthy before I received my second COVID-19 vaccine. I am not sure if these symptoms will disappear any time soon ? or ever go away ? but I am hoping that the Hospital will take some form of responsibility when it comes to the training of its medical professionals (and perhaps consider administering its vaccines not anonymously but with an identification of the vaccinator attached to the patient?s record).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: Bursitis and Tendonitis of shoulder
Andere Medikamente: I started to take Tylenol (500 mg.) after the injection for a few months; I was also prescribed Gabapentin (300 mg., 3 capsules a day, for 3 weeks) over the summer.
Allergien: n/a
Vorherige Impfungen: -

VAERS 1804350

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 74,0
Geschlecht: M
Eingang: 21.10.2021
Impfdatum: 12.03.2021
Beginn: 31.08.2021
Tage bis Beginn: 172,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Arthralgia Chest pain Pain in extremity Pericarditis

Symptomtext

Mild chest pain,, under left arm and in shoulder starting morning of 08/31/2021. Diagnosis = idiopathic pericarditis. Treatment = high dose aspirin + colchicine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: Pasturella & bacterioids infection from cat bite
Vorgeschichte: Congenital spherocytosis, polycythemia vera, chronic atrial fibrillation, high blood pressure, high cholesterol, BPH, asplenia, history of DVTs & PE, coronary artery disease, TIA when withholding warfarin to prep for colonoscopy, kidney stones, ventricular tachycardia, ascending aorta dilation, obstructive sleep apnea, central sleep apnea, inflammatory arthritis in fingers, type II dinettes (A1C = 6.4 on 08/31/2021)
Andere Medikamente: Metformin, Metoprolol, Losarttan, Warfarin Sodium, Aspirin, Simvastatin, Vitamin D3, Tamsulosin, Finasteride, Glucosamine/MSM/chondritin
Allergien: Erythromycin, morphine, codeine
Vorherige Impfungen: -

VAERS 1804298

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: KY
Alter: 84,0
Geschlecht: F
Eingang: 21.10.2021
Impfdatum: 22.02.2021
Beginn: 19.10.2021
Tage bis Beginn: 239,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hospitalisation

Symptomtext

hosp resulting in CCU admission

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hospitalisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: chronic lymphoid leukemia
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1168396

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 68,0
Geschlecht: F
Eingang: 14.10.2021
Impfdatum: 15.03.2021
Beginn: 04.04.2021
Tage bis Beginn: 20,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bell's palsy Facial paralysis Hemiparesis

Symptomtext

Second injection of Pfizer vaccine was given March 15, on April 4 (Easter Sunday)--I was eating brunch with family who noticed my face was drooping. I contacted my GP the following day and was given steroids and an anti-herpes medicine because it clear what I had. The first shot of the Pfizer vaccine resulted in some itching down the right side of my neck to breasts (first shot was given Feb 22)-- it lasted 3-4 days and was something I could tolerate and I did not report it to my GP. After the second shot (given in my left arm), the right side of my face had paralysis from Bell's Palsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: GP referred me to a neurologist -- I went in mid-April. He confirmed it was Bell's Palsy. I mostly recovered after about 6 weeks. I still have some droopiness in right eye.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: regular multi-vitamin
Allergien: I have spring allergies such as hay fever; allergic to pennacilan
Vorherige Impfungen: -

VAERS 1168396

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 68,0
Geschlecht: F
Eingang: 14.10.2021
Impfdatum: 15.03.2021
Beginn: 04.04.2021
Tage bis Beginn: 20,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Bell's palsy Facial paralysis Hemiparesis

Symptomtext

Second injection of Pfizer vaccine was given March 15, on April 4 (Easter Sunday)--I was eating brunch with family who noticed my face was drooping. I contacted my GP the following day and was given steroids and an anti-herpes medicine because it clear what I had. The first shot of the Pfizer vaccine resulted in some itching down the right side of my neck to breasts (first shot was given Feb 22)-- it lasted 3-4 days and was something I could tolerate and I did not report it to my GP. After the second shot (given in my left arm), the right side of my face had paralysis from Bell's Palsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: GP referred me to a neurologist -- I went in mid-April. He confirmed it was Bell's Palsy. I mostly recovered after about 6 weeks. I still have some droopiness in right eye.
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: regular multi-vitamin
Allergien: I have spring allergies such as hay fever; allergic to pennacilan
Vorherige Impfungen: -

VAERS 1759828

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 50,0
Geschlecht: F
Eingang: 04.10.2021
Impfdatum: 28.03.2021
Beginn: 16.08.2021
Tage bis Beginn: 141,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

COVID-19 Chest discomfort Chills Diarrhoea Feeling abnormal Headache Loss of consciousness Migraine Nasal congestion Pruritus Pyrexia SARS-CoV-2 test positive Sinusitis Swelling Vaccine breakthrough infection Vomiting

Symptomtext

3 weeks prior to 08/16/2021- I had a migraine headache that was continuous for 3 weeks and a sinus infection. On 08/11/2021-I went in for the visit and my sinuses and ear were full of fluid. Dr. assistant prescribed my antibiotic- z-pack. My symptoms resolved after the antibiotics. On 08/16/2021, Monday, I did not feel right. I did not have a fever, or a cough. I could still taste, smell and and I still had my appetite. I did not have any of the classic symptoms. That night I got up to go to the bathroom and vomited, and had diarrhea (and I normally do not vomit) and I passed out afterwards. It was only a one shot of vomiting and diarrhea. I did not know I passed out. My husband found me on the floor. The next morning, Tuesday, 08/17/2021, I didn't feel well. I had a low grade fever and chills. I went and bought an over-the-counter COVID-19 test and the results were negative. That same day, I went to the clinic, and they administered a COVID-19 test and it was positive. For 2 days after, I had fever, chills , heavy chest, massive headache. I felt like someone was sitting on my chest and head. The headache was worse than a migraine. The pain felt different than a migraine, a pain I had never felt before. I took Tylenol and it broke my fever, but it was no match for my headache. By Friday my symptoms, began to resolve. I did have a little congestion . A week after my Pfizer 2nd dose - I developed COVID arm. It felt like a bee sting, hot to the touch, swollen and really itched. And went away after a week on it's own.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: COVID-19- TEST -positive
Aktuelle Erkrankungen: no
Vorgeschichte: high blood pressure I have had kidney stones twice, once in 2006 and 15 years after that
Andere Medikamente: Chlorthalidone 25 mg od losartan potassium 25 mg od klor-conm 20 mg 4 tablets a day Zyrtec 10mg od Flonase 50mcg one spray on each side Vit D-3 1000 iu docusate sodium 100 mg od
Allergien: penicillin and it derivatives
Vorherige Impfungen: flu shot 12 years ago, from the live virus, up the nose, I ended up with the flu symptoms.

VAERS 1736834

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: IL
Alter: 34,0
Geschlecht: M
Eingang: 27.09.2021
Impfdatum: 19.03.2021
Beginn: 14.09.2021
Tage bis Beginn: 179,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Anticoagulant therapy Deep vein thrombosis Skin discolouration

Symptomtext

In the morning I noticed my left leg was discolored so I went to the Emergency room where they diagnosed with a blood clot in one of the deep veins in my left leg. I was put on blood thinners and kept over night for observation and then sent home on blood thinners the next day. and I'm also on compression socks

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 1,0
Labordaten: I'm going to have genetic blood test to see if I'm predisposed for blood clots
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Allegra once a day, Flonase, 50 micrograms Vitamin D3 once a day
Allergien: no
Vorherige Impfungen: -

VAERS 1734152

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NC
Alter: 71,0
Geschlecht: F
Eingang: 25.09.2021
Impfdatum: 05.04.2021
Beginn: 01.05.2021
Tage bis Beginn: 26,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Dizziness Feeling hot Hyperhidrosis Joint lock Laboratory test Myalgia Night sweats SARS-CoV-2 antibody test Seizure Spinal pain Visual impairment

Symptomtext

two seizures; muscle pain; every joint in her body hurt; spine which was extremely painful; night sweats; very hot; sweating; she was very dizzy; vision has went to hell; hands are locking she couldn't open it/left trigger finger doesn't open; This is a spontaneous report from a contactable consumer (patient). A 71-year-old female patient received the second dose of bnt162b2, via an unspecified route of administration, administered in Right arm on 05Apr2021 (at the age of 71-year-old) (Lot Number: EN6207) as single dose for covid-19 immunization. Medical history included gum surgery and collagen antibodies and that something foreign causes her to have a rash, scaly skin, problem with her thyroid. There were no concomitant medications. The patient previously received the first dose of bnt162b2, via an unspecified route of administration, administered in Right arm on 15Mar2021 (at the age of 71-year-old) (Lot Number: EN6207) as single dose for covid-19 immunization and experienced Headache and Dizziness. The patient experienced two seizures (medically significant) on May2021, muscle pain, every joint in her body hurt, spine which was extremely painful, night sweats, very hot, sweating, she was very dizzy, vision has went to hell, hands are locking she couldn't open it/left trigger finger doesn't open in 2021. Patient had the second dose of the Pfizer Covid-19 vaccine on 05Apr2021 and had complaints of muscle pain and every joint in her body hurt, especially her spine which was extremely painful. On either 17May2021 or 18May2021, the Patient had two seizures. Patient states that she had a Covid-19 antibody test and the value was 189 units/ml and that below 0.8 is normal. She had a very bad reaction to the Pfizer COVID vaccine. She had multiple tests with her doctor because she thought it was her thyroid or something else. Her doctor did a SARS COVID-2 spike Ab quant S antibody test, and her level was 189 units/mL which below 0.80 is normal. Her doctor doesn't know why it was so high. After the second dose she had muscle pains. Every joint in her body hurt including her spine it was extremely painful. Especially in the morning. It was hard for her to get out of bed. Then, on 17May2021 or the 18May2021, she had two seizures. Now, she has been having night sweats, and she is very hot and sweating. Her hands are locking she couldn't open it. Right now she is much better than before. She is still dizzy, but not every day. Yesterday, she was very dizzy. Her left trigger finger doesn't open. Her eye sight went to hell. Now her memory is starting to phase up. The doctor thought it was her thyroid because she has a problem with her thyroid, but all tests come out normal except for a small variation. The doctor thinks it must be the vaccine. After the second shot, her joints hurt her so much. She couldn't move because of pain. She could feel every little joint in her spine. It was like a domino affect. She went to the doctor 20May2021. Everything else is normal with her. She wonders if her antibody level was even higher in the beginning. The events resulted in Physician Office. The outcome of the event Dizziness was not recovered, other events was unknown. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Test Name: tests; Result Unstructured Data: Test Result:normal; Comments: all tests come out normal except for a small variation; Test Name: SARS COVID-2 spike Ab quant S antibody test; Result Unstructured Data: Test Result:189 IU/ml; Comments: the value was 189 units/ml and that below 0.8 is normal
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Antibody positive; Gum disorder; Rash (something foreign causes her to have a rash, scaly skin); Skin scaly (something foreign causes her to have a rash, scaly skin); Thyroid disorder
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1726311

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 85,0
Geschlecht: F
Eingang: 23.09.2021
Impfdatum: 22.03.2021
Beginn: 03.07.2021
Tage bis Beginn: 103,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Asthenia Bell's palsy Facial paralysis Intestinal obstruction Laboratory test Vomiting

Symptomtext

Starting 7/1/2021, my stomach started hurting and I started throwing up. I called an ambulance and went to the ER. I was diagnosed with bowel obstruction. I was treated and discharged. Then 3 days later on 7/3/2021, I was feeling very weak and not getting better. I had left side droopy eyes and mouth. I was taken back to the hospital and initially they thought I was having a stroke. They ran a bunch of tests and I was not having a stroke. I was in the hospital for 3 days then discharged to a rehab center where I was finally diagnosed with Bell's Palsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 3,0
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension; acid reflux
Andere Medikamente: Omeprazole; metoprolol; vitamin C; vitamin D; coQ10
Allergien: Naproxen
Vorherige Impfungen: -

VAERS 1710065

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 17,0
Geschlecht: M
Eingang: 17.09.2021
Impfdatum: 01.04.2021
Beginn: 13.09.2021
Tage bis Beginn: 165,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Chest discomfort Chest pain Electrocardiogram abnormal Pericarditis

Symptomtext

Chest tightness/pain. Abnormal EKG. Pericarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: Echo and x-ray scheduled.
Aktuelle Erkrankungen: NA
Vorgeschichte: Epidermoloysis Bullosa Tourettes Syndrome
Andere Medikamente: Prevacid Solutab
Allergien: NA
Vorherige Impfungen: -

VAERS 1697194

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 77,0
Geschlecht: M
Eingang: 14.09.2021
Impfdatum: 19.03.2021
Beginn: 11.08.2021
Tage bis Beginn: 145,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Anticoagulant therapy COVID-19 Computerised tomogram thorax Computerised tomogram thorax abnormal Cough Deep vein thrombosis Productive cough SARS-CoV-2 test positive Ultrasound Doppler abnormal

Symptomtext

Covid diagnosed on 8/1 had Remdesiver in R arm at that time. C/O out pt diagnosis of significant RUExt DVT - sent by PCP to be started on heparin drip - and later convert to po anticoag. Admitted on 8/11/21 for heparin drip. Started azithromycin as well. Patient reports he first began experiencing symptoms on 7/28/21, tested positive on 8/1/2021. Patient received 1 dose of remdesivir as an outpatient. Patient reports he was been fully vaccinated against COVID-19. Patient continues to have chronic productive cough. Discharged on 8/14/21 with augmentin x 5 days and azithromycin x 4 days and apixaban

Weitere VAERSDATA-Felder

Praegender Schweregrund: Deep vein thrombosis
Hospital-Tage: 3,0
Labordaten: 8/1/21 COVID19: positive 8/11/21 US: Study positive for extensive DVT right upper extremity described above. 8/11/21 CTA chest: Bilateral airspace disease suggestive of an infectious/inflammatory process such as pneumonia. No PE
Aktuelle Erkrankungen: -
Vorgeschichte: CHF, COPD, psoriasis, HTN, abdominal aortic aneurysm, dyslipidemia, IBS,
Andere Medikamente: Advair diskus, aspirin, carvedilol, entresto, famotidine, fursosemide, krill oil, ocuvit-lutein, pantoprazole, pravastatin,
Allergien: None
Vorherige Impfungen: -

VAERS 1696990

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WI
Alter: 74,0
Geschlecht: F
Eingang: 14.09.2021
Impfdatum: 10.03.2021
Beginn: 03.09.2021
Tage bis Beginn: 177,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Dyspnoea Fatigue Monoclonal antibody immunoconjugate therapy Presyncope Pyrexia SARS-CoV-2 test positive

Symptomtext

Admitted 9/2 due to fatigue, fevers, shortness of breath and near syncope. Tested positive for COVID-19 08/25/2021. Received monoclonal antibody therapy following. Patient is vaccinated for COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: 9,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: calcium carbonate 500 mg,cholecalciferol, desipramine
Allergien: Amoxicillin, Latex, Minocin [Minocycline], Nickel
Vorherige Impfungen: -

VAERS 1693113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: AZ
Alter: 65,0
Geschlecht: F
Eingang: 11.09.2021
Impfdatum: 28.02.2021
Beginn: 31.05.2021
Tage bis Beginn: 92,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Atrial fibrillation Bell's palsy Cardiac monitoring Computerised tomogram Echocardiogram Electrocardiogram Magnetic resonance imaging

Symptomtext

On May 31, 2021, I went into A-Fib and was hospitalized for four days. I did go back into sinus rhythm with medication. On July 5, I thought I having either a stroke or TIA. It turned out to be Bell's Palsy. Prescribed prednisolone, then prednisone. The palsy is almost all gone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 4,0
Labordaten: EKG (May 31, - June 3) , CT scan (May 31), Heart Monitor (May 31 - June 3) EKG (July 5) CT Scan (July 5), MRI (July 6), Echogram (July 6) Hospitalized 3 days
Aktuelle Erkrankungen: None
Vorgeschichte: High Blood Pressure
Andere Medikamente: ? Aspirin (81mg/1) - Heart ? Biotin (5000mcg/1) - Hair & Nails ? Amlodipine/Valsartan (10/320 mg) - Blood Pressure ? Omeprazole (40mg/MWF) - Acid Reflux ? Rosuvastatin (Crestor) 10mg/1x ? Vitamin C 2000mg ? Vitamin D3 4000iu
Allergien: Biaxin
Vorherige Impfungen: -

VAERS 1470779

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 50,0
Geschlecht: F
Eingang: 02.09.2021
Impfdatum: 01.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 23,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: ja ER: ja Erholt: nein

Amnesia Anxiety Aphasia Arthralgia Asthenia Dysarthria Erythema Fatigue Peripheral swelling Balance disorder Blood test normal Botulinum toxin injection Burning sensation Computerised tomogram normal Depression Feeling abnormal Headache Immunology test normal

Symptomtext

5 days after vaccine I was rushed to hospital via ambulance because my blood pressure was 70/40. I was not lucid. Passed out in kitchen. Slurred speak and loss of word choice. Went to neurologist who told me I have neurological damage in left injection site arm. PCP sent me to allergist. Rheumatologist is checking for immune disease which came out negative. Have lost 40lbs. Fatigue, loss of words, foggy thinking, pain in joints. Red swollen hands which ache and burn. Intolerance to heat. No strength in left arm and hand. Cannot use left hand. Weakness in right arm and hand. Loss of balance. Memory loss.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 1,0
Labordaten: MRI head and neck. Normal. Ct scan. Normal. Blood tests. Normal. Neurologist strength test. Loss of strength. Botox for headaches. Psychiatrist said I have anxiety, depression, and sleep disorder. Allergist. Said could not help me. Rheumatologist. No immune disease or arthritis. Trying to figure out outcome of side effects.
Aktuelle Erkrankungen: None
Vorgeschichte: Neurological damage in left arm where Pfizer injection was given. Loss of memory, fatigue, swelling of joints, and pain in joints. Hands turn red and swollen, ache, burn, and are weak. Intolerance to heat and headaches. Loss of balance.
Andere Medikamente: Gabapentin Lamictal Adderall Tramadol
Allergien: Penicillin Sulfa
Vorherige Impfungen: -

VAERS 1662179

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 74,0
Geschlecht: F
Eingang: 01.09.2021
Impfdatum: 18.03.2021
Beginn: 13.08.2021
Tage bis Beginn: 148,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asymptomatic COVID-19 COVID-19 Condition aggravated Dizziness SARS-CoV-2 test positive Syncope Vomiting

Symptomtext

Patient presented to emergency department on 8/13/2021 after testing positive for COVID-19 at an outside facility. She had complained of dizziness and had one instance of nonbloody emesis. Reports no other symptoms related to COVID-19 infection. She was given monoclonal antibodies while in the emergency department. Patient was discharged on 8/13/2021 from ED to home. Patient presented to the emergency department on 8/14/2021 after a syncopal episode while showering at home. Patient was admitted due to quarantine restrictions at assisted living facility. She remained asymptomatic for COVID-19 during admission. Patient was discharged on 8/23/2021 back to facility.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 9,0
Labordaten: COVID-19 test positive on 8/13/2021.
Aktuelle Erkrankungen: None known
Vorgeschichte: Arthritis GERD (gastroesophageal reflux disease) HTN (hypertension) Hyperlipidemia Dementia (HCC) Depression with anxiety IFG (impaired fasting glucose) Overweight (BMI 25.0-29.9) Hyperuricemia Dizziness Left-sided weakness Horizontal nystagmus Acute pain of left shoulder Transient cerebral ischemia, unspecified type Elevated serum creatinine Former smoker Hypokalemia
Andere Medikamente: Cholecalciferol (VITAMIN D3) 1000 UNIT tablet donepezil (ARICEPT) 10 MG tablet FLUoxetine (PROZAC) 20 MG capsule hydrochlorothiazide (HYDRODIURIL) 25 MG tablet memantine (NAMENDA) 5 MG tablet multivitamin (ONCE-A-DAY GEQ VIT) tablet
Allergien: Rabeprazole
Vorherige Impfungen: -

VAERS 1641510

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 70,0
Geschlecht: M
Eingang: 27.08.2021
Impfdatum: 21.03.2021
Beginn: 25.08.2021
Tage bis Beginn: 157,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Atrial fibrillation Chest X-ray abnormal Condition aggravated Echocardiogram Ejection fraction Electrocardiogram abnormal Lung opacity Pulmonary congestion Pulmonary oedema

Symptomtext

Brief hospitalization with suspect cxr findings more likely represent pulmonary edema, diuretics. Lasix IV,

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 2,0
Labordaten: 8/26 Echocardiogram: EF 50-55, 8/25 Chest x ray showed central pulmonary venous congestion with bilateral interstitial opacities, suggestive of pulmonary edema. Initial EKG shows atrial fibrillation with RVR in the 130s
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Chronic A-Fib, Cardiomegaly, CAD, HTN, post herpetic neuralgia, post cardiotomy syndrome, Tricuspid incompetence, Graves Disease, obesity, chronic pain
Andere Medikamente: Unknown
Allergien: Codeine
Vorherige Impfungen: -

VAERS 1628842

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge #EN6207

schwer

Staat: SC
Alter: 66,0
Geschlecht: M
Eingang: 24.08.2021
Impfdatum: 23.03.2021
Beginn: 03.06.2021
Tage bis Beginn: 72,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Arthralgia Chest discomfort Electrocardiogram Enzyme level test Neck pain Pericarditis

Symptomtext

Increasing pain in neck and shoulders (beginning with left shoulder and spreading to right shoulder) and significant pressure in chest area, similar to pain experienced with pericarditis after heart attack in November 2020. I had been off of several heart meds for several months, but after the pericarditis event in June, Dr. prescribed that I resume Colchicine for inflammation related to pericarditis. I continue to take Colchicine, and will do so until my next appointment with him in February. I have not had any further symptoms such as those described above.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 1,0
Labordaten: EKG, enzymes, etc. to rule out heart attack.
Aktuelle Erkrankungen: -
Vorgeschichte: Type I Diabetes (1974), Pacemaker (2012), Heart Attack (November 2020), Sleep Apnea (2015)
Andere Medikamente: Daily (UNO): Aspirin 81, Brilinta 90 (x2), Budesonide 32 (NPR), Budesonide-Formoterol, Bupropion XL, Cyanocobalamin, Ergocalciferol, Famotidine, Humalog, Jardiance, L-Methylfolate, Lutein 10/Zeaxanthin 5, Magnesium Oxide, Methylphenidate, M
Allergien: Shellfish, feathers, dust, smoke
Vorherige Impfungen: -

VAERS 1586551

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 77,0
Geschlecht: M
Eingang: 19.08.2021
Impfdatum: 22.02.2021
Beginn: 16.08.2021
Tage bis Beginn: 175,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

COVID-19 pneumonia Intensive care SARS-CoV-2 test positive

Symptomtext

Patient was hospitalized with COVID19 Pneumonia. He is currently still admitted in our ICU.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 3,0
Labordaten: COVID19 PCR- Positive
Aktuelle Erkrankungen: CAD (coronary artery disease) ? Carotid bruit bilateral ? DM type 2 (diabetes mellitus, type 2) (HCC) ? Family hx of colon cancer ? HTN (hypertension) ? Hyperlipidemia ? mild non proliferative retinapothy bilateral
Vorgeschichte: CAD (coronary artery disease) ? Carotid bruit bilateral ? DM type 2 (diabetes mellitus, type 2) (HCC) ? Family hx of colon cancer ? HTN (hypertension) ? Hyperlipidemia ? mild non proliferative retinapothy bilateral
Andere Medikamente: ? amLODIPine (NORVASC) 10 MG tablet TAKE 1 TABLET DAILY ? Aspirin (ASPIR-81 PO) take 81 mg by mouth Daily. ? atorvastatin (LIPITOR) 40 MG tablet Take 1 tablet by mouth daily. ? BD PEN NEEDLE NANO U/F 32G X 4 MM MISC USE ONE PEN NEEDLE DAILY
Allergien: Lisinopril
Vorherige Impfungen: -

VAERS 1545126

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 60,0
Geschlecht: F
Eingang: 11.08.2021
Impfdatum: 04.06.2021
Beginn: 06.06.2021
Tage bis Beginn: 2,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Fall Poisoning Syncope

Symptomtext

Patient reported received Pfizer on 5/13 and 6/4. Patient reported after her COVID vaccine her ?lower half just collapsed?. On 5/13 patient came to ER for intoxicated with multiple falls. On 6/6 patient was fell down at her home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1536569

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 71,0
Geschlecht: F
Eingang: 09.08.2021
Impfdatum: 22.02.2021
Beginn: 05.08.2021
Tage bis Beginn: 164,0
Dosis: 2
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Condition aggravated Dyspnoea Physical examination abnormal Respiratory distress SARS-CoV-2 test positive

Symptomtext

COVID+8/5. Patient is a 72-year-old female with past medical history of COPD, HTN, insomnia, anxiety, hyperlipidemia who was transferred from the outside hospital due to worsening SOB because of active COVID-19. Symptom onset 8/4 and she got tested on 8/5 and was diagnosed with Covid-19. She received 2 shots of Pfizer vaccine in April. At baseline she is on 5 L of oxygen at home, but had to increase to 10 L at home today due to worsening dyspnea. At the exam she was in moderate distress due to SOB.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Respiratory distress
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1523097

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 73,0
Geschlecht: F
Eingang: 03.08.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Dyspnoea Escherichia infection Renal disorder Thrombosis White blood cell count increased

Symptomtext

Pt. states that after receiving the 2nd dose of Phizer 03/18/2021, started experiencing symptoms of Blood Clot (verified) Urgent Care, shortness of breath (Albuterol), High counts of White Blood Cell Count, Ecoli, and severe kidney disease. Still continuing with planned Primary visits.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Blood Test (estimated 04/01/2021)
Aktuelle Erkrankungen: N/A
Vorgeschichte: COPD
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1515232

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 59,0
Geschlecht: M
Eingang: 30.07.2021
Impfdatum: 13.03.2021
Beginn: 07.07.2021
Tage bis Beginn: 116,0
Dosis: 1
Route/Site: SYR / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

General physical health deterioration Intensive care Oropharyngeal pain

Symptomtext

He is currently admitted at Hospital and started feeling a sore throat last Saturday. He then began feeling progressively worse throughout the next few days and was admitted to Hospital on Tuesday 07/06. PUI has congestive heart failure, COPD, Stints put in, high BP, and is a diabetic. He was given a breathing device today to monitor his o2, but was moved out of ICU. He reports that he rarely leaves his house due to water blisters on his legs, but he comes to the wound clinic once a week. He is medically disabled and does not work

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Diabetes Mellitus Chronic Lung Disease (asthma/emphysema/COPD) Cardiovascular disease Hypertension/High Blood Pressure Obesity
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1502096

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 53,0
Geschlecht: M
Eingang: 26.07.2021
Impfdatum: 06.04.2021
Beginn: 27.04.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Cardiac monitoring Chest X-ray Cough Discomfort Dyspnoea Electrocardiogram Loss of consciousness Palpitations Wheezing

Symptomtext

Within several weeks, I started noticing what felt like heart palpitations that caused me to lose my breath and wheeze/cough. I had called my primary care physician and saw them and said I wanted a visit with a cardiologist. Just one week later, during a work call, it the event happened so severely that I started passing out. Thus, I went immediately to the ER and checked myself in. It was not until mid-July that I got to see a cardiologist, and my symptoms were much less frequent or severe by that time. For several weeks though, it was very uncomfortable and unnerving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: ER Visit: May 24 2021 -- > ECG; Chest Xray; Heart Monitor 24 hour
Aktuelle Erkrankungen: None
Vorgeschichte: Heart Murmur
Andere Medikamente: Amlodipine; Vitamin D
Allergien: None
Vorherige Impfungen: -

VAERS 1493844

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 69,0
Geschlecht: F
Eingang: 22.07.2021
Impfdatum: 10.03.2021
Beginn: 14.03.2021
Tage bis Beginn: 4,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood test Cardiac failure congestive Cardiac infection Chest X-ray abnormal Dyspnoea Echocardiogram abnormal Electrocardiogram normal Feeding disorder Gait disturbance Pulmonary oedema Sleep disorder Surgery

Symptomtext

Congestive Heart Failure, I was healthy prior and heart issues. medical records to prove of heart. I had surgery 3/3/2021, ekg good. Less than 7 days after vaccination, couldn't breath, eat, difficult walking any distance, couldn't lay down to sleep, couldn't really sleep sitting up, shortness of breath. Cardiologist gave a diagnosis of CHF stage C, I was hospitalized for 3 1/2 days. They wanted to keep me longer, I asked to be released. Cardiologist thought I had a viral infection to the heart, still working on improving the heart. Adhering to CHF rules for medicine and diet.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: 4,0
Labordaten: Chest Xray - fluid in lungs. ECHO shows heart failure Blood work
Aktuelle Erkrankungen: none
Vorgeschichte: diabetes 2
Andere Medikamente: trulicity, metformin
Allergien: none
Vorherige Impfungen: -

VAERS 1484970

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 62,0
Geschlecht: F
Eingang: 19.07.2021
Impfdatum: 10.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood pressure fluctuation Blood test normal Cardiac monitoring abnormal Chest pain Dizziness Dyspnoea Electrocardiogram normal Loss of personal independence in daily activities Migraine Syncope Weight increased

Symptomtext

After vaccine, extreme blood pressure fluctuations, trouble with dizziness, lightheaded, feeling like fainted (fainted once), trouble catching breath, significant weight gain because unable to exercise/move as normally. Referred to cardiologist because migraines and chest pain.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Blood test for heart circulation (was fine), 24 hours heart monitor showed slight issues, EKG came back fine
Aktuelle Erkrankungen: N/A
Vorgeschichte: Mild cerabral palsy (right side of the body), sarcoidosis (automimmune disorder)
Andere Medikamente: Thyroid Medicine (Levothyroxine), Losartan (blood pressure medication),both taken every day. Furosemide (swelling) cyclobenvaparine (muscle spasms), hydrocodon (chronic pain), taken as needed
Allergien: Latex, iodine, saline solution
Vorherige Impfungen: -

VAERS 1478203

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 68,0
Geschlecht: F
Eingang: 16.07.2021
Impfdatum: 20.03.2021
Beginn: 28.03.2021
Tage bis Beginn: 8,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Asthenia Computerised tomogram head Computerised tomogram neck Electromyogram abnormal Guillain-Barre syndrome Intervertebral disc degeneration Magnetic resonance imaging head Magnetic resonance imaging spinal abnormal Muscle spasms Paraesthesia Peripheral sensory neuropathy

Symptomtext

Pfizer-BioNTech COVID-19 Vaccine EUA: patient presents to clinic for follow-up with neurology. Approximately ten to fourteen days after immunization patient reports developing paresthesias in arms and legs and left side of face, cramps, weakness, and muscle spasms. Patient was prescribed diazepam which helped symptoms. Patient diagnosed with ADIP/Guillain-Barre syndrome, underwent physical therapy, and has gradually improved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Guillain-Barre syndrome
Hospital-Tage: -
Labordaten: CT head/neck, and MR brain, : no acute intracranial abnormality, MR lumbar spine: spinal stenosis L4-L5, left sacral Tarlov cyst, MR cervical spine: multilevel cervical degenerative changes, EMG: Mild generalized length dependent sensorimotor polyneuropathy, with predominant axonal feature, as may be seen with residual changes with AIDP. There is no primary demyelinating features to suggest ongoing immune mediated polyneuropathy.
Aktuelle Erkrankungen: None reported
Vorgeschichte: Lumbar stenosis, factor V Leiden, osteoporosis, thalassanemia
Andere Medikamente: Denosumab, diazepam, tobramycin ophthalmic
Allergien: Prochlorperazine, terbinafine, amoxicillin, prednisone, linaclotide, penicillins
Vorherige Impfungen: -

VAERS 1471280

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 12,0
Geschlecht: M
Eingang: 14.07.2021
Impfdatum: 10.07.2021
Beginn: 12.07.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Blood chloride normal Blood glucose normal Blood potassium normal Blood sodium decreased Blood urea normal C-reactive protein increased Carbon dioxide increased Chest discomfort Chest pain Eosinophil percentage Full blood count Haematocrit normal Haemoglobin normal Lymphocyte percentage increased Malaise Mean cell volume normal Monocyte percentage increased Myocarditis

Symptomtext

12 Y 4 M old male with a history of chest pain that started two days ago on Monday. On 7/11 night, he didn't feel well felt nauseous. He was able to sleep but had chest pain the following morning that improved after he vomited. The chest pain is midsternal and feels pressure-like. It lasted a few hours. He swam on 7/12 without problems (at a swim club) for an hour. He had his second dose of COVID-19 vaccine on Saturday 7/10/21. There has not been any fevers. Elevated troponin and CRP with recent COVID-19 vaccine, suspicious for post-vaccine myocarditis. He is hemodynamically stable with normal vitals and no evidence of ventricular ectopy or depressed left ventricular function. His troponin peaked at 11.05 and trended down, but his most recent value is slightly up at 8.2 from 7.6. Recommended continuing to trend the troponins for now (if they show a downward trend then twice daily is adequate, unless he develops chest pain). At this time, IVIG is held unless he becomes unstable or the troponins trend upward .

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: -
Labordaten: 07/13/21 2313 NA 135 K 3.5 CO2 30 CL 97* BUN 11 CR 0.46 RBS 106 CBC Recent Labs 07/13/21 1554 WBC 5.8 HGB 14.8 HCT 41.2 PLT 273 MCV 81 NEUT 46 LYMPH 41 MONO 11 EOS 1 Cardiac Recent Labs 07/14/21 1130 07/14/21 0543 07/13/21 2313 TROP 8.20* 7.57* 11.05* Results as of 7/14/2021 17:40 7/13/2021 15:54 CRP, SER QL: 1.0 (H) 7/13/2021 23:13 CRP, SER QL: 0.9 7/14/2021 11:30 CRP, SER QL: 0.6
Aktuelle Erkrankungen: None
Vorgeschichte: Autism Spectrum disorder and Speech delay
Andere Medikamente: -
Allergien: nka
Vorherige Impfungen: -

VAERS 1115626

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: DE
Alter: 59,0
Geschlecht: F
Eingang: 14.07.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cerebral disorder Chest discomfort Dysgeusia Pain in extremity Palpitations Electric shock sensation Head discomfort Panic reaction X-ray

Symptomtext

Metallic Taste in the mouth; head feeling pressure like its full/like air filling up in the brain/getting full all quick/the insides of the head were scrambling/was short circuiting and misfiring/was a scrambling in her brain; heart started racing and pounding; chest tightness; experienced a soreness of the arm; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 59-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EN6207, Expiry date: Unknown) via an unspecified route of administration in Arm Left on 17Mar2021 (at the age of 59 years) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism from an unknown date and unknown if ongoing, morbid obesity from an un-known date and unknown if ongoing. She has had No other vaccines on the same day or 4 week prior. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) 112 mcg taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) 20 mg taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D 3) 1000 iU 2 by mouth taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported. She normally takes a baby aspirin, but she did not that day because she heard don't take aspirin and tylenol before the shot, she didn't take baby aspirin that morning. The patient previously took flu vaccine in Sep2020 and shingles vaccine over a year ago, hydrocodone and experienced heart rate in-creased, toradol and experienced heart rate irregular and ibuprofen and she has had it at larger doses and had a problem. On 17Mar2021, the patient experienced metallic taste in the mouth, head feeling pressure like its full/it was like air filling up in the brain, like it was getting full all quick, and the insides of the head were scrambling/felt like it was short circuiting and misfiring, like there was a scrambling in her brain, heart started racing and pounding, chest tightness and on an unspecified date in 2021, experienced a soreness of the arm. Patient elaborated on what she means by reaction, when she got the shot within 15 or 16 minutes, she had a metallic taste in the mouth and immediately it led to her head feeling pressure like its full, her brain was doing a lot of stuff like it was misfiring or short circuiting, and then her heart started racing and pounding. She doesn't know if her heart racing was because she got scared or it was the shot. She thought the Metallic taste was no bid deal, sometimes with MRI contrast she understand that can happen but with her Brain it was kind of hard to explain, she's had nothing like it. After the metallic taste, it was like air filling up in the brain, like it was getting full all quick, and the insides of the head were scrambling. Outcome was, the metallic taste went away, it was gone in 30 seconds, quickly the brain thing went away, like a quick 30 seconds or minute. Her heart racing and pounding ended the same day also. After the vaccine they had her sit there, she was afraid to get up, and no one was checking on her at the pharmacy, she just sat there with her heart racing for a couple minutes, it then started to subside, her husband was waiting for her. She did go to the pharma-cist and told them she experienced a side effect, the pharmacist hadn't heard of it before, she was then feeling better but then chest tightness occurred after, she clarified that she was not experiencing it now. Her Heart pound and racing was for about 5 minutes it then subsided and the chest tightness was for 3 hours. She has recovered completely. She laughs and states that mentally it gets her Blood pressure up just talking about it. She is Scheduled for second dose, it's supposed to be in 3 weeks, but they did it in 4 weeks, she thinks it's 14Apr2021. She has sensitivity, a little medicine goes a long way for her, she is sensitive to medications, she doesn't know which reacted with her but she had hydrocodone and Toradol and her heart was racing and was irregular. This was several years ago. Caller states that she misspoke when saying irregular heartbeat, she actually doesn't know if it was irregular, they did not tell her this. Her heart was racing and she was uncomfortable. She can take ibuprofen and she has had it at larger doses and had a problem, she was also very sensitive to caffeine. These experienced were back in Feb2018. She has no Lot or Expiry for Ibuprofen, hydrocodone, and Toradol, they have been discarded. She has no Allergies. The patient underwent lab tests and procedures which included 2 weeks ago she had a panoramic Mouth x-ray around the head, normally for pregnant patient they give a cover on their torso, but the lady told her the radiation was less than the sun and didn't need it. Treatment was nothing used to treat it, she just dealt with it, her Sister-in-Law said the tight-ness of the chest could have been like she was having a panic attack. The outcome of all the events was recovered on 17Mar2021 and soreness of arm was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected. Follow-up (09Jul2021): Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: x-ray test; Result Unstructured Data: Test Result:unknown; Comments: weeks ago she had a panoramic Mouth x-ray around the head
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hypothyroidism; Morbid obesity
Andere Medikamente: SYNTHROID; PANTOPRAZOLE; VITAMIN D 3; BABY ASPIRIN
Allergien: -
Vorherige Impfungen: -

VAERS 1115626

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: DE
Alter: 59,0
Geschlecht: F
Eingang: 14.07.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cerebral disorder Chest discomfort Dysgeusia Pain in extremity Palpitations Electric shock sensation Head discomfort Panic reaction X-ray

Symptomtext

Metallic Taste in the mouth; head feeling pressure like its full/like air filling up in the brain/getting full all quick/the insides of the head were scrambling/was short circuiting and misfiring/was a scrambling in her brain; heart started racing and pounding; chest tightness; experienced a soreness of the arm; This is a spontaneous report from a contactable consumer or other non hcp (patient herself). A 59-years-old female patient received bnt162b2 (BNT162B2, Formulation: Solution for injection, Lot Number: EN6207, Expiry date: Unknown) via an unspecified route of administration in Arm Left on 17Mar2021 (at the age of 59 years) as dose 1, single for COVID-19 immunisation. Medical history included hypothyroidism from an unknown date and unknown if ongoing, morbid obesity from an un-known date and unknown if ongoing. She has had No other vaccines on the same day or 4 week prior. Concomitant medication(s) included levothyroxine sodium (SYNTHROID) 112 mcg taken for an unspecified indication, start and stop date were not reported; pantoprazole (PANTOPRAZOLE) 20 mg taken for an unspecified indication, start and stop date were not reported; colecalciferol (VITAMIN D 3) 1000 iU 2 by mouth taken for an unspecified indication, start and stop date were not reported; acetylsalicylic acid (BABY ASPIRIN) taken for an unspecified indication, start and stop date were not reported. She normally takes a baby aspirin, but she did not that day because she heard don't take aspirin and tylenol before the shot, she didn't take baby aspirin that morning. The patient previously took flu vaccine in Sep2020 and shingles vaccine over a year ago, hydrocodone and experienced heart rate in-creased, toradol and experienced heart rate irregular and ibuprofen and she has had it at larger doses and had a problem. On 17Mar2021, the patient experienced metallic taste in the mouth, head feeling pressure like its full/it was like air filling up in the brain, like it was getting full all quick, and the insides of the head were scrambling/felt like it was short circuiting and misfiring, like there was a scrambling in her brain, heart started racing and pounding, chest tightness and on an unspecified date in 2021, experienced a soreness of the arm. Patient elaborated on what she means by reaction, when she got the shot within 15 or 16 minutes, she had a metallic taste in the mouth and immediately it led to her head feeling pressure like its full, her brain was doing a lot of stuff like it was misfiring or short circuiting, and then her heart started racing and pounding. She doesn't know if her heart racing was because she got scared or it was the shot. She thought the Metallic taste was no bid deal, sometimes with MRI contrast she understand that can happen but with her Brain it was kind of hard to explain, she's had nothing like it. After the metallic taste, it was like air filling up in the brain, like it was getting full all quick, and the insides of the head were scrambling. Outcome was, the metallic taste went away, it was gone in 30 seconds, quickly the brain thing went away, like a quick 30 seconds or minute. Her heart racing and pounding ended the same day also. After the vaccine they had her sit there, she was afraid to get up, and no one was checking on her at the pharmacy, she just sat there with her heart racing for a couple minutes, it then started to subside, her husband was waiting for her. She did go to the pharma-cist and told them she experienced a side effect, the pharmacist hadn't heard of it before, she was then feeling better but then chest tightness occurred after, she clarified that she was not experiencing it now. Her Heart pound and racing was for about 5 minutes it then subsided and the chest tightness was for 3 hours. She has recovered completely. She laughs and states that mentally it gets her Blood pressure up just talking about it. She is Scheduled for second dose, it's supposed to be in 3 weeks, but they did it in 4 weeks, she thinks it's 14Apr2021. She has sensitivity, a little medicine goes a long way for her, she is sensitive to medications, she doesn't know which reacted with her but she had hydrocodone and Toradol and her heart was racing and was irregular. This was several years ago. Caller states that she misspoke when saying irregular heartbeat, she actually doesn't know if it was irregular, they did not tell her this. Her heart was racing and she was uncomfortable. She can take ibuprofen and she has had it at larger doses and had a problem, she was also very sensitive to caffeine. These experienced were back in Feb2018. She has no Lot or Expiry for Ibuprofen, hydrocodone, and Toradol, they have been discarded. She has no Allergies. The patient underwent lab tests and procedures which included 2 weeks ago she had a panoramic Mouth x-ray around the head, normally for pregnant patient they give a cover on their torso, but the lady told her the radiation was less than the sun and didn't need it. Treatment was nothing used to treat it, she just dealt with it, her Sister-in-Law said the tight-ness of the chest could have been like she was having a panic attack. The outcome of all the events was recovered on 17Mar2021 and soreness of arm was recovered on an unspecified date in 2021. No follow-up attempts are needed. No further information is expected. Follow-up (09Jul2021): Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: x-ray test; Result Unstructured Data: Test Result:unknown; Comments: weeks ago she had a panoramic Mouth x-ray around the head
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hypothyroidism; Morbid obesity
Andere Medikamente: SYNTHROID; PANTOPRAZOLE; VITAMIN D 3; BABY ASPIRIN
Allergien: -
Vorherige Impfungen: -

VAERS 1252407

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NC
Alter: 17,0
Geschlecht: M
Eingang: 30.06.2021
Impfdatum: 11.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arteriovenous malformation Computerised tomogram Craniotomy Haemorrhage intracranial Headache Back pain Coccydynia Fatigue Lymphadenopathy Intensive care Intraventricular haemorrhage Magnetic resonance imaging head abnormal Myalgia

Symptomtext

Constant headaches mainly frontal headache that is sharp and horizontal between the ears at times; Muscle aches; Tail bone pain; Back pain; Significant fatigue; lymphadenopathy in neck; This is a spontaneous report from a contactable other health care professional. A 17-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Unknown), intramuscularly in the right arm on 11Mar2021 at 20:00 (at the age of 17-years-old) as a single dose for COVID-19 immunisation. Medical history was reported as none. Concomitant medications were not reported. Prior to vaccination, the patient had not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 13Mar2021 at 15:00, the patient experienced constant headaches for the last 11 days. Mainly frontal headache that was sharp and horizontal between the ears at the time. The patient experienced muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue on 13Mar2021 at 15:00. Therapeutic measures were taken as a result of events constant headache, muscle ache, tail bone pain, back pain and lymphadenopathy in neck and included treatment with TYLENOL and ibuprofen. The adverse events resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. The clinical outcome of the events headaches, muscle aches, tail bone pain, back pain, lymphadenopathy in neck and significant fatigue was not recovered at the time of reporting. Information about lot/batch number cannot be obtained. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1424035

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 57,0
Geschlecht: M
Eingang: 24.06.2021
Impfdatum: 08.04.2021
Beginn: 03.06.2021
Tage bis Beginn: 56,0
Dosis: 2
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Chest pain Condition aggravated Pain Pericarditis Rheumatoid arthritis

Symptomtext

Approximately one week after vaccination patient experienced a flare up of RA. Rheumatologist increased Prednisone with only minor improvement. On 6/3/21 patient started experiencing radiating chest pain. Presented to ED and was later admitted. He was diagnosed with pericarditis and treated accordingly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: 1,0
Labordaten: Hospital admission 6/3/21-6/4/21- all care received during this admission
Aktuelle Erkrankungen: N/A
Vorgeschichte: Rheumatoid Arthritis
Andere Medikamente: Prednisone, Arava
Allergien: NKA
Vorherige Impfungen: -

VAERS 1421404

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 24,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 21.04.2021
Beginn: 25.05.2021
Tage bis Beginn: 34,0
Dosis: 2
Route/Site: SYR / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dysmenorrhoea Heavy menstrual bleeding Thrombosis

Symptomtext

Heavy, painful menstrual cycle with extreme clotting that has lasted over a month.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: Chiari Malformation Type 1 Hydrocephalus
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: -

VAERS 1420384

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 61,0
Geschlecht: F
Eingang: 23.06.2021
Impfdatum: 02.04.2021
Beginn: 03.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Chills Computerised tomogram Pain in extremity Pyrexia Ultrasound scan Venous thrombosis X-ray normal

Symptomtext

The night of the vaccination I had a sore arm, fever,and chills. The third day I started having a pain that felt like a Charlie horse in my left leg behind the knee. Went to the doctor that Monday, I was giving an X-ray which showed nothing. On that next Friday I went to the ER where they found I had developed 2 blood clots in calve and behind the knee. Since then I have been put on blood thinners.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Venous thrombosis
Hospital-Tage: -
Labordaten: X-Ray; Blood work; Ultrasound; CT scan
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Wellbutrin, Thyroid medicine, vitamins, Crestor, marzipan
Allergien: No
Vorherige Impfungen: -

VAERS 1409743

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: -
Geschlecht: M
Eingang: 18.06.2021
Impfdatum: 19.03.2021
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Blood test Lymphadenopathy

Symptomtext

The vaccine is causing Bell's palsy; The first shot actually gave me, every lymph node has swollen in my body and I ended up in the ER; there was a problem and then ended up getting Bell's palsy 2 weeks later; This is a spontaneous report from a contactable consumer. A 50-year-old male patient received first dose of bnt162b2 (Pfizer Covid-19 Vaccine), via an unspecified route of administration on 19Mar2021 13:00 (Lot number: EN6207) on right arm as single dose for COVID-19 immunisation. The patient medical history included plaque around the heart, nothing else and Covid-19 on 11Feb2021. Prior Vaccination (4 weeks prior) no other vaccination. Concomitant medications included Nadolol, Trazodone, Atorvastatin, Cyclobenzaprine from an unspecified date to unspecified date and unknown indication. It was reported that that the vaccine was causing bells palsy 2 weeks later from first shot. The first shot gave him, every lymph node has swollen in his body and he ended up in the ER; he thought he have a heart attack and that was the first time there was a problem and then ended up getting bells palsy. Due to this patient was hospitalized (tried to think it was Monday 2 weeks ago, 3 weeks ago Monday). In the hospital had blood work and found out that he has bells palsy so, three Monday back from this last Monday he thought this was the Monday right before the Memorial day (further not clarified hence not captured in tab). The patient was treated with Prednisone and the Meclizine. The outcome of the events were unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Test Name: had blood work; Result Unstructured Data: Test Result:Bell's palsy
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Atherosclerotic plaque; COVID-19
Andere Medikamente: NADOLOL; TRAZODONE; ATORVASTATIN; CYCLOBENZAPRINE
Allergien: -
Vorherige Impfungen: -

VAERS 1127265

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 17,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 23.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiovascular evaluation Hyperhidrosis Loss of consciousness Syncope Dizziness Dyspnoea Eye movement disorder Fatigue Speech disorder Throat irritation

Symptomtext

received the vaccine. Not even 5 minutes after receiving it she passed out. Everyday since that vaccine she faints. She starts sweating very bad and then she faints for about 10 to 15 seconds. She faints at school, on the bus, at the prom. Not a day goes by that she doesn't. I wish that I had not made her get it. She was in the hospital overnight. She has now seen a cardiologist and soon a neurologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: blood clotting disease
Vorgeschichte: blood clotting disease since she was 15.
Andere Medikamente: Concerta 54mg warfarin 5.5 mg
Allergien: -
Vorherige Impfungen: -

VAERS 1127265

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: NY
Alter: 17,0
Geschlecht: F
Eingang: 15.06.2021
Impfdatum: 23.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cardiovascular evaluation Hyperhidrosis Loss of consciousness Syncope Dizziness Dyspnoea Eye movement disorder Fatigue Speech disorder Throat irritation

Symptomtext

received the vaccine. Not even 5 minutes after receiving it she passed out. Everyday since that vaccine she faints. She starts sweating very bad and then she faints for about 10 to 15 seconds. She faints at school, on the bus, at the prom. Not a day goes by that she doesn't. I wish that I had not made her get it. She was in the hospital overnight. She has now seen a cardiologist and soon a neurologist.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: -
Aktuelle Erkrankungen: blood clotting disease
Vorgeschichte: blood clotting disease since she was 15.
Andere Medikamente: Concerta 54mg warfarin 5.5 mg
Allergien: -
Vorherige Impfungen: -

VAERS 1357812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MD
Alter: 22,0
Geschlecht: M
Eingang: 11.06.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary normal Chest X-ray normal Chest discomfort Chest pain Dyspnoea Blood test abnormal Electrocardiogram Fatigue Pain Blood test Chest X-ray Echocardiogram normal Electrocardiogram ST segment elevation Electrocardiogram normal Fibrin D dimer increased Limb discomfort Musculoskeletal pain Myalgia

Symptomtext

He started to feel very tired within a couple of hours. He started to have body aches that evening. This continued all day Saturday as well and then he started to complain about pain in his chest. By Sunday morning we took him to the ER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: EKG, x Ray and bloodwork. Troponin levels were elevated.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1357812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MD
Alter: 22,0
Geschlecht: M
Eingang: 11.06.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary normal Chest X-ray normal Chest discomfort Chest pain Dyspnoea Blood test abnormal Electrocardiogram Fatigue Pain Blood test Chest X-ray Echocardiogram normal Electrocardiogram ST segment elevation Electrocardiogram normal Fibrin D dimer increased Limb discomfort Musculoskeletal pain Myalgia

Symptomtext

He started to feel very tired within a couple of hours. He started to have body aches that evening. This continued all day Saturday as well and then he started to complain about pain in his chest. By Sunday morning we took him to the ER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: EKG, x Ray and bloodwork. Troponin levels were elevated.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1357812

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MD
Alter: 22,0
Geschlecht: M
Eingang: 11.06.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Angiogram pulmonary normal Chest X-ray normal Chest discomfort Chest pain Dyspnoea Blood test abnormal Electrocardiogram Fatigue Pain Blood test Chest X-ray Echocardiogram normal Electrocardiogram ST segment elevation Electrocardiogram normal Fibrin D dimer increased Limb discomfort Musculoskeletal pain Myalgia

Symptomtext

He started to feel very tired within a couple of hours. He started to have body aches that evening. This continued all day Saturday as well and then he started to complain about pain in his chest. By Sunday morning we took him to the ER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Myocarditis
Hospital-Tage: 2,0
Labordaten: EKG, x Ray and bloodwork. Troponin levels were elevated.
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1389136

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MN
Alter: 79,0
Geschlecht: M
Eingang: 10.06.2021
Impfdatum: 01.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 21,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Blood lactic acid increased Dehydration Seizure Troponin increased

Symptomtext

Patient presented to the ED with dehydration, elevated lactic acid and seizure, and was subsequently hospitalized for elevated troponin and seizure. This is within 6 weeks of receiving second covid vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 14,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1377168

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 63,0
Geschlecht: F
Eingang: 07.06.2021
Impfdatum: 09.04.2021
Beginn: 03.05.2021
Tage bis Beginn: 24,0
Dosis: UNK
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Bell's palsy Corneal reflex decreased Electric shock sensation Facial paralysis Headache Hypoaesthesia Lacrimation increased

Symptomtext

I had 1st dose Pfizer (EN5318) on 03/19, the 2nd dose (EN6207) on 04/09. On 05/03, I started having headache on the right side of top scalp, like elctric shot every 1 to 2 minutes. Never had this kind of headache before. Tylenol didn't help. On 05/07, went to emergency room, was given a steroid shot. Still had headache but with less frequency. On 05/13, had tearing of right eye, on 05/15, inable to blink, drooping and numbness on the right side of the face. Was diagnosed Bell's Palsy by Dr. Conincidentally, My Sister-in-Law had two Pfizer doses on 04/06 (EN6207) and 04/28(EN8733). on 05/29, she had all symptons that I had two weeks before and was dignosed Bell's Palsy.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: V-C, V-D, B-Complex, Caltrate, Omega-3 HDA
Allergien: N/A
Vorherige Impfungen: -

VAERS 1374507

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 36,0
Geschlecht: M
Eingang: 04.06.2021
Impfdatum: 12.03.2021
Beginn: 13.04.2021
Tage bis Beginn: 32,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Blood test Dyspnoea Shock symptom

Symptomtext

Mild "shock" feeling in heart. Sometimes shortness of breath. These were very mild until recently, and I was blaming it on diet until a friend told me of a similar issues discovered to be a side-effect or Miocarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Shock symptom
Hospital-Tage: -
Labordaten: No labs yet. Dr made me an appointment for blood work. I will go in as soon as possible.
Aktuelle Erkrankungen: No
Vorgeschichte: Unknown
Andere Medikamente: Emergen-C V8 Juice
Allergien: None
Vorherige Impfungen: -

VAERS 1370634

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 43,0
Geschlecht: F
Eingang: 03.06.2021
Impfdatum: 16.05.2021
Beginn: 16.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Paralysis Ulnar nerve palsy

Symptomtext

Within 30 minutes of receiving the 1st dose of the covid19 vaccine in my left shoulder my left hand and wrist became completely paralyzed.; Ulnar Palsy; This is a spontaneous report from a contactable consumer (patient). A 43-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6207, expiration date not provided), 1st dose via an unspecified route of administration, administered in arm left on 16May2021 15:30 at age of 43 years old as a single dose for COVID-19 immunisation. Medical history included latex sensitivity. The patient's concomitant medications were not reported. The patient experienced within 30 minutes of receiving the 1st dose of the COVID-19 vaccine in her left shoulder her left hand and wrist became completely paralyzed on 16May2021 16:00. The ER said it was random coincidence and diagnosed it as Ulnar Palsy on 16May2021 16:00. The events were reported as being disability. Therapeutic measures were taken as a result of all events. The outcome of the events was not recovered. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not received any other medications within 2 weeks of vaccination. The adverse event resulted in visiting doctor or other healthcare professional office/clinic. The adverse event result in visiting Emergency room/department or urgent care. Treatment for the adverse event was included ER (emergency room) Exam. The patient was not pregnancy at time of vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Information on the lot/batch number has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Latex allergy
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1358560

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 73,0
Geschlecht: F
Eingang: 28.05.2021
Impfdatum: 13.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 3,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Condition aggravated Seizure

Symptomtext

Patient was admitted with a breakthrough seizure episode. Although patient had history of seizures, admitting provider had concerns that breakthrough seizure may have occurred due to vaccine inflammatory response.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 4,0
Labordaten: -
Aktuelle Erkrankungen: Unknown, none documented.
Vorgeschichte: CVA, seizure, L and R ICA stenosis, DM type 2, CAD s/p stenting, Vascular dementia, HTN, HLD
Andere Medikamente: Albuterol HFA, Amlodipine, Aspirin, Atorvastatin, Bisacodyl, Levetiracetam, Lisinopril, Metformin, Metoprolol, Mirtazapine, Multivitamin.
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1349440

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 39,0
Geschlecht: F
Eingang: 26.05.2021
Impfdatum: 26.03.2021
Beginn: 26.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Dyspnoea Food allergy Heart rate Heart rate increased Insomnia Palpitations Panic attack Presyncope Syncope

Symptomtext

could not sleep at all; fainted; felt worse fainted and almost felt passing out; multiple panics attacks during the day; sensitiveness to salty food; palpitations/heart palpitation 138 "bps"; heart raised really quick; felt difficulty breathing; This is a spontaneous report received via COVID-19 Vaccine Adverse Event Reporting System (COVAES). A conta sctable consumer (patient) reported a 39-year-old female patient received dose 1 of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; lot number EN6207) via an unspecified route of administration on 26Mar2021 at 10:00 (at the age of 39-years-old) as aingle dose in the left arm for COVID-19 immunization. Medical history included non-alcoholic steatohepatitis (NASH) and pre-diabetic. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the vaccine. The patient was not diagnosed with COVID-19 prior to the vaccine. Concomitant medications included multivitamins. The patient did not have any allergies. On 26Mar2021, ten minutes after the vaccine (also reported as 10:15) the patient experienced heart raised really quick and felt difficulty breathing but calmed down and left the site. The next day (27Mar2021) she drank coffee like every morning but noticed palpitations, noticed sensitiveness to salty foods after ingestion felt palpitations but was not concerned as she thought it was a side effect. On 31Mar2021 she suddenly woke up at 05:00 with heart palpitations "138 bps." She thought it was going to go away but she felt worse, fainted, and almost "felt" passing out. Paramedics showed up and her heart rate was 115 but nothing serious, suspected panic attack. She never had before so she thought it was going to go away but she had multiple panic attacks during the day and night, could not sleep at all for 3 consecutive days. The patient visited a doctor as a result of the events. She was prescribed trazodone "one at night." The patient also saw a cardiologist for the palpitations and was treated with metoprolol 25 mg twice a day to control palpitations but the meds gave her intrusive thoughts and deep depression with suicidal thoughts. The outcomes of heart raised really quickly/palpitations, difficulty breathing, sensitiveness to salty foods, fainted, almost "felt" passing out, and panic attacks were recovering. No follow-up attempts are possible. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Test Date: 20210331; Test Name: heart; Result Unstructured Data: Test Result:138 "bps"; Test Date: 20210331; Test Name: heart; Result Unstructured Data: Test Result:115
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Non-alcoholic steatohepatitis (NASH); Pre-diabetic
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1346514

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 25.05.2021
Impfdatum: 12.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Hospitalisation

Symptomtext

Patient had an ED visit and/or hospitalization within 6 weeks of receiving COVID vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hospitalisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1323477

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 46,0
Geschlecht: F
Eingang: 22.05.2021
Impfdatum: 14.04.2021
Beginn: 10.05.2021
Tage bis Beginn: 26,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Computerised tomogram Dyspnoea Thrombosis Pulmonary thrombosis SARS-CoV-2 test

Symptomtext

I started having shortness of breath and went to the emergency room. It was determined I had blood clots in both lungs based on a CT Scan; This is a spontaneous report from a contactable consumer (patient). A 46-years-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 14Apr2021 (Lot Number: EW0153) as 2ND DOSE,SINGLE for covid-19 immunisation. Medical history included Sleep apnoea. No other vaccine in four weeks. No COVID prior vaccination. Concomitant medication(s) included phentermine hydrochloride (LOMAIRA); fluoxetine; loratadine (CLARITIN); diphenhydramine and Charlotte24 (unspecified). The patient previously took morphine and tetracycline and experienced drug allergy. Patient took the first dose of bnt162b2 (lot number EN6207) in right arm on 17Mar2021 for covid-19 immunisation. The patient started having shortness of breath and went to the emergency room on 10May2021. It was determined she had blood clots in both lungs based on a CT Scan. AE resulted in Emergency room/department or urgent care, Hospitalization, Life threatening illness (immediate risk of death from the event), Disability or permanent damage. The patient hospitalized for two days. Patient received blood thinners as treatment. The patient had covid test type post vaccination nasal swab on 14May2021 with negative result. The outcome was recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 2,0
Labordaten: Test Date: 20210510; Test Name: CT scan; Result Unstructured Data: Test Result:blood clots in both lungs; Test Date: 20210514; Test Name: Nasal swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Sleep apnoea
Andere Medikamente: LOMAIRA; FLUOXETINE; CLARITINE; DIPHENHYDRAMINE
Allergien: -
Vorherige Impfungen: -

VAERS 1334117

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MA
Alter: 43,0
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: 17.03.2021
Beginn: 29.03.2021
Tage bis Beginn: 12,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Anticoagulant therapy Axillary vein thrombosis Blood test Chest X-ray normal Cyanosis Deep vein thrombosis Differential white blood cell count normal Electrocardiogram normal Full blood count normal International normalised ratio normal Metabolic function test normal Paraesthesia Peripheral swelling Prothrombin time normal Skin discolouration Spinal X-ray normal Subclavian vein thrombosis Ultrasound Doppler abnormal

Symptomtext

Started with the right arm turning purple or changing colors when elevated above the head. This continued for a few weeks. Then I started to get a tingling sensation in the elbow that went into the right pinky. I visited my primary doctor to see what was going on. She did an evaluation, prescribed Ibuprofen and physical therapy, and had a cervical spine x-ray done. The X-ray looked great when it came back. I could not get an appointment with PT for several weeks so I finally went to the chiropractor on 5/13. He worked on the shoulder area stretching it out. By the morning of 5/15 I was being taken to urgent care and eventually the ER because the arm was swelling and fingers were turning blue. They did blood tests, EKG, chest x-ray, and finally an ultrasound that showed a blood clot. It was DVT in the subclavian vein. I was given a blood thinner and sent home. I had a more thorough ultrasound on 5/17 that sent me back to the ER and with vascular surgeons to discuss immediate surgery with lysis therapy. It was decided that the blood clot had probably been there for weeks and the success rate of the surgery would not be as good.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Axillary vein thrombosis
Hospital-Tage: -
Labordaten: See above. 5/15- Protime-INR, basic metabolic panel, CBC with auto differential, ECG 12- lead, XR chest- all came back normal 5/18- Upper limb venous duplex scan- came back saying "large occlusive acute DVT in right proximal subclavian, right proximal axillary, right distal axillary and right brachial veins
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Junel FE
Allergien: none known
Vorherige Impfungen: -

VAERS 1168525

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: MO
Alter: -
Geschlecht: F
Eingang: 20.05.2021
Impfdatum: -
Beginn: -
Tage bis Beginn: -
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Computerised tomogram head Facial paralysis Fibromuscular dysplasia Hypoaesthesia Magnetic resonance imaging head Drug interaction Electroencephalogram Heart rate irregular Hyperthyroidism Paraesthesia oral Pharyngeal paraesthesia Paraesthesia Product dose omission issue Seizure Thyroid function test Visual impairment Weight

Symptomtext

CONVULSIONS/SEIZURES; HYPERTHYROIDISM; DRUG INTERACTION; FLUCTUATING HEART RATE; NUMBNESS DOWN FACE; NUMBNESS AND TINGLING IN ARM; ABNORMAL VISION; SKIPPED DOSES; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included covid-19 infection, and concurrent conditions included neurological issues related to covid, and seizures. On 19-MAR-2021, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, frequency once total, administered for prophylactic vaccination. The patient received Topiramate (capsule, hard, oral, batch number was not reported) 100 mg, 1 time every 1 day, from OCT-2020, 100 mg, 1 time every 1 day, from 08-MAY-2021, and 200 mg, frequency, and therapy dates were not reported for neurological issues related to covid. The batch number was not reported and has been requested. Concomitant medications included thyroid. On an unspecified date in 2021, the patient experienced hyperthyroidism, and was hospitalized (date unspecified) and experienced convulsions/seizures, numbness down face, abnormal vision, fluctuating heart rate, numbness and tingling in arm and had skipped doses (coded as drug dose omission). Patient went to the hospital where she had stopped Topamax for 6 days to check whether electroencephalogram (EEG) would show up, and thyroid function test (NR: not provided) high (hyperthyroid). levels had dropped. The hospital ultimately could not found anything. But she went back to a different hospital for more neurological testing and was taken off of Topamax again. She had another thyroid test and her levels had dropped. On, 07-May-2021, the patient was discharged and started taking it again from the night of 08-May-2021.The numbness had came back. She saw online that Topamax and Armour Thyroid should not be combined. She mentioned that at some point her dose was increased to 200 mg a day and she had experienced more seizures. On an unspecified date in 2021, the patient experienced drug interaction The action taken with covid-19 vaccine ad26.cov2.s was not applicable; and action taken with Topiramate was not reported. The patient recovered from hyperthyroidism, had not recovered from numbness down face, and abnormal vision, convulsions/seizures, fluctuating heart rate and numbness drug interaction and tingling in arm was not reported. This report was serious (Hospitalization Caused / Prolonged). This report was associated with a product quality complaint 90000179114.; Sender's Comments: V0. 20210522141-COVID-19 VACCINE AD26.COV2.S -Convulsions/Seizures, Hyperthyroidism, Drug interaction. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s). 20210522141-TOPOMAX-Convulsions/Seizures. This event(s) is labeled per RSI and is therefore considered potentially related. 20210522141-TOPOMAX-Hyperthyroidism, Drug interaction. This event(s) is considered unassessable. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There is no information on any other factors potentially associated with the event(s).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Test Date: 2021; Test Name: EEG; Result Unstructured Data: Not reported; Test Date: 2021; Test Name: Thyroid function test; Result Unstructured Data: Levels had dropped.; Test Date: 2021; Test Name: Thyroid function test; Result Unstructured Data: High (hyperthyroid).; Test Date: 202103; Test Name: Weight; Result Unstructured Data: Dropped 15 pounds in one month
Aktuelle Erkrankungen: Nervous system disorder; Seizures
Vorgeschichte: Medical History/Concurrent Conditions: COVID-19
Andere Medikamente: TOPAMAX; ARMOUR THYROID
Allergien: -
Vorherige Impfungen: -

VAERS 1331254

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: VA
Alter: 84,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 24.03.2021
Beginn: 06.05.2021
Tage bis Beginn: 43,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

Asthenia Blood pressure decreased Blood test normal Diarrhoea Dysstasia Electroencephalogram normal Hyperhidrosis Loss of consciousness SARS-CoV-2 test negative Syncope Unresponsive to stimuli

Symptomtext

6 weeks after her second Pfizer vaccine, my mom was sitting at the kitchen table after eating breakfast when she had a syncopal episode (she was unresponsive and lost consciousness for a few minutes). I called 911, and when the paramedics came, her blood pressure was very low and she was sweating heavily. She was very weak and couldn't stand up. She had a similar episode 10 days earlier while having a bowel movement (and also experience diarrhea at that time). She was taken to the ER and was admitted to the hospital for 2 days where testing was done.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 2,0
Labordaten: Blood tests showed no issues. EEG was normal, so she did not have a seizure or stroke. Tested negative for Covid-19. Doctors could not find anything wrong with her.
Aktuelle Erkrankungen: none
Vorgeschichte: high blood pressure, history of CVA, CAD and HTN BIBA
Andere Medikamente: lisinopril, amlodipine, aspirin, atorvastatin, carbamazepine, docusate sodium, meloxicam
Allergien: none
Vorherige Impfungen: -

VAERS 1330354

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MA
Alter: 71,0
Geschlecht: F
Eingang: 19.05.2021
Impfdatum: 07.04.2021
Beginn: 18.05.2021
Tage bis Beginn: 41,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

COVID-19 Cough Dyspnoea Hypoxia Pleural effusion Pulmonary oedema SARS-CoV-2 test positive

Symptomtext

Breakthrough case hospitalized with complications of COVID-19 including hypoxia, pleural effusions, and interstitial edema. First positive test on 5/10/21. Hospitalized on 5/18/21. Other symptoms include shortness of breath and cough.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pulmonary oedema
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: COPD, chronic respiratory failure, CHF
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1323543

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MS
Alter: 20,0
Geschlecht: M
Eingang: 17.05.2021
Impfdatum: 21.04.2021
Beginn: 21.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

Patient stated he " blacked out after vaccine"RN spoke with Dr. and advised that patient receive second dose of vaccine in physicians office. Patient verbalized understanding. Patient declined ED services.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: no
Allergien: n/a
Vorherige Impfungen: -

VAERS 1322837

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IN
Alter: 26,0
Geschlecht: F
Eingang: 17.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction Aphasia Chest discomfort Choking Cough Dizziness Dyspnoea Pharyngeal swelling Throat tightness Visual impairment

Symptomtext

Anaphylaxis 2 hours after vaccine. Extreme swelling/tightening of throat, difficulty breathing, talking, dizziness and feeling faint, spots in vision, choking, coughing, chest tightness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: no
Vorgeschichte: chronic, severe allergies. Hives. Possible Mast Cell disorder.
Andere Medikamente: zrytec
Allergien: celexa, onion, garlic, all fragrance and chemical smells, cats, dogs, rabbits, mold, pollen
Vorherige Impfungen: flu shot, 16, fainting rest unknown

VAERS 1322368

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 36,0
Geschlecht: F
Eingang: 16.05.2021
Impfdatum: 17.03.2021
Beginn: 16.05.2021
Tage bis Beginn: 60,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood thyroid stimulating hormone Dizziness Dyspnoea Echocardiogram Electrocardiogram abnormal Full blood count Metabolic function test Presyncope Pruritus Tachycardia Urticaria

Symptomtext

Tachycardia with symptoms of lightheadedness, shortness of breath, presyncope. Started 11 days after second dose of vaccine. Tachycardia is occurring daily now and appears to be associated with standing/walking and better/normal when sitting/laying. Also new itching/hives on face, neck, and chest that began 4/1/2021. Lasts 1-2 days and happens once a week or so.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: EKG sinus tachycardia ECHO and tilt table test pending CBC, BMP, TSH WNL
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1320895

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 21,0
Geschlecht: M
Eingang: 15.05.2021
Impfdatum: 15.05.2021
Beginn: 15.05.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Loss of consciousness Syncope

Symptomtext

Pt mentioned prior history of fainting after IVs. Seemed apprehensive to receive vaccine but did want to receive it. Before being able to apply bandaid to injection site, pt wiped their arm (x2) and had blood on hand. Seemed uncomfortable with sight of blood. Pt was asked to take a seat and wait for 25-30 minutes to be monitored since having prior history of loss of consciousness. Pt went to waiting area and was walking around when he lost consciousness and fell to the ground. Fell on his back and did not hit his head. Was able to answer questions about his name/DOB/current date. Pt was immediately responsive and alert. 911 was called. Pt refused medical care other than cold compress and water. Pt was alert and walking on their own at the time of leaving

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: Vyvanse, Temazepam
Allergien: N/A
Vorherige Impfungen: history of fainting at sight of needles and previous IVs

VAERS 1305668

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 56,0
Geschlecht: F
Eingang: 11.05.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction Balance disorder Blood pressure measurement Cough Disease recurrence Headache Hypoaesthesia Investigation Nausea Throat irritation Throat tightness Vision blurred Visual field defect

Symptomtext

anaphylaxis; headache with numbness; headache with numbness; blurred vision and nausea from headache; blurred vision and nausea from headache; has been trapping food since in her throat; had irritation in her throat; coughing; coughing; off balance; couldn't see straight; This is a spontaneous report from a contactable consumer (patient). A 56-year-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN6207), via an unspecified route of administration, administered in Left Arm on 18Mar2021 10:30 (at age of 56 years old) as single dose for COVID-19 immunisation. Relevant medical history included: Asthma, immune problems, upper respiratory stuff, all ongoing; Her Diagnosed allergies include iodine fish, Propofol, and preservatives, sleep apnea, had COVID in Jan2021, and had a cough (Jan2021) from that. There were no concomitant medications. The patient previously took iodine, propofol and had allergies. Patient took first dose on 18Mar for reason that patient has lost all allergies that cannot be detected by blood work. After first short she was told to wait an extra 15 mins not vitals taken she can leave a felt like a specimen unpaid but paying with life. Patient started coughing while everyone watched her so she said she better take Benadryl cause she doesn't wanna die. Patient left had off balance couldn't see straight. She was the one that had all side effects from vaccine as well as COVID signs. She had research medicine/food that cause her to have anaphylaxis. Patient found same ingredients in vaccine but food and drug said it ok. Patient was an experiment. She need to no from your board it is ok for me to take 2nd vaccine. Patient should be getting paid. Her doctor making it seem it up to her she gotta go out and get and epi pen she cant afford. In running out of gloves and mask. The patient experienced Anaphylaxis, has been trapping food since in her throat, headache with numbness, Cough, blurred vision and nausea from headache, all on 18Mar2021. Caller has been coordinating with the CDC by email. Since day one she had a bad reaction to the COVID vaccine. This has been going on a month now. The CDC advised her not to get the second shot. She has went back and forth with the doctor. She had anaphylaxis from the vaccine. Her throat closed. She had irritation in her throat. She has been trapping food since in her throat. This has been since the anaphylactic reaction. She has to chew her food as fine as possible. She tries not to eat that much. This is still the same. It hasn't improved or worsened. She has also had a headache with numbness that is pretty much 24 hours a day. This started right after. She really felt it the next day. She tried to take Tylenol for four days, three times a day, and nothing happened. It was not going away. Her doctor also put her on a migraine medication, but it didn't work either. The headache has worsened over time. No medication is helping, and the doctors are confused. The migraine medicine is not helping. Her pressure is going up and down. She is wondering if she needs an emergency echo to see what is going on. She is still having bad effects. No doctor knows what to do. She has been to a lung specialist. Her cough just keeps getting worse. The cough started to get worse after the vaccine. She had COVID in Jan2021, and had a cough from that, but the vaccine made it worse. It is a ruff cough. She is on cough suppressant medication. Caller did not have a prescribing doctor. She got it at the hospital. She figured that was the safest, and since she is a patient there they emailed her because she was eligible to get it. She is mostly calling because the doctors don't know how to help. She is about to pass out from this headache. She is even losing vision from the headache. She feels like she is going to have a heart attack before her time. They are trying to figure out why her head is hurting. They do not think it is a migraine. Her headache is a 9/11 or a 10/12. She feels like after the vaccine she has been chemically off balance. She wants to get her thyroid checked too. Mostly because her food is getting trapped in her throat. Her throat is irritated and hoarse. The headache has given her blurred vision, and a felling like she is going to throw up. She feels off balance from the blurred vision. Caller had difficulty seeing information on Tylenol and Nurtec. She asked her husband to help. They cannot read the lot on the Tylenol. She has been to so many specialists to try to find answers, and no one has a clue. She saw on Pfizer's paperwork that she needs to reach out to a immunologist. Her allergist had no clue. From the world trade centers falling she has ongoing issues from that. She has sleep apnea, allergies, asthma, etc. She spent 30 minutes being monitored at the hospital. She had started coughing. Her husband said she needed water. She always carries Benadryl with her. Finally she felt like she needed to take her Benadryl. It saved her. She knows the Benadryl probably won't work forever, but she cannot afford an epi Pen. Time of Onset (24 hours clock): right after vaccine (18Mar2021). All events require a visit to Physician Office. She didn't have to go the ER. She was lucky with the Benadryl. She takes Benadryl with her everywhere even to restaurants. No Prior Vaccinations (within 4 weeks). Treatment received for coughing, headache with numbness, blurred vision and nausea from headache. The outcome of the event has been trapping food since in her throat, had irritation in her throat, headache with numbness, blurred vision and nausea from headache was not recovered, for other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: pressure; Result Unstructured Data: Test Result:going up and down; Test Name: blood work; Result Unstructured Data: Test Result:lost all allergies that cannot be detected; Comments: lost all allergies that cannot be detected by blood work; Test Name: headache; Result Unstructured Data: Test Result:9/11; Test Name: headache; Result Unstructured Data: Test Result:10/12
Aktuelle Erkrankungen: Asthma; Immune system disorder; Upper respiratory disorder
Vorgeschichte: Medical History/Concurrent Conditions: Cough (She had COVID in Jan2021, and had a cough from that); COVID-19; Fish allergy; Reaction to preservatives; Sleep apnea
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1302977

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 46,0
Geschlecht: F
Eingang: 10.05.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Anaphylactic reaction Eye swelling Hypersensitivity Throat irritation Throat tightness

Symptomtext

Eye swollen closed, throat scratchy and swollen. Per ED MD, severe allergic reaction consistent with anaphylaxis. Also has allergy to ibuprofen and reports took some earlier today; mistook the brand name for acetaminophen.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1288419

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WI
Alter: 97,0
Geschlecht: F
Eingang: 05.05.2021
Impfdatum: 11.03.2021
Beginn: 01.03.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Dizziness Eye disorder Fatigue

Symptomtext

fatigue; Eyesight; Dizzy; bell's palsy; This is a spontaneous report from a contactable consumer (patient's son). A 97-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/lot number: EN6207) intramuscularly in the right arm on 11Mar2021 at 14:00 as a single dose for COVID-19 immunization. Patient's medical history included glaucoma for more than 25 years - 'implants caser' (as reported), thyroid disorder for more than 25 years, eye disorder, and gastrointestinal disorder. The patient had no other prior vaccinations to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Batch/lot number: EN6201) intramuscularly in the right arm on 18Feb2021 at 15:00 as a single dose for COVID-19 immunization and experienced cannot focus with her eyes and full body aches and pains. Ongoing concomitant medications included timolol ("Timnol") drops for the eyes since more than 5 years, levothyroxine sodium (LEVOTHYROXIN) pill for thyroid since more than 20 years, and omeprazaole pill for stomach for 5 years. One week after the second injection (Mar2021), the patient experienced Bell's Palsy at 20:30, reported as serious for important medical event. On 12Mar2021 at 22:00, patient was dizzy and 'eyesight', both events reported as non-serious. It was further described as, "She saw patient over everything so she slept. Day after 2nd she had to had most of day as too Dizzy/fatigued to be mobile. Dangling/twisting side of face last 7 days ongoing." The patient did not receive treatment for Bell's palsy, dizzy or eyesight. The clinical outcome of Bell's palsy was not recovered, of dizzy was recovering, of eyesight was recovered on unspecified date, of fatigued was unknown.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021185916 Same patient, reporter, event, different vaccine dosing

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Eye disorder; Gastrointestinal disorder; Glaucoma (Onset Date: 25+yrs Pertinent Details: implants caser?); Thyroid disorder (Onset Date: 25+yrs)
Andere Medikamente: TIMOLOL; LEVOTHYROXIN; OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1286643

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 64,0
Geschlecht: F
Eingang: 04.05.2021
Impfdatum: 25.03.2021
Beginn: 26.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Apraxia Asthenia Base excess increased Blood bicarbonate increased Carbon dioxide increased Chest X-ray abnormal Condition aggravated Diplopia Dysphagia Dyspnoea Immunoglobulin therapy Impaired driving ability Impaired work ability Insomnia Intensive care Mastication disorder Myasthenia gravis Posture abnormal

Symptomtext

EXACERBATION OF MYASTHENIA GRAVIS:DOUBLE VISION, DIFFICULTY SWALLOWING, THROAT CLOSES UP,CHEWING DIFFICULTY, EXTREME WEAKNESS,BREATHING PROBLEMS DIAPHRAM GETS EXTREMELY WEAK, LEGS GIVE OUT WHILE WALKING, ARMS ARE WEAK, EYELIDS WONT STAY OPEN, CANTS HOLD MY HEAD UP MOST OF THE TIME, SLEEPLESSNESS, THESE SYMTOMS STARTED SLOWLY AND ADVANCED AS TIME WENT ON. I STILL STRUGGLE TO THIS DAY, CANT TAKE CARE OF MYSELF, CANT DRIVE, CAN'T WORK I WAS SENT TO THE EMERGENCY ROOM BY MY DOCTOR, THEY PUT ME IN THE ICU, WAS GIVEN 2 TRATMENTS OF IVIG IT DID NOT HELP. THIS FORM WILL NOT LET ME FILL IN NAME OF HOSPITAL: I WAS IN THE HOSPITAL FOR 3 DAYS. I HAD THIS CONDITION UNDER CONTROL FOR 12 yr

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: ARTERIAL BLOOD GAS/HCO3 ARTERIAL-30MMOL/L--HIGH, BASE EXCESS ARTERIAL -5-HIGH BLOOD TEST SHOW CARBON DIOXIDE HIGH DUE TO EXACERATION OF MYASTHENIA GRAVIS CHEST XRAY SHOWS LOW LUNG V
Aktuelle Erkrankungen: none
Vorgeschichte: MYASTHENIA GRAVIS,HYPOTHYROIDISM,HYPERTENION,KIDNEY DISEASE, DIVERTIUOSIS,NEUROPATHY,TIA,OSTEOPORSIS,AETRIAL FIBILLATI
Andere Medikamente: POTASSIUM CIT,CLONIDINE,PYRIDOSTIGMINE,LEVOTHYROXINE,FUROSEMID
Allergien: SULFA,ZOFRAM,CIPROFLOXCIN,FLUCINELONE,INHALED ANESTHETICS,MEPE
Vorherige Impfungen: -

VAERS 1282675

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 46,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 22.04.2021
Beginn: 23.04.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Seizure

Symptomtext

Seizure

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 5,0
Labordaten: 4/23/2021
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Vitamin c breo albuterol psyllium iron pills
Allergien: None
Vorherige Impfungen: -

VAERS 1281729

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MN
Alter: 47,0
Geschlecht: M
Eingang: 03.05.2021
Impfdatum: 13.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Hyperhidrosis Loss of consciousness Pallor Syncope

Symptomtext

Pt Pt became pale & diaphoretic, losing conciousness for 2-3 seconds. Transported to Observation Area. BP 118/72 P60 R16. Says has a history of fainting with IV's. Pt stabilized & released & he notified wife that he was coming home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1122166

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 87,0
Geschlecht: F
Eingang: 03.05.2021
Impfdatum: 20.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: ja

C-reactive protein Chest X-ray Chest pain Computerised tomogram abdomen Computerised tomogram head Chills Communication disorder Dyspnoea Eye movement disorder Lethargy Echocardiogram Electrocardiogram Fibrin D dimer Full blood count Malaise Nausea Pallor Posture abnormal

Symptomtext

Outcome - recovered, discharged from hospital to home. Events: 5 minutes after vaccination patient reported not feeling well, became pale, eyes intermittently rolling back, lethargic and unable to keep head upright, nauseated, had trouble breathing. No hives. She was treated with an Epi Pen, oxygen, and transported via EMS to hospital. Symptoms in ER also included chest pain treated with NTG, ASA and solumedrol/benadryl/pepcid orally. Chest pain resolved with treatment. Inpatient testing unrevealing.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: 5,0
Labordaten: breathing: chest xray. nuclear perfusion study of lungs syncope: ultrasound carotids ; CT head ; EKG and Echo persistent nausea: CT abd/pelvis LABS: COVID and respiratory pathogen testing testing; chemistries; CBC, D-dimer, CRP, Troponins.
Aktuelle Erkrankungen: HTN, chronic CHF
Vorgeschichte: CHF, ASCVD, MR, HTN, atrial fibrillation, has pacemaker , hx pancreatitis, arthritis (hx bilat TKR); remote hx MI, GERD, CKD3, meningeal neoplasm, OSA, bronchiectasis, ILD, Lumbar radiculopathy, cervical spondylosis , thrombocytopenia
Andere Medikamente: ASA 81 mg daily; atorvastatin 40 mg daily, metoprolol XL 25 mg daily, NTG prn, omeprazole 20 mg daily; fluticasone nasal spray ; amlodipine 5 mg daily; furosemide 5 mg daily , myrbetriq prn, spironolactone 25 mg daily
Allergien: ACE inhibitors, fentanyl, iv contrast, morphine, penicillin , possible allergy to hydrochlorotihiazide (possible pancreatitis trigger).
Vorherige Impfungen: -

VAERS 1171733

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angioedema Blood pressure increased Blood test Electric shock sensation Flushing Blood pressure measurement Burning sensation Chills Eating disorder Frustration tolerance decreased Heart rate Heart rate increased Hot flush Respiratory rate increased Hypersensitivity Hypertension Jaw disorder Lip swelling

Symptomtext

body is responding to food, water and medicine like it is foreign; she is frustrated; elevated heart rate/rapid heart rate; Angioedema; having a hard time finding food to eat; water makes tongue swell and tingle; lip swelling; respiration changes from clothing; extreme hypersensitivity; heart racing; tongue tingling; rapid breathing/rapid respirations; nervousness; chills; burning sensation in her body; skin itches; bumps on back and abdomen; lock jaw at night; skin feels like it is thinning out; breathing stops and starts at night; electrical charges that were prickly in her body; warm flush; high blood pressure/blood pressure went up; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 17Mar2021 at 08:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history was none. There were no concomitant medications. On an unspecified date, the patient experienced body is responding to food, water and medicine like it is foreign and she is frustrated. On 17Mar2021, the patient experienced high blood pressure/blood pressure went up (which required an emergency room visit), electrical charges that were prickly in her body, and warm flush. On 18Mar2021, the patient experienced angioedema, extreme hypersensitivity, heart racing, tongue tingling (which required an emergency room visit), rapid breathing/rapid respirations (which required an emergency room visit), nervousness, chills, burning sensation in her body, skin itches, bumps on back and abdomen, lock jaw at night, skin feels like it is thinning out, breathing stops and starts at night, having a hard time finding food to eat, water makes tongue swell and tingle, lip swelling (which required an emergency room visit), and respiration changes from clothing, elevated heart rate/rapid heart rate (which required an emergency room visit). The patient underwent lab tests and procedures which included blood pressure measurement: high on an unknown date, blood pressure measurement: had gone down on 17Mar2021, blood pressure measurement: 164/100 on 17Mar2021, blood pressure measurement: 176/100 on 17Mar2021, blood pressure measurement: went up on 17Mar2021, heart rate: rapid on 18Mar2021, heart rate: elevated on 18Mar2021, respiratory rate: rapid on 18Mar2021. Therapeutic measures were taken as a result of high blood pressure/blood pressure went up (hypertension). The outcome of electrical charges that were prickly in her body, body is responding to food, water and medicine like it is foreign, warm flush and frustrated was unknown. The outcome of the other events was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021427769 Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:High; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:had gone down; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:164/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:176/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:went up; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:rapid; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Date: 20210318; Test Name: breathing; Result Unstructured Data: Test Result:rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1171733

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge en6207

schwer

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angioedema Blood pressure increased Blood test Electric shock sensation Flushing Blood pressure measurement Burning sensation Chills Eating disorder Frustration tolerance decreased Heart rate Heart rate increased Hot flush Respiratory rate increased Hypersensitivity Hypertension Jaw disorder Lip swelling

Symptomtext

body is responding to food, water and medicine like it is foreign; she is frustrated; elevated heart rate/rapid heart rate; Angioedema; having a hard time finding food to eat; water makes tongue swell and tingle; lip swelling; respiration changes from clothing; extreme hypersensitivity; heart racing; tongue tingling; rapid breathing/rapid respirations; nervousness; chills; burning sensation in her body; skin itches; bumps on back and abdomen; lock jaw at night; skin feels like it is thinning out; breathing stops and starts at night; electrical charges that were prickly in her body; warm flush; high blood pressure/blood pressure went up; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 17Mar2021 at 08:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history was none. There were no concomitant medications. On an unspecified date, the patient experienced body is responding to food, water and medicine like it is foreign and she is frustrated. On 17Mar2021, the patient experienced high blood pressure/blood pressure went up (which required an emergency room visit), electrical charges that were prickly in her body, and warm flush. On 18Mar2021, the patient experienced angioedema, extreme hypersensitivity, heart racing, tongue tingling (which required an emergency room visit), rapid breathing/rapid respirations (which required an emergency room visit), nervousness, chills, burning sensation in her body, skin itches, bumps on back and abdomen, lock jaw at night, skin feels like it is thinning out, breathing stops and starts at night, having a hard time finding food to eat, water makes tongue swell and tingle, lip swelling (which required an emergency room visit), and respiration changes from clothing, elevated heart rate/rapid heart rate (which required an emergency room visit). The patient underwent lab tests and procedures which included blood pressure measurement: high on an unknown date, blood pressure measurement: had gone down on 17Mar2021, blood pressure measurement: 164/100 on 17Mar2021, blood pressure measurement: 176/100 on 17Mar2021, blood pressure measurement: went up on 17Mar2021, heart rate: rapid on 18Mar2021, heart rate: elevated on 18Mar2021, respiratory rate: rapid on 18Mar2021. Therapeutic measures were taken as a result of high blood pressure/blood pressure went up (hypertension). The outcome of electrical charges that were prickly in her body, body is responding to food, water and medicine like it is foreign, warm flush and frustrated was unknown. The outcome of the other events was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021427769 Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:High; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:had gone down; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:164/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:176/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:went up; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:rapid; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Date: 20210318; Test Name: breathing; Result Unstructured Data: Test Result:rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1171733

UNKNOWN MANUFACTURER · VACCINE NOT SPECIFIED (NO BRAND NAME) · Charge en6207

schwer

Staat: VA
Alter: 64,0
Geschlecht: F
Eingang: 01.05.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Angioedema Blood pressure increased Blood test Electric shock sensation Flushing Blood pressure measurement Burning sensation Chills Eating disorder Frustration tolerance decreased Heart rate Heart rate increased Hot flush Respiratory rate increased Hypersensitivity Hypertension Jaw disorder Lip swelling

Symptomtext

body is responding to food, water and medicine like it is foreign; she is frustrated; elevated heart rate/rapid heart rate; Angioedema; having a hard time finding food to eat; water makes tongue swell and tingle; lip swelling; respiration changes from clothing; extreme hypersensitivity; heart racing; tongue tingling; rapid breathing/rapid respirations; nervousness; chills; burning sensation in her body; skin itches; bumps on back and abdomen; lock jaw at night; skin feels like it is thinning out; breathing stops and starts at night; electrical charges that were prickly in her body; warm flush; high blood pressure/blood pressure went up; This is a spontaneous report from a Pfizer-sponsored program from a contactable consumer (patient). A 64-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in the left arm on 17Mar2021 at 08:00 (Batch/Lot Number: EN6207) as single dose for COVID-19 immunisation. Medical history was none. There were no concomitant medications. On an unspecified date, the patient experienced body is responding to food, water and medicine like it is foreign and she is frustrated. On 17Mar2021, the patient experienced high blood pressure/blood pressure went up (which required an emergency room visit), electrical charges that were prickly in her body, and warm flush. On 18Mar2021, the patient experienced angioedema, extreme hypersensitivity, heart racing, tongue tingling (which required an emergency room visit), rapid breathing/rapid respirations (which required an emergency room visit), nervousness, chills, burning sensation in her body, skin itches, bumps on back and abdomen, lock jaw at night, skin feels like it is thinning out, breathing stops and starts at night, having a hard time finding food to eat, water makes tongue swell and tingle, lip swelling (which required an emergency room visit), and respiration changes from clothing, elevated heart rate/rapid heart rate (which required an emergency room visit). The patient underwent lab tests and procedures which included blood pressure measurement: high on an unknown date, blood pressure measurement: had gone down on 17Mar2021, blood pressure measurement: 164/100 on 17Mar2021, blood pressure measurement: 176/100 on 17Mar2021, blood pressure measurement: went up on 17Mar2021, heart rate: rapid on 18Mar2021, heart rate: elevated on 18Mar2021, respiratory rate: rapid on 18Mar2021. Therapeutic measures were taken as a result of high blood pressure/blood pressure went up (hypertension). The outcome of electrical charges that were prickly in her body, body is responding to food, water and medicine like it is foreign, warm flush and frustrated was unknown. The outcome of the other events was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021427769 Pfizer

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:High; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:had gone down; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:164/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:176/100; Test Date: 20210317; Test Name: blood pressure; Result Unstructured Data: Test Result:went up; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:rapid; Test Date: 20210318; Test Name: heart rate; Result Unstructured Data: Test Result:elevated; Test Date: 20210318; Test Name: breathing; Result Unstructured Data: Test Result:rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1268429

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 17,0
Geschlecht: F
Eingang: 28.04.2021
Impfdatum: 22.04.2021
Beginn: 22.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Hyperhidrosis Pallor Presyncope

Symptomtext

Pt received Pfizer COVID vaccine, was walking with father next to her, felt faint, and father eased her to the floor, no head or body injury. Positive pallor and diaphoresis noted, legs elevated and pt color improved with pt now alert and oriented. Assisted to upright position, onto stretcher, given 1 small bottle water po, BP: 108/68, HR: 87, RR: 16 nonlabored, SaO2: 100% on RA. Pt currently has menses. 1023: drank 1 apple juice, feeling better. 1038: BP: 94/53, HR: 64, RR: 16 nonlabored, Sa02: 100% on RA. Sat upright on stretcher, legs dangling. 1044: BP 91/58, HR: 70, RR: 16 nonlabored, SaO2: 100% on RA, feeling well, drank 2 apple juice cups, standing up. 1049: standing up BP: 84/46, HR: 62, RR: 16 nonlabored, SaO2: 100% on RA. 1100: Pt feeling well, no c/o, escorted to front door of hospital, father at side. Pt aware to drink fluids today and especially during menses. Pt is also a dancer and practices every day. Discussed hydration needs prior to discharge from vaccine clinic. Pt aware to discuss vasovagal response from this injection at next visit so pt can lay down.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1265982

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 76,0
Geschlecht: F
Eingang: 28.04.2021
Impfdatum: 17.03.2021
Beginn: 29.03.2021
Tage bis Beginn: 12,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Arthralgia Computerised tomogram Nervous system disorder Pain in extremity Thrombosis

Symptomtext

Blood clot in her lower abdominal area; had the worst pain through her side that ran down her left leg and to her ankle; had the worst pain through her side that ran down her left leg and to her ankle; nerves are all tangled up; This is a spontaneous report from a contactable consumer (patient). A 76-year-old female patient received the second dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6207), via an unspecified route of administration, administered in Arm Right on 17Mar2021 13:50 (at 76-years-old) as single dose for COVID-19 immunisation. The vaccine was administered at a hospital. It was not administered at a military facility. Medical history included hip replacement four years ago in 2017 (First right then 2 months later left) and knee replacement six years ago in 2015 (both 2 months apart). There were no concomitant medications. The patient previously received the first dose of bnt162b2 (BNT162B2, Solution for injection, Lot Number: EN6203), administered in Left Arm on 25Feb2021 (at 76-years-old) for COVID-19 immunisation and experienced bad headaches. The patient received the second dose of vaccine on 17Mar2021. On 29Mar2021, she was not hurting and went to brunch with friends. Afterwards (on the same date, 29Mar2021), she was sitting and got the worst pain through her side that ran down her left leg and to her ankle. She drove herself home but was in such misery. She went to the emergency room the next day, on 30Mar2021, wherein she had a CT (computerized tomography) scan that showed a blood clot in her lower abdominal area. She was taking pain medication every 6 hours, or she could hardly stand it. On 08Apr2021, she went back to the emergency room because she could hardly stand it. She was kept in observation status but was not admitted. She was scheduled to have another CT scan on 06May2021. She is not sure what they will do because the nerves are wrapped around it. She also mentioned that her doctor wants to do a biopsy. The pain was also running down to her ankle. She stated that she has had both of her hips replaced in the past. She added that her doctor will do an MRI (magnetic resonance imaging). He will put in a drain if it has not shrunk. The doctor can't do anything because the nerves are all tangled up (2021). As corrective treatment, the patient was taking pain medication for the blood clot and pain through her side that ran down her left leg and to her ankle. Outcome of nerves are all tangled up was unknown, while outcome of the other events was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210330; Test Name: CT scan; Result Unstructured Data: Test Result:blood clot
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Hip replacement (Verbatim: Hip Replacement/4 years ago First right then 2 months later left); Knee replacement (Verbatim: Knee replacement/6 years ago both 2 months apart)
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1256836

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 21,0
Geschlecht: F
Eingang: 25.04.2021
Impfdatum: 22.04.2021
Beginn: 24.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Facial paresis Hypoaesthesia

Symptomtext

Within 48 hours, patient developed left sided facial numbness, weakness of the left face (forehead, eyebrows, L eyelid, cheeks and corner of the mouth). Patient was seen on 4/25 and diagnosed with Bell's Palsy and started on Prednisone.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: Celexa 10 mg, Estradiol Valerate 10 mg/mL injection every 2 week injection (last given 4/23), Wellbturin 200 mg
Allergien: None
Vorherige Impfungen: -

VAERS 1256043

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: FL
Alter: 18,0
Geschlecht: F
Eingang: 25.04.2021
Impfdatum: 25.04.2021
Beginn: 25.04.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

Immediately following pt receiving Pfizer vaccine, she fainted in chair. Symptoms lasted approx 3-4 mins. Medic placed on stretcher and observed for over 30minutes. VS WNLs. Pt diaphoretic and provided juice, water and peanut butter crackers. Pt's mother reported no PMH.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: -
Allergien: NKA
Vorherige Impfungen: -

VAERS 1255241

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 68,0
Geschlecht: M
Eingang: 25.04.2021
Impfdatum: 17.03.2021
Beginn: 27.03.2021
Tage bis Beginn: 10,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Thrombosis

Symptomtext

blood clot in lessor saphenous vein left leg; This is a spontaneous report from a contactable consumer (patient). A 68-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Left on 17Mar2021 at 15:15 (lot number EN6207) as single dose for covid-19 immunization, administered at the hospital. The patient received the first dose on 24Feb2021 at 15:15 in the right arm (lot number EN6198) for covid-19 immunisation. The patient did not receive other vaccines in four weeks. Medical history included type 2 diabetes, deep vein thrombosis (DVT), and pulmonary embolism (PE). The patient has not had COVID prior to vaccination and not tested for COVID post vaccination. The patient's concomitant medications were not reported. The patient experienced blood clot in lessor saphenous vein left leg on 27Mar2021 at 18:00 with outcome of recovering. The patient's hematologist put the patient on Eliquis 5mg 2 BID and at the time of report, this medicine has started to dissolve the clot.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: DVT; Pulmonary embolism; Type 2 diabetes mellitus
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1255233

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 75,0
Geschlecht: F
Eingang: 25.04.2021
Impfdatum: 15.03.2021
Beginn: 30.03.2021
Tage bis Beginn: 15,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Computerised tomogram Epistaxis Full blood count Infection Thrombosis

Symptomtext

infection; Abnormal nose bleed with blood cloths the first day; Abnormal nose bleed with blood cloths the first day/6 more nose bleed that it was taking me to control up to 30 min; This is a spontaneous report from a contactable other HCP (patient). A 75-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207), via an unspecified route of administration on 15Mar2021 10:45 (at 75 years old, not pregnant), single dose for covid-19 immunisation. Medical history included Type II diabetes, Hypertension, GERD and hypercholesterilymia, sulfa allergy, all from an unknown date. Concomitant medications included verapamil; rosuvastatin calcium (CRESTOR); metformin; omeprazole, unspecified blood thinners. The patient previously took tetracycline for known allergies: Tethracycline. Patient experienced abnormal nose bleed with blood cloths the first day (reported as 30Mar2021 0130). Five days later in two days had 6 more nose bleed that it was taking me to control up to 30 min. She went to ER in the morning and had a CBC having results normal with normal levels of platelets. She was referred to PCP. She saw a NP next day and gave me referral to ENT specialist. Using an scope could not find anything and ordered to have CT Scan. Results show negative for polips, tumors and show only a shadow by eye socket which MD believe it was an infection that was leading to the bleed. Prescribe a very small amount of Amoxicilline 125 mg, twice a day for 7 days plus a saline gel. Patient had the last nose bleed at midnight. For 3 days did not have any bleeding until today, at 10:15 am, with heavy bleeding which took me 15 min. to control. She has no history of nose bleed, taking blood thinners, no head traumas either. No other vaccine in four weeks. No Covid prior vaccination. No Covid tested post vaccination. The outcome of the event infection was unknown, other events was not recovered.; Sender's Comments: Information provided was so limited to prevent a meaningful and definite medical assessment for the events. A causal relationship cannot be completely excluded for BNT162B2 injection and development of Thrombosis and Epistaxis, only based on a plausible chronological sequence. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees, and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Name: CT Scan; Result Unstructured Data: Test Result:Results show negative; Comments: Results show negative for polips, tumors and show only a shadow by eye socket which MD believe it was an infection that was leading to the bleed.; Test Name: CBC; Result Unstructured Data: Test Result:Normal; Comments: had a CBC having results normal with normal levels of platelets
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: GERD; Hypercholesterolemia; Hypertension; Sulfonamide allergy; Type II diabetes mellitus
Andere Medikamente: VERAPAMIL; CRESTOR; METFORMIN; OMEPRAZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1189904

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 25.04.2021
Impfdatum: 01.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Feeling cold Hypoaesthesia oral

Symptomtext

Bell's Palsy; right side of mouth felt numb; freezing cold; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6207), via an unspecified route of administration administered in right arm on 01Apr2021 15:15 (at the age of 60-year-old) as SINGLE DOSE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and was not COVID tested post vaccination. Medical history included high blood pressure. The patient had known allergies with Allegra. Concomitant medications included pravastatin; ascorbic acid, betacarotene, cupric oxide, tocopheryl acetate, zinc oxide (PRESERVISION); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); and bupropion. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6199), administered in the left arm on 14Mar2021 at 04:00 PM for COVID-19 immunisation. On 02Apr2021 at 13:00, the patient got freezing cold. The patient was cold for several hours. On 03Apr2021, the patient woke up and right side of mouth felt numb. The patient went to urgent care and was diagnosed with Bell's Palsy on 03Apr2021. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of bell's palsy, freezing cold, and right side of mouth felt numb. The patient had not yet recovered from the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure high
Andere Medikamente: PRAVASTATIN; PRESERVISION; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; BUPROPION
Allergien: -
Vorherige Impfungen: -

VAERS 1189904

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 60,0
Geschlecht: F
Eingang: 25.04.2021
Impfdatum: 01.04.2021
Beginn: 02.04.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Feeling cold Hypoaesthesia oral

Symptomtext

Bell's Palsy; right side of mouth felt numb; freezing cold; This is a spontaneous report from a contactable consumer (patient). A 60-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6207), via an unspecified route of administration administered in right arm on 01Apr2021 15:15 (at the age of 60-year-old) as SINGLE DOSE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no other vaccine in four weeks. The patient had no COVID prior vaccination and was not COVID tested post vaccination. Medical history included high blood pressure. The patient had known allergies with Allegra. Concomitant medications included pravastatin; ascorbic acid, betacarotene, cupric oxide, tocopheryl acetate, zinc oxide (PRESERVISION); cetirizine hydrochloride (ZYRTEC [CETIRIZINE HYDROCHLORIDE]); and bupropion. Historical vaccine includes first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: EN6199), administered in the left arm on 14Mar2021 at 04:00 PM for COVID-19 immunisation. On 02Apr2021 at 13:00, the patient got freezing cold. The patient was cold for several hours. On 03Apr2021, the patient woke up and right side of mouth felt numb. The patient went to urgent care and was diagnosed with Bell's Palsy on 03Apr2021. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of bell's palsy, freezing cold, and right side of mouth felt numb. The patient had not yet recovered from the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure high
Andere Medikamente: PRAVASTATIN; PRESERVISION; ZYRTEC [CETIRIZINE HYDROCHLORIDE]; BUPROPION
Allergien: -
Vorherige Impfungen: -

VAERS 1247924

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: UT
Alter: 56,0
Geschlecht: F
Eingang: 23.04.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaphylactic reaction Dysphagia Mouth swelling Swollen tongue

Symptomtext

pt had the 1st dose of COVID-19 vaccine and had oral swelling, tongue swelling and difficulty swallowing. patient was transferred to the ED. IV access was established and patient was given IV fluids, IV Benadryl, famotidine and Solu-Medrol for initial management of possible allergic reaction. Patient was later given 0.5 mg IM epinephrine for treatment of anaphylaxis. Patient was observed in the emergency department for 3 hours with no return of symptoms. and discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: Eggs, almond oil, pitted fruit, soy
Vorherige Impfungen: -

VAERS 1246547

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 52,0
Geschlecht: M
Eingang: 23.04.2021
Impfdatum: 20.03.2021
Beginn: 21.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Computerised tomogram head normal Generalised tonic-clonic seizure Muscle twitching Tremor

Symptomtext

52 yo male received first dose of Pfizer vaccine on 3/20 at outside institution. The next morning, pt experienced uncontrollable tremors and twitching and presented to the ED. In the ED, patient had generalized tonic-clonic seizure that lasted for about 1-3 minutes. CT head scan was unremarkable. Neurology started pt on Keppra 500 mg BID and plan for MRI and routine EEG. The next morning, pt felt back to baseline and was alert and oriented. Patient has a history of HIV and stroke with residual right-sided weakness. He has no history of seizure nor reactions to vaccines. Physician advised patient that he should not receive second dose of vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: HIV, history of stroke
Andere Medikamente: Descovy, Prezista, ritonavir
Allergien: Acetaminophen, azithromycin, Bactrim
Vorherige Impfungen: -

VAERS 1238941

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 68,0
Geschlecht: M
Eingang: 21.04.2021
Impfdatum: 17.03.2021
Beginn: 17.04.2021
Tage bis Beginn: 31,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

Cough Dyspnoea Febrile convulsion Hypoxia Pain Pyrexia SARS-CoV-2 test positive Tachycardia

Symptomtext

Patient was fully vaccinated (dose 1: 2/24, dose 2: 3/17). Patient developed body aches, fever, cough and SOB on 4/17 and presented to healthcare facility where he tested positive for SARS-CoV-2 on 4/21. In ED patient was febrile (38.8), hypoxic satting 90% on RA requiring NC, tachycardic (HR 114 bpm) and in AKI (sCr 1.2 mg/dL). Medications initiated for COVID-19 included enoxaparin and remdesivir. Patient is admitted, today is day 1 of hospitalization (4/21).

Weitere VAERSDATA-Felder

Praegender Schweregrund: Febrile convulsion
Hospital-Tage: 1,0
Labordaten: SARS-CoV-2 PCR - positive (4/21) COVID-19 Rapid Ab - negative (4/21)
Aktuelle Erkrankungen: -
Vorgeschichte: HTN, HLD, prostate cancer, NASH cirrhosis/HCC (treated with SBRT in 2019) s/p OLT 9/23/2020
Andere Medikamente: Amlodipine, mycophenolate mofetil, pantoprazole, predniSONE , tacrolimus
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1235838

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MN
Alter: 54,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 21.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Angiogram Inflammation SARS-CoV-2 test Thrombosis

Symptomtext

Extreme inflammatory response. In ER/hospitalized 5 days post vaccine; Had Angiogram, found clot in Obtuse Marginal; This is a spontaneous report from a contactable consumer (patient). A 54-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 21Mar2021 12:00 (Lot Number: EN6207), age at vaccination of 54-years-old, as single dose for covid-19 immunisation. Medical history included cardiac failure from an unknown date and unknown if ongoing, connective tissue disorder from an unknown date and unknown if ongoing. Patient was not pregnant. Concomitant medications included hydroxychloroquine sulfate (PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]) taken for an unspecified indication, start and stop date were not reported; isosorbide mononitrate (IMDUR) taken for an unspecified indication, start and stop date were not reported; metoprolol (METOPROLOL) taken for an unspecified indication, start and stop date were not reported; rosuvastatin calcium (CRESTOR) taken for an unspecified indication, start and stop date were not reported; furosemide (FUROSEMIDE) taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced hypersensitivity. The patient experienced extreme inflammatory reaction on 24Mar2021 at 04:00 AM and clot blood on 24Mar2021; events were serious as resulted in Emergency room/department or urgent care, hospitalization (for 5 days), life threatening illness (immediate risk of death from the event). The patient had extreme inflammatory response; in ER/hospitalized 5 days post vaccine. Angiogram was performed and clot in obtuse marginal was found; unable to remove clot, surgeon was able to break it apart and balloon the vessel open. It was unknown if patient had COVID prior vaccination. Patient had no other vaccine in four weeks. Sars-cov-2 test was negative on 15Apr2021. The patient was considered to be recovering from the events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: 5,0
Labordaten: Test Date: 20210324; Test Name: Angiogram; Result Unstructured Data: Test Result:found clot in Obtuse Marginal; Test Date: 20210415; Test Name: Nasal Swab/ Rapd test; Result Unstructured Data: Test Result:Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Connective tissue disorder; Heart failure
Andere Medikamente: PLAQUENIL [HYDROXYCHLOROQUINE SULFATE]; IMDUR; METOPROLOL; CRESTOR; FUROSEMIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1235749

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 56,0
Geschlecht: F
Eingang: 21.04.2021
Impfdatum: 17.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Balance disorder Blood pressure measurement Dizziness Head discomfort Hypertension Loss of consciousness Lymphadenopathy Vision blurred

Symptomtext

Blacked out; feel light headed; unbalanced; Having trouble to focus with my eyes; Head feels full; Lymph nodes in head, neck and under arms swollen; very high blood pressure; This is a spontaneous report from a contactable consumer or other non hcp. A 56-years-old non pregnant female patient received bnt162b2 (BNT162B2, PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 17Mar2021 10:45 (Batch/Lot Number: EN6207) as SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient not received any other vaccines within 4 weeks prior to the COVID vaccine. Six days after the vaccine (on 23Mar2021 10:15 ), the patient started to feel light headed, unbalanced. Blacked out on March 23rd for a very short time. Having trouble to focus with his eyes. Head feels full. Lymph nodes in head, neck and under arms swollen. Very high blood pressure and now needing medication for that. These last two weeks have been a nightmare and thinking he was going to die and was in the Emergency room. No treatment was received for the events. Event blacked out seriousness was medically significant. The events outcome was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Test Name: blood pressure; Result Unstructured Data: Test Result:Very high
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1218777

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: LA
Alter: 53,0
Geschlecht: F
Eingang: 19.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Activated partial thromboplastin time Blood magnesium Brain natriuretic peptide Chest X-ray Computerised tomogram abnormal Computerised tomogram head Contusion Dizziness Electrocardiogram Erythema Computerised tomogram normal Condition aggravated Full blood count abnormal Magnetic resonance imaging normal Nausea Full blood count Hemiparesis Loss of consciousness

Symptomtext

53yo female with a Hx of migraines/seizures/normal pressure hydrocephalus received her second dose of COVID-19 vaccine 04/08/2021. 10 minutes after vaccination she started feeling nauseated and then doesn't remember what happened next. Was transported "unresponsive" to ER. CT MRI negative. Upon lab exam it was noted that her platelets had dropped from 245K to 86K. Received dose of epinephrine/solumedrol, pepcid. Diagnosed with having a seizure and thrombocytopenia. The next day her platelets had recovered to normal. Patient recovered and was discharged.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: MRI/CT - negative CBD - thrombocytopenia
Aktuelle Erkrankungen: -
Vorgeschichte: h/o migraines, seizures
Andere Medikamente: Imitrex, Vyvance, antidepressant
Allergien: -
Vorherige Impfungen: -

VAERS 1224846

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

schwer

Staat: IN
Alter: 41,0
Geschlecht: M
Eingang: 18.04.2021
Impfdatum: 23.03.2021
Beginn: 05.04.2021
Tage bis Beginn: 13,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blindness Paralysis Pyrexia SARS-CoV-2 test Vomiting

Symptomtext

complete body went paralyzed; lost vision; throwing up; fever; This is a spontaneous report from a contactable consumer. A 41-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: En6207), dose 1 via an unspecified route of administration, administered in left arm on 23Mar2021 08:30 as single dose for covid-19 immunisation. Medical history was reported as none. There were no concomitant medications. The patient started throwing up, fever, complete body went paralyzed and lost vision all it the ER on 05Apr2021 13:00. The events were resulted in emergency room /department or urgent care. There is some treatment (saline and ondansetron) for the events. The patient did not have covid prior vaccination, did not test covid post vaccination. The patient received Covid test post vaccination via Nasal Swab on 05Apr2021, covid test result was negative. There is no known allergies, no other medical history, no other vaccine in four week, no other medications in two weeks. The outcome of the events was resloving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Paralysis
Hospital-Tage: -
Labordaten: Test Date: 20210405; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1224670

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IN
Alter: 54,0
Geschlecht: M
Eingang: 18.04.2021
Impfdatum: 18.03.2021
Beginn: 01.03.2021
Tage bis Beginn: -
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal distension Cough Dizziness Dyspnoea Eye disorder Fatigue Feeling of body temperature change Influenza like illness Pain in extremity Peripheral swelling Thrombosis Wheezing

Symptomtext

This is a spontaneous report received from a contactable consumer (patient). A 54-year-old male patient (height: 193cm, weight: 99.79kg) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, batch/lot number: EN6207) via an unspecified route of administration at right upper arm on 18Mar2021 18:00 (54-year-old at time of vaccination), at single dose, for COVID-19 immunization. The patient's medical history included blood pressure, teeth cleaned (Shortly before the shot, went to the dentist to have teeth cleaned. Directly from Dentist went to pharmacy. Went to pharmacy's Drive Thru to pick up a little antibiotic from the dentist. It was 4 capsules of Amoxicillin. He was supposed to take the Amoxicillin before the dentist office visit, but he forgot to do that. Therefore, soon as he left the dentist office he went to pharmacy to pick it up so he could take it. While he was there, was offered the COVID 19 vaccine and that it was the last shot). Concomitant medications included atenolol tablet from 2016 (been taking for 5 years) and ongoing for blood pressure, and ascorbic acid/ cyanocobalamin/ ergocalciferol/ nicotinamide/ pyridoxine hydrochloride/ retinol/ riboflavin/ thiamine mononitrate (ONE-A-DAY). No additional vaccines administered on same date. No history of all previously immunizations. No prior vaccincations wtihin 4 weeks. He got the shot Thursday and by Sunday, many different side effects were coming in. He has had side effects from the COVID VACCINE, but initially he does not want to file report, just thinks that everyone needs to get the shot. He does not have complaints. He is wondering how long the side effects will last, and when they go away. States that he is being treated as he has gone to the doctor's. Also states that he made an appointment with the doctor and almost went to the emergency room a couple of times. Right after the shot, he was getting in the car and his right leg started hurting (on 18Mar2021). It didn't go away for a couple of days. It went away but then noticed his shoes started feeling funny. He wasn't looking at his feet, put his shoes on they felt tight. Then he started to look at feet more. Below his knees, his legs are swollen. Swelling started within 2 to 3 days after the vaccine. The swelling is really severe when standing. Everybody at work has seen how sick he is and his legs. Swelling in the legs has him concerned, thinking maybe it's a blood clot. He was given medicine and would like to see it go away. He keeps his legs up. He has other side effects (all in Mar2021) and is having flu like symptoms. He basically has the flu. He has never had the flu shot. This is the first flu shot (He referred to the COVID vaccine as the flu shot as documented. However, confirmed suspect product as Pfizer covid vaccine) he has had that he knows of. He is questioning if he should get the second shot. He feels a little dizzy. Quick questions get him confused and that it comes and goes. Lungs felt full, gasping for air: not now but, since the doctor gave him antibiotics (unspecified injections, he was given 2 shots at the doctor's office, one in each arm), his lungs felt full. At times he was gasping for air. It went away but thought he was going to die. Now when he gets winded, it feels like he has a dry cough. Gets winded easily. The doctor ordered him an inhaler, Symbicort, but it was very expensive, so he did not get it at that time. He never picked it up because it was too much money. The fluid is not there anymore and he does not feel like he needs this as does not feel like it needs to be cleared. He is having wheezing. He can now take deeper breaths. Fatigue: initially, that he was feeling tired within 1 or 2 days, but he did not recall the next day feeling that way (later stated it was within 2-3 days he started to feel tired). He is still tired. Unable to clarify time frame of fatigue further. He feels bloated and full. Hasn't really eaten but feels real full and bloated. Hot and cold flashes started occurring about the same time as the other symptoms. He had these last evening. He does not get the flu very often and doesn't take the Flu shot. This is the closest thing he can remember having a pretty good episode with the flu. He was also given prescriptions for 2 new medications: Triamterene 37.5mg daily, for leg swelling; Clindamycin, 300mg, twice a day, an antibiotic. The odd thing is that it seems like his eyes are big, like really, really big, like they are really open. It is like big eye balls. States that he is just sick and his body is reacting to getting better. He has not been to work in the last 3 days. States that he is fine, just worried about work. Patient asked for personal advice about going back to work. The outcome of "his right leg started hurting" was recovered; outcome of "below his knees, his legs are swollen/ swelling in the legs/ put his shoes on they felt tight" and Fatigue/feeling tired was not recovered; outcome of other events was unknown.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Blood pressure abnormal; Dental cleaning
Andere Medikamente: ATENOLOL; ONE-A-DAY [ASCORBIC ACID;CYANOCOBALAMIN;ERGOCALCIFEROL;NICOTINAMIDE;PYRIDOXINE HYDROCHLORIDE;RETINOL
Allergien: -
Vorherige Impfungen: -

VAERS 1224611

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NJ
Alter: 61,0
Geschlecht: F
Eingang: 18.04.2021
Impfdatum: 23.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Cough Decreased appetite Dizziness Headache Migraine Pyrexia Syncope

Symptomtext

dizziness; headache; fever; stomach cramps; migraine; no appetite; dry cough; fainting; stomachache; This is a spontaneous report received from a contactable consumer (patient). A non-pregnant 61-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), via an unspecified route of administration at the age of 61 years old, administered in arm left on 23Mar2021 19:15 (Lot Number: EN6207) at single dose for covid-19 immunisation. Medical history included ongoing rheumatoid arthritis, arthrosis, osteoporosis, due to arthritis the patient couldn't eat pork because her joints get swollen. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included etanercept (ENBREL); methotrexate sodium (METHOTREXAAT). The patient experienced fainting, stomachache, stomach cramps, migraine, no appetite, dry cough on 24Mar2021 15:30, dizziness, headache, fever on 25Mar2021. The patient stopped using Enbrel and taking Methotrexate a few days prior Pfizer's vaccine. Next day on 24Mar2021, the patient had stomachache, 3rd day (25Mar2021) started with dizziness, headache and fever. Symptoms kept going after 10 days. 5 days later the patient went to the hospital and was prescribed something for stomach cramps and migraine. But the fever continued. 3 days later doctor prescribed an antibiotic since she didn't know the reason of the fever. During the course of the fever the patient had been taking Tylenol on daily basis. Fever came and went and the patient had no appetite and keep with fainting. Doctor ordered lung rx but the patient couldn't do it. 10 days later the patient had dry cough (event onset date was also reported as 24Mar2021, 15:30). The same symptoms remained. The patient did not receive treatment for all events (except fever). Events resulted in Emergency room/department or urgent care and Doctor or other healthcare professional office/clinic visit. The outcome of the all events was reported as not recovered. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Rheumatoid arthritis
Vorgeschichte: Medical History/Concurrent Conditions: Arthrosis; Osteoporosis
Andere Medikamente: ENBREL; METHOTREXAAT [METHOTREXATE SODIUM]
Allergien: -
Vorherige Impfungen: -

VAERS 1224098

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 39,0
Geschlecht: M
Eingang: 18.04.2021
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Blood glucose Blood test Disorientation Dizziness Feeling abnormal Heart rate normal Paraesthesia Presyncope Pruritus SARS-CoV-2 antibody test Stress

Symptomtext

He felt like he was going to pass out, like he was disoriented; He felt like he was going to pass out, like he was disoriented; He experienced disorientation; Itchiness on the abdomen area, knees, and toes; Feeling weird; feeling overwhelmed; Like itchy or pins and needles all over his body; Lightheaded; This is a spontaneous report from a contactable consumer (patient himself). A 39-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EN6207), via an unspecified route of administration in right arm on 25Mar2021 as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient's prior vaccinations included tetanus shot on 09Feb2021. On 28Mar2021, 2 days after taking the first dose, the patient experienced reactions from the vaccine which included Itchiness on the abdomen area, knees, and toes and disorientation and went to emergency room for treatment. The patient wanted to know whether these are normal side effects of the vaccine. Upon follow-up on 28Mar2021, the patient reported that he felt weird after receiving the vaccine and lightheadedness. He told the nurse that he didn't eat before getting the vaccine. And wasn't sure if getting the vaccine was like having blood drawn so he hadn't eaten anything. The nurse told him he might be feeling lightheaded because he didn't eat and she gave him some lollipops and the patient felt much better. The patient also stated that on 28Mar2021, he was feeling overwhelmed and cannot describe the feeling. It was like itchy or pins and needles all over his body. The patient felt like he was going to pass out, as he as disoriented. The patient stated that he went to the Emergency Department. They kept him overnight, checked his heart, did some blood work, checked his blood sugar, gave him a Covid 19 test. The patient stated that everything came back normal. The Emergency Department concluded that the events could be due to the Covid 19 vaccine and described that his system was fighting the Covid 19 vaccine or something. The patient was asking if this is normal. He was also asking for a copy of this safety report for work purposes. The patient went to the Emergency Department on 28Mar2021 (around 7pm) and was in observation overnight. He was discharged from the Emergency Department this morning, 29Mar2021 at around 11:00AM. The patient confirmed that he was not hospitalized. The patient stated that he may be overthinking about the events and really paying attention to his body. He thinks he needs to rest as he was in the Emergency Department for a long time. The patient lab test included Blood sugar test. The outcome of the events was resolved for dizziness, unknown for feeling abnormal and overwhelmed and not resolved for other events. Information on lot/batch number obtained. Additional information has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Test Date: 20210328; Test Name: Glucose level; Result Unstructured Data: Test Result:Glucose level normal; Test Date: 20210328; Test Name: blood work; Result Unstructured Data: Test Result:blood work normal; Test Date: 20210328; Test Name: Heart rate normal; Result Unstructured Data: Test Result:Normal; Test Date: 20210328; Test Name: Covid 19 test; Result Unstructured Data: Test Result:Normal
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1136372

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WY
Alter: 59,0
Geschlecht: M
Eingang: 18.04.2021
Impfdatum: 11.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Blood disorder Coagulopathy Computerised tomogram Contusion Blood test Ear pain Magnetic resonance imaging Dyskinesia Eyelid disorder Hypoaesthesia Oedema peripheral Mobility decreased Neck pain Scan with contrast Swelling of eyelid Peripheral swelling Skin fissures

Symptomtext

Bell's palsy; eye sight in that eye is getting worse every day; right eyelid was sticking on his eye and wouldn't shut; he couldn't move his face on the left side and he can't control it at all; blood got really thin and wouldn't clot; left hand got really swollen; entire arm bruised; edema in his hand; edema in his hand got to the point where his skin was cracking; blood got really thin and wouldn't clot; face went numb; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207, Expiration Date: Jul2021), via an unspecified route of administration, administered in Arm Right on 11Mar2021 (at the age of 59 years old) as single dose for covid-19 immunisation. Medical history included lupus from 2020 and ongoing, ongoing High Blood Pressure, Spinal Surgeries from 1999, Chronic Pain,Retention water, blood clot issue. The patient previously had tetanus shot. Concomitant medications included losartan potassium; allopurinol; hydroxychloroquine; methocarbamol; morphine sulfate (MS CONTIN); oxycodone; furosemide. Caller states he is calling about the Pfizer Covid 19 Vaccine. Seven days later the dose of vaccine (18Mar2021), patient developed Bell's Palsy which he has never had before and has never had any other problem with. He has seen an ENT, his pain doctor, and his medical doctor and they all say the Covid vaccine has caused the problem he is having. He was told by his ENT this is very possibly permanent. Emergency Doctors are who he went to because he thought he was having a stroke, because half of his face went numb. He has been to the doctor 10 times in the last 7 days, it has not been fun at all. He didn't put it together until he saw the ENT, who said Bell's Palsy is caused from a virus. States he had no idea until he said that, that it could possibly be from the injection. States he has never had Bells Palsy before and it started 8 days after the initial shot. His right eyelid was sticking on his eye and wouldn't shut and he couldn't move his face on the left side and he can't control it at all. Clarifies he couldn't shut his right eye all of the way. Since then they have told him he needs to tape his eye shut for 12 hours a day to keep from going blind. The thing that bothers him is his eye sight in that eye is getting worse every day even though he uses the cream and tapes it shut. His wife told him even with both eyes shut, it will not completely shut because his lower eyelid is hanging down too far. The ENT told him he needs a hearing test today at 2:00p.m. to see if this is going to be a permanent problem. He is getting ready to go to the ear doctor to find out more. At the same time he developed the Bells Palsy, his blood got really thin and wouldn't clot which seems really weird. Also on 18MAR2021, his left hand got really swollen and the entire arm bruised and they said the edema in his hand got to the point where his skin was cracking because his blood got so thin that it couldn't clot at all. He had a blood clot issue in the past. States his arm and hand have improved, he can move his hand again finally. The ENT said that since he has been on Prednisone, for recovery for Bells Palsy, for over a week and gotten worse instead of better, it may be permanent. Prednisone is not working, it has actually gotten worse. Prednisone 10mg for 7 days and to decrease by one tablet every day until gone but states he has gotten worse. Treatments (assessed as for all events): Prednisone. States that it has been two weeks since this happened and the doctor told him the only other option is skull surgery. The bones in his head would be drilled out to make room for the nerves in hopes he would be able to work his mouth again, so not a good thing. Eye cream. He is on disability and his house payment is 3/4 of what he makes, so he can't take care of the medical bills himself otherwise he wouldn't worry about it. It is very depressing. His medical doctor said he hadn't seen any cases of Bell's Palsy for 2 years, and he has seen 4 in the last week so that doesn't give him a lot of confidence even though he is still encouraging people to get the vaccine because it is safer than not.He has multiple visits to the ER 3 times between 18MAR2021 and 19MAR2021 within 24 hours; states he was in the ER for hours and hours but no admission. States they did a CT Scan, MRI, CT with contrast and then after that ended up 22 saw ENT who confirmed the fact that Covid Vaccine that gave Bells Palsy and on 22-23 saw his GM again. Prior Vaccinations (within 4 weeks): None within 4 weeks; states 9 months ago he had a Tetanus Shot. No AE(s) following prior vaccinations. The outcome of the event Bell's palsy, Visual acuity decreased, Eyelid disorder, Orofacial dyskinesia, numbness in face was not recovered; other events was recovering. All events happened on 18Mar2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Test Date: 202103; Test Name: CT SCAN; Result Unstructured Data: Test Result:Unknown; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:Unknown
Aktuelle Erkrankungen: Blood pressure high; Lupus-like syndrome
Vorgeschichte: Medical History/Concurrent Conditions: Back surgery; Chronic pain; Clotting disorder; Retention water
Andere Medikamente: LOSARTAN POTASSIUM; ALLOPURINOL; HYDROXYCHLOROQUINE; METHOCARBAMOL; MS CONTIN; OXYCODONE; FUROSEMIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1136372

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WY
Alter: 59,0
Geschlecht: M
Eingang: 18.04.2021
Impfdatum: 11.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 7,0
Dosis: UNK
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Blood disorder Coagulopathy Computerised tomogram Contusion Blood test Ear pain Magnetic resonance imaging Dyskinesia Eyelid disorder Hypoaesthesia Oedema peripheral Mobility decreased Neck pain Scan with contrast Swelling of eyelid Peripheral swelling Skin fissures

Symptomtext

Bell's palsy; eye sight in that eye is getting worse every day; right eyelid was sticking on his eye and wouldn't shut; he couldn't move his face on the left side and he can't control it at all; blood got really thin and wouldn't clot; left hand got really swollen; entire arm bruised; edema in his hand; edema in his hand got to the point where his skin was cracking; blood got really thin and wouldn't clot; face went numb; This is a spontaneous report from a contactable consumer (patient). A 59-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot number: EN6207, Expiration Date: Jul2021), via an unspecified route of administration, administered in Arm Right on 11Mar2021 (at the age of 59 years old) as single dose for covid-19 immunisation. Medical history included lupus from 2020 and ongoing, ongoing High Blood Pressure, Spinal Surgeries from 1999, Chronic Pain,Retention water, blood clot issue. The patient previously had tetanus shot. Concomitant medications included losartan potassium; allopurinol; hydroxychloroquine; methocarbamol; morphine sulfate (MS CONTIN); oxycodone; furosemide. Caller states he is calling about the Pfizer Covid 19 Vaccine. Seven days later the dose of vaccine (18Mar2021), patient developed Bell's Palsy which he has never had before and has never had any other problem with. He has seen an ENT, his pain doctor, and his medical doctor and they all say the Covid vaccine has caused the problem he is having. He was told by his ENT this is very possibly permanent. Emergency Doctors are who he went to because he thought he was having a stroke, because half of his face went numb. He has been to the doctor 10 times in the last 7 days, it has not been fun at all. He didn't put it together until he saw the ENT, who said Bell's Palsy is caused from a virus. States he had no idea until he said that, that it could possibly be from the injection. States he has never had Bells Palsy before and it started 8 days after the initial shot. His right eyelid was sticking on his eye and wouldn't shut and he couldn't move his face on the left side and he can't control it at all. Clarifies he couldn't shut his right eye all of the way. Since then they have told him he needs to tape his eye shut for 12 hours a day to keep from going blind. The thing that bothers him is his eye sight in that eye is getting worse every day even though he uses the cream and tapes it shut. His wife told him even with both eyes shut, it will not completely shut because his lower eyelid is hanging down too far. The ENT told him he needs a hearing test today at 2:00p.m. to see if this is going to be a permanent problem. He is getting ready to go to the ear doctor to find out more. At the same time he developed the Bells Palsy, his blood got really thin and wouldn't clot which seems really weird. Also on 18MAR2021, his left hand got really swollen and the entire arm bruised and they said the edema in his hand got to the point where his skin was cracking because his blood got so thin that it couldn't clot at all. He had a blood clot issue in the past. States his arm and hand have improved, he can move his hand again finally. The ENT said that since he has been on Prednisone, for recovery for Bells Palsy, for over a week and gotten worse instead of better, it may be permanent. Prednisone is not working, it has actually gotten worse. Prednisone 10mg for 7 days and to decrease by one tablet every day until gone but states he has gotten worse. Treatments (assessed as for all events): Prednisone. States that it has been two weeks since this happened and the doctor told him the only other option is skull surgery. The bones in his head would be drilled out to make room for the nerves in hopes he would be able to work his mouth again, so not a good thing. Eye cream. He is on disability and his house payment is 3/4 of what he makes, so he can't take care of the medical bills himself otherwise he wouldn't worry about it. It is very depressing. His medical doctor said he hadn't seen any cases of Bell's Palsy for 2 years, and he has seen 4 in the last week so that doesn't give him a lot of confidence even though he is still encouraging people to get the vaccine because it is safer than not.He has multiple visits to the ER 3 times between 18MAR2021 and 19MAR2021 within 24 hours; states he was in the ER for hours and hours but no admission. States they did a CT Scan, MRI, CT with contrast and then after that ended up 22 saw ENT who confirmed the fact that Covid Vaccine that gave Bells Palsy and on 22-23 saw his GM again. Prior Vaccinations (within 4 weeks): None within 4 weeks; states 9 months ago he had a Tetanus Shot. No AE(s) following prior vaccinations. The outcome of the event Bell's palsy, Visual acuity decreased, Eyelid disorder, Orofacial dyskinesia, numbness in face was not recovered; other events was recovering. All events happened on 18Mar2021.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Test Date: 202103; Test Name: CT SCAN; Result Unstructured Data: Test Result:Unknown; Test Date: 202103; Test Name: MRI; Result Unstructured Data: Test Result:Unknown
Aktuelle Erkrankungen: Blood pressure high; Lupus-like syndrome
Vorgeschichte: Medical History/Concurrent Conditions: Back surgery; Chronic pain; Clotting disorder; Retention water
Andere Medikamente: LOSARTAN POTASSIUM; ALLOPURINOL; HYDROXYCHLOROQUINE; METHOCARBAMOL; MS CONTIN; OXYCODONE; FUROSEMIDE
Allergien: -
Vorherige Impfungen: -

VAERS 1126776

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 49,0
Geschlecht: F
Eingang: 18.04.2021
Impfdatum: 10.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Cough Dyspnoea Pharyngeal swelling Sneezing

Symptomtext

anaphylaxis; sneezing; throat swelling; Continued having breathing difficulty; coughing; This is a spontaneous report from a contactable consumer (patient). A 49-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), (Batch/Lot Number: OCDPH) via an unspecified route of administration, administered in the left arm on 10Mar2021 16:15 (at the age of 49 years-old) as SINGLE DOSE for covid-19 immunisation. Medical history included Crohn's Disease and chronic Migraines. Patient has allergies to medications, food, or other products such as Milk Protein and Compazine. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient hasn't been tested for COVID-19. Concomitant medications included midodrine taken for an unspecified indication, start and stop date were not reported; and rizatriptan benzoate (MAXALT) taken for an unspecified indication, start and stop date were not reported. On 10Mar2021 16:30 (as reported), patient was sneezing within 5-10 minutes of receiving dose, had anaphylaxis within 15-20 minutes of receiving dose. She continued having breathing difficulty, sneezing, coughing and throat swelling for 5 days which was treated with Benadryl. Second dose of Epipen was required 20 hrs. later and continued use of Benadryl, Allegra and inhaler for 4-6 days. Continued issues with over stimulation of allergic reaction to other known allergies continues. The outcome of events was reported as recovered with sequelae. The events required emergency room and physician's office visit. Therapeutic measures taken as a result of the events included EpiPen, Steroid, Benadryl and inhaler (unspecified). The events were assessed as serious, life threatening illness (immediate risk of death from the event). Follow-up attempts are completed. The information on the batch/lot number has already been obtained.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Chronic migraine; Crohn's disease; Drug allergy; Milk protein allergy
Andere Medikamente: MIDODRINE; MAXALT
Allergien: -
Vorherige Impfungen: -

VAERS 1219748

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Seizure like phenomena

Symptomtext

Patient experienced seizure like activity. EMS was on site to evaluate patient and transported him to emergency room. Spouse reports frequent seizure activity.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1218735

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 53,0
Geschlecht: M
Eingang: 16.04.2021
Impfdatum: 17.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: nein

C-reactive protein increased Catheterisation cardiac abnormal Chest pain Coronary artery stenosis Echocardiogram Electrocardiogram ST segment elevation Electrocardiogram abnormal Percutaneous coronary intervention Pericardial effusion Pericarditis Pleuritic pain

Symptomtext

Patient received 1st COVID vaccine on 3/17. On 3/24, he experience pleuritic chest pain and was admitted to the hospital for pericarditis confirmed by EKG. During this hospitalization, he was incidentally found to have left main stenosis 60-70% on the LHC, requiring PCI. Patient did not have an acute MI - hence Dressler Syndrome was thought to be less likely. He was discharged after a week on 3/30/21 with colchicine and other cardioprotective medications. He received his 2nd vaccine on 4/7/21. On 4/14/21, patient was readmitted for pleuritic chest pain attributed to recurrent pericarditis.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: 1st hospitalization: 3/25/21: CRP = 4.7 and not repeated; EKG showed diffuse ST elevation, consistent with acute pericarditis 2nd hospitalization: 4/14/21: Elevated CRP = 139.5; 4/15/21 = 206.7; 4/16/21 = 156.6 EKG did not show any obvious ST elevations Repeat TTE 4/14 showed small pericardial effusion. Repeat on 4/15 showed no significant interval change in pericardial effusion.
Aktuelle Erkrankungen: CAD, esophagitis
Vorgeschichte: HTN, DM
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1212392

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 50,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 13.04.2021
Beginn: 13.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Chills Cough Feeling cold Loss of consciousness Pain Photophobia Pyrexia Skin warm

Symptomtext

When i took the first does, i passed out the morning after the vaccine and had fever for 2 days. I also had body ache and a light cough. The second dose, i had sever chills starting within 3 hours of the injections. Thru out the night i was freezing but my skin was hot to the touch and i had a fever. The second day i was very sensitive to light and sounds. I couldn't keep my eyes open and had no energy to do anything. I had chills the whole day. I was bundled in 3 blanket and still shivering. The following day i couldn't remember the event of the prior day. It felt as if i was in fog the whole day. Note: I have COVID end of January 2021

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: 1st done of vaccine had fever and body ache

VAERS 1210075

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: KS
Alter: 32,0
Geschlecht: F
Eingang: 15.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Cold sweat Erythema of eyelid Eye pruritus Eyelid rash Facial paralysis Herpes zoster Herpes zoster oticus Hot flush Feeling hot Foreign body sensation in eyes Headache Nausea Swelling of eyelid

Symptomtext

Hot flashes, shingles, face paralysis. Dr diagnosis Ramsey Hunt Syndrome. Given prednisone and valacyclovir for treatment

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: None
Vorgeschichte: Fibromyalgia Asthma Bipolar
Andere Medikamente: Lithium
Allergien: Ceclore, lorotab
Vorherige Impfungen: -

VAERS 1210605

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: UT
Alter: 36,0
Geschlecht: M
Eingang: 14.04.2021
Impfdatum: 10.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test Chromaturia Dysuria Thrombosis Ultrasound bladder Ultrasound kidney Urine abnormality Urine flow decreased

Symptomtext

I had the 1st shot on Wednesday March 10th. On Sunday the 14th, just before going to bed at about 11pm, I went to pee. The urine was very dark brown. Didn't appear to have any red for blood. The next day I felt like water was being retained and it felt that I couldn't empty the bladder and pee was coming out slower than usual. Late Monday the 15th before bed I peed another dark brown urine and a red blood clot came out. At that point I became very concerned and sent to see the doctor on the 16th. Referred to a kidney specialist for March 31st. Between March 14th to March 29th , somedays I felt like I was retaining water, most days felt like I couldn't empty my bladder with slow flow. With the recent news of the concerns of blood clots with vaccines, I felt that I should report this.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Blood drawn on March 16th and 29th. Ultrasound of kidneys and bladder.
Aktuelle Erkrankungen: -
Vorgeschichte: Pre-high blood pressure
Andere Medikamente: Centrum multivitamin, Ibuprofen 600mg
Allergien: -
Vorherige Impfungen: -

VAERS 1332998

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 66,0
Geschlecht: M
Eingang: 13.04.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Aphasia Asthenia Blood pressure increased Cerebellar stroke Cerebral small vessel ischaemic disease Dysarthria Facial paralysis Gaze palsy Hemiparesis Hypertension Magnetic resonance imaging abnormal NIH stroke scale abnormal Neurological symptom Speech disorder Transient ischaemic attack

Symptomtext

elevated blood pressure, garbled speech, TIA Pt presented for acute stroke-like symptoms (L hemibody weakness, dysarthria, L gaze preference, dysarthria, word-finding difficulties) following a COVID vaccination (about 1-15 min after) at 1230 on 3/18/21. PMHx notable for multiple prior TIAa, HTN, HLD, PVD c/b R femoral artery thrombus (2017, no intervention, on Plavix), T2DM (prior A1c 6.5%, recently 6.2% not on meds), COPD, prior splenectomy (childhood re: car accident), chronic L ulnar neuropathy, bilateral hearing loss, complex partial seizure disorder following Rocky Mountain spotted fever. Symptoms resolved fully within 24 hours of event; diagnosed with TIA. MRI without new ischemic findings; chronic small vessel disease and chronic small R cerebellar stroke noted. TIA likely occurred in setting of hypertensive event with systolic BP to 220s. ED attending reported an NIHSS of 9. Of note, blood pressure was in the 210s systolic on admission, and subsequently down trended. Per resident, initially had left gaze deviation however on exam had full ocular motility. Pupils were of equal (size: OD 3, S 3) and reactive. Ocular motility was full without nystagmus. Facial sensation normal. Initial mild left facial droop, which also resolved. As the exam progressed, the patient's symptoms began resolving. Patient was able to articulate his thoughts better without dysarthria and strength markedly improved in the left upper and lower extremities to full 5/5 strength within about 30-45 minutes. NIHSS improved from 9-1. Of note, the patient reported having several episodes similar in nature, in the setting of significant hypertension as well. Denied ever having a true stroke in the past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebellar stroke
Hospital-Tage: -
Labordaten: CT head was negative for hemorrhage or stroke. CTA head and neck was negative for any acute occlusion.
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1205963

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

schwer

Staat: GA
Alter: 43,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 17.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Abdominal pain upper Chest X-ray Chest pain Computerised tomogram Dyspnoea Echocardiogram Electrocardiogram Fatigue Headache Pain Pericarditis Pyrexia Sleep disorder

Symptomtext

Day 1-3 severe headache, fever, fatigue, body aches I was in the bed for 2.5 days. Day 5 - severe chest pain landed me in the ER at Hospital - pericarditis caused by the vaccine. Day 21- finally got into see a cardiologist, started colchicine to try to reduce the inflammation around my heart and prevent it from coming back. An echocardiogram is going to be performed on 4/14/21. Also, right upper quadrant pain when taking a deep breath, a ct scan is being scheduled. Ive not been able to sleep laying down since day 5 following the vaccine. Chest pain, shortness of breath and right upper quadrant pain are all a result of the vaccine.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Pericarditis
Hospital-Tage: -
Labordaten: 3/22/21 - ER-chest x-ray, blood work, EKG 4/7/21 - appt w/ cardiologist 4/13/21 - appt w/primary care 4/14/21- appt for echocardiogram TBD - CT Scan w/contrast 4/21/21 follow up/ discuss results of echocardiogram with cardiologist TBD - following up with primary care after CTScan is done
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma
Andere Medikamente: Singular, Adderall XR, metformin
Allergien: Peanuts, sulfa drugs, penicillin, codeine, morphine
Vorherige Impfungen: -

VAERS 1205179

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 78,0
Geschlecht: F
Eingang: 13.04.2021
Impfdatum: 17.03.2021
Beginn: 01.03.2021
Tage bis Beginn: -
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Asthenia Feeling cold Feeling hot Loss of consciousness Myalgia Tremor

Symptomtext

passed out for a very short period of time; was awakened by total body shaking and it was not just shivers but was uncontrollable shaking; her body felt warm but then she was freezing; her body felt warm but then she was freezing; was sick and was different and very weak; muscles were sore; This is a spontaneous report from a contactable consumer. A 78-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE)), via an unspecified route of administration, administered in the left arm on 17Mar2021 12:10 (Batch/Lot Number: EN6207; Expiration Date: 31May2021) as a single dose for covid-19 immunization. The patient's medical history was not reported. There were no concomitant medications. The patient received her first dose of the Pfizer BioNTech COVID19 vaccine on 23Feb2021 (lot number: EN6198 with expiry date 31May2021) for Covid-19 immunization. The patient experienced passed out for a very short period of time and awakened by total body shaking and it was not just shivers but was uncontrollable shaking on 18Mar2021; her body felt warm but then she was freezing, she was sick and was different and very weak, and muscles were sore in Mar2021. It was further reported that the patient got the 2nd dose of the Pfizer BioNTech vaccine that day on 17Mar2021 and about 12:45am or 1:30am the next morning she was awakened by total body shaking and it was not just shivers but was uncontrollable shaking; the shaking has resolved completely but she is not sure when it resolved but she was shaking for a good while because she can remember being so uncomfortable with her body moving so much which went on for maybe 20 minutes or so when her husband woke up.Patient's husband then woke up and got Ibuprofen and gave it to her and that stopped the shaking which surprised her and she did not know the Ibuprofen would work to stop the shaking that well and the Ibuprofen did work in stopping the shaking. The Ibuprofen stopped the shaking and she can remember to touch her body felt warm but then she was freezing and she does not know what this means but this was not ongoing and resolved when her husband gave her the ibuprofen and she stopped shaking right away which always amazed her that the Ibuprofen worked. She stated fortunately the Ibuprofen stopped her from shaking and she was able to sleep until early morning when she woke up and knew she was sick and was different and very weak; states the weakness was not ongoing and the approximate time the weakness resolved was unknown but she was down the rest of the day and after that she passed out for a very short period of time and held her head up and stood up and thought wow something was going on and asked where was this coming from and it was not nausea but she was just weak. She has not passed out for a huge amount of time but fortunately she had some towels laying close by and was able to use a towel; states after that she stopped for the rest of the day and only got up to go to the potty and was just so weak and heard that from many people that they just slept afterwards.Caller states her muscles were sore and she realized that was just normal and after the 2nd dose of the vaccine she knew her muscles would probably be sore and this was resolved. She came downstairs and was sitting on a chair and then stood and no longer sat in the chair and her husband knew things were not right with her and her eyes looked funny and she passed out and that never happened to her before and she was passed out for a few moments. Other than the Ibuprofen she did not have treatment and did not go to the emergency room or the HCP office. Patient only took one Ibuprofen and she has a very small body and her husband sometimes takes 2-3 Ibuprofen and she thinks wow that is so many but she herself does not have any medication and she just took one Ibuprofen and it worked; She took the Ibuprofen on 18Mar2021 in the early morning. Fortunately she was in good health. Outcome of the event passed out for a very short period of time, was awakened by total body shaking and it was not just shivers but was uncontrollable shaking and muscles were sore was recovered in Mar2021, and unknown outcome for the remaining events.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1193112

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 34,0
Geschlecht: M
Eingang: 11.04.2021
Impfdatum: 29.03.2021
Beginn: 07.04.2021
Tage bis Beginn: 9,0
Dosis: UNK
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Disturbance in attention Dizziness Electrocardiogram Headache Syncope Vision blurred

Symptomtext

April 7, woke up with a headache, took ibuprofen. A few hours later, started feeling hazy, lightheaded and had trouble concentrating while working from home. Felt like I was going to pass out. Took a break from computer screen, symptoms appeared to subside. An hour later, same haziness feeling came back. Thought I was going to pass out again. Called 911. ER diagnosed me with near syncope. Told me to keep an eye on symptoms and come back if things worsen. I informed them I had received one dose of vaccine, they didn?t seem to think it was related. Symptoms have slightly improved since, but still have bouts of dizziness four days later.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: April 7, ER did blood work, it all came back fine. Electrocardiograph came back fine. They diagnosed me with near syncope. Told me to keep an eye on symptoms and come back if things worsen.
Aktuelle Erkrankungen: -
Vorgeschichte: History of non-Hodgkin?s lymphoma
Andere Medikamente: Ibuprofen as needed for pain
Allergien: Raglan, phenergen
Vorherige Impfungen: -

VAERS 1127824

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 59,0
Geschlecht: F
Eingang: 11.04.2021
Impfdatum: 11.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Blood test Dizziness Electrocardiogram Facial nerve disorder Pharyngeal swelling Hypoaesthesia oral Nervous system disorder Optic nerve disorder

Symptomtext

nerve problems behind left eye; nerve problems in face; lips had nerve problems; tongue was numb; throat felt swollen; Bell's palsy; lightheaded and dizzy; This is a spontaneous report received from a contactable consumer (who is also the patient). A 59-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in the left arm, on 11Mar2021 15:30, as single dose, for covid-19 immunisation. Medical history included known allergies to antihistamine (unspecified) and sulfur drugs. The patient was not pregnant at the time of vaccination. The patient did not have COVID-19 prior the vaccination and was not tested for COVID-19 post vaccination. Concomitant medications included levothyroxine sodium (SYNTHROID); omeprazole; and anastrozole, all taken for unspecified indications, start and stop dates were not reported. Historical vaccine included the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6200) received at age 59 years, via an unspecified route of administration in the left arm, on 18Feb2021 15:45, for COVID-19 immunization. The patient did not receive other vaccines in four weeks. On 11Mar2021 at 15:45, 15 minutes after the second dose, the patient got lightheaded and dizzy. On the same day at 16:15, 45 minutes after the second dose, the patient experienced nerve problems behind left eye, then nerve problems in face, then lips had nerve problems, then tongue was numb, and throat felt swollen. The patient reported the side effects on the hotline, and she was transferred to a nurse who told her to go to the emergency room immediately as she could be getting Bell's palsy from the vaccine. The events resulted to emergency room visit and hospitalization (unspecified date in Mar2021). Treatment for the events included unspecified IV. The patient was hooked up to an EKG and her blood was drawn for checking in Mar2021 (results were unknown). The patient was recovering from the events. Follow-up attempts are completed. No further information is expected.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Test Date: 202103; Test Name: blood checking; Result Unstructured Data: Test Result:Unknown result; Test Date: 202103; Test Name: EKG; Result Unstructured Data: Test Result:Unknown result
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Drug allergy
Andere Medikamente: SYNTHROID; OMEPRAZOLE; ANASTROZOLE
Allergien: -
Vorherige Impfungen: -

VAERS 1191810

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

schwer

Staat: MI
Alter: 55,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 18.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Pain in extremity SARS-CoV-2 test Thrombosis Ultrasound scan

Symptomtext

they had a ultrasound done and found out I had a number of clots in that position; a sore Leg, Upper part of the left calf 2 inches below the knee on the backside; This is a spontaneous report from a contactable consumer. A 55-years-old male patient received bnt162b2 (PFIZER-BIONTECH mRNA COVID-19 VACCINE), dose 1 via an unspecified route of administration, administered in Arm Left on 18Mar2021 15:00 (Batch/Lot Number: En6207) as SINGLE DOSE for covid-19 immunisation. Medical history included Treatable Acid reflex, anxiety and mild depression. Concomitant medications included omeprazole, buspirone and alprazolam for unspecified indication. Patient had the Covid shot on 18Mar2021 at about 3 PM the next morning (on 19Mar2021 06:00) patient woke up with a sore Leg, Upper part of the left calf 2 inches below the knee on the backside. After it did not go away, he went to the doctor then they had a ultrasound done and found out he had a number of clots in that position. Treatment received for the adverse event includes they put patient on a blood thinner. Prior to vaccination, was the patient did not diagnose with COVID-19. Since the vaccination, the patient has been tested for COVID-19. patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 24Mar2021. Covid test post vaccination done via nasal Swab, They had the results in 15 minutes, covid test result Negative, ultrasound scan: clots in that position on 19Mar2021 found out, had a number of clots in that position. Outcome of the events was recovering.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: Test Date: 20210324; Test Name: Nasal Swab; Result Unstructured Data: Test Result:Negative; Comments: They had the results in 15 minutes. covid test result Negative; Test Date: 20210319; Test Name: ultrasound; Result Unstructured Data: Test Result:clots in that position; Comments: found out, had a number of clots in that position
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Acid reflux (esophageal); Anxiety; Depression
Andere Medikamente: OMEPRAZOLE; BUSPIRONE; ALPRAZOLAM
Allergien: -
Vorherige Impfungen: -

VAERS 1190545

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 24,0
Geschlecht: M
Eingang: 10.04.2021
Impfdatum: 10.04.2021
Beginn: 10.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Erythema Fall Seizure

Symptomtext

Pt received Covid vaccine, was told you wait 15 minutes to be monitored. While waiting, he was adjusting his sweatshirt and was flailing with the sleeves and hood. It was witnessed that his face became red, he started to convulse and fell to the ground while pulling on the handle of his shopping cart. He was able to sit up on his own; at which time 911 was dispatched. Paramedics arrived quickly and assessed patients blood pressure and condition. They cleared him and they left at 11:40am. Pt was escorted to his truck by staff pharmacist and left before noon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Unknown
Andere Medikamente: unknown
Allergien: NA
Vorherige Impfungen: -

VAERS 1158181

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 54,0
Geschlecht: F
Eingang: 09.04.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Fatigue Heart rate increased Hot flush Immediate post-injection reaction Hypoaesthesia Paraesthesia Throat tightness

Symptomtext

Patient received the first dose of Pfizer Covid-19 vaccine and about 5 minutes after complained of numbness and tingling in her face and felt her throat was closing up. Patient was medicated with 0.3mg epinephrine one dose, 911 called. EMS inserted IV line and Benadryl 50mg was administered once. The patient was transferred to the Emergency department where she was observed for 4 hours and given prescriptions for Prednisone and Benadryl for an additional 3 days on discharge.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1182572

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 73,0
Geschlecht: M
Eingang: 08.04.2021
Impfdatum: 09.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: OT / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: ja ER: ja Erholt: nein

Eye movement disorder Eye pain Oculofacial paralysis

Symptomtext

Paralysis of right upper eyelid impaired motility of right eye and eye pain.; Paralysis of right upper eyelid impaired motility of right eye and eye pain.; Paralysis of right upper eyelid impaired motility of right eye and eye pain.; This is a spontaneous report from a contactable physician. A 73-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EN6207), first dose intramuscular, administered in Arm Right on 09Mar2021, single dose for covid-19 immunisation. Patient had no relevant medical history. Concomitant medicine included an unspecified vitamin. On 10Mar2021, patient experienced, paralysis of right upper eyelid impaired motility of right eye and eye pain. It was unknown if treatment was given for all adverse events. The outcome of the events was unknown. The events was assessed as serious, disability criteria. No other vaccine given in four weeks. No Covid prior vaccination. Not Covid tested post vaccination. No known allergies.; Sender's Comments: Considering the plausible temporal association and lacking any reported alternative explanation, a causative role of BNT162B2 vaccine for the reported paralysis of right upper eyelid, impaired motility of right eye, and eye pain cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Oculofacial paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: none
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1182553

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 35,0
Geschlecht: M
Eingang: 08.04.2021
Impfdatum: 08.04.2021
Beginn: 08.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Refusal of treatment by patient Seizure

Symptomtext

Patient was having seizure symptoms within 10 mins of receiving his first dose of the COVID-19 Pfizer vaccination. 911 was called immediately and while the EMS was arriving to the scene patient was starting to feel better. There was no reports of any signs of trouble breathing. EMS arrived on the scene and assessed the patient. Patient refused to go to the hospital with the EMS and reports to be feeling fine. Recommendations to follow up with a physician was advised.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Aspirin and Ibuprofen
Vorherige Impfungen: -

VAERS 1178264

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 56,0
Geschlecht: M
Eingang: 07.04.2021
Impfdatum: 22.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Chills Diarrhoea Hyperhidrosis SARS-CoV-2 test Seizure Vomiting

Symptomtext

Complex seizures; Explosive diarrhea; Profuse vomiting; Chills; sweats; This is a spontaneous report from a contactable consumer (patient). A 56-year-old male patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Lot Number: EN6207), via an unspecified route of administration in the left arm, on 22Mar2021 at 09:30 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies to medications, food, or other products. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and atorvastatin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced complex seizures, explosive diarrhea, profuse vomiting, chills, and sweats on 22Mar2021 at 19:00. All of the events required hospitalization from an unspecified date to an unspecified date for one day. The patient underwent lab tests and procedures which included nasal swab: negative on 22Mar2021. Therapeutic measures were taken as a result of all of the events, which included intravenous fluids. The clinical outcome of complex seizures, explosive diarrhea, profuse vomiting, chills, and sweats was recovered on an unspecified date. The batch/lot number for the vaccine, BNT162B2, was not provided and will be requested during follow up.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: 1,0
Labordaten: Test Date: 20210322; Test Name: Nasal Swab; Test Result: Negative
Aktuelle Erkrankungen: -
Vorgeschichte: Comments: List of non-encoded Patient Relevant History: Patient Other Relevant History 1: None
Andere Medikamente: LISINOPRIL; ATORVASTATIN
Allergien: -
Vorherige Impfungen: -

VAERS 1176893

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 18,0
Geschlecht: M
Eingang: 07.04.2021
Impfdatum: 07.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Fainting about 2-3 minutes after shot was administered. Could have been anxiety. He has never fainted from just a shot but has when he has had blood drawn.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1175299

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 29,0
Geschlecht: F
Eingang: 07.04.2021
Impfdatum: 05.04.2021
Beginn: 07.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Lymph node pain Lymphadenopathy Syncope

Symptomtext

Vasovagal syncope, painful/inflamed lymph nodes on right side of neck/clavicle

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NA
Vorgeschichte: NA
Andere Medikamente: Zoloft, mirena IUD, Zyrtec
Allergien: NA
Vorherige Impfungen: -

VAERS 1174294

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 62,0
Geschlecht: M
Eingang: 07.04.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Anaphylactic reaction Blood pressure increased Blood pressure systolic Body temperature Chills Eye pruritus Fatigue Feeling abnormal Freezing phenomenon Hypersomnia Hyperventilation Illness Job dissatisfaction Lethargy Nasopharyngitis Periorbital swelling Pyrexia Thinking abnormal

Symptomtext

'blood pressure had been up to 180/increase in blood pressure'; he was freezing; he was cold; ''he is usually up at work every day and he hasn't been able to work the last few days''; feels like he can't think'', ''tired; ''he may be getting in for breathing treatments today''; so sick; feels like he can't think'', ''tired; Feeling lousy; Lethargic; Running temperature; Chills; Hives; Anaphylaxis; fell asleep for 16 hours. Caller reported that he doesn't normally sleep for 16 hours; Throat scratching; Eye itching; Bags under eyes; This is a spontaneous report received from a contactable consumer (patient). A 62-year-old male received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE; Solution for injection, Batch/Lot number: EN6207), via unspecified route of administration on right arm on 19Mar2021 13:09 as a single dose, for COVID-19 immunization. The patient medical history included Ongoing COPD (about 5 years ago), high blood pressure (about 10 years ago and still ongoing) extensive allergies to food and insect bites. The patient was diagnosed with the allergies when he was a little kid, allergic to penicillin ongoing. Concomitant medications included lisinopril at 20 mg once daily in the morning for high blood pressure and albuterol at 2 pumps in AM and 2 in PM before going to bed for COPD (Chronic obstructive pulmonary disease). The patient previously took historical vaccine ampicillin for infection. On 19Mar2021, the patient experienced, ended up feeling really sick right after the shot. He has a lot of allergies and he was advised to take his Epi-Pen kit and stay an additional 30 minutes past the recommended waiting time after receiving his vaccine. His throat began scratching after getting the shot and lasted for about 3 to 4 hours for which the patient received Benadryl and resolved completely. His eyes were itching and lasted for 24 hours, and bags started to form under his eyes like anaphylactic shock. It was reported that the bags under his eyes would normally stay after anaphylaxis for a day or two. His eyes were still a little puffy at the bottom. He did not saw a rash but started to get hives, the paramedics were called and monitored him for another 30 minutes. The paramedics administered a shot of Benadryl. After the Benadryl was administered, his body and blood pressure started to come down. The paramedics reported that his blood pressure had been up to 180. It was reported that on 19Mar2021, afternoon, when the patient got home, he was sick, laid down and fell asleep for 16 hours. He does not normally sleep for 16 hours. He was unsure if his eyes were itchy in his sleep. Later in the call it was clarified that this might have only lasted 3-4 hours, he was so tired he just went to sleep. It was reported that he was not a sleeper, that he was usually up at work every day and he had not been able to work the last few days. It was reported that he started feeling the side effects of the Covid-19 vaccine at 13:20 on 19Mar2021. On 20Mar2021, he felt lousy ever since he received the COVID-19 vaccine. On the same day, his wife took his temperature, and his temperature was hovering around 100-100.9. He felt lethargic, running a temperature between 100.5 and 100.9 pretty consistent every day. On an unspecified date, his wife took his temperature, and it was 99.9. He felt like his mind was in a fog, intoxicated and he had not felt good since receiving the first dose of the Covid-19 vaccine. It was reported that the mental fog made him felt like he cannot think. The paramedics gave him a test and asked him to add 5+7. The patient answered 14, even though he knew that the answer is 12because he could not think, and he felt punch drunk. He reported that he can concentrate a little more, but he still felt drunk, this was hanging around the same now. It was reported that the paramedics were asking him questions and gave him things to do, addition and subtraction formulas, to keep his mind. He could not finish those formulas and that he told the paramedics that he felt foggy or punch drunk. He spoke with his health care provider at the VA and the provider advised him not to get the second dose of the Covid-19 vaccine. It was reported that the patient was inquired if he had any immunity to Covid-19 without taking the second shot and if he was protected with just the one dose of the Covid-19 vaccine. It was also reported that, the reporter also looked through the list of side effects for Covid-19 vaccine and it was like patient had all of them. The patient experienced chills, he was freezing, and he was cold. The patient had the whole list of them. It reported that he had doctor appointment on Monday, 29Mar2021, and that he may be getting in for breathing treatments today. He was waiting for his insurance to finalize the approval for the breathing treatments in the evening. The outcome of the events throat scratching and eye itching was recovered on 19Mar2021, Outcome of the events bags under eyes and blood pressure had been up to 180/increase in blood pressure were recovering. The outcome of the events feeling lousy, lethargic, running temperature and chills were not recovered. Outcome of the other events was unknown. Information on the lot/batch number has been requested. Information on the lot/batch number has been requested.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Date: 20210319; Test Name: Blood pressure; Result Unstructured Data: Test Result:Systolic blood pressure was 180; Test Date: 20210320; Test Name: Temperature; Result Unstructured Data: Test Result:temperature between 100.5 and 100.'', ''his temp; Comments: ''temperature between 100.5 and 100.'', ''his temperature has been hovering around 100-100.9.'', ''his wife took his temperature this morning and it was 99.9
Aktuelle Erkrankungen: Allergy; Blood pressure high ('diagnosed with high blood pressure about 10 years ago''); COPD (''diagnosed with COPD about 5 years ago"); Penicillin allergy
Vorgeschichte: Medical History/Concurrent Conditions: Food allergy (Caller reported that he was diagnosed with the allergies when he was a little kid); Insect bite allergy (Caller reported that he was diagnosed with the allergies when he was a little kid)
Andere Medikamente: LISINOPRIL; ALBUTEROL HFA
Allergien: -
Vorherige Impfungen: -

VAERS 1173068

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 32,0
Geschlecht: F
Eingang: 06.04.2021
Impfdatum: 02.04.2021
Beginn: 04.04.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Chest pain Electrocardiogram Headache Syncope

Symptomtext

Chest/sternal pain, syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: will check EKG when Pt returns to clinic
Aktuelle Erkrankungen: headaches
Vorgeschichte: n/a
Andere Medikamente: Chateal 0.15-30 buproprion ER 150mg
Allergien: nka
Vorherige Impfungen: -

VAERS 1171418

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 86,0
Geschlecht: F
Eingang: 06.04.2021
Impfdatum: 22.02.2021
Beginn: 10.03.2021
Tage bis Beginn: 16,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

COVID-19 Cardiac function test normal Monoclonal antibody immunoconjugate therapy Presyncope SARS-CoV-2 test positive

Symptomtext

Developed COVID after first dose of vaccine. Pt arrived to vaccine clinic on 03/13 for her second dose. Had symptoms consistent with COVID since 3/10- sore throat, fevers, body aches, diarrhea, congested. Tested positive for COVID 3/14. Received bamlanivimab on 3/15. Was referred to ED 2 hours after monoclonal infusion after presyncopal episode. Cardiac workup done and was negative. Admitted for monitoring received IV hydration and supportive care (no supplemental O2)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1169393

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 16,0
Geschlecht: F
Eingang: 05.04.2021
Impfdatum: 05.04.2021
Beginn: 05.04.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness Tonsillectomy Vomiting

Symptomtext

Pfizer 1st dose administered at COVID-19 Clinic. Client reported being diagnosed with COVID-19 during the last week of September 2020. Reviewed with client what to expect with side effects after receiving 1st dose. No questions or concerns voiced. Gave vaccine at 1505. Mother then stated after vaccine administered that client has history of syncopal episodes after vaccines. Provided water to client and recommended for client to be moved to a supine position. Client declined lying down. About 1506, client lost consciousness for 4 seconds. Client returned to consciousness without intervention and was alert and oriented x 4. Client had 10mL emesis after returning to consciousness. Recommended for client to lie down, client declined. Provided graham crackers and cycling floor fan. Client able to tolerate water and graham crackers. After 5 minutes, client stated feeling better. Mother elaborated that about 1 year ago had first vagal response to needles when having wisdom teeth removed. Happened again during IV initiation for tonsillectomy surgery and during flu vaccination 2020. Monitored client in clinic room for 20 minutes, no further reaction. Advised for client to state needing to lie down when returns for 2nd dose. Client and mother verbalize understanding. Mother escorted client from clinic to private vehicle.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Mother stated had syncopal episode after receiving influenza vaccine 9/23/2020.

VAERS 1164160

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 35,0
Geschlecht: F
Eingang: 03.04.2021
Impfdatum: 12.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 6,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Lyme disease

Symptomtext

Bells Palsy on left side of face. First started with numb feeling on eye on Thursday and by Friday evening had lost muscle control on left eye and left side of mouth with numbness on left cheek. Urgent care doctor prescribed 6 doses of Predisone and ordered a Lyme disease test, which was negative.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Lyme test on 3/13/21
Aktuelle Erkrankungen: -
Vorgeschichte: Valve disease Graves disease Hyperthyroidism
Andere Medikamente: Propranolol Methimizole Multivitamins
Allergien: No
Vorherige Impfungen: -

VAERS 1158985

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: SC
Alter: 27,0
Geschlecht: M
Eingang: 02.04.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cyanosis Dizziness Gaze palsy Hyperhidrosis Loss of consciousness Pallor

Symptomtext

Patient had received Covid vaccination and was seated in monitoring area. Patient was being monitored by nurse. She states patient complained of feeling lightheaded. Took off coat and drank some water. She checked his pulse at that time, and reports 60. She reported to other staff in area. Patient explained that he has done this in the past with injections, but not always. He was sipping water, diaphoretic. At 0918 patient became was extremely diaphoretic, lips blue, eyes rolled back, and patient was unconscious, No pulse detected. I lowered him to floor from chair. EMT checked again for carotid pulse and I placed hands in position to start compressions. Faint pulse noted, and did not begin compressions. Nurse practitioner came over assisted by raising lower extremities onto chair. 0919 patient oxygen sats 91-93 percent. Ambulance en route. Patient color improving, responding appropriately, alert and oriented. heart rate 51. blood pressure 112/59. 0921. EMS on site, patient still pale, and slightly diaphoretic, much improved though, b/p 119/62. hr 61 pulse ox 91 percent. EMS assumed care.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: Patient states similar reaction, no details available

VAERS 1158706

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 67,0
Geschlecht: F
Eingang: 02.04.2021
Impfdatum: 11.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Computerised tomogram Echocardiogram Inappropriate schedule of product administration Magnetic resonance imaging Off label use X-ray

Symptomtext

Bell's palsy; got second dose early on 11Mar2021, it was originally scheduled for 14Mar2021; got second dose early on 11Mar2021, it was originally scheduled for 14Mar2021; This is a spontaneous report from a contactable consumer (patient's daughter). A 67-year-old female patient (mother) received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), second dose intramuscular, administered in the left arm on 11Mar2021 at 19:20 (batch/lot number: EN6207) as a single dose for COVID-19 immunisation. Medical history included ongoing high cholesterol. Concomitant medications included ongoing high cholesterol meds (unspecified). The patient had no vaccinations within four weeks prior to the first administration date of the suspect vaccine. The consumer was calling on behalf of her mother who doesn't speak English who got the Pfizer COVID-19 vaccine second dose on the 11Mar2021 then was admitted to the hospital on 17Mar2021 with a diagnosis of Bell's palsy. She said that her mother's vaccine card was handwritten and does not provide NDC/EXP. She said that the LOT for her mother's first dose was EN6203, which she got on 21Feb2021 at 02:30PM. She said that the second dose for her mother was injected at 07:20PM 11Mar2021. She said that her mother was admitted to the hospital at 03:00PM 17Mar2021 after she took her to the emergency room. She said her mother was prescribed steroids and antivirals. She said for diagnosis at first they did CAT scan, X-ray, MRI, and an echo to verify not a stroke, which those were negative for stroke. She said that her mother was discharged from the hospital yesterday on the 18th at about 03:15PM. She said her mother was currently feeling about the same right now, she has no issues with motor skills, it was primarily facial droopage. She clarified that the steroids her mother was prescribed for treatment was Prednisone 20 mg, that came in a pharmacy bottle that does not provide NDC/LOT/EXP on the label. She said the label says discard by 18Mar2022. She said her mother was prescribed to take Prednisone 20 mg tabs, 3 tabs by mouth in the morning for 6 days. She says for the antivirals for treatment, her mother was prescribed Valacyclovir HCl 1 gm tab twice a day morning and night for 7 days. She said this was also dispensed in a pharmacy bottle without NDC/LOT/EXP provided on pharmacy label. She said her mother has not had any other recent vaccinations or started any new medications. She asked if the purpose of calling was just to give information about what had happened, since the hospital said to report it to Pfizer, and she was not sure exactly why. She said her mother was on insurance plan and she doesn't know if there was any assistance with that for hospital bills, but they didn't say if there was anything towards that. She said she wonders if there was information with medical bill assistance for this being kind of diagnosed or someone to notify. She said she would also like to know if this could be because her mother's second dose was early, it was originally scheduled for 14Mar2021, but due to the weather there, the blizzard, they had her mother come in early to get shot. The seriousness criteria of the event Bell's palsy was hospitalization, duration of stay was overnight: 17Mar2021 to 18Mar2021. The outcome of the event Bell's palsy was not recovered.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 1,0
Labordaten: Test Date: 20210317; Test Name: CAT scan; Result Unstructured Data: Test Result:negative for stroke; Test Date: 20210317; Test Name: echo; Result Unstructured Data: Test Result:negative for stroke; Test Date: 20210317; Test Name: MRI; Result Unstructured Data: Test Result:negative for stroke; Test Date: 20210317; Test Name: X-ray; Result Unstructured Data: Test Result:negative for stroke
Aktuelle Erkrankungen: High cholesterol
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1156110

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge E N6207

schwer

Staat: OH
Alter: 64,0
Geschlecht: F
Eingang: 01.04.2021
Impfdatum: 30.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 1,0
Dosis: UNK
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: unbekannt

Dizziness Feeling hot Loss of consciousness

Symptomtext

Passed out at the casino and transported to Hospital b y Ambulance. I Was kept overnight. Feeling light headed , dizzy and hot. . 1 day after the second doze of the pfizer shot. Passed out approximately 15 minutes after filling the symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 1,0
Labordaten: -
Aktuelle Erkrankungen: high Blood Pressure
Vorgeschichte: -
Andere Medikamente: -
Allergien: none
Vorherige Impfungen: -

VAERS 1155949

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: SC
Alter: 23,0
Geschlecht: F
Eingang: 01.04.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Dizziness Gait disturbance Syncope Unresponsive to stimuli

Symptomtext

After injection, upon standing up, patient became light headed. Assisted to chair. Patient immediately went limp, clammy, and unresponsive. 911 called. Assisted to floor. Legs raised. Became active at about 15 seconds, speaking to nurses. Began recovering. Pulse 96 BP 98/56 Pulse 52 Repeated vital signs when standing up, 72/47 Pulse 51 became slightly lightheaded again. Returned to laying position on floor, continued to talk to nurses. EMS arrived and took over assessment. Declined to go to hospital. Return to chair with no issues. Stood with no issues. To recovering area for further observation before leaving. In recovery area Participant lying on monitor cot post EMS departure. 1619 BP 88/56, P 65, O2 Sat 99%. Voiced lighted headedness better and mother at side. 1622 Assisted to sitting position BP 84/62. Encouraged to sit and continue hydration. 1625 Participant and mother voiced readiness to leave. Educated to monitor closely for p.m. and call 911 for s/s return and or resp. distress. Both voiced will return to urgent care / hospital if any issues. 1625 Participant stood with minimal assist. BP 90/47, P 57. Ambulating without c/o. At time participant departed Howard vaccine site via private car.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1155906

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: SC
Alter: 44,0
Geschlecht: M
Eingang: 01.04.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Dyspnoea Fall Hyperhidrosis Loss of consciousness Pallor

Symptomtext

Nnurse was called to assist a patient that had left the monitoring area. Upon arrival, patient was sitting in mall with back leaning on wall. Patient was AAAx3. He was pale and diaphoretic. Patient stated he waited his 15 minutes and felt fine. Patient received dose 1 of Pfizer Covid Vaccine (Lot #EN6207, Exp 5/31/21). When he was walking back to his car he "blacked out" and fell to the floor. Patient stated he hit his head on the ground. No visible injury to back of head was observed. Patient reported he did not eat or drink anything prior to coming. He stated it was warm in the mall and he was having difficulty breathing with the mask on. Patient was instructed to take his mask off. VS were assessed: 98/68, HR 82, pulse ox 98% room air. Patient was given water and some chocolate. Patient stated he started to feel better. Patient was assisted into wheelchair and continued to be observed. Patient stated he initially started to feel better, but then felt lightheaded again. VS reassessed @ 0948 BP 92/64, HR 72, pulse ox 98% room air. This nurse advised patient EMS should be called for further evaluation. Patient refused and stated he did not want to go to the hospital. Nurse again advised that his blood pressure remained low and he should be further evaluated. Patient continued to refuse. Patient was advised to call someone for a ride home as it was advised he should not drive at this time. Patient called his father for transport home. Patient was given a sprite to drink while waiting for his ride. Patient was accompanied by monitor until ride arrived. Patient was picked up and left without further incident.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: EGGS OR EGG BYPRODUCTS, FISH, SHELLFISH
Vorherige Impfungen: -

VAERS 1109026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 31,0
Geschlecht: F
Eingang: 01.04.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chest discomfort Confusional state Dyspnoea Disorientation Heart rate Flushing Hypoaesthesia oral Pharyngeal swelling Heart rate increased Swollen tongue Pharyngeal hypoaesthesia Throat irritation

Symptomtext

Anaphylaxis; Swelling/tightness of the throat and chest; Swelling/tightness of the throat and chest; Swelling of the tongue; numbness of the tongue; persistent disorientation; confusion; Rapid heartbeat; This is a spontaneous report from a contactable consumer (patient herself). A 31-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in left arm on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA) and asthma. The patient had no known medical allergens. Concomitant medications in two weeks included amoxicillin, clavulanic acid (AMOXCLAV 875-125 MG) and cetirizine hydrochloride (ZYRTEC 10 MG). The patient did not receive other vaccines in four weeks. The patient was not pregnant and was not diagnosed with COVID prior to vaccination. On 17Mar2021 12:15 PM, the patient experienced anaphylaxis, swelling/tightness of the throat and chest, swelling of the tongue, numbness of the tongue, persistent disorientation and confusion, and rapid heartbeat. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment included 2 Epipens, Benadryl 25 mg, and intravenous Benadryl. Outcome of the events was not recovered. The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: Heartbeat; Result Unstructured Data: Test Result:Rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma; RA
Andere Medikamente: AMOXCLAV [AMOXICILLIN;CLAVULANIC ACID]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1109026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 31,0
Geschlecht: F
Eingang: 01.04.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chest discomfort Confusional state Dyspnoea Disorientation Heart rate Flushing Hypoaesthesia oral Pharyngeal swelling Heart rate increased Swollen tongue Pharyngeal hypoaesthesia Throat irritation

Symptomtext

Anaphylaxis; Swelling/tightness of the throat and chest; Swelling/tightness of the throat and chest; Swelling of the tongue; numbness of the tongue; persistent disorientation; confusion; Rapid heartbeat; This is a spontaneous report from a contactable consumer (patient herself). A 31-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in left arm on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA) and asthma. The patient had no known medical allergens. Concomitant medications in two weeks included amoxicillin, clavulanic acid (AMOXCLAV 875-125 MG) and cetirizine hydrochloride (ZYRTEC 10 MG). The patient did not receive other vaccines in four weeks. The patient was not pregnant and was not diagnosed with COVID prior to vaccination. On 17Mar2021 12:15 PM, the patient experienced anaphylaxis, swelling/tightness of the throat and chest, swelling of the tongue, numbness of the tongue, persistent disorientation and confusion, and rapid heartbeat. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment included 2 Epipens, Benadryl 25 mg, and intravenous Benadryl. Outcome of the events was not recovered. The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: Heartbeat; Result Unstructured Data: Test Result:Rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma; RA
Andere Medikamente: AMOXCLAV [AMOXICILLIN;CLAVULANIC ACID]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1109026

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 31,0
Geschlecht: F
Eingang: 01.04.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Anaphylactic reaction Asthenia Chest discomfort Confusional state Dyspnoea Disorientation Heart rate Flushing Hypoaesthesia oral Pharyngeal swelling Heart rate increased Swollen tongue Pharyngeal hypoaesthesia Throat irritation

Symptomtext

Anaphylaxis; Swelling/tightness of the throat and chest; Swelling/tightness of the throat and chest; Swelling of the tongue; numbness of the tongue; persistent disorientation; confusion; Rapid heartbeat; This is a spontaneous report from a contactable consumer (patient herself). A 31-year-old female patient received her first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EN6207), via an unspecified route of administration in left arm on 17Mar2021 as a single dose for COVID-19 immunisation. Medical history included rheumatoid arthritis (RA) and asthma. The patient had no known medical allergens. Concomitant medications in two weeks included amoxicillin, clavulanic acid (AMOXCLAV 875-125 MG) and cetirizine hydrochloride (ZYRTEC 10 MG). The patient did not receive other vaccines in four weeks. The patient was not pregnant and was not diagnosed with COVID prior to vaccination. On 17Mar2021 12:15 PM, the patient experienced anaphylaxis, swelling/tightness of the throat and chest, swelling of the tongue, numbness of the tongue, persistent disorientation and confusion, and rapid heartbeat. The events resulted in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care, life threatening illness (immediate risk of death from the event). Treatment included 2 Epipens, Benadryl 25 mg, and intravenous Benadryl. Outcome of the events was not recovered. The patient was not tested for COVID post vaccination.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Test Name: Heartbeat; Result Unstructured Data: Test Result:Rapid
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Asthma; RA
Andere Medikamente: AMOXCLAV [AMOXICILLIN;CLAVULANIC ACID]; ZYRTEC [CETIRIZINE HYDROCHLORIDE]
Allergien: -
Vorherige Impfungen: -

VAERS 1153497

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CT
Alter: 25,0
Geschlecht: F
Eingang: 31.03.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Delirium Disorientation Dizziness Nausea Pyrexia Syncope

Symptomtext

Delirium; Fainting episode with convulsions; Fever with Chills; Nausea; Dizziness and disoriented; Dizziness and disoriented; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient (not pregnant) received first dose of bnt162b2 (Batch/Lot Number: EN6207), via an unspecified route of administration, administered in left arm on 18Mar2021 08:30 as single dose for covid-19 immunization. Medical history included cystitis interstitial from an unknown date and unknown if ongoing. Concomitant medications included ethinylestradiol, ferrous fumarate, norethisterone acetate (LO LOESTRIN FE) taken for an unspecified indication, start and stop date were not reported. The patient experienced delirium, fainting episode with convulsions, fever with chills, nausea, dizziness and disoriented on 18Mar2021 09:00. No other vaccine in four weeks. The adverse event was not resulted in a visit to doctor or other healthcare professional office/clinic or Emergency room/department or urgent care. No treatment received. The outcome of events was resolving. No Covid prior vaccination. No Covid tested post vaccination. Not Known allergies.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Cystitis interstitial
Andere Medikamente: LO LOESTRIN FE
Allergien: -
Vorherige Impfungen: -

VAERS 1152285

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

schwer

Staat: OK
Alter: 47,0
Geschlecht: F
Eingang: 31.03.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Facial paralysis Mouth swelling Pruritus

Symptomtext

Oral swelling , itching ,right side facial drooping. Taken to ER by staff in wheelchair

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Neurological disorder
Vorgeschichte: Neurological disorder
Andere Medikamente: -
Allergien: Benadryl
Vorherige Impfungen: -

VAERS 1152156

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MA
Alter: 70,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 16.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Abdominal pain upper Arthralgia Back pain Fatigue Feeling hot Headache Neck pain Pain in extremity Presyncope Visual brightness

Symptomtext

Got the vaccine, had no reactions. Then about 4 days later he was going for a 2 mile walk and started out on the walk and had not done a 1/4 of a mile and he started to feel warm. He had pain in his trapezius muscles into his neck, had a headache and had a bad pain in the pit of his stomach, joint pain in his knees and started to get vasovagal event, everything looked bright and the white things seemed to glow. He then walked back to his vehicle slowly. Since then every time he does anything exertionally, walking for any short distance the same symptoms seem to come on. He also has a tired feeling. He called his cardiologist and he suggested that he should try drinking a lot of water to hydrate himself. His brother-in-law is a paramedic who also told him to hydrate before his vaccine. He's been drinking a lot of water. He does have a stomach issue, and has been having the nausea but believes that was preexistent to the vaccine. He has not had any reactions around the injection site itself. He did have some soreness in the arm for a couple of days initially, but had also gotten a regular flu vaccine through the hospital and had the same reaction with that.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: None.
Aktuelle Erkrankungen: Stomach issues, nauseous feeling with pain, and told by pharmacist and other medical personnel that it could be an ulcer since the first of March, still continuing. APT for endoscopy.
Vorgeschichte: High blood pressure, high cholesterol, heart disease, atherosclerosis, stent implant in heart, esophagitis.
Andere Medikamente: Metoprolol supinate, Rosuvastatin, Nitroglycerin prn, Omeprazole, 81 mg aspirin, Vitamin D3, Coenzyme Q10, Supra B complex, Omega 3 fish oil, multivitamin.
Allergien: None.
Vorherige Impfungen: -

VAERS 1151559

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 33,0
Geschlecht: F
Eingang: 31.03.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Generalised tonic-clonic seizure

Symptomtext

Grand mal seizure for 30 seconds occurring 20-30 minutes post-vaccine. No history of seizures in past.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: UNKNOWN
Aktuelle Erkrankungen: UNKNOWN
Vorgeschichte: UNKNOWN
Andere Medikamente: UNKNOWN
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1150715

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OK
Alter: 46,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 31.03.2021
Beginn: 31.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Electric shock sensation Haemorrhage

Symptomtext

On or about 0845 am, RN administered Covid vaccine (2nd one for patient). Attempted administration with syringe (a Haiou, 1ml, 23g, 1'', Lot 20JC2, Exp: 10-17-25) resulted in needle going into patient's arm, but the 2 piece retractable distal needle and hub separated from the proximal tube part of the syringe resulting in COVID vaccine dose being lost. None of the 1st dose entered patient's arm. With needle and distal hub still fully immersed in patient's arm, RN removed it and held pressure on bleeding. RN informed patient that needle failed, to which pt stated he was "shocked," and felt an "electric" sensation when needle was inserted. Patient tolerated well. Bleeding abated. RN administered a 2nd dose of vaccine to the patient with no problems on the same LUE, more medial by about 2 inches than the first attempt. Bandage applied to both sites due to scant bleeding. Patient tolerated well, but showed no emotion. Pt complied with all instructions, and RN thanked patient for coming in.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: NA
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1150377

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 31.03.2021
Impfdatum: 10.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: - / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Thrombosis Varicose vein

Symptomtext

Superficial blood clot on left calf at the lower end of some varicose veins two days after injection; Superficial blood clot on left calf at the lower end of some varicose veins two days after injection; This is a spontaneous report from a contactable consumer (patient). A 62-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot: EN6207), via an unspecified route of administration in right arm on 10Mar2021 14:30 (at the age of 62-years-old) as single dose for covid-19 immunisation. The vaccine facility type was a pharmacy or drug store. The patient had no other vaccine in four weeks. The patient did not have Covid prior vaccination and was not Covid tested post vaccination. Medical history included macular. Concomitant medication included amitriptyline. The patient previously took erythromycin and statins and experienced drug allergies from these. The reported adverse events were superficial blood clot on left calf at the lower end of some varicose veins two days after injection (on 12Mar2021 at 10:00). It may be unrelated, but the patient wanted to let know. The events resulted in emergency room/department or urgent care. AE treatment included hot compress, support stockings and ibuprofen (MOTRIN). The outcome of the events was recovering.; Sender's Comments: Varicose veins most probably was a preexisting condition, unrelated to BNT162B2 vaccine. The reported superficial blood clots are considered a complication of varicose vein and unlikely related to BNT162B2.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Thrombosis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Medical History/Concurrent Conditions: Macular degeneration
Andere Medikamente: AMITRIPTYLINE
Allergien: -
Vorherige Impfungen: -

VAERS 1148908

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NH
Alter: 48,0
Geschlecht: M
Eingang: 30.03.2021
Impfdatum: 30.03.2021
Beginn: 30.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Feeling abnormal Hyperhidrosis Hypotension Pallor Syncope Tremor

Symptomtext

PT was administered vaccine at 1025 and shortly there after started to shake, felt sweaty and just felt weird. Then passed out. PT was quickly assisted by vaccination staff at car side and then medical staff was notified. Upon arrival PT was very pail and lacked color, but was awake and stated that he has never had that happen before. Denies any history of having adverse effects to medications. NKDA. Ambulance was called. 1045 Vitals BP: 80/60 Pul: 68 Sp02: 97 1045 Ambulance arrived 1050 BP: 92/58 PT was taken to local ER for further observation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: Vitals
Aktuelle Erkrankungen: none
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1148902

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: CO
Alter: 39,0
Geschlecht: F
Eingang: 30.03.2021
Impfdatum: 30.03.2021
Beginn: 30.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Dysphagia Hypoaesthesia oral Pruritus

Symptomtext

After administration, pt presented with itchy/ numb tongue . Patient took benadryl first , after 40 minutes, patient complained of trouble swallowing. At this time, an ambulance was called to evaluate the patient for anaphylaxis. She was fine after an hour and EMT sent patient home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: na
Allergien: cephalosporins
Vorherige Impfungen: -

VAERS 1148131

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 31,0
Geschlecht: F
Eingang: 30.03.2021
Impfdatum: 29.03.2021
Beginn: 29.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Presyncope Vertigo

Symptomtext

patient complaint of dizzy, light-headed, vertigo. patient was lowered to the floor. feet were elevated. Negative findings: SOB, wheeze, stridor, angioedema, nausea or vomiting, syncope. vital signs: bp 100/80, heart rate 78, oxygen saturartion 98%. 15:40 bp 122/72 good color. Assessment mild vasovagal reaction. Plan to d/c to home in care of husband with instructions to push fluids and follow up with pcp if further symptoms.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1146953

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 63,0
Geschlecht: F
Eingang: 30.03.2021
Impfdatum: 15.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 3,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Back pain Bell's palsy Blood test normal Computerised tomogram normal Ear discomfort Facial paralysis Headache Neck pain

Symptomtext

On Wednesday during the night in the middle of night with a feeling that her right ear was on fire. It hurt under the ear in a straight line about 3-4". The next day she had the same hurting, the straight line, but then the pain started to go around the back of her neck and up the right side of her head. That was this way Thursday and Friday. She got into her chiropractor, seemed to be a little better after that. She got up Saturday morning and took a drink of water and it came right back up, and looked in the mirror and saw that her face was drooping, and worried she was having a stroke and went to the ER at the Hospital. They did stroke protocol in the ER and they determined that she was not having a stroke but was having Bell's palsy. Gave her some medications (steroids and antiviral) and told her to see her PCP. She saw her PCP yesterday and he advised her to get the vaccine and advised her about Guilllain Barre.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: They did blood work in the ER, and told her that everything looked good. They did a CT scan which also was good.
Aktuelle Erkrankungen: None.
Vorgeschichte: Psoriatic arthritis, non-alcoholic fatty liver disease, diabetes.
Andere Medikamente: Dexilent, Prinivil, Glucophage XR, Glucotrol, Zetia, Ditropan XL, Toprol XL, Cimzia, Otezla, Pazeo, Osempic, slow magnesium, cranberry, vitamin D, Allegra.
Allergien: Demerol, Remicade, Statin's.
Vorherige Impfungen: -

VAERS 1146350

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 56,0
Geschlecht: F
Eingang: 30.03.2021
Impfdatum: 15.03.2021
Beginn: 22.03.2021
Tage bis Beginn: 7,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy

Symptomtext

Bell's Palsy (Right side of face)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: Doctor conducted visual inspection of face and affected eye mouth area on 3/24/21
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: B12 Multiple Vitamin Collagen
Allergien: None
Vorherige Impfungen: -

VAERS 1144651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 72,0
Geschlecht: F
Eingang: 29.03.2021
Impfdatum: 20.03.2021
Beginn: 27.03.2021
Tage bis Beginn: 7,0
Dosis: 2
Route/Site: SYR / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Activated partial thromboplastin time Blood calcium increased Blood glucose normal Blood pressure increased Computerised tomogram head normal Facial paralysis Glomerular filtration rate Liver function test normal Mean platelet volume increased Metabolic function test normal Prothrombin level normal Troponin White blood cell count increased

Symptomtext

Presented to the ED with difficulty closing the R eye with notable R-sided facial droop that began on Saturday, March 27th. On physical exam, cranial nerves 2-12 intact, but notable R-sided facial droop and 7th nerve lesion in the peripheral distribution. VFF, PERRLA, 4/4 strength in the biceps/triceps/hand grip/hamstrings/quads/plantar/dorsiflexion. SILT UE/LE. No pronator drift. Normal finger-nose-finger. Normal rapid alternating movements. Reflexes 2+ in the patella bilaterally. Normal gait. BP on the presentation was 226/111, pulse was 78, respiratory rate was 20, oral temperature was 36.8 degrees Celsius, and SpO2 was 99%. Denied COVID-19 symptoms, activity change, chills, fever, congestion or dental problems, discharge or itching of the eye, chest tightness, shortness of breath, stridor, chest pain, leg swelling, abdominal distention or pain, dysuria, frequency, arthralgias, joint swelling, color change or rash, dizziness, syncope, back or neck pain, weakness, N/V, HA, vision changes, confusion, bowel changes, behavioral problems or confusion. Has been taking medications as prescribed, no prior history of CVA. PMH of DM and HTN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: Labs 3/29/2021: BMP, troponin, prothrombin wnl. Calcium slightly elevated at 11.6. CBC largely wnl, slightly elevated WBC 11.46, red cell diameter 14.8, mean platelet volume 12.7, mean cell Hgb concentration 31.4, hepatic panel wnl, aPTT 36.1, eGFR between 72 and 83, whole blood glucose wnl Non-contrast head CT on 3/29/2021: No evidence of intracranial hemorrhage, mass effect or large acute infarct. NIHSS of 2 for facial palsy. Neurology consulted, agreed with plan. No indication for TPA, out of window, not a candidate for thrombectomy. Discharge pending final imaging and workup.
Aktuelle Erkrankungen: -
Vorgeschichte: Hypertension Diabetes mellitus Congestive heart failure
Andere Medikamente: -
Allergien: No known allergies
Vorherige Impfungen: -

VAERS 1144171

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CO
Alter: 32,0
Geschlecht: F
Eingang: 29.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Fear of injection Gait disturbance Gaze palsy Hyperhidrosis Pallor Seizure

Symptomtext

Patient was wheeled in on a rolling chair(no wheelchair available at time) from nurse that administered vaccine because of anxiety and a needle phobia that put the patient into a kind of shocked state. Patient was sweating profusely, white to the face, and not speaking very much but would answer questions correctly. EMT was speaking with the PT before walking away to continue other monitor duties when he turned back to see patient limp in chair, head back, eyes rolled back, and some twitching movements of the body. EMT called for rapid response because first thought of seizure and seizure like activity with the twitching movements. EMT got to patient, supported head up straight, and opened jaw to ensure airway was clear. Patient had no response to EMT trying to communicate. Sternum rub was performed where patient came back conscious nearly instantly. PT was unresponsive for roughly 10-15 seconds. Patient was told of what happened and vitals were taken on her, response team was cancelled with most them already on scene. PT was feeling better, sweating stopped, color to the face returned, and PT was speaking and understanding more clearly than before. PT was given a snack and water and was monitored by EMT for an additional 15mins before patient and staff were confident with her leaving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1140676

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MA
Alter: 22,0
Geschlecht: F
Eingang: 28.03.2021
Impfdatum: 11.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: OT / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blindness Dyspnoea Palpitations Syncope

Symptomtext

Brief loss of vision; Faint; Short of breath; Palpitations; This is a spontaneous report from a contactable other health professional. A 22-year-old female patient received the 1st dose of bnt162b2 (BNT162B2, Manufacturer Pfizer-BioNTech), intramuscular in arm left, on 11Mar2021 at 13:00 (Lot Number EN6207), as single dose, for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Patient did not have COVID-19 prior to vaccination. The patient experienced brief loss of vision (medically significant) on 11Mar2021 at 13:00 with outcome of unknown, faint (medically significant) on 11Mar2021 at 13:00 with outcome of unknown, short of breath (non-serious) on 11Mar2021 at 13:00 with outcome of unknown, palpitations (non-serious) on 11Mar2021 at 13:00 with outcome of unknown. Therapeutic measures were taken as a result of the events. It was reported that the events were evaluated and advanced life support (ALS) transported the patient to the emergency department (ED). It was unknown if patient was tested for COVID-19 post vaccination. Follow-up attempts are completed. No further information is expected.; Sender's Comments: The possibility that suspect drug may have contributed to the reported events cannot be excluded. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1140144

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 84,0
Geschlecht: M
Eingang: 27.03.2021
Impfdatum: 17.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Computerised tomogram head abnormal Hypoaesthesia Magnetic resonance imaging head abnormal

Symptomtext

Starting evening of 3/18 noticed right side of face was numb. It continued to worsen during day on 3/19. Went to ER, Sat. AM and was admitted same day. Tests were run and it was determined no Stroke had happened and the was told it was Bells Palsey. Spent 2 days in hospital while they ran more tests. Numbness continues.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: 2,0
Labordaten: An MRI & CT scan on brain was done on 3/20/21
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1139783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 44,0
Geschlecht: F
Eingang: 27.03.2021
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: unbekannt Erholt: ja

Anion gap Band neutrophil count decreased Basophil count normal Basophil percentage decreased Blood chloride normal Blood creatinine normal Blood glucose increased Blood magnesium normal Blood osmolarity normal Blood potassium normal Blood sodium decreased Blood urea decreased Blood urea nitrogen/creatinine ratio Carbon dioxide decreased Condition aggravated Cough Dysphagia Dysphonia

Symptomtext

She received the first dose of the Pfizer COVID-19 vaccine on 3/25, and had some lip and tongue swelling and vocal changes with wheezing within 15 minutes of receiving the vaccine. She was treated with benadryl and albuterol and sent home after improvement. After going home, continued to have some lip/throat swelling. She then presented to local hospital with worsened symptoms, treated with benadryl and steroids, given a script for prednisone, and sent home. She did not fill the prednisone script initially, but had some prednisone (unknown strength) at home and took a pill. The following morning (3/26), she continued to have throat and lip swelling and began to develop some dyspnea. Due to these worsening symptoms, she came to ED. She received a total of 5 doses of IM epinephrine (1734, 1938, 2010, 2320, 0017) along with IV pepcid and IV solumedrol for persistent subjective throat swelling, dyspnea, and difficulty tolerating secretions. She was admitted to the ICU for close monitoring of symptoms and consideration of an epinephrine drip, but did NOT require this. In the morning of 3/27, she noted substantial improvement in symptoms of tongue/lip swelling, improved wheezing, dyspnea, and dysphagia. Still with some mild hoarseness that she attributes to cough, also improving.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: 1,0
Labordaten: 3/26/2021 21:50 SODIUM: 134 POTASSIUM: 4.2 CHLORIDE: 104 CARBON DIOXIDE (CO2): 17 (L) BUN: 7 CREATININE SERUM: 0.64 BUN/CREA RATIO: 11 ESTIMATED GFR, NON AFRICAN AMER: >=60 ESTIMATED GFR, AFRICAN AMERICAN: >=60 MAGNESIUM: 1.9 ANION GAP: 17 OSMOLALITY (CALC): 286 GLUCOSE: 196 (H) 3/26/2021 21:50 WBC: 16.11 (H) RBC: 4.70 HEMOGLOBIN (HGB): 13.1 HEMATOCRIT (HCT): 39.3 MEAN CELL VOLUME: 83.6 Mean Cell HGB: 27.9 MEAN CELL HGB CONCENTRATION: 33.3 RBC DISTRIBUTION: 13.0 PLATELET COUNT: 429 (H) MEAN PLATELET VOLUME: 9.6 RBC, NUCLEATED: 0.0 NEUTROPHILS %: 93.4 LYMPHOCYTES %: 4.1 MONOCYTES %: 1.5 EOSINOPHILS %: 0.0 BASOPHILS %: 0.1 IMMATURE GRANS%: 0.9 SEGS + Bands, Absolute: 15.05 (H) IMMATURE GRANS ABSOLUTE: 0.14 (H) LYMPHS, ABSOLUTE: 0.66 (L) MONOS, ABSOLUTE: 0.24 EOS, ABSOLUTE: <0.04 Abs Baso Auto: <0.04 DIFF STATUS: Electronic Differential
Aktuelle Erkrankungen: None
Vorgeschichte: Non-specific "autoimmune disease" Previous history hyperthyroidism, now s/p thyroidectomy with post-op hypothyroidism GERD Seasonal rhinitis
Andere Medikamente: Hydroxychloroquine 200 mg BID Levonorgestrel-ethinyl estradiol 0.15-30 mg-mcg daily Levothyroxine (175 mcg Saturdays, 200 mcg all other days) Multi-vitamin Omega 3 fatty acid Albuterol inhaler 2 puffs q6h PRN
Allergien: Doxycycline (Hives, shortness of breath, cough) Ciprofloxacin (Hives) Penicillins (Anaphylaxis) Cephalosporins (Anaphylaxis) Azithromax (Hives) Topiramate (Hives) Compazine (Agitation)
Vorherige Impfungen: -

VAERS 1139414

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 66,0
Geschlecht: F
Eingang: 27.03.2021
Impfdatum: 17.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anal incontinence Contusion Dizziness Fall Loss of consciousness Nausea

Symptomtext

Had expected body aches and chills during the night. Very lightheaded when I got up and some nausea. Thought to ?sit down before you fall down? then ?came to? next to toilet. Head resting on toilet seat. Had some bruising on cheek but don?t remember going to floor. Rest of day was okay with just the most common side effects. Never fainted before but not uncommon for me to be lightheaded with nausea. Most embarrassing...passed some stool.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Anxiety
Andere Medikamente: Celexa Singulair Vitamin D Calcium/Magnesium/Zinc Alkalol Nasal Mist
Allergien: Peanut Seasonal pollen
Vorherige Impfungen: -

VAERS 1138603

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NC
Alter: 68,0
Geschlecht: M
Eingang: 26.03.2021
Impfdatum: 14.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Cerebral venous sinus thrombosis

Symptomtext

Experienced a CVST

Weitere VAERSDATA-Felder

Praegender Schweregrund: Cerebral venous sinus thrombosis
Hospital-Tage: 3,0
Labordaten: See ER and hospital records
Aktuelle Erkrankungen: none
Vorgeschichte: cataract surgery on both eyes in January 2021
Andere Medikamente: Probiotic, K2-D3, B-Complex Plus, Curcumin, Fish Oil, vitamin C crystals
Allergien: none
Vorherige Impfungen: -

VAERS 1137380

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 28,0
Geschlecht: F
Eingang: 26.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Computerised tomogram head Facial paralysis Hypoaesthesia oral Magnetic resonance imaging head normal Magnetic resonance imaging neck Paraesthesia oral

Symptomtext

28 yo female received second dose of Pfizer COVID-19 vaccine 3/19 at 0933. Around 1130 pt reports numbness and tingling in her mouth and right sided facial drooping. Presents to ED. History of right frontal cavernous malformation, removed in 2013. PMH significant for migraine headaches and vestibular disorder. Evaluated by neurovascular with low suspicion for stroke. Symptoms improving. Received diphenhydramine, ketorolac and prochlorperazine in the CDU. CT brain and angio brain and neck without acute findings. Recommended pt to complete brain MRI with and without contrast to rule out possibility of stroke or underlying lesions to be performed outpatient. Pt discharged later that day with symptoms fully resolved.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Facial paralysis
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: Right frontal cavernous malformation removal (2013), migraine headaches, vestibular disorder
Andere Medikamente: -
Allergien: Lacosamide, lorazepam, hydrocodone, latex, Trileptal, codeine
Vorherige Impfungen: -

VAERS 1136238

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AL
Alter: 17,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Hypotension Loss of consciousness

Symptomtext

Pt was nervous about the shot, but seemed ok immediately after it was administered. He went to the chair to wait his 15 minutes with his mom. A minute later, his mom was calling that he was having a reaction. A technician called 911 while I went to check. He passed out for just a moment and came to quickly. His mom said he was ok but paramedics arrived within minutes and were checking him out. His blood pressure was super low and they monitored him and took over. They were gone within probably 10 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: BP monitoring only
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: No known
Vorherige Impfungen: -

VAERS 1136031

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 25,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Bradycardia Hypotension Pallor Syncope Tremor

Symptomtext

patient was sitting in chair in observation room. approximately 3 minutes after his vaccine, he had a syncopal episode, fell out of the chair, hit is left jaw and left hip on the floor. Upon immediate assessment, he was hypotensive (83/28) bradycardic (P38), and pale. He has whole body "shaking" for about 10 seconds. He was responsive almost immediately after that, AOx4. assisted to a gurney where he rested. No SOB noted. His VS improved. He was sent to the ED via ambulance. d/c'd from ER without treatment. (ct jaw negative for fx)

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None
Vorgeschichte: None (allergic rhinitis, mild)
Andere Medikamente: None
Allergien: None
Vorherige Impfungen: -

VAERS 1136006

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NH
Alter: 56,0
Geschlecht: F
Eingang: 25.03.2021
Impfdatum: 25.03.2021
Beginn: 25.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Fall Seizure

Symptomtext

Pt received 2nd dose vaccine, waited her 15 minutes and upon leaving was witnessed by PD to have slumped on the floor, without trauma and began to seize. EMS called to scene and medical OIC called. Upon arrival, 911 called, SpO2 placed. VSS and respirations adequate. Negative for emesis. After 2 seizures, the patient regained consciousness and was able to communicate that her husband was outside, his name was in a blue vehicle. She confirmed she had a history of seizures. Her husband informed us she has a history of these seizures and brain CA. EMS arrived and took control of patient and transported to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: Unknown
Vorgeschichte: Brain CA, Seizure disorder
Andere Medikamente: Unknown
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1134650

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 52,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 18.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 6,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bell's palsy Computerised tomogram head Computerised tomogram normal Facial paralysis

Symptomtext

On 03/24/2021 @ 0730 am, I experienced drooping and weakness of right side of face and mouth. Diagnosed with Bells Palsy at emergency room. CT was negative for mass. Prescribed Prednisone 20 mg 3 tab daily for 7 days, & Acyclovir 800mg 5 tablets daily for 10 days..

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: CT Brain/Head w/o Contrast. Negative results.
Aktuelle Erkrankungen: None
Vorgeschichte: Hypertension & Pacemaker.
Andere Medikamente: RX: Cardizem, Amoxicillin. OTR: Vitamin C, Saw Palmetto, Super Beta Prostate, Probiotic
Allergien: Lisinopril, Metoprolol, HCTZ, Aspirin, Some wheat & corn.
Vorherige Impfungen: -

VAERS 1134107

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 50,0
Geschlecht: F
Eingang: 25.03.2021
Impfdatum: 22.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood test Computerised tomogram Electrocardiogram Seizure

Symptomtext

While I was asleep my partner saw me having what looked like a seizure on Tuesday 03/23/2021 @11:30pm. I was sleeping on my stomach, my partner describes it like a fish flopping.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: Ct Scan no contrast, Blood wood, & EKG. doctor did not find anything concerning.
Aktuelle Erkrankungen: NONE
Vorgeschichte: DIABETES
Andere Medikamente: GLIPIZIDE, LASINOPRIL , NASINA, SIMVISTATIN, HYROCHLOROTHIAZIDE
Allergien: NONE
Vorherige Impfungen: -

VAERS 1132406

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 30,0
Geschlecht: M
Eingang: 25.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Presyncope

Symptomtext

Patient complained of "lightheadedness" following vaccine administration. Patient was taken by POV to the ED where he was diagnosed with a vasovagal episode and discharged without activity restrictions

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1131869

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: PA
Alter: 69,0
Geschlecht: F
Eingang: 25.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Bradycardia Dizziness Presyncope

Symptomtext

About 30 minutes post vaccination the recipient complained of dizziness and lightheadedness. Recipient was evaluated by an on-site EMT who said vitals were normal with the exception of mild bradycardia. Patient felt close to syncopal episode and so was transported by ambulance to hospital for observation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1131583

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 42,0
Geschlecht: M
Eingang: 24.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure measurement Dizziness Syncope

Symptomtext

Pt. began to feel dizzy 10 min after vaccination. He had intermittent syncope, no AMS, symptoms resolved and pt. went home at 1801. BP: 102/67, HR 68, O2 95%

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: none
Allergien: N/A
Vorherige Impfungen: -

VAERS 1130976

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MD
Alter: 19,0
Geschlecht: F
Eingang: 24.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncope with seizure like activity lasting 20 seconds; occurred twice within 2-3 minutes while seated in car

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: none
Vorherige Impfungen: -

VAERS 1130694

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 21,0
Geschlecht: F
Eingang: 24.03.2021
Impfdatum: 24.03.2021
Beginn: 24.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Syncopal episode SpO2 98%@RA BP 66/32 P 54 before discharge BP = 121/71

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: NKA
Allergien: none
Vorherige Impfungen: -

VAERS 1127140

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: WA
Alter: 25,0
Geschlecht: M
Eingang: 23.03.2021
Impfdatum: 23.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient fainted approximately 3 minutes after receiving his vaccine. He was in a monitoring chair and rested his head back. Pt did not fall or incur any injuries as a result of fainting. Pharmacy staff noticed it happening and gave him attention immediately. He revived right away. Patient was moved to counseling room floor and laid on floor with legs up for 15 minutes. Patient drank some apple juice and was monitored for a total of 30 minutes. Pt confirmed he felt ready to leave at that time and was advised to report any other symptoms to us immediately.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None reported
Vorgeschichte: None reported
Andere Medikamente: None reported
Allergien: None reported
Vorherige Impfungen: pt was uncertain of what vaccine but reports he has fainted before with vaccinations.

VAERS 1126957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge En6207

schwer

Staat: DE
Alter: 24,0
Geschlecht: F
Eingang: 23.03.2021
Impfdatum: 23.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anxiety Asthenia Blood glucose increased Cold sweat Dizziness Feeling cold Hyperhidrosis Loss of consciousness Nervousness

Symptomtext

Patient reported feeling dizzy and briefly loss consciousness after walking over to the first aid area. Patient was clammy, sweating. Vital signs were obtained at 3:17pm blood pressure 87/73, pulse 52, temp 96.8, respiration 17. Pt denied any medical history. Pt reported while donating blood had a similar reaction. EMS called and arrived at 3 :30pm. Pt stated she felt shaky, anxious, and lightheaded. FSBS 131. Pt reported feeling cold. EMS left the facility at 3:40pm. Pt declined EMS services, vital signs were rechecked at 3:20pm 134/69, 52, 17, 97.0, denied any pain. client stayed with nurses for 30 extra minutes and reported feeling better, no longer feeling light-headed, reported feeling weak. Pt was advised to call someone to pick her up as she drove herself. Pt declined stating that she lives an hour away and will be ok to drive herself home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: Nuvaring birth control was just removed on 3/21/21
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1126245

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MN
Alter: 50,0
Geschlecht: F
Eingang: 23.03.2021
Impfdatum: 21.03.2021
Beginn: 21.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood glucose Chest X-ray Chest discomfort Computerised tomogram Dizziness Dysarthria Dyspnoea Fatigue Fibrin D dimer Full blood count Heart rate increased Loss of consciousness Metabolic function test Paraesthesia oral Pharyngeal swelling Tongue pruritus Troponin

Symptomtext

Patient felt fatigued, tongue felt heavy. When bringing patient to UC felt heart beating fast. After bringing patient to UC patient felt itching of tongue, feeling like throat is swelling, shortness of breath, dizziness, slurred speech, loss of consciousness, and chest heaviness.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: 3/21/21- Random glucose, CBC, BMP, Troponin, Necleated Red Blood Cells as Percent of blood leukocytes, D-dimer quantattive, CT chest PE study, XR chest 2 views PE and lateral
Aktuelle Erkrankungen: breathing problem
Vorgeschichte: Vitamin D deficiency Environmental allergies Fibromyalgia Chronic anemia- Baseline Hgb 11 left knee ACL (anterior cruciate ligament) tear right ITBFS, extensor mechanism deficits left knee derangement of posterior horn of medial meniscus Right knee Pes anserine bursitis left knee pes anserine bursitis Primary osteoarthritis of left knee underlying right knee medial chondromalacia Heel spur - posterior, .bl Plantar fasciitis Lumbar radiculopathy- left sided Bulging lumbar disc Facet arthropathy, lumbar Anxiety and depression DDD (degenerative disc disease), cervical Mild persistent asthma without complication Mood disorder due to medical condition Rupture of anterior cruciate ligament of left knee Elevated BP s/p left knee ACL reconstruction with hamstring autograft and partial medial menisectomy on 1/27/2017 Chronic pain syndrome DDD (degenerative disc disease), lumbar Idiopathic peripheral neuropathy Somatoform disorder PTSD (post-traumatic stress disorder) Narcolepsy and cataplexy Irritable bowel syndrome with diarrhea Carpal tunnel syndrome, bilateral Fatty liver Tricompartment osteoarthritis of left knee Sprain of anterior cruciate ligament of left knee Hematuria RLS (restless legs syndrome) ASCUS with positive high risk HPV cervical Dissociative identity disorder (HC) Tinnitus aurium, bilateral
Andere Medikamente: unknown
Allergien: Cortisporin, Zoloft
Vorherige Impfungen: -

VAERS 1126136

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: DE
Alter: 33,0
Geschlecht: M
Eingang: 23.03.2021
Impfdatum: 23.03.2021
Beginn: 23.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

Patient loss consciousness after vaccine was administered

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: n/a
Aktuelle Erkrankungen: none
Vorgeschichte: deny any illness
Andere Medikamente: none
Allergien: bee sting with localized swelling
Vorherige Impfungen: -

VAERS 1125684

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TN
Alter: 27,0
Geschlecht: M
Eingang: 23.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Fall Presyncope

Symptomtext

Vasovagal response. Patient arouse from his chair in waiting area after vaccination and while conscious, fell to the ground. Patient was assisted with ambulatory back to exam room and laid on the exam table. Feet were raised above the level of heart and he stated that he felt much better within 5 minutes of this maneuver. Over a 45 minute period, patient positioning was slowly elevated from laying to sitting, then to standing, and was escorted in a walk around the store. Patient performed all of these tasks without incident. Called patient the next morning to check on status. Patient reported that he did just fine getting home and had no other incidents since vasovagal response.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1272740

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 33,0
Geschlecht: M
Eingang: 22.03.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: ja Disable: unbekannt ER: ja Erholt: nein

Balance disorder Condition aggravated Eye movement disorder Feeling abnormal Generalised tonic-clonic seizure Posture abnormal Staring Unresponsive to stimuli

Symptomtext

Narrative: Pt received his COVID vaccine at 1208. Pt stayed in the COVID vaccine waiting room for 15 minutes for observation per protocol. After leaving the clinic, patient came back around 1230 because he stated: "I am feeling stoned and loopy." Had the patient sit down in the ante room of the Covid vaccine clinic. 1234: While sitting, CNA noticed that pt had a blank stare, unresponsive, and started to lean towards his R side. 1235: clinic nurses and 911 were called. Patient's eyes rolled back and is eased the patient out of the chair onto the floor. Cleared the area around of anything hard or sharp. Pillow placed underneath patient's head. VS taken as follows: 130/75 HR 119 bpm, O2 Sat 99%. While on the floor, pt remained unresponsive to verbal or any noxious stimuli. 1238: Epipen administered on RUE. Pt woke and sat up asking what happened to him. Pt reports: "I forgot to tell you guys that I have history of seizures." Placed pt on O2 at 2lpm via nasal cannula. VS as follows: 130/75 hr 122 BPM, O2 Sat 99%. 1240: Pt had grand mal seizures again for 2 minutes. Placed pt on his L side. Dr. arrived. Pt is monitored with pulse oximetry. HR 119 bpm, O2 sat 99%. 1243: Pt woke up from his seizure and asked what happened. He stood up for about 10 seconds and pt suddenly lost his balance and knelt. 1245: EMS arrived, handoff given. Pt is transported to Medical Center.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1124310

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: CA
Alter: 72,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 21.03.2021
Beginn: 21.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Heart rate decreased Hypopnoea Loss of consciousness Pulse abnormal Stridor Urinary incontinence

Symptomtext

Pt. became unconscious and lost bladder control-she had shallow, infrequent respirations with an exp. stridor noted-pulse faint and slow. Epinephrine given IM per clinic standing order and pt. became conscious within 15 seconds-could not remember losing consciousness. Taken to the hospital for further evaluation.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: no
Vorgeschichte: hypothyroidism
Andere Medikamente: Thyroid medication
Allergien: none
Vorherige Impfungen: -

VAERS 1124218

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NJ
Alter: 52,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Dizziness Hypotension Presyncope

Symptomtext

Pfizer-BioNTech COVID- 19 Vaccine EUA: During the post-vaccination observation period, vaccine recipient developed dizziness, near syncope, and hypotension. They were seen by EMS and given fluids then transported to emergency department. They were discharged to home the same day.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: n/a
Vorgeschichte: n/a
Andere Medikamente: n/a
Allergien: n/a
Vorherige Impfungen: -

VAERS 1123379

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 52,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 20.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling abnormal Presyncope

Symptomtext

Patient described feeling a "fluttering feeling" in her stomach. Vital signs were taken and shown BP 148/108; heart rate 88. Temperature 100.5. Patient stated she felt like she might pass out. Patient's head lowered and she experienced a vasovagal reaction 2 minutes following vaccination. After recovery, the patient was given a granola bar and a bottle of water. Patient's symptoms improved after 30 minutes. Patient was released home with her husband.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: -
Andere Medikamente: -
Allergien: Nuvigil; Amoxicillin; Hydrocodone; Omnicef
Vorherige Impfungen: -

VAERS 1123189

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 35,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood pressure measurement Electrocardiogram Presyncope Syncope

Symptomtext

Vasovagal syncope

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: They monitored my blood pressure, oxygen levels, as well as ordered an EKG. I do not have the specifics to the results on hand.
Aktuelle Erkrankungen: Regular allergies (Bermuda grass and common mold) in addition to seasonal allergies
Vorgeschichte: None
Andere Medikamente: None. I do regularly take Zyrtec-D for my allergies but had not taken any on this date. Had taken a pill the evening prior.
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1118494

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 28,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Facial paralysis Pallor Loss of consciousness

Symptomtext

At 12:35 PM mother hollered for help, patient was pale, skin was cold and clammy, and slight left side facial droop, facial droop resolved pretty quickly, Patient was given soda to drink and a squad was called for further evaluation, squad arrived at 12:57, vital signs was taken, BP 106/72, Spo2 100%, Pulse 76, Patient refused to go to hospital, patient left with family.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: No
Vorgeschichte: No
Andere Medikamente: Unknown
Allergien: No Known Allergies
Vorherige Impfungen: -

VAERS 1091174

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 30,0
Geschlecht: F
Eingang: 22.03.2021
Impfdatum: 11.03.2021
Beginn: 11.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Blood glucose Chills Computerised tomogram Electrocardiogram Fatigue Fall Head injury Loss of consciousness Feeling abnormal Headache Myalgia Pregnancy test Presyncope Pyrexia

Symptomtext

10 minutes after shot experienced vagovasal episode. Had a headache, sore muscles, and tiredness for 3 days after shot. Experienced a low grade fever and chills the 4th day on and off. Experienced brain fog for about 6 days.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Ct scan of brain after vasovagal. Blood glucose Pregnancy test EKG
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: Nexplanon birth control implant
Allergien: Sulfa
Vorherige Impfungen: Gardasil- was due to lack of meals/low blood sugar

VAERS 1121278

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: AZ
Alter: 76,0
Geschlecht: F
Eingang: 21.03.2021
Impfdatum: 17.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 1,0
Dosis: 2
Route/Site: IM / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Arthralgia Dizziness Headache Limb injury Loss of consciousness Nasopharyngitis Taste disorder

Symptomtext

Fine after shot and evening; went to bed approximately at 9pm and got so cold, put 3 blankets on and was fine. Got up about 2AM to go to the bathroom; started back to bed; had a bad taste in mouth, so decided to brush my teeth. Started brushing and all of a sudden, felt faint; before I could get the toothbrush back, I fell and my husband rushed over. Said I was out completely; got me awake and back up and went to bed and slept. until 11am. At 3pm when taking a shower, noticed my left shoulder blade was real sore and looked and there were 3 red strips below should blade - no bleeding tho. top R. side of head kinda sore, so must have hit when falling. Went back to bed and slept good. Didn't need to go to the Dr. and am feeling good now. Just rested for a couple days. Had been feeling really good and don't take any prescriptions, so could only think it had to have something to do with the shot. Today is the 4th day and feel good.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Didn't go to the Dr. as didn't feel that bad.
Aktuelle Erkrankungen: none
Vorgeschichte: had valley fever; have nodules on left lung; chronic cough
Andere Medikamente: no prescriptions: Vit.C, Vit.D, Zinc, Apple Cider Vinegar gummies, OmegaQ Plus vitamins
Allergien: none
Vorherige Impfungen: -

VAERS 1120511

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 22,0
Geschlecht: F
Eingang: 21.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chills Condition aggravated Cough Differential white blood cell count abnormal Dyspnoea Eye pain Fatigue Full blood count abnormal Headache Hyperhidrosis Lymphadenopathy Lymphocyte count decreased Mental impairment Mononucleosis heterophile test negative Nausea Neutrophil count decreased Oropharyngeal blistering Oropharyngeal pain

Symptomtext

*TIME OF WRITING IS THE 7th DAY* Onset of incredible fatigue 30 minutes post-vaccination lasting 5 days Fever ranging from 99.6 to 102 which began 5 hours after vaccination and has lasted 7 days post-vaccination Nausea 5 days post-vaccination Headache 7 days post-vaccination Severe arm pain 3 days post-vaccination Eye pain 3 days post-vaccination Intense sweating 7 days post-vaccination Chills 7 days post-vaccination Labored breathing 2nd and 3rd day post-vaccination Significant face swelling 2nd day post-vaccination Decreased mental status 6 days post-vaccination All lymph nodes in neck hard and swollen 7+ days Aggravation of pre-existing sleep paralysis day of vaccination Severe throat pain in the morning, red bumps in back of throat, white pus on tonsils which has worsened and began 1 day after vaccination (antibiotics were prescribed and condition continues to worsen, no one with whom I have been in close contact with has been sick - e.g. boyfriend I kissed the day before vaccine, toddlers I babysat morning before vaccine) - followed eventually by mild cough and congestion

Weitere VAERSDATA-Felder

Praegender Schweregrund: Sleep paralysis
Hospital-Tage: -
Labordaten: 03/16/2021 - strep A rapid test (& subsequent culture) - negative; mononucleosis antibody screen - negative; CBC & differential - WBC count 3.0, neutrophil 1.6, lymphocytes 0.9 03/19/2021 - Covid rapid test & PCR test - negative
Aktuelle Erkrankungen: Unknown - very mild sore throat that began 5 days before vaccination (thought to be allergies) and swollen submandibular lymph node that began 1 day prior to vaccination
Vorgeschichte: Low metabolizer for cytochrome p450 2D6
Andere Medikamente: Daily morning: vitex berry 1,000 mg Daily night: magnesium 800 mg, vitamin D3 2,000 IU, vitamin A 5,000 IU, B-complex dietary supplement, Omega-3 dietary supplement (DHA, EPA, other) 715 mg, melatonin 2.5 mg
Allergien: Seasonal allergies Suspected latex allergy (minor)
Vorherige Impfungen: Arm pain lasted 2 years after meningitis vaccine and doctors suspect nerve damage that eventually repaired itself

VAERS 1120229

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 46,0
Geschlecht: M
Eingang: 21.03.2021
Impfdatum: 21.03.2021
Beginn: 21.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Presyncope

Symptomtext

vasovagal with N/V resolved after no treatment within one hour

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1119113

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: CA
Alter: 24,0
Geschlecht: M
Eingang: 20.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Syncope

Symptomtext

Patient fainted after vaccination, while waiting in the seating area during the 15 min observation period

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: unknown
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: unknown
Allergien: none stated
Vorherige Impfungen: -

VAERS 1119016

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 46,0
Geschlecht: M
Eingang: 20.03.2021
Impfdatum: 20.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Malaise Nausea Pallor Seizure like phenomena Unresponsive to stimuli

Symptomtext

After receiving first dose of pfizer covid vaccine, patient alerted EMS he didn't fell well. When EMS responded to the patient the patient went unresponsive slumped over in his chair with seizure like activity. Patient was being moved when he regained consciousness. Patient was moved to EMS area. Patient was pale, lightheaded and nauseous. Blood pressure was taken as well as oxygen and heart rate. Blood sugar was checked and an IV was started. Patient was stable and transported.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure like phenomena
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1118193

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 45,0
Geschlecht: M
Eingang: 20.03.2021
Impfdatum: 20.03.2021
Beginn: 20.03.2021
Tage bis Beginn: 0,0
Dosis: UNK
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness Presyncope

Symptomtext

pt felt lightheaded and was taken to triage area. vitals taken and were bp 147/83, HR 86, Po2 97. pt had a vasovagal episode and lost consciousness for 1 second. regained consciousness. pt states this has happened before. last time was 1 .5 years ago at work. pt states he is feeling well and feels fine to go home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Pt vitals taken and ok. water and granola bar given.
Aktuelle Erkrankungen: High blood pressure, hx of syncopal episodes, seasonal allergies,
Vorgeschichte: same as above
Andere Medikamente: Amlodipine, Zoloft, singular
Allergien: denies, NKDA
Vorherige Impfungen: -

VAERS 1117205

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: VA
Alter: 52,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Loss of consciousness

Symptomtext

Patient received vaccine at 3:42 pm. At 3:50pm, patient was unconscious but breathing in his chair in the post-vaccine waiting area. 911 was called. Patient was placed on the floor in the recovery position, he regained consciousness after about 1 minute. He stated that he has passed out previously after giving blood as he has a fear of needles. EMS took his BP several times (last reading at 4:13 pm was 96/63) after arriving at 3:57pm. At 4:13 pm he signed a waiver that he did not want to go to the ER.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: Sitting BP @4:02 pm 100/63 Standing BP @4:06pm 62/36 Standing BP @4:13 pm 96/63
Aktuelle Erkrankungen: Unknown
Vorgeschichte: None reported
Andere Medikamente: Unknown
Allergien: NKDA
Vorherige Impfungen: h/o fainting with needles

VAERS 1117160

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 36,0
Geschlecht: F
Eingang: 19.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Syncope

Symptomtext

Patient with syncope after vaccine. Recovered well. Provided rest and water. Vitals stable. Sent home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1116882

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 22,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Hyperhidrosis Loss of consciousness

Symptomtext

Patient became lightheaded and diaphoretic and passed out

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: NKDA
Vorherige Impfungen: -

VAERS 1116638

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 51,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling abnormal Hyperhidrosis Pallor Syncope

Symptomtext

3-17-21 1:10PM PT STATES HE 'DOESN'T FEEL WELL'. SYNCOPE APROX 1 MIN - WIFE HELD PT IN CHAIR. RN X3 AND MEDIC ASSISTED PT TO FLOOR AND ELEVATED LEGS. PT BECAME RESPONSIVE. PT PALE AND DIAPHORETIC. 1:16PM ASSISTED PT TO CHAIR 'FEELS BETTER NOW'. A/O, PINK, W/D, RESP REG WITH EASE. WIFE HERE TO DRIVE PT HOME. 3-19-21 3:30PM TC: PT STATES 'FULL RECOVERY'.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: 1:10PM BP 90/58, HR 68, R 18, 02 SAT 97%. 1:16PM BP 140/68
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: 'PASSES OUT WITH SHOTS, PROCEEDURES OR SEEING PROCEEDURES'

VAERS 1116547

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 40,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: unbekannt

Presyncope

Symptomtext

vasovagal reaction

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1115957

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 29,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 19.03.2021
Beginn: 19.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Bradycardia Hypotension Syncope

Symptomtext

syncopal episode with bradycardia and hypotension, treated with IV atropine 1 mg and 1 L NS IVF. transported to an emergency department

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: none
Allergien: no
Vorherige Impfungen: -

VAERS 1114722

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OK
Alter: 35,0
Geschlecht: F
Eingang: 19.03.2021
Impfdatum: 11.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 5,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Blood test Computerised tomogram Feeling abnormal Migraine with aura Pain in extremity Seizure

Symptomtext

Sore arm for first few days. Woke up on day 5 feeling off. Had an aura start in the left side of vision and thought it was just a migraine. Took migraine medication and 45 minutes later had a seizure. This is the first in my life.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Seizure
Hospital-Tage: -
Labordaten: CT Scan 3/16/21; bloodwork 3/16/21
Aktuelle Erkrankungen: Gallbladder removal surgery 2/12/21
Vorgeschichte: Migraines
Andere Medikamente: Estradoil, Fluoxetine, and Omniprozole
Allergien: NA
Vorherige Impfungen: -

VAERS 1114504

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: PA
Alter: 64,0
Geschlecht: M
Eingang: 19.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: ja ER: ja Erholt: nein

Blood glucose fluctuation Blood pressure fluctuation Blood test Dizziness Loss of consciousness Pneumonia Pyrexia Visual impairment Vomiting X-ray

Symptomtext

Spots in vision, dizziness, light headed, passed out multiple times, BP and sugar fluctuations on day of vaccine. approximate 5 days later developed a fever, vomiting and pneumonia. currently being treated at Hospital in by Dr.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: 7,0
Labordaten: CT scans, xrays, mutiple tests, blood work etc. at hospital between 3/12/21 and today. he is currently still in hospital.
Aktuelle Erkrankungen: Diabetes
Vorgeschichte: Diabetes
Andere Medikamente: Protonix, flowmax, oxybutinin, plavix
Allergien: -
Vorherige Impfungen: -

VAERS 1112449

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 34,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Dizziness Loss of consciousness

Symptomtext

Pt felt light headed and passed out for approx. 30 seconds

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: NONE
Vorgeschichte: NONE
Andere Medikamente: NONE
Allergien: NONE
Vorherige Impfungen: After every shot Pt passes out

VAERS 1112407

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 61,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Bell's palsy Chills Eye disorder Fatigue Headache

Symptomtext

Bells Palsy affect 60 hours after injection. Right eye.....same manifestation as I had during Covid-hospitalization in 2020. Seems to be abating finally (approx 18 hrs from detection). Severe headaches, chills and fatigue commenced approx 8 hours after injection. LAsted two days. On third day, headaches and fatigue continued, but mildly.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Bell's palsy
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Had Covid-19 in March of 2020. Was hospitalized for 8 days with pneumonia.
Vorgeschichte: blood pressure, anxiety
Andere Medikamente: Valsartan, Rosuvastatin, Metropolol, Serteraline, Vascepa, Centrum multi-vitamin, vitamin C, Vitamin D, Zinc
Allergien: to Ceclore (antibiotic)
Vorherige Impfungen: -

VAERS 1111884

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: TX
Alter: 59,0
Geschlecht: F
Eingang: 18.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Blood test Chest discomfort Dyspnoea Electrocardiogram Wheezing

Symptomtext

Anaphylaxis - Diffculty breathing, chest heaviness, wheezing Reaction began 1:05 pm, Admitted to ER at 1:52, Released at 4:00 pm

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: EKG, Blood tests 03/16/2021 ER; MD
Aktuelle Erkrankungen: On 03/03/2021 he a 24 hour stomach bug including vomiting
Vorgeschichte: hypertension Chronic back pain
Andere Medikamente: Amlodipine 10 mg; Hydrochlorot 25 mg; Benazepril 10 mg; Hydroxyzine HCL 50 mg; Bupropion 150 mg; Promethazine 25 mg; Melatonin 10 mg; L-Theanine 200 mg; Tizanidine 4 mg; MS Contin ER 15 mg; Hydromorphone 2 mg
Allergien: Penicillin, Sulfa Drugs, Cipro, Levaquen, shellfish, Codeine
Vorherige Impfungen: -

VAERS 1110479

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: OH
Alter: 52,0
Geschlecht: F
Eingang: 18.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Generalised tonic-clonic seizure

Symptomtext

Pt had a tonic clinic seizure in the observation area. Pt was brought to the ground and EMS called. Vital signs stable. Cold compress to forehead . Transported to hospital.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: Unknown
Aktuelle Erkrankungen: None
Vorgeschichte: None
Andere Medikamente: None
Allergien: Penicillin
Vorherige Impfungen: -

VAERS 1110344

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 57,0
Geschlecht: F
Eingang: 18.03.2021
Impfdatum: 18.03.2021
Beginn: 18.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Cough Electrocardiogram normal Generalised tonic-clonic seizure Seizure Throat tightness

Symptomtext

Recipient with history of epilepsy induced by stress started seizing approximately 5-6 minutes after receiving her vaccine. Before onset of first seizure pt reported throat tightness and had a mild dry cough. Dr. (Med eval) evaluated patient- lung sounds clear, pulse strong and steady 92 bpm, heart sounds normal. Pt reported that she felt like she was going to seize. Generalized tonic clonic seizure lasting approximately 1 minute. Post ictal period noted with minimal responsiveness but good color and respirations x 1 minute. Second seizure lasted approximately 1 minute, again generalized tonic-clonic with good color and respirations. Post ictal for approximately 3-4 minutes. Pt was transfered from car to stretcher. Sats 97% on room air. lung sounds clear with good respirations. 3rd generalized tonic clonic seizure ensued (lasting approximately 1 minute). EMS gave 5mg IM midazolam in her right deltoid. Transfered into ambulance, 3 lead EKG reviewed by Med Eval and no acute findings were noted. Recipient transferred to emergency department.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Generalised tonic-clonic seizure
Hospital-Tage: -
Labordaten: EKG- no acute findings
Aktuelle Erkrankungen: none
Vorgeschichte: Crohn's disease, epilepsy, GERD, hypertension
Andere Medikamente: omeprazole, klonopin, two antihypertensive meds
Allergien: Dilaudid and "something else"
Vorherige Impfungen: -

VAERS 1110294

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 17,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Disorientation Dizziness Dyspnoea Throat tightness Stridor

Symptomtext

Anaphylactic Reaction. Throat began closing up, difficulty breathing, dizzy, disoriented. Received several treatments of Epinephrine, Streroids, Benadryl, and Ativan. Put on Oxygen. He is now on Benadryl every 6 hours for the next 3 days and been told to carry around an Epi-pen in case he has more adverse reactions. Follow-up with his primary care is scheduled for tomorrow 3/19/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Type 1 Diabetes
Andere Medikamente: Lamictal Zoloft Trazodone Humalog Tresiba
Allergien: Seroquel Risperdal Adhesives
Vorherige Impfungen: -

VAERS 1110294

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 17,0
Geschlecht: M
Eingang: 18.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Disorientation Dizziness Dyspnoea Throat tightness Stridor

Symptomtext

Anaphylactic Reaction. Throat began closing up, difficulty breathing, dizzy, disoriented. Received several treatments of Epinephrine, Streroids, Benadryl, and Ativan. Put on Oxygen. He is now on Benadryl every 6 hours for the next 3 days and been told to carry around an Epi-pen in case he has more adverse reactions. Follow-up with his primary care is scheduled for tomorrow 3/19/21.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Type 1 Diabetes
Andere Medikamente: Lamictal Zoloft Trazodone Humalog Tresiba
Allergien: Seroquel Risperdal Adhesives
Vorherige Impfungen: -

VAERS 1109392

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: GA
Alter: 20,0
Geschlecht: F
Eingang: 17.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Cold sweat Loss of consciousness Pallor

Symptomtext

Vaccine was administered. Within approximately 1 to 2 minutes after administration patient got very clammy, lost color in her face and passed out while sitting in the chair. Patient regained consciousness within a matter of seconds. Patient remained seated and was observed for another 30 minutes before she was allowed to leave facility. Patient did state that she has a history of fainting with vaccinations.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: None noted
Vorgeschichte: None noted
Andere Medikamente: None
Allergien: NKDA
Vorherige Impfungen: with previous vaccines. patient not able to give names or dates of vaccines, but states it happens pretty much every time she ha

VAERS 1108768

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 37,0
Geschlecht: F
Eingang: 17.03.2021
Impfdatum: 17.03.2021
Beginn: 17.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaphylactic reaction Dysphagia Dyspnoea Feeling hot

Symptomtext

PT RECEIVED FIRST DOSE OF PFIZER COVID-19 VACCINE (LOT NO. EN6207, EXP 07/2021). FIVE MINUTES AFTER RECEIVING DOSE, PT COMPPLAINED OF FEELING HOT, DIFFICULTY SWALLOWING, AND DIFFICULTY BREATHING. HX OF ANAPHYLAXIS AND CARRIES AN EPIPEN AROUND. PT RECEIVED ONE DOSE OF EPIPEN (LOT NO. 0FM407, EXP 02/2022). NO OTHER VACCINES RECEIVED WITHIN THE LAST 14 DAYS ON PATIENT?S RECORD. TRANSPORTED TO EMERGENCY DEPARTMENT FOR FURTHER EVALUATION. EMERGENCY DEPARTMENT VISIT TIME SEEN BY PROVIDER: 0958, 17 MAR 2021. CHIEF COMPLAINT: ALLERGIC REACTION. NO SKIN RASH, DIZZINESS, OR FAINTING EPISODE. HAD DIFFICULTY BREATHING BUT NOT HAD ITCHING OR SWELLING. SYMPTOMS STARTED PRIOR TO ARRIVAL AND IS STILL PRESENT BUT IMPROVING. VAERS REPORT: . PATIENT DISCHARGED FROM THE EMERGENCY DEPARTMENT AT 1143, 17 MAR 2021. CONDITION: STABLE. CLINICAL IMPRESSION: ANAPHYLAXIS DUE TO A DRUG.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1108043

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 18,0
Geschlecht: F
Eingang: 17.03.2021
Impfdatum: 11.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 2,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Mouth swelling Rash Urticaria

Symptomtext

Patient developed urticarial rash on 3/13/21 which began on her lower extremities and progressed to most of her body by the following day. She was seen on 3/15/21, and had no other symptoms besides the rash and was treated with zyrtec and benadryl but prescribed an Epipen (Auvi-Q) in case of worsening. The next day, 3/16/21 she awoke with swelling in her mouth and worse rash, used her Auvi-Q and called 911 and was taken to ER where she was treated for anaphylaxis with IV solumedrol,, IV fluids and IV benadryl and was sent home on Prednisone and benadryl and Pepcid.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: Treated for sinus infection with amoxicillin beginning 2/28/21 for a 10-day course.
Vorgeschichte: -
Andere Medikamente: Flonase
Allergien: Pollen, stone fruits
Vorherige Impfungen: -

VAERS 1294880

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN 6207

schwer

Staat: -
Alter: 63,0
Geschlecht: F
Eingang: 16.03.2021
Impfdatum: 16.02.2021
Beginn: 16.03.2021
Tage bis Beginn: 28,0
Dosis: 2
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: unbekannt

Alanine aminotransferase increased Angioedema Anion gap Aspartate aminotransferase increased Basophil count decreased Basophil percentage decreased Blood albumin normal Blood alkaline phosphatase normal Blood bilirubin normal Blood calcium decreased Blood chloride increased Blood creatinine Blood glucose normal Blood potassium normal Blood sodium normal Blood urea normal Carbon dioxide normal Dysphagia

Symptomtext

dysphagia, dyspnea, edema Narrative: Pt c/o neck swelling/angioedema, dysphagia, dyspnea, and edema on 3/8/21 three hours after COVID-19 (Pfizer) vaccine administration. Pt was admitted to hospital and discharged on 3/11/21. Pt with recurring sx's hours after discharge and readmitted to hospital on 3/11/21. Pt was transferred to ICU on the same day and discharged on 3/14/21. Pt with another episode of recurring sxs on 3/15/21 and referred by provider on 3/16/21 to go to ED. Pt was seen in ED and discharged with low-dose steroid taper. Told that vaccine needed to get out of system and that after vaccine had run its course that sxs would improve.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Intensive care
Hospital-Tage: -
Labordaten: BLOOD Mar 16 Nov 25 Jan 28 Nov 19 Reference 2021 2020 2020 2019 14:20 12:47 11:04 10:03 Units Ranges WBC 9.8 4.9 6.7 5.7 K/cmm 4.2 - 10.3 RBC 6.24 H 5.11 5.23 5.14 M/cmm 4.2 - 5.8 HGB 18.4 H 16.1 16.5 16.0 g/dL 13 - 17 HCT 58.3 H 48.8 48.8 47.9 % 39 - 50 MCV 93.4 95.5 93.3 93.2 fL 80 - 100 MCH 29.5 31.5 31.5 31.1 pg 27 - 35 MCHC 31.6 L 33.0 33.8 33.4 g/dL 32 - 36 RDW 14.3 12.1 12.2 12.7 % 11.3 - 16.5 PLT 211 229 238 224 K/cmm 150 - 410 MPV 9.3 9.1 9.4 9.0 fL 8.5 - 12.5 IPF % 1.1 - 6.1 NEUT% 75.8 57.5 63.1 61.3 % 39 - 79 LYMPH % 13.3 26.2 23.0 24.6 % 12 - 45 MONO% 7.3 8.6 7.9 8.3 % 2 - 12 EOS % 2.5 5.9 4.7 4.2 % 0 - 6 BASO % 0.2 1.6 1.0 1.2 % 0 - 2 IG%(AUTO) 0.9 H 0.2 0.3 0.4 % 0 - .6 NEUT # 7.4 H 2.8 4.3 3.5 K/cmm 1.6 - 6.2 LYMPH # 1.3 1.3 1.6 1.4 K/cmm 1.1 - 3.4 MONO # 0.7 0.4 0.5 0.5 K/cmm .3 - .9 EOS # 0.2 0.3 0.3 0.2 K/cmm .1 - .5 BASO # 0.0 0.1 0.1 0.1 K/cmm 0 - .1 IG#(AUTO) 0.10.00.0 0.0 K/cmm 0 - .5 PLASMA Mar 16 Nov 25 Jan 28 Nov 19 Reference 2021 2020 2020 2019 14:20 12:47 11:04 10:03 Unit Ranges GLUCOSE 118 H 103 98 mg/dL 70 - 105 BUN 18 18 18 mg/dL 7 - 20.6 CREAT 1.1 1.1 1.2 mg/dL 0.7 - 1.3 NA 136 140 140 mEq/L 136 - 145 K 4.8 4.4 4.4 mEq/L 3.5 - 5.2 CL 101 105 107 mEq/L 98 - 109 CO2 25.0 28.0 24.0 mmol/L 22 - 31 ANI GAP 10.0 7.0 9 5 - 18 CA 8.8 9.4 9.9 mg/dL 8.4 - 10.6 TP 7.5 7.7 g/dL 6.4 - 8.3 ALBUMIN 4.5 4.4 g/dL 2.8 - 4.5 ALT 63 H 36 U/L 10 - 55 AST 37 H 23 U/L 5 - 34 ALK PHO 95 101 U/L 40 - 150 T BILI 0.53 0.43 mg/dL .16 - 1.25 EGFR >60 >60 >60 mL/min
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1105955

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 32,0
Geschlecht: M
Eingang: 16.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure decreased Hyperhidrosis Mydriasis Pallor Pulse abnormal Speech disorder Staring Syncope

Symptomtext

He had a syncopal event witnessed by his wife. He was leaning to the left when the staff came to be by his side. He was unable to speak, fixed stare with dilated eyes. He became pale and diaphoretic. During this time he had a strong pulse. He He quickly (within 5 seconds) was oriented and speaking again. He did this twice. His blood pressure was 110/60. He was then moved to a bench and his feet were elevated. He was able to drink and eat some crackers. 10 minutes later his BP was rechecked and was 100/60. He was no longer pink and was easily conversing. By 20 minutes later, he was able to be sitting up, normal color, pupils at normal size, stating he feels much better. BP was 110/64 at that time. He did state he has done this before when getting blood drawn. His wife was able to walk him out and drive him home.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: None mentioned by patient
Andere Medikamente: None
Allergien: Unknown
Vorherige Impfungen: -

VAERS 1105783

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 60,0
Geschlecht: M
Eingang: 16.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood pressure increased Dizziness Heart rate increased Hyperhidrosis Loss of consciousness Pallor

Symptomtext

Pt began to feel lightheaded and dizzy. He did pass out while sitting in chair. Quickly came back, woke back up and was able to answer orientation questions. He did report that this always happens to him when he takes antihistamines. Observed for a period of 5-7 minutes and felt / looked better. Told him we would observe him for a period of 30 minutes. Within 5 minutes, he had the exact same reaction. Patient passed out, was pale and diaphoretic. Blood pressure was 65/39 with HR 45 (3/16 @ 1430). At that time, he was moved to a gurney and placed in Trendelenburg position. Patient observed. repeat blood pressure at 1435 was 104/64 with HR 68. Patient continued in Trendelenburg position. Patient observed until 1455. Repeat blood pressure at 1452 was 105/69 with HR 73. Patient looked and felt better. He refused to go to ED. Wife to stay with patient and observe this evening and afternoon.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: unknown
Vorgeschichte: unknown
Andere Medikamente: UNKNOWN
Allergien: antihistamines and dramamine
Vorherige Impfungen: -

VAERS 1105651

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 61,0
Geschlecht: M
Eingang: 16.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Echocardiogram Electrocardiogram T wave inversion Syncope

Symptomtext

Syncopal episode post vaccine (approximately 30 minutes post vaccine) patient had no recall of episode Vital signs and & B/P WNL Cardiac strip - Inverted T-waves(by paramedics) local Squad notified - client transported to hospital

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: None
Aktuelle Erkrankungen: none known
Vorgeschichte: none known
Andere Medikamente: No Known
Allergien: Walnuts, Beestings
Vorherige Impfungen: Wife states patient is severely afraid of needles historically

VAERS 1104621

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 22,0
Geschlecht: F
Eingang: 16.03.2021
Impfdatum: 16.03.2021
Beginn: 16.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Blood glucose normal Dizziness Syncope

Symptomtext

10 minutes after receiving the first dose of Pfizer, the patient began feeling dizzy and had a syncope event. BP 105/59. HR 59. 100% saturation on room air. Repeat vitals 10 minutes later: BP 95/39, HR 66, 100% sat on room air. Blood glucose 109. Patient noted she came from the gym and had not eaten a full meal. Patient reports passing out after donating blood, and felt similar to that experience. No history of syncope events related to vaccines.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1103407

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: CO
Alter: 30,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Anaphylactic reaction Throat tightness

Symptomtext

Patient waited in pharmacy for 15 minutes after receiving vaccine and was fine. Approximately 30 minutes after administration she began experiencing throat tightness described by the patient to feel like an anaphylactic reaction. She immediately took oral Benadryl and returned to normal.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1103084

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MI
Alter: 62,0
Geschlecht: M
Eingang: 15.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Presyncope Syncope

Symptomtext

Severe Vasovagal reaction with syncope. He has a past history of the same but assumed he had outgrown it based on recent experiences.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: CAD, hyperliipidemia
Andere Medikamente: atorvastatin, lisinopril, metoprolol
Allergien: oxycodone
Vorherige Impfungen: multiple times in the past to all types of injections

VAERS 1102989

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 31,0
Geschlecht: M
Eingang: 15.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / AR

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Hyperhidrosis Mobility decreased Mydriasis Presyncope

Symptomtext

He had a vasovagal response. He was diaphoretic, had dilated pupils, and was seen drooping his head. He was attended to by RNs who checked his blood pressure and pulse. His BP was 60/30 and his pulse was in the 40s. He was laid flat with his feet up. His blood pressure was then rechecked a few minutes later and it had come up to 102/60. His pupils constricted back to a normal size and he said he was feeling better. He was given water to drink, observed for 30 minutes and walked out to his car by an RN after 30 minutes of observation. He did report that he does this with all vaccines. He was driven home by another driver.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: None known
Allergien: -
Vorherige Impfungen: -

VAERS 1102678

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: OH
Alter: 57,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / UN

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: unbekannt

Anxiety Dizziness Feeling hot Flushing Hypoaesthesia oral Migraine Nausea Paraesthesia oral Presyncope Tongue disorder

Symptomtext

11:45 AM ? Patient approached me and stated she had numbness and tingling of lips, and slight dizziness, she denied any SOB or breathing difficulty. Assisted Pt. back to sitting in chair. 11:50 AM ? Client states she had her vaccine at 11:20 AM and stayed for 30 min at which time she started to experience the numbness and tingling of lips. B/P 150/70, Pt had own O2 Sat monitor which included pulse, O2 sat was 96%, pulse 92, no respiratory distress noted. 11:51 AM- 12.5mg Benadryl given P.O. Pt states she gets very tired with ?full dose?. Pt states she is ?queasy?, light-headed, dizzy and has vasovagal responses to vaccines. She carries an Epi-pen for various food allergies, an O2 sat monitor and emesis bags in case she has a vagal response which she states this is what she feels like. 12:00 PM ? B/P 156/90, HR ? 92, O2 sat 97%, RR ? 20, No swelling, redness or irritation at Right Deltoid injection site. 12:06 ? Pt denies any dizziness or lightheadedness at this time but continues with tingling at lips and thick front of tongue, numbness B/P 152/92, HR 76, o2 sat 95%, RR- 20, cool cloth applied to back of neck, lower legs elevated on chair. Pt wearing compression hose. 12:20 PM ? Consult with Pharmacist who stated another dose of Benadryl would not be recommended and suggested lying down on stretcher and possible anxiety reaction. Pt refuses to lie down on stretcher and states is fine sitting with legs elevated. 12:24 PM B/P 146/90, P ? 64, RR ? 20, O2 sat 97%, Pt has flushed face and states her cheeks feel tight. She states she has Rosecea but her cheeks aren?t usually very flushed. She c/o warmth on cheeks and numbness in front area of tongue. No difficulties noted with swallowing water. Daughter arrived. Site director consulted to determine next steps and decision made to transfer to ED. Discussed transfer to ED with pt who verbalized agreement. 12:34 PM Pt states dizziness resolved however she now has a H/A and possible onset of a migraine. 12:35 PM B/P 162/90 P- 80, RR-20, O2 sat 98%. Pt denies any respiratory distress, refuses food due to many food allergies. Continues to tolerate water without swallowing difficulty or emesis. 12:40 PM Assisted Pt to wheelchair and transferred to Emergency Department for further evaluation and observation. Dtr present and verbal report given to ED RN.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1102611

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge en6207

schwer

Staat: WI
Alter: 22,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Concussion Fall Nervousness Syncope

Symptomtext

patient was nervous about the injection but still got it. she said she was okay but sat down to make sure, then fell off her chair and fainted. patient woke up shortly after and paramedics evaluated her for concussion

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1102298

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: IL
Alter: 49,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 14.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 1,0
Dosis: 1
Route/Site: SYR / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein

Arthralgia Chills Electric shock sensation Headache Myalgia Pain Pyrexia

Symptomtext

All symptoms on the side effect list... 101.4 fever, pain, chills, headache, joint pain, muscle pain, brain buzz.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Electric shock sensation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: None
Vorgeschichte: Asthma, thyroid condition, acid reflux, depression & anxiety.
Andere Medikamente: Montelukast 10mg, Losartan/HCTL 100/12.5mg, Vibryd 10mg, Levothyroxine 0.1mg, Escitalopram 20mg, Omeprazole 40mg, & stool softener 250mg. Albuterol 8.5gm inhaler
Allergien: Morphine, latex, triple antibiotic, & watermelon.
Vorherige Impfungen: -

VAERS 1101818

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: ME
Alter: 87,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 15.03.2021
Beginn: 15.03.2021
Tage bis Beginn: 0,0
Dosis: 2
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Defaecation urgency Dizziness Flushing Nausea Presyncope

Symptomtext

Presyncopal episode with nausea, flushing, lightheadedness, need to defecate

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: none
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1101760

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NC
Alter: 36,0
Geschlecht: F
Eingang: 15.03.2021
Impfdatum: 10.03.2021
Beginn: 10.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: ja Hospital: unbekannt Disable: unbekannt ER: ja Erholt: ja

Anaphylactic reaction Differential white blood cell count Electrocardiogram abnormal Epinephrine Full blood count Ischaemia Metabolic function test Rash Troponin I Urticaria Wheezing

Symptomtext

Patient with anaphylaxis to COVID-19 vaccine. Onset of symptoms occurred five minutes after receiving vaccine. Urticarial rash occurred on chest and abdomen. Shortly after, she developed a wheeze. EMS was onsite so they administered methylprednisolone, diphenhydramine, Zofran, Phenergran and epinephrine IM. Second and third dose of epinephrine was administered due to partial response from previous doses. Patient was taken to Health care hospital for further evaluation and treatment.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Anaphylactic reaction
Hospital-Tage: -
Labordaten: Troponin I, BMP, ECG 12 lead, CBC with diff. ECG showed global ischemia likely secondary to rate and epinephrine administration(according to ED note).
Aktuelle Erkrankungen: -
Vorgeschichte: Abdominal pain, agitation, anxiety, back pain, colitis, constipation, depression, dizziness, headache, high cholesterol, insomnia, irritable bowel disease, kidney calculi, myalgia, neck pain, photophobia, synscope, ulcerative colitis, visual disturbance, vomiting
Andere Medikamente: Epi-pen, Tylenol prn, Bentyl PO TID, Motrin prn, Ativan prn PO TID, Percocet PO every 4 hrs prn, Seroquel PO hs, Maxalt PO prn, Crestor PO hs.
Allergien: Shellfish, Hydrocodone, Covid-19 Vaccine, Mrna (Pfizer)
Vorherige Impfungen: -

VAERS 1098804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 72,0
Geschlecht: M
Eingang: 15.03.2021
Impfdatum: 13.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: - / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling hot Hyperhidrosis Loss of consciousness Malaise Vomiting Syncope

Symptomtext

BEFORE THE TIME WAS UP WAITING TO BE RELEASED AFTER THE SHOT. I STARTED TO SWEATING , JUST THOUGH IT WAS WARM IN BUILDING. SO THEY SAID MY TIME WAS UP THAT I COULD LEAVE. MADE IT TO MY CAR OK AND SETTING BEHIND THE WHEEL , I TOOK A FEW SHIPS OF WATER . THEN I TOLD MY WIFE I WAS FEELING LIKE I WAS GOING TO GET SICK. I TOLD HER GO GET SOME HELP AND SHE WENT BACK IN AND GOT SOME NURSES AND THEY CAME RUNNING, BUT THE TIME THEY GOT BACK I WAS ALL READY PASSED OUT . THEN I THREW UP THEY SAID . I DON'T REMEMBER. THEY CALLED AN AMBULANCE THEY GOT THERE AND TOOK ME TO THE HOSPITAL EMERGENCY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: CARVEDILOL 3.125 TWICE A DAY BusPLRone 7.5 twice a day Amlodipine 5 twice a day provastatin 20 1 a day
Allergien: no
Vorherige Impfungen: -

VAERS 1098804

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: MO
Alter: 72,0
Geschlecht: M
Eingang: 15.03.2021
Impfdatum: 13.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: SYR / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Feeling hot Hyperhidrosis Loss of consciousness Malaise Vomiting Syncope

Symptomtext

BEFORE THE TIME WAS UP WAITING TO BE RELEASED AFTER THE SHOT. I STARTED TO SWEATING , JUST THOUGH IT WAS WARM IN BUILDING. SO THEY SAID MY TIME WAS UP THAT I COULD LEAVE. MADE IT TO MY CAR OK AND SETTING BEHIND THE WHEEL , I TOOK A FEW SHIPS OF WATER . THEN I TOLD MY WIFE I WAS FEELING LIKE I WAS GOING TO GET SICK. I TOLD HER GO GET SOME HELP AND SHE WENT BACK IN AND GOT SOME NURSES AND THEY CAME RUNNING, BUT THE TIME THEY GOT BACK I WAS ALL READY PASSED OUT . THEN I THREW UP THEY SAID . I DON'T REMEMBER. THEY CALLED AN AMBULANCE THEY GOT THERE AND TOOK ME TO THE HOSPITAL EMERGENCY

Weitere VAERSDATA-Felder

Praegender Schweregrund: Syncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: none
Vorgeschichte: none
Andere Medikamente: CARVEDILOL 3.125 TWICE A DAY BusPLRone 7.5 twice a day Amlodipine 5 twice a day provastatin 20 1 a day
Allergien: no
Vorherige Impfungen: -

VAERS 1099022

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: UT
Alter: 73,0
Geschlecht: F
Eingang: 14.03.2021
Impfdatum: 01.03.2020
Beginn: 12.03.2020
Tage bis Beginn: 11,0
Dosis: UNK
Route/Site: - / -

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Chest pain Dyspnoea Hospitalisation Hypoxia Orthopnoea

Symptomtext

Shortness of Breath, Orthopnea, chest pain, hypoxia Hospitalized as inpatient at Hospital *Electronic form was not allowing form to give this information in section 21

Weitere VAERSDATA-Felder

Praegender Schweregrund: Hospitalisation
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1097630

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 59,0
Geschlecht: F
Eingang: 13.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

PATIENT REPORTED SHE BEGAN TO FEEL LIKE SHE WAS GOING TO VAGAL. EMS CAME OVER TO CHECK HER OUT AND VITALS WERE NORMAL. SHE SAID SHE NEEDED TO GO TO THE BATHROOM, WAS ESCORTED TO THE RESTROOM AND HAD A BOWL MOVEMENT AND RECOVERED FINE

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: -

VAERS 1097611

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: -
Alter: 21,0
Geschlecht: F
Eingang: 13.03.2021
Impfdatum: 12.03.2021
Beginn: 12.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / RA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja

Presyncope

Symptomtext

PATIENT HAD A VAGAL RESPONSE WHICH SHE REPORTS IS A TYPICAL REPSONE FOR HER

Weitere VAERSDATA-Felder

Praegender Schweregrund: Presyncope
Hospital-Tage: -
Labordaten: -
Aktuelle Erkrankungen: -
Vorgeschichte: -
Andere Medikamente: -
Allergien: -
Vorherige Impfungen: VAGAL RESPONSE

VAERS 1097536

PFIZER\BIONTECH · COVID19 (COVID19 (PFIZER-BIONTECH)) · Charge EN6207

schwer

Staat: NY
Alter: 31,0
Geschlecht: M
Eingang: 13.03.2021
Impfdatum: 13.03.2021
Beginn: 13.03.2021
Tage bis Beginn: 0,0
Dosis: 1
Route/Site: IM / LA

Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: ja Erholt: nein

Dizziness Drug hypersensitivity Fall Fear of injection Loss of consciousness Malaise

Symptomtext

Patient has a fear of needles, which was not mentioned initially. The patient got the vaccine and was told to have a seat outside the immunization room for 15 minutes at least to ensure no side effects. The patient wanted to get something in the store. Pharmacist was immunizing the next patient already. Patient knocked on the door and stated he didn't feel good and was dizzy. I told him to take a seat I was going to get him some water. As he was about to sit down he passed out and hit the door with his head. EMS was called and patient was taken to hospital. The patient woke up 30 seconds after and was dizzy. He felt better after about 5 minutes.

Weitere VAERSDATA-Felder

Praegender Schweregrund: Loss of consciousness
Hospital-Tage: -
Labordaten: N/A
Aktuelle Erkrankungen: N/A
Vorgeschichte: N/A
Andere Medikamente: N/A
Allergien: N/A
Vorherige Impfungen: Patient has a fear of needles